0001414932-24-000004 | 10-Q | XBRL Viewer | Oaktree Specialty Lending Corp

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

Realized Gains or Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.

During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Continental Intermodal Group LP	$	(6.8)
P&L Development LLC	(1.9)
Zephyr Bidco Limited (1)	(1.7)
Lift Brands Holdings, Inc.	(1.4)
Foreign currency forward contracts	4.1
Other, net	(0.8)
Total, net	$	(8.5)

__________

(1)This investment was denominated in British Pounds and the realized loss shown in this table includes losses due to foreign currency translation, which was offset by gains on foreign currency forward contracts.

During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	4.4
Carvana Co.	(2.8)
ASP Unifrax Holdings Inc.	(2.1)
Global Medical Response Inc.	(1.0)
Other, net	(1.7)
Total, net	$	(3.2)

Net Unrealized Appreciation or Depreciation

Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.

During the three months ended December 31, 2023 and 2022, the Company recorded net unrealized depreciation of $25.0 million and $23.0 million, respectively. For the three months ended December 31, 2023, this consisted of $18.8 million of net unrealized depreciation on equity investments, $13.7 million of net unrealized depreciation on debt investments and $7.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $15.3 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses). For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments.

Portfolio Investments - Summary of Portfolio (Details)
€ in Thousands, £ in Thousands, $ in Thousands

Dec. 31, 2023

USD ($)

borrower

Dec. 31, 2023

EUR (€)

borrower

Dec. 31, 2023

GBP (£)

borrower

Sep. 30, 2023

USD ($)

borrower

Sep. 30, 2023

EUR (€)

borrower

Sep. 30, 2023

GBP (£)

borrower

Dec. 31, 2022

USD ($)

Investment Company, Nonconsolidated Subsidiary [Line Items]

Number of borrowers | borrower

146

143

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,269

^{[1],[2],[3],[4]}

$ 1,269

^{[5],[6],[7],[8]}

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

12.50%

^{[1],[2],[3],[9],[10]}

12.50%

^{[1],[2],[3],[9],[10]}

12.50%

^{[1],[2],[3],[9],[10]}

12.50%

^{[5],[6],[8],[11],[12]}

12.50%

^{[5],[6],[8],[11],[12]}

12.50%

^{[5],[6],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 18,869

^[1],[2],[4]

$ 18,869

^[5],[7],[8]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

11.00%

^{[1],[2],[9],[10]}

11.00%

^{[1],[2],[9],[10]}

11.00%

^{[1],[2],[9],[10]}

11.00%

^{[5],[8],[11],[12]}

11.00%

^{[5],[8],[11],[12]}

11.00%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,274

^{[1],[2],[3],[4]}

$ 4,070

^{[5],[6],[7],[8]}

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

12.00%

^{[1],[2],[3],[9],[10]}

12.00%

^{[1],[2],[3],[9],[10]}

12.00%

^{[1],[2],[3],[9],[10]}

12.00%

^{[5],[6],[8],[11],[12]}

12.00%

^{[5],[6],[8],[11],[12]}

12.00%

^{[5],[6],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 21,434

^{[1],[4],[13],[14]}

$ 21,434

^{[7],[8],[15],[16]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

14.25%

^{[1],[9],[10],[13],[14]}

14.25%

^{[1],[9],[10],[13],[14]}

14.25%

^{[1],[9],[10],[13],[14]}

14.25%

^{[8],[11],[12],[15],[16]}

14.25%

^{[8],[11],[12],[15],[16]}

14.25%

^{[8],[11],[12],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

$ 6,329

^[1],[4],[13]

$ 6,021

^[7],[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,373

^[1],[4],[10]

$ 3,446

^[7],[8],[11]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

12.11%

^[1],[9],[10]

12.11%

^[1],[9],[10]

12.11%

^[1],[9],[10]

11.90%

^{[8],[11],[12]}

11.90%

^{[8],[11],[12]}

11.90%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 944

^[1],[4],[10]

$ 17,901

^[7],[8],[11]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

12.14%

^[1],[9],[10]

12.14%

^[1],[9],[10]

12.14%

^[1],[9],[10]

12.15%

^{[8],[11],[12]}

12.15%

^{[8],[11],[12]}

12.15%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 17,532

^[1],[4],[10]

$ 963

^[7],[8],[11]

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

12.11%

^[1],[9],[10]

12.11%

^[1],[9],[10]

12.11%

^[1],[9],[10]

12.13%

^{[8],[11],[12]}

12.13%

^{[8],[11],[12]}

12.13%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10],[13]}

$ 6,589

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

^{[8],[11],[12],[15]}

13.04%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,589

^{[1],[4],[10],[13]}

$ 0

^{[5],[7],[8],[11],[15]}

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

^[9],[10]

13.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[11],[15]}

€ 5,500

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

^{[11],[12],[15]}

8.86%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 16,032

^[1],[4],[10]

$ 17,873

^[7],[8],[11]

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

13.21%

^[1],[9],[10]

13.21%

^[1],[9],[10]

13.21%

^[1],[9],[10]

13.17%

^{[8],[11],[12]}

13.17%

^{[8],[11],[12]}

13.17%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

$ 0

^{[1],[2],[4],[10],[13]}

$ 0

^{[5],[7],[8],[11],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,268

^{[1],[4],[10],[13]}

$ 3,276

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

11.64%

^[9],[10]

11.64%

^[9],[10]

11.64%

^[9],[10]

11.63%

^{[8],[11],[12],[15]}

11.63%

^{[8],[11],[12],[15]}

11.63%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

$ 12,583

^{[1],[4],[13],[14]}

$ 12,222

^{[7],[8],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,033

^{[1],[2],[4],[10]}

$ 2,033

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

11.52%

^{[1],[2],[9],[10]}

11.52%

^{[1],[2],[9],[10]}

11.52%

^{[1],[2],[9],[10]}

11.55%

^{[5],[8],[11],[12]}

11.55%

^{[5],[8],[11],[12]}

11.55%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10]}

$ 20,234

^[7],[8],[11]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

^{[8],[11],[12]}

11.55%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 20,182

^[1],[4],[10]

$ 0

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

11.52%

^[1],[9],[10]

11.52%

^[1],[9],[10]

11.52%

^[1],[9],[10]

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,333

^{[1],[2],[4],[10]}

$ 1,333

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

12.72%

^{[1],[2],[9],[10]}

12.72%

^{[1],[2],[9],[10]}

12.72%

^{[1],[2],[9],[10]}

12.72%

^{[5],[8],[11],[12]}

12.72%

^{[5],[8],[11],[12]}

12.72%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,400

^[1],[4],[10]

$ 6,400

^[7],[8],[11]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

12.74%

^[1],[9],[10]

12.74%

^[1],[9],[10]

12.74%

^[1],[9],[10]

12.34%

^{[8],[11],[12]}

12.34%

^{[8],[11],[12]}

12.34%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 25,332

^{[1],[2],[4],[10]}

$ 25,332

^[7],[8],[11]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

12.74%

^{[1],[2],[9],[10]}

12.74%

^{[1],[2],[9],[10]}

12.74%

^{[1],[2],[9],[10]}

12.34%

^{[8],[11],[12]}

12.34%

^{[8],[11],[12]}

12.34%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

$ 23,562

^{[1],[4],[10],[17]}

$ 23,562

^{[7],[8],[11],[18]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,050

^[4],[13]

$ 4,050

^[7],[15]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

5.50%

^{[9],[10],[13]}

5.50%

^{[9],[10],[13]}

5.50%

^{[9],[10],[13]}

5.50%

^{[11],[12],[15]}

5.50%

^{[11],[12],[15]}

5.50%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,331

^[1],[4],[10]

$ 9,057

^[7],[8],[11]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

5.00%

^{[8],[11],[12]}

5.00%

^{[8],[11],[12]}

5.00%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 16,825

^[1],[4],[10]

$ 17,053

^[7],[8],[11]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

13.00%

^[1],[9],[10]

13.00%

^[1],[9],[10]

13.00%

^[1],[9],[10]

13.04%

^{[8],[11],[12]}

13.04%

^{[8],[11],[12]}

13.04%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 28,964

^[1],[4],[13]

$ 28,464

^[7],[8],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 28,178

^[1],[4],[13]

$ 2,121

^[7],[8],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,159

^[1],[4],[13]

$ 27,692

^[7],[8],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,100

^[1],[4],[13]

$ 2,064

^[7],[8],[15]

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[1],[9],[10],[13]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

8.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 17,048

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

^{[8],[11],[12]}

14.14%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 17,048

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

^[1],[9],[10]

14.25%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 14,907

^[4],[10]

$ 19,115

^[7],[11]

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

11.91%

^[9],[10]

11.91%

^[9],[10]

11.91%

^[9],[10]

11.81%

^[11],[12]

11.81%

^[11],[12]

11.81%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[11],[15]}

$ 12,500

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

^{[11],[12],[15]}

13.54%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 33,558

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

^[1],[9],[10]

11.10%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,691

^[4],[10]

$ 3,700

^[7],[11]

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

9.36%

^[9],[10]

9.36%

^[9],[10]

9.36%

^[9],[10]

9.40%

^[11],[12]

9.40%

^[11],[12]

9.40%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 47,810

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

^[1],[9],[10]

10.86%

Investment Company, Nonconsolidated Subsidiary [Line Items]

€ 4,949

^{[1],[4],[10],[13]}

€ 3,017

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

10.95%

^{[8],[11],[12],[15]}

10.95%

^{[8],[11],[12],[15]}

10.95%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 10,519

^{[1],[4],[10],[13]}

$ 10,519

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

11.82%

^{[1],[9],[10],[13]}

11.82%

^{[1],[9],[10],[13]}

11.82%

^{[1],[9],[10],[13]}

11.57%

^{[8],[11],[12],[15]}

11.57%

^{[8],[11],[12],[15]}

11.57%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

£ 3,649

^{[1],[4],[10],[13]}

£ 4,949

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

9.95%

^{[1],[9],[10],[13]}

9.95%

^{[1],[9],[10],[13]}

9.95%

^{[1],[9],[10],[13]}

12.46%

^{[8],[11],[12],[15]}

12.46%

^{[8],[11],[12],[15]}

12.46%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

£ 3,017

^{[1],[4],[10],[13]}

£ 23,675

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

11.20%

^{[1],[9],[10],[13]}

11.20%

^{[1],[9],[10],[13]}

11.20%

^{[1],[9],[10],[13]}

12.46%

^{[8],[11],[12],[15]}

12.46%

^{[8],[11],[12],[15]}

12.46%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

£ 23,675

^{[1],[4],[10],[13]}

£ 3,649

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

9.70%

^{[8],[11],[12],[15]}

9.70%

^{[8],[11],[12],[15]}

9.70%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 21,852

^{[5],[7],[8],[11]}

$ 21,464

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

12.14%

^{[5],[8],[11],[12]}

12.14%

^{[5],[8],[11],[12]}

12.14%

^{[5],[8],[11],[12]}

11.48%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 15,688

^[4],[10]

$ 8,490

^[7],[11]

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

10.86%

^[9],[10]

10.86%

^[9],[10]

10.86%

^[9],[10]

10.90%

^[11],[12]

10.90%

^[11],[12]

10.90%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 29,801

^{[1],[4],[10],[13]}

$ 29,509

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

8.45%

^{[1],[9],[10],[13]}

8.45%

^{[1],[9],[10],[13]}

8.45%

^{[1],[9],[10],[13]}

11.49%

^{[8],[11],[12],[15]}

11.49%

^{[8],[11],[12],[15]}

11.49%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 50,470

^[1],[4],[10]

$ 50,470

^[7],[8],[11]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

12.60%

^[9],[10]

12.60%

^[9],[10]

12.60%

^[9],[10]

12.64%

^{[8],[11],[12]}

12.64%

^{[8],[11],[12]}

12.64%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,239

^[1],[4],[10]

$ 3,247

^[7],[8],[11]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,258

^[1],[4],[10]

$ 1,261

^[7],[8],[11]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,091

^[1],[4],[10]

$ 8,920

^[7],[8],[11]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

14.15%

^[1],[9],[10]

14.15%

^[1],[9],[10]

14.15%

^[1],[9],[10]

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,361

^[1],[4],[10]

$ 2,091

^[7],[8],[11]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

14.11%

^[1],[9],[10]

14.11%

^[1],[9],[10]

14.11%

^[1],[9],[10]

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,920

^[1],[4],[10]

$ 4,361

^[7],[8],[11]

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

14.11%

^[1],[9],[10]

14.11%

^[1],[9],[10]

14.11%

^[1],[9],[10]

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

14.15%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,836

^{[1],[2],[4],[10]}

$ 2,221

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

13.00%

^{[1],[2],[9],[10]}

13.00%

^{[1],[2],[9],[10]}

13.00%

^{[1],[2],[9],[10]}

13.00%

^{[5],[8],[11],[12]}

13.00%

^{[5],[8],[11],[12]}

13.00%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 40,557

^[1],[4],[10]

$ 40,660

^[7],[8],[11]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

11.03%

^[1],[9],[10]

11.03%

^[1],[9],[10]

11.03%

^[1],[9],[10]

11.02%

^{[8],[11],[12]}

11.02%

^{[8],[11],[12]}

11.02%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10],[13]}

$ 6,757

^[7],[8],[15]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

^{[8],[11],[12],[15]}

8.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,815

^{[1],[4],[10],[13]}

$ 3,316

^{[5],[7],[8],[15],[16]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

^{[1],[9],[10],[13]}

12.89%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[13]}

$ 0

^{[5],[7],[8],[15]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[5],[8],[11],[12],[15]}

8.00%

^{[5],[8],[11],[12],[15]}

8.00%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[13]}

$ 0

^{[5],[7],[8],[15]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[1],[2],[9],[10],[13]}

8.00%

^{[5],[8],[11],[12],[15]}

8.00%

^{[5],[8],[11],[12],[15]}

8.00%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,785

^[1],[4],[13]

$ 0

^{[5],[7],[8],[15],[16]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

^{[1],[9],[10],[13]}

8.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

^{[5],[7],[8],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 30,625

^[4],[10]

$ 30,625

^[7],[11]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

12.46%

^[9],[10]

12.46%

^[9],[10]

12.46%

^[9],[10]

12.43%

^[11],[12]

12.43%

^[11],[12]

12.43%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,257

^[1],[4]

$ 5,257

^[7],[8]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

9.00%

^[1],[9],[10]

9.00%

^[1],[9],[10]

9.00%

^[1],[9],[10]

9.00%

^{[8],[11],[12]}

9.00%

^{[8],[11],[12]}

9.00%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[4],[10],[13]}

$ 16,185

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

^{[9],[10],[13]}

11.29%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

$ 727

^{[1],[4],[10],[17]}

$ 727

^{[7],[8],[11],[18]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 37

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

^{[8],[11],[12]}

12.07%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 3,031

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

^{[8],[11],[12]}

12.07%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 1,557

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

^{[8],[11],[12]}

12.07%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 1,024

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

^{[8],[11],[12]}

12.07%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,632

^[4],[13]

$ 2,632

^[7],[15]

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

7.50%

^{[9],[10],[13]}

7.50%

^{[9],[10],[13]}

7.50%

^{[9],[10],[13]}

7.50%

^{[11],[12],[15]}

7.50%

^{[11],[12],[15]}

7.50%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 176

^[4],[13]

$ 176

^[7],[15]

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

7.75%

^{[9],[10],[13]}

7.75%

^{[9],[10],[13]}

7.75%

^{[9],[10],[13]}

7.75%

^{[11],[12],[15]}

7.75%

^{[11],[12],[15]}

7.75%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 10,720

^[4]

$ 8,420

^[7]

Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond

7.38%

^[9],[10]

7.38%

^[9],[10]

7.38%

^[9],[10]

7.38%

^[11],[12]

7.38%

^[11],[12]

7.38%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[13]

$ 1,670

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

^{[9],[10],[13]}

6.75%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

^{[7],[8],[11],[18]}

$ 22,084

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[2],[4],[10]}

$ 13,157

^[7],[8],[11]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

^{[8],[11],[12]}

12.82%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 13,157

^[1],[4],[10]

$ 0

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

^[1],[9],[10]

12.86%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 14,713

^[4],[10]

$ 14,750

^[7],[11]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

10.35%

^[9],[10]

10.35%

^[9],[10]

10.35%

^[9],[10]

10.39%

^[11],[12]

10.39%

^[11],[12]

10.39%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^[1],[4],[10]

$ 933

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

^{[5],[8],[11],[12]}

11.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 17,967

^[1],[4],[10]

$ 18,013

^[7],[8],[11]

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

11.53%

^[9],[10]

11.53%

^[9],[10]

11.53%

^[9],[10]

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

^[1],[4],[10]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4]

$ 20,924

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

^[9],[10]

12.10%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,938

^[4],[10]

$ 4,950

^[7],[11]

Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond

10.13%

^[9],[10]

10.13%

^[9],[10]

10.13%

^[9],[10]

10.12%

^[11],[12]

10.12%

^[11],[12]

10.12%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 440

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

^[9],[10]

8.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 32,104

^[1],[4],[13]

$ 17,465

^{[5],[7],[8],[15]}

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 20,757

^[1],[4],[10]

$ 20,757

^[7],[8],[11]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

14.50%

^[1],[9],[10]

14.50%

^[1],[9],[10]

14.50%

^[1],[9],[10]

14.54%

^{[8],[11],[12]}

14.54%

^{[8],[11],[12]}

14.54%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

$ 667

^[1],[4]

$ 654

^[7],[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 578

^{[1],[2],[4],[10]}

$ 284

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

12.45%

^{[1],[2],[9],[10]}

12.45%

^{[1],[2],[9],[10]}

12.45%

^{[1],[2],[9],[10]}

12.49%

^{[5],[8],[11],[12]}

12.49%

^{[5],[8],[11],[12]}

12.49%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 12,355

^[1],[4],[10]

$ 12,386

^[7],[8],[11]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

12.45%

^[1],[9],[10]

12.45%

^[1],[9],[10]

12.45%

^[1],[9],[10]

12.49%

^{[8],[11],[12]}

12.49%

^{[8],[11],[12]}

12.49%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,514

^[4],[10]

$ 4,641

^[7],[11]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond

10.65%

^[9],[10]

10.65%

^[9],[10]

10.65%

^[9],[10]

10.43%

^[11],[12]

10.43%

^[11],[12]

10.43%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 5,090

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

^[9],[10]

5.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,574

^[1],[4],[10]

$ 5,574

^[7],[8],[11]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan

10.50%

^[1],[9],[10]

10.50%

^[1],[9],[10]

10.50%

^[1],[9],[10]

10.54%

^{[8],[11],[12]}

10.54%

^{[8],[11],[12]}

10.54%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 14,297

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

9.73%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 14,033

^[1],[4],[10]

$ 14,068

^[7],[8],[11]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

10.50%

^[1],[9],[10]

10.50%

^[1],[9],[10]

10.50%

^[1],[9],[10]

10.54%

^{[8],[11],[12]}

10.54%

^{[8],[11],[12]}

10.54%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,393

^{[1],[2],[4],[10]}

$ 2,090

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

10.46%

^{[1],[2],[9],[10]}

10.46%

^{[1],[2],[9],[10]}

10.46%

^{[1],[2],[9],[10]}

10.42%

^{[5],[8],[11],[12]}

10.42%

^{[5],[8],[11],[12]}

10.42%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,974

^[1],[4],[10]

$ 8,974

^[7],[8],[11]

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

13.00%

^[1],[9],[10]

13.00%

^[1],[9],[10]

13.00%

^[1],[9],[10]

13.04%

^{[8],[11],[12]}

13.04%

^{[8],[11],[12]}

13.04%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 24,865

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

^[1],[9],[10]

10.84%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,799

^[1],[4],[13]

$ 11,065

^[7],[8],[15]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[8],[11],[12],[15]}

3.00%

^{[8],[11],[12],[15]}

3.00%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[13]}

$ 1,772

^[7],[8],[15]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[8],[11],[12],[15]}

3.00%

^{[8],[11],[12],[15]}

3.00%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[13]}

$ 0

^{[5],[7],[8],[15]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[1],[2],[9],[10],[13]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,232

^[1],[4],[13]

$ 0

^{[5],[7],[8],[15]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[1],[9],[10],[13]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

3.00%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 14,736

^{[1],[2],[4],[10]}

$ 14,736

^[7],[8],[11]

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

11.35%

^[9],[10]

11.35%

^[9],[10]

11.35%

^[9],[10]

11.32%

^{[8],[11],[12]}

11.32%

^{[8],[11],[12]}

11.32%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[10]

$ 4,324

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

^[9],[10]

9.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 31,074

^[4],[10]

$ 31,074

^{[7],[11],[15]}

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

12.22%

^[9],[10]

12.22%

^[9],[10]

12.22%

^[9],[10]

12.18%

^{[11],[12],[15]}

12.18%

^{[11],[12],[15]}

12.18%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 61,500

^[1],[2],[4]

$ 59,950

^[5],[7],[8]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

9.00%

^{[1],[2],[9],[10]}

9.00%

^{[1],[2],[9],[10]}

9.00%

^{[1],[2],[9],[10]}

9.00%

^{[5],[8],[11],[12]}

9.00%

^{[5],[8],[11],[12]}

9.00%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 322

^{[1],[2],[4],[10],[13]}

$ 258

^{[5],[7],[8],[11],[15]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

12.61%

^{[1],[2],[9],[10],[13]}

12.61%

^{[1],[2],[9],[10],[13]}

12.61%

^{[1],[2],[9],[10],[13]}

12.55%

^{[5],[8],[11],[12],[15]}

12.55%

^{[5],[8],[11],[12],[15]}

12.55%

^{[5],[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,742

^{[1],[4],[10],[13]}

$ 11,742

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

12.71%

^{[1],[9],[10],[13]}

12.55%

^{[8],[11],[12],[15]}

12.55%

^{[8],[11],[12],[15]}

12.55%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,918

^[1],[4],[13]

$ 11,918

^[7],[8],[15]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

11.00%

^{[1],[9],[10],[13]}

11.00%

^{[1],[9],[10],[13]}

11.00%

^{[1],[9],[10],[13]}

11.00%

^{[8],[11],[12],[15]}

11.00%

^{[8],[11],[12],[15]}

11.00%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,881

^[4],[13]

$ 4,881

^[7],[15]

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

6.00%

^{[9],[10],[13]}

6.00%

^{[9],[10],[13]}

6.00%

^{[9],[10],[13]}

6.00%

^{[11],[12],[15]}

6.00%

^{[11],[12],[15]}

6.00%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,215

^{[1],[2],[4],[10]}

$ 1,638

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

12.60%

^{[1],[2],[9],[10]}

12.60%

^{[1],[2],[9],[10]}

12.60%

^{[1],[2],[9],[10]}

12.64%

^{[5],[8],[11],[12]}

12.64%

^{[5],[8],[11],[12]}

12.64%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 23,714

^[1],[4],[10]

$ 23,774

^[7],[8],[11]

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

12.60%

^[1],[9],[10]

12.60%

^[1],[9],[10]

12.60%

^[1],[9],[10]

12.64%

^{[8],[11],[12]}

12.64%

^{[8],[11],[12]}

12.64%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,450

^[1],[4],[10]

$ 2,456

^[7],[11]

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

10.66%

^[1],[9],[10]

10.66%

^[1],[9],[10]

10.66%

^[1],[9],[10]

10.57%

^[11],[12]

10.57%

^[11],[12]

10.57%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

€ 1,000

^{[4],[10],[13]}

€ 1,000

^{[7],[11],[15]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

6.84%

^{[9],[10],[13]}

6.84%

^{[9],[10],[13]}

6.84%

^{[9],[10],[13]}

6.56%

^{[11],[12],[15]}

6.56%

^{[11],[12],[15]}

6.56%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[2],[4],[10]}

$ 17,444

^[7],[8],[11]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

^{[8],[11],[12]}

13.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 17,400

^[1],[4],[10]

$ 0

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

^[1],[9],[10]

13.46%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,538

^[4],[10]

$ 14,347

^[7],[11]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan

10.71%

^[9],[10]

10.71%

^[9],[10]

10.71%

^[9],[10]

10.67%

^[11],[12]

10.67%

^[11],[12]

10.67%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[4],[10],[13]}

$ 7,448

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

^{[1],[9],[10],[13]}

12.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10],[13]}

$ 7,448

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

^{[8],[11],[12],[15]}

11.89%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,432

^{[1],[4],[10],[13]}

$ 0

^{[5],[7],[8],[11],[15]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

^[9],[10]

12.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[8],[11],[15]}

$ 1,432

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

^{[8],[11],[12],[15]}

12.04%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,406

^[4],[13]

$ 6,808

^[7],[8],[15]

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

4.46%

^{[9],[10],[13]}

4.46%

^{[9],[10],[13]}

4.46%

^{[9],[10],[13]}

4.46%

^{[8],[11],[12],[15]}

4.46%

^{[8],[11],[12],[15]}

4.46%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 23,975

^{[1],[4],[10],[13]}

$ 23,975

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

13.63%

^{[1],[9],[10],[13]}

13.63%

^{[1],[9],[10],[13]}

13.63%

^{[1],[9],[10],[13]}

13.62%

^{[8],[11],[12],[15]}

13.62%

^{[8],[11],[12],[15]}

13.62%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 43,931

^[1],[4],[10]

$ 44,550

^[7],[8],[11]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

11.36%

^[1],[9],[10]

11.36%

^[1],[9],[10]

11.36%

^[1],[9],[10]

11.40%

^{[8],[11],[12]}

11.40%

^{[8],[11],[12]}

11.40%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 40,587

^[1],[4],[10]

$ 40,587

^[7],[8],[11]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

12.06%

^[1],[9],[10]

12.06%

^[1],[9],[10]

12.06%

^[1],[9],[10]

11.92%

^{[8],[11],[12]}

11.92%

^{[8],[11],[12]}

11.92%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

$ 1,001

^[1],[4],[17]

$ 26,613

^[7],[8],[11]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

2,232

^{[1],[4],[10],[17]}

787

^[7],[8],[11]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4

839

^{[1],[4],[10],[17]}

688

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

^{[1],[4],[10],[17]}

28,010

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[8],[11],[15]}

$ 7,179

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

^{[8],[11],[12],[15]}

11.14%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 33,331

^[1],[4],[10]

$ 33,414

^[7],[8],[11]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

12.97%

^[1],[9],[10]

12.97%

^[1],[9],[10]

12.97%

^[1],[9],[10]

12.93%

^{[8],[11],[12]}

12.93%

^{[8],[11],[12]}

12.93%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 13,939

^[4],[10]

$ 13,939

^[7],[11]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

12.91%

^[9],[10]

12.91%

^[9],[10]

12.91%

^[9],[10]

12.78%

^[11],[12]

12.78%

^[11],[12]

12.78%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10]}

$ 272

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

^{[5],[8],[11],[12]}

11.84%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 38,015

^[1],[4],[10]

$ 16,752

^[7],[8],[11]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

11.99%

^[9],[10]

11.99%

^[9],[10]

11.99%

^[9],[10]

11.84%

^{[8],[11],[12]}

11.84%

^{[8],[11],[12]}

11.84%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 16,722

^[1],[4],[10]

$ 38,015

^[7],[8],[11]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

11.84%

^[1],[9],[10]

11.84%

^[1],[9],[10]

11.84%

^[1],[9],[10]

11.80%

^{[8],[11],[12]}

11.80%

^{[8],[11],[12]}

11.80%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,729

^[1],[4],[10]

$ 2,736

^[7],[8],[11]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

11.46%

^[1],[9],[10]

11.46%

^[1],[9],[10]

11.46%

^[1],[9],[10]

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 23,435

^[1],[4],[10]

$ 23,494

^[7],[8],[11]

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

11.46%

^[9],[10]

11.46%

^[9],[10]

11.46%

^[9],[10]

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 26,356

^{[4],[10],[13]}

$ 26,422

^{[7],[11],[15]}

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

15.08%

^{[9],[10],[13]}

15.08%

^{[9],[10],[13]}

15.08%

^{[9],[10],[13]}

14.95%

^{[11],[12],[15]}

14.95%

^{[11],[12],[15]}

14.95%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 45,125

^[1],[4],[10]

$ 45,243

^[7],[8],[11]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.61%

^[1],[9],[10]

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

10.65%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

^[7],[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,012

^[1],[4],[10]

$ 5,403

^[7],[8],[11]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

13.99%

^{[8],[11],[12]}

13.99%

^{[8],[11],[12]}

13.99%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,536

^[1],[4],[10]

$ 2,939

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

5.00%

^[1],[9],[10]

13.99%

^{[5],[8],[11],[12]}

13.99%

^{[5],[8],[11],[12]}

13.99%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10]}

$ 964

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

^{[5],[8],[11],[12]}

11.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,624

^[1],[4],[10]

$ 20,125

^[7],[8],[11]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

11.53%

^[1],[9],[10]

11.53%

^[1],[9],[10]

11.53%

^[1],[9],[10]

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,802

^{[1],[2],[4],[10]}

$ 2,631

^[7],[8],[11]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

11.53%

^[9],[10]

11.53%

^[9],[10]

11.53%

^[9],[10]

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

11.52%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,308

^{[1],[2],[4],[10]}

$ 1,466

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

12.86%

^{[1],[2],[9],[10]}

12.86%

^{[1],[2],[9],[10]}

12.86%

^{[1],[2],[9],[10]}

12.83%

^{[5],[8],[11],[12]}

12.83%

^{[5],[8],[11],[12]}

12.83%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 40,538

^[1],[4],[10]

$ 40,538

^[7],[8],[11]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

12.89%

^[1],[9],[10]

12.89%

^[1],[9],[10]

12.89%

^[1],[9],[10]

12.89%

^{[8],[11],[12]}

12.89%

^{[8],[11],[12]}

12.89%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 21,272

^[1],[4],[10]

$ 13,973

^[7],[8],[11]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

10.95%

^[9],[10]

10.95%

^[9],[10]

10.95%

^[9],[10]

10.99%

^{[8],[11],[12]}

10.99%

^{[8],[11],[12]}

10.99%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 13,937

^[1],[4],[10]

$ 21,328

^[7],[8],[11]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

10.95%

^[1],[9],[10]

10.95%

^[1],[9],[10]

10.95%

^[1],[9],[10]

10.99%

^{[8],[11],[12]}

10.99%

^{[8],[11],[12]}

10.99%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,568

^[1],[4],[13]

$ 8,568

^[7],[8],[15]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,568

^[1],[4],[13]

$ 4,284

^[7],[8],[15]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,284

^[1],[4],[13]

$ 8,568

^[7],[8],[15]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[1],[9],[10],[13]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

11.50%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,129

^[1],[4],[13]

$ 9,106

^[7],[8],[15]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

8.00%

^{[1],[9],[10],[13]}

8.00%

^{[1],[9],[10],[13]}

8.00%

^{[1],[9],[10],[13]}

8.00%

^{[8],[11],[12],[15]}

8.00%

^{[8],[11],[12],[15]}

8.00%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

^[7],[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

^[7],[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 46,687

^[1],[4],[10]

$ 5,248

^[7],[8],[11]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

12.53%

^[9],[10]

12.53%

^[9],[10]

12.53%

^[9],[10]

12.52%

^{[8],[11],[12]}

12.52%

^{[8],[11],[12]}

12.52%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,248

^[1],[4],[10]

$ 46,687

^[7],[8],[11]

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

12.53%

^[1],[9],[10]

12.53%

^[1],[9],[10]

12.53%

^[1],[9],[10]

12.52%

^{[8],[11],[12]}

12.52%

^{[8],[11],[12]}

12.52%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 49,266

^[1],[4],[10]

$ 54,559

^[7],[8],[11]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

13.60%

^[1],[9],[10]

13.60%

^[1],[9],[10]

13.60%

^[1],[9],[10]

12.51%

^{[8],[11],[12]}

12.51%

^{[8],[11],[12]}

12.51%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 10,191

^[4]

$ 10,191

^[7]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

6.88%

^[9],[10]

6.88%

^[9],[10]

6.88%

^[9],[10]

6.88%

^[11],[12]

6.88%

^[11],[12]

6.88%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 73,547

^{[1],[4],[10],[13]}

$ 73,362

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

12.33%

^{[1],[9],[10],[13]}

12.33%

^{[1],[9],[10],[13]}

12.33%

^{[1],[9],[10],[13]}

12.29%

^{[8],[11],[12],[15]}

12.29%

^{[8],[11],[12],[15]}

12.29%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 30,339

^[1],[4],[10]

$ 30,339

^[7],[8],[11]

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

13.93%

^[1],[9],[10]

13.93%

^[1],[9],[10]

13.93%

^[1],[9],[10]

13.99%

^{[8],[11],[12]}

13.99%

^{[8],[11],[12]}

13.99%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 64,606

^[1],[4],[10]

$ 64,606

^[7],[8],[11]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

14.83%

^[1],[9],[10]

14.83%

^[1],[9],[10]

14.83%

^[1],[9],[10]

14.89%

^{[8],[11],[12]}

14.89%

^{[8],[11],[12]}

14.89%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 19,995

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

^[1],[9],[10]

11.37%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 58,349

^{[1],[2],[4],[10],[13],[19]}

$ 58,349

^{[5],[7],[8],[15],[20]}

$ 59,049

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

9.94%

^{[1],[2],[9],[10],[13],[19]}

9.94%

^{[1],[2],[9],[10],[13],[19]}

9.94%

^{[1],[2],[9],[10],[13],[19]}

9.76%

^{[5],[8],[11],[12],[15],[20]}

9.76%

^{[5],[8],[11],[12],[15],[20]}

9.76%

^{[5],[8],[11],[12],[15],[20]}

7.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,323

^[1],[4],[10]

$ 9,323

^[7],[8],[11]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

12.46%

^[1],[9],[10]

12.46%

^[1],[9],[10]

12.46%

^[1],[9],[10]

12.49%

^{[8],[11],[12]}

12.49%

^{[8],[11],[12]}

12.49%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

$ 1,303

^{[1],[4],[10],[17]}

$ 25,712

^[7],[8],[11]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

31,515

^{[1],[4],[10],[17]}

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

233

^{[1],[2],[4],[10],[17]}

1,210

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

^{[1],[2],[4],[10]}

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 15,231

^[1],[4],[10]

$ 15,231

^[7],[8],[11]

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

13.13%

^[1],[9],[10]

13.13%

^[1],[9],[10]

13.13%

^[1],[9],[10]

13.12%

^{[8],[11],[12]}

13.12%

^{[8],[11],[12]}

13.12%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7]

$ 4,519

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

^[11],[12]

7.75%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 98

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

^{[1],[2],[9],[10]}

12.35%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 10,868

^[1],[4],[10]

$ 10,895

^[7],[8],[11]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

12.36%

^[1],[9],[10]

12.36%

^[1],[9],[10]

12.36%

^[1],[9],[10]

12.32%

^{[8],[11],[12]}

12.32%

^{[8],[11],[12]}

12.32%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 38,308

^[1],[4],[10]

$ 38,414

^[7],[8],[11]

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

12.04%

^[1],[9],[10]

12.04%

^[1],[9],[10]

12.04%

^[1],[9],[10]

12.01%

^{[8],[11],[12]}

12.01%

^{[8],[11],[12]}

12.01%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,651

^[4],[10]

$ 9,676

^[7],[11]

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

10.46%

^[9],[10]

10.46%

^[9],[10]

10.46%

^[9],[10]

10.42%

^[11],[12]

10.42%

^[11],[12]

10.42%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 22,375

^[1],[4],[10]

$ 22,375

^[7],[8],[11]

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

11.32%

^[1],[9],[10]

11.32%

^[1],[9],[10]

11.32%

^[1],[9],[10]

11.57%

^{[8],[11],[12]}

11.57%

^{[8],[11],[12]}

11.57%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 52,639

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

^[1],[9],[10]

11.36%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 2,300

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

^[9],[10]

6.50%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 36,499

^[1],[4],[10]

$ 36,499

^[7],[8],[11]

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

12.70%

^[1],[9],[10]

12.70%

^[1],[9],[10]

12.70%

^[1],[9],[10]

12.74%

^{[8],[11],[12]}

12.74%

^{[8],[11],[12]}

12.74%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,722

^{[1],[2],[4],[10]}

$ 3,003

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

13.56%

^{[1],[2],[9],[10]}

13.56%

^{[1],[2],[9],[10]}

13.56%

^{[1],[2],[9],[10]}

13.45%

^{[5],[8],[11],[12]}

13.45%

^{[5],[8],[11],[12]}

13.45%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 67,244

^[1],[4],[10]

$ 67,244

^[7],[8],[11]

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

13.56%

^[1],[9],[10]

13.56%

^[1],[9],[10]

13.56%

^[1],[9],[10]

13.45%

^{[8],[11],[12]}

13.45%

^{[8],[11],[12]}

13.45%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[4],[10],[13]}

$ 28,818

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

^{[1],[9],[10],[13]}

12.60%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 24,503

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

^{[8],[11],[12]}

12.78%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 2,819

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

^{[8],[11],[12]}

12.78%

Investment Company, Nonconsolidated Subsidiary [Line Items]

£ 6,136

^{[1],[4],[10],[13]}

£ 4,626

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

10.96%

^{[1],[9],[10],[13]}

10.96%

^{[1],[9],[10],[13]}

10.96%

^{[1],[9],[10],[13]}

11.21%

^{[8],[11],[12],[15]}

11.21%

^{[8],[11],[12],[15]}

11.21%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 32,329

^[1],[4],[10]

$ 32,329

^[7],[8],[11]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

11.96%

^[1],[9],[10]

11.96%

^[1],[9],[10]

11.96%

^[1],[9],[10]

11.92%

^{[8],[11],[12]}

11.92%

^{[8],[11],[12]}

11.92%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,697

^{[1],[4],[10],[13]}

$ 36,707

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

13.86%

^{[1],[9],[10],[13]}

13.86%

^{[1],[9],[10],[13]}

13.86%

^{[1],[9],[10],[13]}

13.90%

^{[8],[11],[12],[15]}

13.90%

^{[8],[11],[12],[15]}

13.90%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 32,133

^{[1],[4],[10],[13]}

$ 13,504

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond

13.86%

^{[1],[9],[10],[13]}

13.86%

^{[1],[9],[10],[13]}

13.86%

^{[1],[9],[10],[13]}

13.90%

^{[8],[11],[12],[15]}

13.90%

^{[8],[11],[12],[15]}

13.90%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 1,680

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

^[9],[10]

4.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 990

^{[1],[2],[4],[10]}

$ 8,010

^[7],[8],[11]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

14.20%

^{[1],[2],[9],[10]}

14.20%

^{[1],[2],[9],[10]}

14.20%

^{[1],[2],[9],[10]}

14.18%

^{[8],[11],[12]}

14.18%

^{[8],[11],[12]}

14.18%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,010

^[1],[4],[10]

$ 0

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

^[1],[9],[10]

14.21%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

$ 16,355

^[1],[4]

15,874

^[7],[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

3,005

^[1],[2],[4]

1,359

^[5],[7],[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,440

^[1],[4],[10]

$ 4,452

^[7],[8],[11]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

10.39%

^[1],[9],[10]

10.39%

^[1],[9],[10]

10.39%

^[1],[9],[10]

10.38%

^{[8],[11],[12]}

10.38%

^{[8],[11],[12]}

10.38%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 12,034

^[1],[4],[10]

$ 12,034

^[7],[8],[11]

Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond

13.64%

^[1],[9],[10]

13.64%

^[1],[9],[10]

13.64%

^[1],[9],[10]

13.63%

^{[8],[11],[12]}

13.63%

^{[8],[11],[12]}

13.63%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 1,590

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

^[9],[10]

8.75%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 25,462

^{[1],[4],[10],[17]}

$ 25,527

^[7],[8],[11]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

^{[8],[11],[12]}

12.40%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 25,418

^[1],[4],[10]

$ 25,558

^[7],[8],[11]

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

15.36%

^[1],[9],[10]

15.36%

^[1],[9],[10]

15.36%

^[1],[9],[10]

15.24%

^{[8],[11],[12]}

15.24%

^{[8],[11],[12]}

15.24%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 112,656

^{[1],[2],[4],[10],[13],[19]}

$ 112,656

^{[5],[7],[8],[15],[20]}

$ 112,656

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

12.44%

^{[1],[2],[9],[10],[13],[19]}

12.44%

^{[1],[2],[9],[10],[13],[19]}

12.44%

^{[1],[2],[9],[10],[13],[19]}

12.26%

^{[5],[8],[11],[12],[15],[20]}

12.26%

^{[5],[8],[11],[12],[15],[20]}

12.26%

^{[5],[8],[11],[12],[15],[20]}

10.17%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10],[13]}

$ 7,191

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

^{[8],[11],[12],[15]}

12.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[2],[4],[10],[13]}

$ 2,697

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

^{[8],[11],[12],[15]}

12.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,191

^{[1],[4],[10],[13]}

$ 0

^{[5],[7],[8],[11],[15]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

^{[1],[9],[10],[13]}

12.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,697

^{[1],[4],[10],[13]}

^{[5],[7],[8],[11],[15]}

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

^{[1],[9],[10],[13]}

12.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 821

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

^{[8],[11],[12]}

13.04%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 0

^{[1],[2],[4],[10]}

$ 618

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

^{[5],[8],[11],[12]}

10.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,477

^[1],[4],[10]

$ 4,488

^[7],[8],[11]

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

10.71%

^[9],[10]

10.71%

^[9],[10]

10.71%

^[9],[10]

10.67%

^{[8],[11],[12]}

10.67%

^{[8],[11],[12]}

10.67%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 4,700

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

^[9],[10]

7.50%

Investment Company, Nonconsolidated Subsidiary [Line Items]

€ 23,731

^{[1],[4],[10],[13]}

€ 23,731

^{[7],[8],[11],[15]}

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

12.21%

^{[1],[9],[10],[13]}

12.21%

^{[1],[9],[10],[13]}

12.21%

^{[1],[9],[10],[13]}

12.32%

^{[8],[11],[12],[15]}

12.32%

^{[8],[11],[12],[15]}

12.32%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 49,395

^[1],[4],[10]

$ 49,520

^[7],[8],[11]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

13.36%

^[1],[9],[10]

13.36%

^[1],[9],[10]

13.36%

^[1],[9],[10]

13.32%

^{[8],[11],[12]}

13.32%

^{[8],[11],[12]}

13.32%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,552

^[1],[4],[10]

$ 1,552

^{[7],[8],[11],[21]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

12.66%

^[1],[9],[10]

12.66%

^[1],[9],[10]

12.66%

^[1],[9],[10]

12.44%

^{[8],[11],[12],[21]}

12.44%

^{[8],[11],[12],[21]}

12.44%

^{[8],[11],[12],[21]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[5],[7],[8],[11],[21]}

$ 1,099

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

^{[5],[8],[11],[12],[21]}

12.51%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,742

^[1],[4],[10]

$ 32,104

^{[7],[8],[11],[21]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

12.66%

^[1],[9],[10]

12.66%

^[1],[9],[10]

12.66%

^[1],[9],[10]

12.51%

^{[8],[11],[12],[21]}

12.51%

^{[8],[11],[12],[21]}

12.51%

^{[8],[11],[12],[21]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,298

^[1],[4],[10]

$ 2,749

^{[7],[8],[11],[21]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

14.50%

^[1],[9],[10]

14.50%

^[1],[9],[10]

14.50%

^[1],[9],[10]

12.51%

^{[8],[11],[12],[21]}

12.51%

^{[8],[11],[12],[21]}

12.51%

^{[8],[11],[12],[21]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 32,022

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

^[1],[9],[10]

12.66%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[6],[7],[8],[15]}

$ 4,984

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

^{[6],[8],[11],[12],[15]}

11.50%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 50,419

^[1],[4],[13]

$ 50,419

^[7],[8],[15]

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

13.00%

^{[1],[9],[10],[13]}

13.00%

^{[1],[9],[10],[13]}

13.00%

^{[1],[9],[10],[13]}

13.00%

^{[8],[11],[12],[15]}

13.00%

^{[8],[11],[12],[15]}

13.00%

^{[8],[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 12,843

^[1],[4],[10]

$ 12,843

^[7],[11]

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

13.47%

^[1],[9],[10]

13.47%

^[1],[9],[10]

13.47%

^[1],[9],[10]

13.43%

^[11],[12]

13.43%

^[11],[12]

13.43%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

^{[5],[7],[8],[11],[15]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[8],[11],[15]}

$ 28,826

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

^{[8],[11],[12],[15]}

11.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,119

^{[1],[2],[4],[10]}

$ 1,861

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

15.21%

^{[1],[2],[9],[10]}

15.21%

^{[1],[2],[9],[10]}

15.21%

^{[1],[2],[9],[10]}

15.17%

^{[5],[8],[11],[12]}

15.17%

^{[5],[8],[11],[12]}

15.17%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 23,363

^[1],[4],[10]

$ 23,423

^[7],[8],[11]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

15.28%

^[1],[9],[10]

15.28%

^[1],[9],[10]

15.28%

^[1],[9],[10]

15.26%

^{[8],[11],[12]}

15.26%

^{[8],[11],[12]}

15.26%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 19,894

^[1],[4],[10]

$ 19,947

^[7],[8],[11]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

11.36%

^[1],[9],[10]

11.36%

^[1],[9],[10]

11.36%

^[1],[9],[10]

11.32%

^{[8],[11],[12]}

11.32%

^{[8],[11],[12]}

11.32%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

^{[7],[8],[11],[18]}

$ 19,163

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

^[1],[4],[17]

$ 5,065

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

^[1],[4],[17]

20,871

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

^{[7],[8],[11],[18]}

4,641

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

46,832

^{[1],[4],[10],[17]}

46,832

^[7],[8],[11]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,642

^[1],[4],[10]

$ 11,671

^[7],[8],[11]

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

11.48%

^[1],[9],[10]

11.48%

^[1],[9],[10]

11.48%

^[1],[9],[10]

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

11.42%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,000

^{[4],[10],[13]}

$ 1,000

^{[7],[11],[15]}

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

13.12%

^{[9],[10],[13]}

13.12%

^{[9],[10],[13]}

13.12%

^{[9],[10],[13]}

13.06%

^{[11],[12],[15]}

13.06%

^{[11],[12],[15]}

13.06%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 300

^[4],[13]

$ 4,500

^[7],[15]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

4.75%

^{[9],[10],[13]}

4.75%

^{[9],[10],[13]}

4.75%

^{[9],[10],[13]}

6.50%

^{[11],[12],[15]}

6.50%

^{[11],[12],[15]}

6.50%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,500

^[4],[13]

$ 300

^[7],[15]

Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond

6.50%

^{[9],[10],[13]}

6.50%

^{[9],[10],[13]}

6.50%

^{[9],[10],[13]}

4.75%

^{[11],[12],[15]}

4.75%

^{[11],[12],[15]}

4.75%

^{[11],[12],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[10]

$ 6,620

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

^[9],[10]

9.50%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 1,140

Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^{[8],[11],[12]}

12.68%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 1,290

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

^[1],[9],[10]

21.66%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

^{[1],[2],[4],[10]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 29,838

^[1],[4],[10]

$ 11,792

^[7],[11]

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

12.06%

^[1],[9],[10]

12.06%

^[1],[9],[10]

12.06%

^[1],[9],[10]

9.27%

^[11],[12]

9.27%

^[11],[12]

9.27%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 5,000

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^{[8],[11],[12]}

12.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[4],[10]

$ 1,543

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

^[1],[9],[10]

21.66%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 1,565

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

^{[8],[11],[12]}

21.68%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[7],[8],[11]

$ 1,323

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

^{[8],[11],[12]}

21.68%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,664

^[4],[10]

$ 8,983

^[7],[11]

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

11.71%

^[9],[10]

11.71%

^[9],[10]

11.71%

^[9],[10]

11.67%

^[11],[12]

11.67%

^[11],[12]

11.67%

^[11],[12]

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 19,578

^[1],[4],[10]

$ 19,578

^[7],[8],[11]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

9.35%

^[1],[9],[10]

9.35%

^[1],[9],[10]

9.35%

^[1],[9],[10]

9.32%

^{[8],[11],[12]}

9.32%

^{[8],[11],[12]}

9.32%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[8],[11],[15]}

£ 20,000

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond

^{[8],[11],[12],[15]}

12.72%

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 4,960

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

^[9],[10]

6.50%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 377

^{[1],[2],[4],[10]}

$ 377

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

12.10%

^[9],[10]

12.10%

^[9],[10]

12.10%

^[9],[10]

12.14%

^{[5],[8],[11],[12]}

12.14%

^{[5],[8],[11],[12]}

12.14%

^{[5],[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 24,427

^[1],[4],[10]

$ 24,427

^[7],[8],[11]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

12.62%

^[1],[9],[10]

12.62%

^[1],[9],[10]

12.62%

^[1],[9],[10]

12.63%

^{[8],[11],[12]}

12.63%

^{[8],[11],[12]}

12.63%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,636

^[1],[4],[10]

$ 3,636

^[7],[8],[11]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

12.62%

^[1],[9],[10]

12.62%

^[1],[9],[10]

12.62%

^[1],[9],[10]

12.63%

^{[8],[11],[12]}

12.63%

^{[8],[11],[12]}

12.63%

^{[8],[11],[12]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

$ 0

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[2],[4],[10]}

$ 5,212

^[7],[8],[11]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

^{[8],[11],[12]}

11.75%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

^{[1],[2],[4],[10]}

$ 0

^{[5],[7],[8],[11]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,212

^[1],[4],[10]

^{[5],[7],[8],[11]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

^[1],[9],[10]

11.75%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4]

$ 0

SLF JV I

Number of borrowers | borrower

$ 334,754

$ 332,637

SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,124

$ 1,149

SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2

12.11%

11.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,631

$ 6,771

SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver

12.11%

12.15%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,124

$ 4,134

SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan

11.64%

11.63%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,575

$ 8,596

SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan

12.11%

10.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,786

$ 2,969

SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan

9.64%

9.63%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,681

$ 8,798

SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan

13.00%

13.04%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,957

SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,596

SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2

9.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,944

SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan

9.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,811

$ 4,824

SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan

11.91%

11.81%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,720

SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan

9.54%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,519

$ 1,523

SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan

9.36%

9.40%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,052

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1

10.86%

10.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,920

$ 4,950

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2

9.46%

9.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 613

$ 1,990

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3

9.46%

9.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,985

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan

9.71%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,346

SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan

10.68%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,351

$ 6,289

SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1

8.45%

11.49%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,749

$ 1,753

SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2

10.61%

10.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,290

$ 6,306

SLF JV I | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan

10.61%

10.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,990

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver

8.71%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 600

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1

11.54%

11.57%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,348

$ 2,354

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2

11.53%

11.55%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,978

$ 1,983

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3

11.53%

11.55%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,955

$ 1,960

SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan

11.53%

11.55%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,327

$ 6,343

SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan

10.35%

10.39%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,708

$ 8,730

SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan

9.85%

9.89%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,698

$ 7,920

SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan

10.13%

10.12%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,196

$ 5,799

SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan

10.65%

10.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,992

SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers

9.60%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan

$ 51,354

$ 54,051

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,992

SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan

9.22%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,350

$ 7,369

SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan

10.66%

10.57%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,900

$ 7,920

SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan

10.71%

10.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,875

$ 9,000

SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan

11.36%

11.40%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,313

$ 7,331

SLF JV I | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan

10.86%

10.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,910

$ 10,000

SLF JV I | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan

10.36%

10.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,952

$ 3,962

SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower

10.46%

10.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan

$ 11,220

$ 11,286

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,350

$ 7,369

SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan

11.41%

11.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 11,220

$ 11,249

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver

10.61%

10.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,297

$ 8,319

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2

10.95%

10.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,205

$ 2,211

SLF JV I | Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan

10.95%

10.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,925

$ 5,940

SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver

9.19%

9.18%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,669

SLF JV I | Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan

12.53%

12.52%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,977

$ 2,985

SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan

9.40%

9.18%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,615

SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan

10.15%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 10,958

$ 10,987

SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan

9.46%

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 9,799

$ 9,825

SLF JV I | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan

10.46%

10.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,995

SLF JV I | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan

9.21%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,000

SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan

9.21%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,410

$ 2,416

SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan

9.61%

9.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,503

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver

12.70%

12.74%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 394

$ 318

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan

13.56%

13.45%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,116

SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan

13.56%

13.45%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,988

$ 5,000

SLF JV I | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan

10.11%

9.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,991

SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1

9.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 158

$ 138

SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2

10.61%

10.86%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,091

$ 8,113

SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan

10.63%

10.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,970

$ 2,977

SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan

10.39%

10.38%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,801

SLF JV I | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan

9.96%

9.92%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,661

$ 7,680

SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan

9.47%

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,820

$ 8,843

SLF JV I | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan

10.71%

10.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,000

SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan

9.35%

9.33%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 8,194

$ 8,215

SLF JV I | Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan

9.95%

9.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan

$ 332,637

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 7,194

$ 7,212

SLF JV I | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan

11.48%

11.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,992

SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan

9.61%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,289

$ 6,305

SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan

10.47%

10.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,965

SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan

9.27%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,249

$ 6,148

SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan

11.71%

11.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,320

SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1

8.57%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,394

SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2

8.61%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,309

SLF JV I | Weighted Average

8.61%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.57%

10.62%

Glick JV LLC

Number of borrowers | borrower

$ 130,946

$ 130,589

Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 562

$ 574

Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2

12.11%

11.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,669

$ 3,746

Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver

12.11%

12.15%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,712

$ 1,716

Glick JV LLC | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan

11.64%

11.63%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,995

$ 2,000

Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan

10.39%

10.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,147

$ 6,230

Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan

13.00%

13.04%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,270

$ 2,478

Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan

9.47%

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,853

$ 2,860

Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan

11.91%

11.81%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,895

Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan

9.54%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,993

Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan

10.45%

10.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 905

$ 907

Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan

9.36%

9.40%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,078

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1

10.86%

10.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 993

$ 1,980

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2

9.71%

9.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,773

$ 995

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan

9.46%

9.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,423

Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan

10.68%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,664

$ 3,628

Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1

8.45%

11.49%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,355

$ 3,363

Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2

10.61%

10.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 798

$ 800

Glick JV LLC | Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan

10.61%

10.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,995

Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan

8.71%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,759

$ 2,766

Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan

10.35%

10.39%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,834

$ 2,841

Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan

9.85%

9.89%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,361

$ 2,970

Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan

10.13%

10.12%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,171

$ 2,460

Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan

10.65%

10.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,496

Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers

9.60%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Glick JV LLC | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan

$ 27,867

$ 28,396

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,496

Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan

9.22%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,920

$ 3,930

Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan

10.66%

10.57%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,950

$ 3,960

Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan

10.71%

10.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,219

$ 2,250

Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan

11.36%

11.40%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,900

$ 3,910

Glick JV LLC | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan

10.86%

10.90%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,560

$ 4,500

Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower

10.36%

10.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan

$ 6,147

$ 6,230

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,920

$ 3,930

Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver

11.41%

11.32%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,625

$ 1,630

Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan

10.95%

10.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,198

Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan

10.15%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,839

$ 3,849

Glick JV LLC | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan

9.46%

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 997

Glick JV LLC | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan

9.21%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,000

Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan

9.21%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 681

$ 683

Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan

9.61%

9.65%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,842

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver

12.70%

12.74%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 281

$ 226

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan

13.56%

13.45%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,182

Glick JV LLC | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan

13.56%

13.45%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,495

Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1

9.47%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 6,012

$ 6,029

Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2

10.63%

10.88%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 117

$ 103

Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan

10.61%

10.86%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 5,228

$ 5,227

Glick JV LLC | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan

9.96%

9.92%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,283

$ 3,292

Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan

9.47%

9.43%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,900

$ 4,913

Glick JV LLC | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan

10.71%

10.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 4,000

Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan

9.35%

9.33%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,634

$ 2,641

Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan

9.95%

9.99%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,986

$ 2,993

Glick JV LLC | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan

11.48%

11.42%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 1,496

Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan

9.61%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 983

Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan

9.27%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,035

$ 3,843

Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan

11.71%

11.67%

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 2,965

$ 1,772

Glick JV LLC | Senior Secured Loans

8.61%

8.57%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Glick JV LLC | Weighted Average

$ 130,946

$ 130,589

Investment Company, Nonconsolidated Subsidiary [Line Items]

Derivative Instruments and Hedging Activities Disclosure [Abstract]

10.58%

10.77%

[1]	As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[2]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[3]	This investment represents a participation interest in the underlying securities shown.
[4]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[5]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[6]	This investment represents a participation interest in the underlying securities shown.
[7]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[8]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[9]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[10]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[11]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[12]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[13]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[14]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[15]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[16]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[17]	This investment was on non-accrual status as of December 31, 2023.
[18]	This investment was on non-accrual status as of September 30, 2023.
[19]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[20]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[21]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,605,288	2,501,385
Debt investments in the JVs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	163,613	162,673
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,726,123	2,619,912
Level 3 \| Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,393,175	2,292,691
Level 3 \| Senior secured debt \| Valuation, Market Approach \| Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,966,262	$ 1,904,140
Level 3 \| Senior secured debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.090	0.090
Level 3 \| Senior secured debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.400	0.320
Level 3 \| Senior secured debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.143	0.147
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 18,042
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.2
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.4
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.3
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 77,424	$ 64,802
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	2.3	3.0
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	9.8	6.0
Level 3 \| Senior secured debt \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	6.0	4.6
Level 3 \| Senior secured debt \| Valuation, Transaction Precedent \| Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 132,614	$ 33,816
Level 3 \| Senior secured debt \| Valuation, Broker Quotations \| Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	198,833	289,933
Level 3 \| Subordinated Debt \| Valuation, Market Approach \| Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 32,747	$ 22,881
Level 3 \| Subordinated Debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.100	0.100
Level 3 \| Subordinated Debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.230	0.220
Level 3 \| Subordinated Debt \| Valuation, Market Approach \| Measurement Input, Market Yield \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.103	0.112
Level 3 \| Subordinated Debt \| Valuation, Broker Quotations \| Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 4,170
Level 3 \| Debt investments in the JVs \| Valuation, Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 163,613	162,673
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 42,156	$ 32,318
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.4	0.4
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	3.2	3.2
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Revenue Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	0.6	0.5
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 88,566	$ 103,661
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.7	1.7
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	15.1	15.1
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, EBITDA Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	6.3	8.8
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Asset Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,001	$ 1,097
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Asset Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.0	1.0
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Asset Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.5	1.4
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Enterprise Value \| Measurement Input, Asset Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment Company, Investment Owned, Measurement Input	1.4	1.4
Level 3 \| Equity Securities, Preferred & Common \| Valuation, Transaction Precedent \| Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 4,865	$ 421

Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020
Debt Instrument [Line Items]
Unamortized financing costs	$ (6,534)	$ (7,076)
Net carrying value	1,622,717	1,600,731
2025 Notes
Debt Instrument [Line Items]
Principal	300,000	300,000			$ 300,000
Unamortized financing costs	(900)	(1,100)
Unaccreted discount	(600)	(700)			$ (2,500)
Interest rate swap fair value adjustment	0	0
Net carrying value	298,500	298,200
Fair Value	291,200	286,400
2027 Notes
Debt Instrument [Line Items]
Principal	350,000	350,000		$ 350,000
Unamortized financing costs	(2,300)	(2,500)
Unaccreted discount	(500)	(600)		$ (1,000)
Interest rate swap fair value adjustment	(30,400)	(40,500)
Net carrying value	316,800	306,400
Fair Value	315,100	301,800
2029 Notes
Debt Instrument [Line Items]
Principal	300,000	300,000	$ 300,000
Unamortized financing costs	(3,400)	(3,500)
Unaccreted discount	(3,200)	(3,400)	$ (3,500)
Interest rate swap fair value adjustment	4,000	(7,000)
Net carrying value	297,400	286,100
Fair Value	$ 310,400	$ 290,000

Derivative Instruments

3 Months Ended

Dec. 31, 2023

Derivative Instruments

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.

Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	36,775	€	34,350	2/8/2024	$	—	$	1,227	Derivative liability
Foreign currency forward contract	$	47,403	£	38,500	2/8/2024	—		1,687		Derivative liability
						$	—	$	2,914

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	42,182	€	38,026	11/9/2023	$	1,857	$	—	Derivative asset
Foreign currency forward contract	$	72,098	£	56,556	11/9/2023	3,053		—		Derivative asset
						$	4,910	$	—

In connection with the issuance of the 2027 Notes and 2029 Notes, the Company entered into interest rate swap agreements with the Royal Bank of Canada pursuant to ISDA Master Agreements. As of December 31, 2023, the Company paid $26.5 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreements, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.

Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	30,415	Derivative liability
Interest rate swap	300,000		2/15/2029	4,013		—		Derivative liability
				$	4,013	$	30,415

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	40,519	Derivative liability
Interest rate swap	300,000		2/15/2029	—		7,000		Derivative liability
				$	—	$	47,519

Consolidated Statements of Assets and Liabilities (Parenthetical)
shares in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

USD ($)

$ / shares

Sep. 30, 2023

USD ($)

$ / shares

Unamortized financing costs

$ 3,187,750

$ 3,044,119

$ 6,534

$ 7,076

Common stock, par value, (in dollars per share) | $ / shares

$ 0.01

Common stock, shares authorized (in shares) | shares

250,000

Common stock, shares issued (in shares) | shares

78,965

77,225

Common stock, shares outstanding (in shares) | shares

78,965

^[1]

77,225

Net asset value per common share (in dollars per share) | $ / shares

$ 19.14

^[1]

$ 19.63

0.3333

$ 363,124

^[2],[3]

$ 345,245

^[4],[5]

26,916

24,898

$ 2,797,710

^[6]

$ 2,673,976

^[5]

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.
[2]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[3]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[4]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[5]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[6]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Consolidated Statements of Operations
shares in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

USD ($)

$ / shares

Dec. 31, 2022

USD ($)

$ / shares

Interest on cash and cash equivalents

$ 2,364

$ 472

Total interest income

91,414

69,978

Interest income, PIK

3,849

6,130

General and administrative expenses

1,307

2,021

Dividend income

1,415

1,050

Total investment income

97,985

79,179

Expenses:

Base management fee

11,477

9,917

Part I incentive fee

9,028

7,703

Professional fees

1,504

1,500

Directors fees

160

Interest expense

32,170

20,719

Administrator expense

366

298

591

746

Total expenses

55,296

41,043

Fees waived

(1,500)

(750)

Net expenses

53,796

40,293

Net investment income before taxes

44,189

38,886

Excise tax

(78)

Net investment income

44,189

38,808

Foreign currency forward contracts

(7,824)

(11,001)

Foreign currency forward contracts

(25,025)

(22,982)

Realized gains (losses):

4,101

4,448

Net realized gains (losses)

(8,453)

(3,203)

(Provision) benefit for taxes on realized and unrealized gains (losses)

(176)

549

Net realized and unrealized gains (losses), net of taxes

(33,654)

(25,636)

Net increase (decrease) in net assets resulting from operations

$ 10,535

$ 13,172

Net investment income per common share - basic and diluted (in dollars per share) | $ / shares

^[1]

$ 0.57

$ 0.63

Earnings (loss) per common share - basic (dollars per share) | $ / shares

^[1]

0.14

0.22

Earnings (loss) per common share - diluted (dollars per share) | $ / shares

^[1]

$ 0.14

$ 0.22

Weighted average common shares outstanding - basic (shares) | shares

^[1]

77,840

61,142

Weighted average common shares outstanding - diluted (shares) | shares

^[1]

77,840

61,142

0.3333

Interest income

$ 6,005

$ 4,567

Interest income, PIK

544

Dividend income

1,400

1,050

1,339

(3,309)

Realized gains (losses):

Realized gain (loss)

786

Interest income

324

641

(925)

Interest income

82,721

64,298

Interest income, PIK

3,305

6,130

1,289

2,003

Dividend income

Stockholders' Equity Note [Abstract]

(17,615)

(8,675)

Realized gains (losses):

Realized gain (loss)

$ (13,340)

$ (7,651)

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Due from broker	$ 26,520	$ 54,260

Share Data and Net Assets

3 Months Ended

Dec. 31, 2023

Share Data and Net Assets

The share and per share information for the three months ended December 31, 2022 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three months ended December 31, 2023 and 2022:


(Share amounts in thousands)	Three months ended December 31, 2023		Three months ended December 31, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	10,535	$	13,172
Weighted average common shares outstanding — basic and diluted	77,840		61,142
Earnings (loss) per common share — basic and diluted	$	0.14	$	0.22

Changes in Net Assets

The following table presents the changes in net assets for the three months ended December 31, 2023:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2023	77,225	$	772	$	2,166,330	$	(651,338)	$	1,515,764
Net investment income	—	—		—		44,189		44,189
Net unrealized appreciation (depreciation)	—	—		—		(25,025)		(25,025)
Net realized gains (losses)	—	—		—		(8,453)		(8,453)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(176)		(176)
Distributions to stockholders	—	—		—		(48,897)		(48,897)
Issuance of common stock in connection with the "at the market" offering	1,641	17		32,296		—		32,313
Issuance of common stock under dividend reinvestment plan	99	1		1,935		—		1,936
Balance as of December 31, 2023	78,965	$	790	$	2,200,561	$	(689,700)	$	1,511,651

The following table presents the changes in net assets for the three months ended December 31, 2022:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2022	61,125	$	611	$	1,827,721	$	(582,769)	$	1,245,563
Net investment income	—	—		—		38,808		38,808
Net unrealized appreciation (depreciation)	—	—		—		(22,982)		(22,982)
Net realized gains (losses)	—	—		—		(3,203)		(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		549		549
Distributions to stockholders	—	—		—		(58,679)		(58,679)
Issuance of common stock under dividend reinvestment plan	95	1		1,932		—		1,933
Balance as of December 31, 2022	61,220	$	612	$	1,829,653	$	(628,276)	$	1,201,989

Distributions

Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.

For income tax purposes, the Company has reported its distributions for the 2023 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2023 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.

The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 2023 and 2022:


Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value
Quarterly	November 8, 2023	December 15, 2023	December 29, 2023	$	0.55	$	41.7	million	87,472	(1)	$	1.7	million
Special	November 8, 2023	December 15, 2023	December 29, 2023	$	0.07	$	5.3	million	11,133	(1)	$	0.2	million
Total for the three months ended December 31, 2023				$	0.62	$	47.0	million	98,605		$	1.9	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	$	0.42	$	24.8	million	41,510	(1)	$	0.8	million
Total for the three months ended December 31, 2022				$	0.96	$	56.8	million	94,879		$	1.9	million

__________

(1) New shares were issued and distributed.

Common Stock Issuances

During the three months ended December 31, 2023 and 2022, the Company issued 98,605 and 94,879 shares, respectively, of common stock as part of the DRIP.

On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement and on August 8, 2023 to add Jefferies LLC as an additional placement agent and to remove SMBC Nikko Securities America, Inc. as a placement agent. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.

In connection with the "at the market" offering, the Company issued and sold 1,641,416 shares of common stock during the three months ended December 31, 2023 for net proceeds of $32.3 million (net of offering costs).


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	1,641,416	$	32,725	$	327	$	32,398	$	19.94

(1) Net proceeds excludes offering costs of $0.1 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the three months ended December 31, 2022.

The entire disclosure for equity.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands

Dec. 31, 2023

Sep. 30, 2023

ASSETS

Cash and cash equivalents

$ 3,018,552

$ 2,892,420

112,369

136,450

Restricted cash

19,328

9,089

Interest, dividends and fees receivable

43,038

44,570

Due from portfolio companies

7,912

6,317

Receivables from unsettled transactions

23,931

55,441

Due from broker

26,520

54,260

Deferred financing costs

11,827

12,541

Deferred offering costs

131

160

Derivative assets at fair value

4,910

Other assets

2,587

1,681

Total assets

3,266,195

3,217,839

Liabilities:

Accounts payable, accrued expenses and other liabilities

3,273

2,950

Base management fee and incentive fee payable

19,004

19,547

Due to affiliate

3,815

4,310

Interest payable

18,980

16,007

Director fees payable

160

Payables from unsettled transactions

57,279

11,006

Derivative liability at fair value

29,316

47,519

Deferred tax liability

Credit facilities payable

710,000

Unsecured notes payable (net of $6,534 and $7,076 of unamortized financing costs as of December 31, 2023 and September 30, 2023, respectively)

912,717

890,731

Total liabilities

1,754,544

1,702,075

Commitments and contingencies (Note 13)

Net assets:

Common stock, $0.01 par value per share, 250,000 shares authorized; 78,965 and 77,225 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively

790

772

Additional paid-in-capital

2,200,561

2,166,330

Accumulated overdistributed earnings

(689,700)

(651,338)

Total net assets (equivalent to $19.14 and $19.63 per common share as of December 31, 2023 and September 30, 2023, respectively) (Note 11)

1,511,651

1,515,764

Total liabilities and net assets

3,266,195

3,217,839

ASSETS

316,309

^[1],[2]

297,091

^[3],[4]

ASSETS

24,442

23,349

ASSETS

Composition of Investments

$ 2,677,801

^[5]

$ 2,571,980

^[4]

[1]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[2]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[3]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[4]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[5]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Portfolio Investments (Tables)

3 Months Ended

Dec. 31, 2023

Schedule of Investments [Abstract]

The composition of the Company's investments as of December 31, 2023 and September 30, 2023 at cost and fair value was as follows:


	December 31, 2023				September 30, 2023
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,779,477	$	2,680,454	$	2,654,484	$	2,557,102
Investments in equity securities	190,205		144,898		171,858		143,767
Debt investments in the JVs	163,277		163,613		162,986		162,673
Equity investments in the JVs	54,791		29,587		54,791		28,878
Total	$	3,187,750	$	3,018,552	$	3,044,119	$	2,892,420

The following table presents the composition of the Company's debt investments as of December 31, 2023 and September 30, 2023 at fixed rates and floating rates:


	December 31, 2023				September 30, 2023
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,397,664	84.30	%	$	2,345,205	86.23	%
Fixed rate debt securities	446,403		15.70		374,570		13.77
Total	$	2,844,067	100.00	%	$	2,719,775	100.00	%

The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 2023 and September 30, 2023:


	December 31, 2023				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Application Software	$	472,016	14.82	%	$	468,483	15.39	%
Multi-Sector Holdings (1)	219,766		6.89		219,469		7.21
Health Care Services	137,713		4.32		81,560		2.68
Data Processing & Outsourced Services	133,399		4.18		133,410		4.38
Health Care Technology	130,701		4.10		106,915		3.51
Biotechnology	127,672		4.01		126,349		4.15
Industrial Machinery & Supplies & Components	102,785		3.22		99,511		3.27
Real Estate Operating Companies	85,374		2.68		83,754		2.75
Broadline Retail	83,290		2.61		83,290		2.74
Pharmaceuticals	74,100		2.32		84,948		2.79
Other Specialty Retail	68,033		2.13		41,088		1.35
Personal Care Products	67,619		2.12		68,146		2.24
Interactive Media & Services	66,109		2.07		19,013		0.62
Fertilizers & Agricultural Chemicals	64,689		2.03		64,720		2.13
Aerospace & Defense	63,768		2.00		51,797		1.70
Diversified Support Services	63,265		1.98		23,435		0.77
Environmental & Facilities Services	63,022		1.98		63,064		2.07
Health Care Distributors	62,010		1.95		62,044		2.04
Diversified Financial Services	61,608		1.93		61,725		2.03
Internet Services & Infrastructure	61,012		1.91		60,934		2.00
Airport Services	57,897		1.82		55,961		1.84
Metal, Glass & Plastic Containers	57,679		1.81		55,530		1.82
Insurance Brokers	52,472		1.65		52,856		1.74
Diversified Metals & Mining	49,898		1.57		49,842		1.64
Automotive Retail	49,603		1.56		57,596		1.89
Home Improvement Retail	49,001		1.54		54,236		1.78
Auto Parts & Equipment	48,462		1.52		48,536		1.59
Systems Software	45,509		1.43		23,111		0.76
Real Estate Services	44,652		1.40		44,717		1.47
Specialized Finance	42,215		1.32		73,035		2.40
Soft Drinks & Non-alcoholic Beverages	42,158		1.32		42,628		1.40
Leisure Facilities	39,724		1.25		39,076		1.28
Specialty Chemicals	37,622		1.18		38,640		1.27
Electrical Components & Equipment	32,500		1.02		32,440		1.07
Distributors	32,189		1.01		37,666		1.24
Advertising	25,597		0.80		25,597		0.84
Passenger Airlines	24,952		0.78		24,920		0.82
Real Estate Development	24,198		0.76		23,965		0.79
Gold	23,347		0.73		23,310		0.77
Home Furnishings	23,085		0.72		23,859		0.78
Health Care Equipment	22,509		0.71		22,441		0.74
Construction & Engineering	21,668		0.68		22,102		0.73
Hotels, Resorts & Cruise Lines	17,169		0.54		17,195		0.56
Oil & Gas Storage & Transportation	16,172		0.51		22,042		0.72
Integrated Telecommunication Services	14,657		0.46		18,801		0.62
Restaurants	12,617		0.40		12,603		0.41
Health Care Supplies	11,618		0.36		11,646		0.38
Cable & Satellite	8,946		0.28		4,619		0.15
Education Services	8,257		0.26		13,871		0.46
Food Distributors	7,677		0.24		5,897		0.19
Oil & Gas Refining & Marketing	6,620		0.21		—		—
Research & Consulting Services	4,862		0.15		4,871		0.16
Other Specialized REITs	4,395		0.14		4,379		0.14
Apparel Retail	4,375		0.14		4,999		0.16
Office Services & Supplies	4,162		0.13		—		—
Paper & Plastic Packaging Products & Materials	3,247		0.10		3,254		0.11
Housewares & Specialties	2,854		0.09		2,908		0.10
Leisure Products	2,070		0.06		2,055		0.07
Alternative Carriers	1,625		0.05		—		—
Diversified Chemicals	1,539		0.05		—		—
Consumer Finance	—		—		16,440		0.54
Movies & Entertainment	—		—		12,188		0.40
Air Freight & Logistics	—		—		4,925		0.16
Integrated Oil & Gas	—		—		4,894		0.16
Technology Distributors	—		—		813		0.03
	$	3,187,750	100.00	%	$	3,044,119	100.00	%


	December 31, 2023						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	460,072	15.23	%	30.41	%	$	455,719	15.73	%	30.03	%
Multi-Sector Holdings (1)	195,163		6.47		12.91		193,431		6.69		12.76
Biotechnology	127,586		4.23		8.44		125,678		4.35		8.29
Data Processing & Outsourced Services	126,731		4.20		8.38		125,259		4.33		8.26
Health Care Services	122,076		4.04		8.08		66,683		2.31		4.40
Health Care Technology	107,574		3.56		7.12		95,404		3.30		6.29
Industrial Machinery & Supplies & Components	104,217		3.45		6.89		98,352		3.40		6.49
Real Estate Operating Companies	84,517		2.80		5.59		82,463		2.85		5.44
Pharmaceuticals	71,320		2.36		4.72		80,455		2.78		5.31
Other Specialty Retail	69,533		2.30		4.60		41,115		1.42		2.71
Interactive Media & Services	66,304		2.20		4.39		19,199		0.66		1.27
Aerospace & Defense	63,981		2.12		4.23		51,862		1.79		3.42
Fertilizers & Agricultural Chemicals	63,185		2.09		4.18		63,185		2.18		4.17
Diversified Financial Services	62,687		2.08		4.15		60,003		2.07		3.96
Diversified Support Services	62,669		2.08		4.15		23,352		0.81		1.54
Environmental & Facilities Services	62,180		2.06		4.11		62,413		2.16		4.12
Internet Services & Infrastructure	60,771		2.01		4.02		60,579		2.09		4.00
Health Care Distributors	60,654		2.01		4.01		60,865		2.10		4.02
Personal Care Products	59,562		1.97		3.94		59,928		2.07		3.95
Metal, Glass & Plastic Containers	55,586		1.84		3.68		53,459		1.85		3.53
Airport Services	55,577		1.84		3.68		54,453		1.88		3.59
Insurance Brokers	54,927		1.82		3.63		53,050		1.83		3.50
Diversified Metals & Mining	49,869		1.65		3.30		49,869		1.72		3.29
Auto Parts & Equipment	48,901		1.62		3.23		49,148		1.70		3.24
Automotive Retail	48,109		1.59		3.18		55,805		1.93		3.68
Home Improvement Retail	48,034		1.59		3.18		53,168		1.84		3.51
Systems Software	45,148		1.50		2.99		21,968		0.76		1.45
Real Estate Services	43,771		1.45		2.90		43,886		1.52		2.90
Soft Drinks & Non-alcoholic Beverages	41,868		1.39		2.77		42,391		1.47		2.80
Specialized Finance	41,677		1.38		2.76		69,590		2.41		4.59
Broadline Retail	39,230		1.30		2.60		69,040		2.39		4.55
Leisure Facilities	39,022		1.29		2.58		36,963		1.28		2.44
Specialty Chemicals	37,692		1.25		2.49		38,615		1.34		2.55
Electrical Components & Equipment	32,491		1.08		2.15		32,573		1.13		2.15
Distributors	31,221		1.03		2.07		37,311		1.29		2.46
Passenger Airlines	27,163		0.90		1.80		27,512		0.95		1.82
Real Estate Development	23,881		0.79		1.58		23,679		0.82		1.56
Gold	23,519		0.78		1.56		23,328		0.81		1.54
Health Care Equipment	21,410		0.71		1.42		22,436		0.78		1.48
Construction & Engineering	21,347		0.71		1.41		21,903		0.76		1.45
Hotels, Resorts & Cruise Lines	17,024		0.56		1.13		16,991		0.59		1.12
Oil & Gas Storage & Transportation	16,173		0.54		1.07		16,040		0.55		1.06
Home Furnishings	14,131		0.47		0.93		19,954		0.69		1.32
Integrated Telecommunication Services	13,261		0.44		0.88		16,492		0.57		1.09
Restaurants	12,847		0.43		0.85		12,464		0.43		0.82
Advertising	12,140		0.40		0.80		11,955		0.41		0.79
Health Care Supplies	11,321		0.38		0.75		11,363		0.39		0.75
Cable & Satellite	9,309		0.31		0.62		4,546		0.16		0.30
Education Services	8,396		0.28		0.56		13,618		0.47		0.90
Food Distributors	7,353		0.24		0.49		5,166		0.18		0.34
Oil & Gas Refining & Marketing	7,009		0.23		0.46		—		—		—
Research & Consulting Services	4,893		0.16		0.32		4,831		0.17		0.32
Apparel Retail	4,419		0.15		0.29		5,002		0.17		0.33
Office Services & Supplies	4,377		0.15		0.29		—		—		—
Other Specialized REITs	3,511		0.12		0.23		3,198		0.11		0.21
Paper & Plastic Packaging Products & Materials	3,048		0.10		0.20		3,061		0.11		0.20
Housewares & Specialties	2,684		0.09		0.18		2,808		0.10		0.19
Leisure Products	2,197		0.07		0.15		2,063		0.07		0.14
Alternative Carriers	1,661		0.06		0.11		—		—		—
Diversified Chemicals	1,573		0.05		0.10		—		—		—
Consumer Finance	—		—		—		15,087		0.52		1.00
Movies & Entertainment	—		—		—		11,865		0.41		0.78
Integrated Oil & Gas	—		—		—		4,785		0.17		0.32
Air Freight & Logistics	—		—		—		4,263		0.15		0.28
Technology Distributors	—		—		—		776		0.03		0.05
Total	$	3,018,552	100.00	%	199.69	%	$	2,892,420	100.00	%	190.82	%

___________________

(1)This industry includes the Company's investments in the JVs.

SLF JV I Portfolio as of December 31, 2023


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	12.11%		8/18/2028		$	8,575	$	8,486	$	8,600
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.11%		12/18/2025		1,124		1,112		1,098		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.11%		12/18/2025		6,631		6,571		6,479		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.64%		8/14/2026		1,786		1,722		1,670
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.00%		6/30/2025		8,681		8,629		8,117		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.47%		6/9/2028		1,596		1,488		1,513
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.47%		6/9/2028		4,944		4,734		4,688
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.91%		10/20/2028		4,811		4,751		4,050		(4)
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.36%		8/11/2025		1,519		1,187		929		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(30)		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.64%		12/29/2027		4,124		4,069		3,876		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.86%		10/25/2028		5,052		4,895		3,294		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.46%		8/19/2028		5,920		5,734		5,904
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.46%		8/19/2028		613		589		612
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.71%		8/19/2028		1,985		1,884		1,981
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.61%		2/15/2029		2,394		2,364		2,387
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.61%		2/15/2029		4,309		4,081		4,296
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	8.45%	4.00%	12/24/2026		6,351		6,284		6,033		(4)
Bausch + Lomb Corp	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.71%		5/10/2027		3,990		3,884		3,957
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.61%		6/11/2027		1,749		1,737		1,684		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.61%		6/11/2027		6,290		6,231		6,057		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.53%		8/10/2027		2,348		2,318		2,125
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.53%		8/10/2027		1,978		1,951		1,790
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.54%		8/10/2027		600		593		543
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.53%		8/10/2027		1,955		1,932		1,769
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.35%		10/13/2029		6,327		5,985		6,332		(4)
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.50%	9.85%		7/31/2029		8,708		8,621		8,714
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.65%		8/2/2027		7,196		7,110		7,209		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.13%		4/26/2029		8,698		8,563		8,619		(4)
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	9.60%		4/2/2029		2,992		2,948		2,971
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.75%	9.22%		10/8/2027		2,992		2,955		2,981
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.66%		8/11/2028		7,350		7,277		6,590		(4)


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.71%		4/9/2029		$	7,900	$	7,720	$	7,769	(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.86%		6/30/2026		7,313		7,238		7,313
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.36%		3/25/2027		8,875		8,728		7,100		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.36%		8/15/2028		7,910		7,658		7,857
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.46%		10/29/2028		3,952		3,813		3,801
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.41%		10/14/2027		7,350		7,257		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.61%		5/9/2026		11,220		11,091		10,883		(4)
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.19%		3/1/2029		5,925		5,653		5,916
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	SOFR+	7.00%			2/14/2025		—		(2)		(7)		(4)(5)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	7.00%	12.53%		2/14/2025		4,669		4,652		4,603		(4)
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.75%	9.40%		10/15/2028		2,977		2,845		2,980
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2027		—		(3)		(2)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.95%		2/10/2027		8,297		8,143		8,215		(4)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.95%		2/10/2027		2,205		2,205		2,183		(4)
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.46%		9/25/2026		10,958		10,810		10,954
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.46%		11/10/2027		9,799		9,488		9,778		(4)
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.21%		2/1/2028		1,995		1,994		2,002
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	9.21%		2/11/2028		4,000		3,930		3,962
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.61%		12/17/2027		2,410		2,299		2,395
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.70%		12/18/2028		4,503		4,435		4,120		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.56%		4/6/2027		394		379		375		(4)(5)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.56%		4/6/2027		8,116		7,869		7,807		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	10.11%		4/5/2030		4,988		4,853		5,012
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	4.00%	9.47%		3/16/2027		2,991		2,991		2,999
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.61%		4/27/2024		158		158		107
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.63%		4/27/2024		8,091		8,090		5,482
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	10.39%		4/17/2028		2,970		2,595		2,881		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.47%		10/5/2027		7,661		7,622		7,646
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.71%		11/20/2028		8,820		8,697		8,743		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.96%		4/5/2029		8,801		8,459		8,842
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.35%		9/27/2030		8,000		7,880		7,926
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.95%		3/30/2029		8,194		7,570		8,025
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.48%		12/29/2028		7,194		7,091		6,996		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	9.61%		9/15/2028		2,992		2,944		2,987
Veritas US Inc.	Application Software	First Lien Term Loan	SOFR+	5.00%	10.47%		9/1/2025		6,289		6,247		5,248
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.71%		9/21/2027		3,249		3,180		3,083		(4)
Total Portfolio Investments									$	334,754	$	334,451	$	325,769

_________

(1) Represents the interest rate as of December 31, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of December 31, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35% and the 90-day LIBOR at 5.64%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of December 31, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of December 31, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

SLF JV I Portfolio as of September 30, 2023


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028		$	8,596	$	8,503	$	8,499
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025		1,149		1,135		1,128		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025		6,771		6,701		6,648		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.63%		8/14/2026		2,969		2,853		2,810
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025		8,798		8,737		8,218		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028		4,957		4,734		4,614
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028		4,824		4,763		4,239		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026		7,720		7,643		7,720
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025		1,523		1,191		1,099		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(29)		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027		4,134		4,076		3,892		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028		5,052		4,888		3,817		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028		4,950		4,747		4,809
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028		1,990		1,884		1,937
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029		4,346		4,036		3,871
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029		4,320		4,080		4,251
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026		6,289		6,216		6,028		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		1,753		1,742		1,711		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		6,306		6,247		6,155		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		2,354		2,322		2,281
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,983		1,954		1,921
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.57%		8/10/2027		600		592		581
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,960		1,935		1,899
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029		6,343		5,983		6,285		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029		8,730		8,642		8,730
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027		5,799		5,715		5,681		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029		7,920		7,792		7,729		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028		7,369		7,295		6,190		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029		7,920		7,731		7,517		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026		7,331		7,249		7,340
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027		9,000		8,839		7,080		(4)


KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%	8/15/2028	10,000		9,666		9,665
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.42%	10/29/2028	$	3,962	$	3,815	$	3,955
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%	10/14/2027	7,369		7,269		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.65%	5/9/2026	11,249		11,106		10,912		(4)
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.18%	3/1/2029	5,940		5,654		5,812
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	SOFR+	7.00%		2/14/2025	—		(2)		(8)		(4)(5)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	7.00%	12.52%	2/14/2025	4,669		4,648		4,594		(4)
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.75%	9.18%	10/15/2028	2,985		2,845		2,941
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%		2/10/2026	—		(3)		(7)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%	2/10/2026	8,319		8,164		8,147		(4)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%	2/10/2026	2,211		2,210		2,165		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%	3/31/2025	6,615		6,608		6,565
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%	9/25/2026	10,987		10,827		10,971
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.42%	11/10/2027	9,825		9,492		9,698		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%	12/17/2027	2,416		2,298		2,390
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%	12/18/2028	4,503		4,435		4,098		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%	4/6/2027	318		301		297		(4)(5)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%	4/6/2027	8,116		7,850		7,773		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%	4/5/2030	5,000		4,860		4,969
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%	4/27/2024	138		138		94
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%	4/27/2024	8,113		8,111		5,531
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	10.38%	4/17/2028	2,977		2,580		2,799		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%	10/5/2027	7,680		7,642		7,643
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%	11/20/2028	8,843		8,713		8,717		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%	4/5/2029	8,801		8,442		8,794
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%	9/19/2030	8,000		7,880		7,834
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%	3/30/2029	8,215		7,559		7,913
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%	12/29/2028	7,212		7,103		7,022		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	SOFR+	5.00%	10.43%	9/1/2025	6,305		6,257		5,500
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%	9/21/2027	6,148		6,008		5,939		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%	4/30/2025	1,965		1,920		1,855		(4)
Total Portfolio Investments							$	332,637	$	331,808	$	322,179

_________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39% and the 30-day LIBOR at 5.43%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2023.

Glick JV Portfolio as of December 31, 2023


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.39%		8/18/2028	$	1,995	$	1,957	$	2,001
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.11%		12/18/2025	562		557		549		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.11%		12/18/2025	3,669		3,637		3,585		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.00%		6/30/2025	6,147		6,110		5,747		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.47%		6/9/2028	3,270		3,111		3,100
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.91%		10/20/2028	2,853		2,818		2,402		(4)
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.45%		2/28/2028	2,993		2,917		3,000
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.36%		8/11/2025	905		703		554		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.64%		12/29/2027	1,712		1,689		1,609		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(12)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.86%		10/25/2028	2,078		2,040		1,355		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.71%		8/19/2028	993		942		990
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.46%		8/19/2028	2,773		2,687		2,765
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.61%		2/15/2029	2,965		2,856		2,956
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	8.45%	4.00%	12/24/2026	3,664		3,625		3,481		(4)
Bausch + Lomb Corp	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.71%		5/10/2027	1,995		1,942		1,979
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.61%		6/11/2027	3,355		3,323		3,230		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.61%		6/11/2027	798		793		768		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.35%		10/13/2029	2,759		2,607		2,762		(4)
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.50%	9.85%		7/31/2029	2,834		2,813		2,836
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.65%		8/2/2027	3,171		3,144		3,176		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.13%		4/26/2029	3,361		3,309		3,331		(4)


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	9.60%		4/2/2029	$	1,496	$	1,474	$	1,486
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.75%	9.22%		10/8/2027	1,496		1,477		1,491
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.66%		8/11/2028	3,920		3,881		3,515		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.71%		4/9/2029	3,950		3,860		3,884		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.86%		6/30/2026	3,900		3,860		3,900
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.36%		3/25/2027	2,219		2,182		1,775		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.36%		8/15/2028	3,560		3,447		3,536
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.41%		10/14/2027	3,920		3,870		3,876
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.95%		2/10/2027	1,625		1,612		1,609		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2027	—		(1)		(1)		(4)(5)
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.46%		9/25/2026	3,839		3,821		3,837
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.21%		2/1/2028	997		997		1,001
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	9.21%		2/11/2028	2,000		1,965		1,981
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.61%		12/17/2027	681		650		677
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.70%		12/18/2028	2,842		2,799		2,600		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.56%		4/6/2027	5,182		5,040		4,985		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.56%		4/6/2027	281		271		266		(4)(5)
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	4.00%	9.47%		3/16/2027	1,495		1,495		1,500
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.63%		4/27/2024	6,012		6,010		4,073
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.61%		4/27/2024	117		117		79
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.47%		10/5/2027	3,283		3,267		3,277
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.71%		11/20/2028	4,900		4,832		4,857		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.96%		4/5/2029	5,228		5,041		5,252
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.35%		9/27/2030	4,000		3,940		3,963
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.95%		3/30/2029	2,634		2,442		2,580
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.48%		12/29/2028	2,986		2,943		2,904		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	9.61%		9/15/2028	1,496		1,472		1,494
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.71%		9/21/2027	2,035		1,992		1,931		(4)
Total Portfolio Investments								$	130,946	$	128,333	$	124,492

__________

(1) Represents the interest rate as of December 31, 2023. All interest rates are payable in cash, unless otherwise noted.

SOFR at 5.36% and the 90-day SOFR at 5.35%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(4) This investment was held by both the Company and the Glick JV as of December 31, 2023.

Glick JV Portfolio as of September 30, 2023


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028	$	2,000	$	1,960	$	1,978
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025	574		568		564		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025	3,746		3,709		3,678		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025	6,230		6,185		5,819		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028	2,478		2,367		2,307
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028	2,860		2,825		2,514		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026	2,895		2,866		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.42%		2/28/2028	2,993		2,913		2,997
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025	907		705		654		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027	1,716		1,692		1,616		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(12)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028	2,078		2,039		1,570		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028	1,980		1,899		1,924
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028	995		942		968
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029	2,423		2,244		2,158
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029	1,772		1,674		1,744
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026	3,628		3,586		3,478		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	3,363		3,332		3,282		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	800		795		780		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029	2,766		2,607		2,741		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029	2,841		2,820		2,841
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027	2,460		2,435		2,410		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029	2,970		2,922		2,899		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028	3,930		3,891		3,301		(4)


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029	$	3,960	$	3,865	$	3,759	(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026	3,910		3,866		3,915
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027	2,250		2,210		1,770		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%		8/15/2028	4,500		4,350		4,349
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%		10/14/2027	3,930		3,877		3,876
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026	1,630		1,616		1,596		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(3)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%		3/31/2025	5,198		5,192		5,159
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%		9/25/2026	3,849		3,830		3,843
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%		12/17/2027	683		650		676
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%		12/18/2028	2,842		2,799		2,586		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%		4/6/2027	5,182		5,029		4,964		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%		4/6/2027	226		216		211		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%		4/27/2024	6,029		6,025		4,110
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%		4/27/2024	103		102		70
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%		10/5/2027	3,292		3,275		3,276
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%		11/20/2028	4,913		4,840		4,843		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%		4/5/2029	5,227		5,032		5,224
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%		9/27/2030	4,000		3,939		3,916
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%		3/30/2029	2,641		2,439		2,544
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%		12/29/2028	2,993		2,948		2,914		(4)
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%		9/21/2027	3,843		3,756		3,712		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%		4/30/2025	983		960		927		(4)
Total Portfolio Investments								$	130,589	$	127,788	$	123,343

__________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for all of the floating rate loans is indexed to SOFR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day SOFR at 5.32% and the 90-day SOFR at 5.39%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2023.

Schedule of Financial Instruments Carried at Fair Value

The following table presents the financial instruments carried at fair value as of December 31, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	212,113	$	2,393,175	$	—	$	2,605,288
Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes)	—		42,419		196,360		—		238,779
Investments in equity securities (preferred)	—		—		69,261		—		69,261
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,416		3,894		67,327		29,587		105,224
Total investments at fair value	4,416		258,426		2,726,123		29,587		3,018,552
Cash equivalents	8,722		—		—		—		8,722
Total assets at fair value	$	13,138	$	258,426	$	2,726,123	$	29,587	$	3,027,274
Derivative liability	$	—	$	29,316	$	—	$	—	$	29,316
Total liabilities at fair value	$	—	$	29,316	$	—	$	—	$	29,316

__________

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	208,694	$	2,292,691	$	—	$	2,501,385
Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes)	—		28,666		189,724		—		218,390
Investments in equity securities (preferred)	—		—		86,057		—		86,057
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,317		1,953		51,440		28,878		86,588
Total investments at fair value	4,317		239,313		2,619,912		28,878		2,892,420
Cash equivalents	83,262		—		—		—		83,262
Derivative assets	—		4,910		—		—		4,910
Total assets at fair value	$	87,579	$	244,223	$	2,619,912	$	28,878	$	2,980,592
Derivative liability	$	—	$	47,519	$	—	$	—	$	47,519
Total liabilities at fair value	$	—	$	47,519	$	—	$	—	$	47,519

__________

Schedule of Roll-Forward in the Changes in Fair Value

The following table provides a roll-forward in the changes in fair value from September 30, 2023 to December 31, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors:


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs and CLO Notes)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2023	$	2,292,691	$	189,724	$	86,057	$	51,440	$	2,619,912
Purchases	281,278		14,639		4,440		—		300,357
Sales and repayments	(172,647)		(4,932)		—		(786)		(178,365)
Transfers in (a)(b)	17,121		—		—		17,330		34,451
Transfers out (b)	(16,172)		(4,657)		(1,159)		—		(21,988)
Capitalized PIK interest income	3,835		13		—		—		3,848
Accretion of OID	4,005		298		—		—		4,303
Net unrealized appreciation (depreciation)	(7,904)		1,229		(20,077)		662		(26,090)
Net realized gains (losses)	(9,032)		46		—		(1,319)		(10,305)
Fair value as of December 31, 2023	$	2,393,175	$	196,360	$	69,261	$	67,327	$	2,726,123
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2023	$	(18,446)	$	648	$	(20,231)	$	(1,444)	$	(39,473)

__________

(a) There was a $12.4 million transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) There were investment restructurings during the three months ended December 31, 2023 in which (1) $16.2 million of

Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt and (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity.

The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors:


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs and CLO Notes)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases	177,599		21,104		2,579		2,181		203,463
Sales and repayments	(55,885)		(699)		—		(48)		(56,632)
Transfers in (a)	19,075		—		—		—		19,075
Capitalized PIK interest income	5,763		6		—		—		5,769
Accretion of OID	4,114		398		—		—		4,512
Net unrealized appreciation (depreciation)	(12,271)		(566)		(1,477)		4,505		(9,809)
Net realized gains (losses)	(1,159)		—		—		46		(1,113)
Fair value as of December 31, 2022	$	2,047,842	$	179,631	$	80,625	$	26,642	$	2,334,740
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022	$	(12,398)	$	(566)	$	(1,477)	$	4,505	$	(9,936)

__________

(a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

Schedule of Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2023:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

1,966,262

Market Yield

(b)

9.0%

40.0%

14.3%

18,042

Enterprise Value

Revenue Multiple

(c)

0.2x

0.4x

0.3x

77,424

Enterprise Value

EBITDA Multiple

(c)

2.3x

9.8x

6.0x

132,614

Transaction Precedent

Transaction Price

(d)

N/A

198,833

Broker quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

32,747

Market Yield

(b)

10.0%

23.0%

10.3%

Debt Investments in the JVs

163,613

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

42,156

Enterprise Value

Revenue Multiple

(c)

0.4x

3.2x

0.6x

88,566

Enterprise Value

EBITDA Multiple

(c)

1.7x

15.1x

6.3x

1,001

Enterprise Value

Asset Multiple

(c)

1.0x

1.5x

1.4x

4,865

Transaction Precedent

Transaction Price

(d)

N/A

Total

2,726,123

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

1,904,140

Market Yield

(b)

9.0%

32.0%

14.7%

64,802

Enterprise Value

EBITDA Multiple

(c)

3.0x

6.0x

4.6x

33,816

Transaction Precedent

Transaction Price

(d)

N/A

289,933

Broker quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

22,881

Market Yield

(b)

10.0%

22.0%

11.2%

4,170

Broker Quotations

Broker Quoted Price

(e)

N/A

Debt Investments in the JVs

162,673

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

32,318

Enterprise Value

Revenue Multiple

(c)

0.4x

3.2x

0.5x

103,661

Enterprise Value

EBITDA Multiple

(c)

1.7x

15.1x

8.8x

1,097

Enterprise Value

Asset Multiple

(c)

1.0x

1.4x

421

Transaction Precedent

Transaction Price

(d)

N/A

Total

2,619,912

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

Schedule of Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 2023 and the level of each financial liability within the fair value hierarchy:


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	298,554		291,204		—		291,204		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	316,745		315,147		—		315,147		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	297,418		310,425		—		310,425		—
Total	$	1,622,717	$	1,626,776	$	—	$	916,776	$	710,000

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy:


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	298,241		286,437		—		286,437		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	306,412		301,784		—		301,784		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	286,078		289,980		—		289,980		—
Total	$	1,600,731	$	1,588,201	$	—	$	878,201	$	710,000

Schedule of Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:


	December 31, 2023				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,703,890	84.82	%	$	2,594,640	85.24	%
Debt investments in the JVs	163,277		5.12	%	162,986		5.35	%
Preferred equity	102,877		3.23	%	99,597		3.27	%
Common equity and warrants	87,328		2.74	%	72,261		2.37	%
Subordinated debt	75,587		2.37	%	59,844		1.97	%
LLC equity interests of the JVs	54,791		1.72	%	54,791		1.80	%
Total	$	3,187,750	100.00	%	$	3,044,119	100.00	%


	December 31, 2023						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,605,288	86.31	%	172.36	%	$	2,501,385	86.47	%	165.01	%
Debt investments in the JVs	163,613		5.42	%	10.82	%	162,673		5.62	%	10.73	%
Common equity and warrants	75,637		2.51	%	5.00	%	57,710		2.00	%	3.81	%
Subordinated debt	75,166		2.49	%	4.97	%	55,717		1.93	%	3.68	%
Preferred equity	69,261		2.29	%	4.58	%	86,057		2.98	%	5.68	%
LLC equity interests of the JVs	29,587		0.98	%	1.96	%	28,878		1.00	%	1.91	%
Total	$	3,018,552	100.00	%	199.69	%	$	2,892,420	100.00	%	190.82	%

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:


	December 31, 2023				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Northeast	$	1,054,445	33.08	%	$	1,012,955	33.27	%
West	417,364		13.09	%	393,390		12.92	%
Southeast	412,397		12.94	%	375,247		12.33	%
International	370,987		11.64	%	418,595		13.75	%
Midwest	365,262		11.46	%	360,506		11.84	%
South	222,299		6.97	%	202,374		6.65	%
Southwest	216,429		6.79	%	153,318		5.04	%
Northwest	128,567		4.03	%	127,734		4.20	%
Total	$	3,187,750	100.00	%	$	3,044,119	100.00	%


	December 31, 2023						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	964,560	31.95	%	63.80	%	$	945,422	32.69	%	62.37	%
West	398,128		13.19	%	26.34	%	384,055		13.28	%	25.34	%
Southeast	385,269		12.76	%	25.49	%	354,444		12.25	%	23.38	%
International	374,156		12.40	%	24.75	%	414,079		14.32	%	27.32	%
Midwest	357,502		11.84	%	23.65	%	350,620		12.12	%	23.13	%
South	216,121		7.16	%	14.30	%	188,541		6.52	%	12.44	%
Southwest	196,779		6.52	%	13.02	%	130,455		4.51	%	8.61	%
Northwest	126,037		4.18	%	8.34	%	124,804		4.31	%	8.23	%
Total	$	3,018,552	100.00	%	199.69	%	$	2,892,420	100.00	%	190.82	%

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023:


	December 31, 2023	September 30, 2023
Senior secured loans (1)	$334,754	$332,637
Weighted average interest rate on senior secured loans (2)	10.57%	10.62%
Number of borrowers in SLF JV I	52	48
Largest exposure to a single borrower (1)	$11,220	$11,286
Total of five largest loan exposures to borrowers (1)	$51,354	$54,051

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023:


	December 31, 2023	September 30, 2023
Senior secured loans (1)	$130,946	$130,589
Weighted average current interest rate on senior secured loans (2)	10.58%	10.77%
Number of borrowers in the Glick JV	42	38
Largest loan exposure to a single borrower (1)	$6,147	$6,230
Total of five largest loan exposures to borrowers (1)	$27,867	$28,396

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


(Share amounts in thousands)	Three months ended December 31, 2023	Three months ended December 31, 2022 (6)
Net asset value per share at beginning of period	$19.63	$20.38
Net investment income (1)	0.57	0.63
Net unrealized appreciation (depreciation) (1)	(0.33)	(0.38)
Net realized gains (losses) (1)	(0.11)	(0.05)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	0.01
Distributions of net investment income to stockholders	(0.62)	(0.96)
Net asset value per share at end of period	$19.14	$19.63
Per share market value at beginning of period	$20.12	$18.00
Per share market value at end of period	$20.42	$20.61
Total return (2)	4.70%	19.90%
Common shares outstanding at beginning of period	77,225	61,125
Common shares outstanding at end of period	78,965	61,220
Net assets at beginning of period	$1,515,764	$1,245,563
Net assets at end of period	$1,511,651	$1,201,989
Average net assets (3)	$1,524,243	$1,241,806
Ratio of net investment income to average net assets (7)	11.50%	12.40%
Ratio of total expenses to average net assets (7)	14.39%	13.11%
Ratio of net expenses to average net assets (7)	14.00%	12.87%
Ratio of portfolio turnover to average investments at fair value	7.36%	4.24%
Weighted average outstanding debt (4)	$1,660,435	$1,441,326
Average debt per share (1)	$21.33	$23.57
Asset coverage ratio at end of period (5)	188.66%	176.31%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			Interim periods are annualized.

Summarized Financial Information

Below is certain summarized financial information for SLF JV I as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022:


	December 31, 2023		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost December 31, 2023: $334,451; cost September 30, 2023: $331,808)	$	325,769	$	322,179
Cash and cash equivalents	35,218		31,950
Restricted cash	363		2,987
Other assets	11,408		18,988
Total assets	$	372,758	$	376,104

Senior credit facility payable	$	149,000	$	149,000
Secured borrowings	30,760		38,845
SLF JV I Notes payable at fair value (proceeds December 31, 2023: $128,750; proceeds September 30, 2023: $128,750)	128,750		128,750
Other liabilities	30,648		26,630
Total liabilities	$	339,158	$	343,225
Members' equity	33,600		32,879
Total liabilities and members' equity	$	372,758	$	376,104


	Three months ended December 31, 2023		Three months ended December 31, 2022
Selected Statements of Operations Information:
Interest income	$	9,708	$	8,781
Other income	57		—
Total investment income	9,765		8,781
Senior credit facility and secured borrowing interest expense	3,906		3,709
SLF JV I Notes interest expense	4,093		2,982
Other expenses	71		69
Total expenses (1)	8,070		6,760
Net investment income	1,695		2,021
Net unrealized appreciation (depreciation)	947		(2,207)
Net realized gains (losses)	(322)		(992)
Net income (loss)	$	2,320	$	(1,178)

__________

(1) There are no management fees or incentive fees charged at SLF JV I.

Below is certain summarized financial information for the Glick JV as of December 31, 2023 and September 30, 2023 and for the three months ended December 31, 2023 and 2022:


	December 31, 2023		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost December 31, 2023: $128,333; cost September 30, 2023: $127,788)	$	124,492	$	123,343
Cash and cash equivalents	8,953		12,119
Restricted cash	194		184
Other assets	5,537		5,521
Total assets	$	139,176	$	141,167

Senior credit facility payable	$	53,000	$	53,000
Glick JV Notes payable at fair value (proceeds December 31, 2023: $66,685; proceeds September 30, 2023: $66,685)	58,259		57,201
Secured borrowings	12,965		18,106
Other liabilities	14,952		12,860
Total liabilities	$	139,176	$	141,167
Members' equity	—		—
Total liabilities and members' equity	$	139,176	$	141,167


	Three months ended December 31, 2023		Three months ended December 31, 2022
Selected Statements of Operations Information:
Interest income	$	3,798	$	3,403
Fee income	25		—
Total investment income	3,823		3,403
Senior credit facility and secured borrowing interest expense	1,452		1,285
Glick JV Notes interest expense	1,694		1,324
Other expenses	37		53
Total expenses (1)	3,183		2,662
Net investment income	640		741
Net unrealized appreciation (depreciation)	(453)		(651)
Realized gain (loss)	(187)		(90)
Net income (loss)	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

Share Data and Net Assets - Schedule of Common Stock Issued and Sold (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Changes in Net Assets [Line Items]
Gross Proceeds	$ 32,398	$ 0
Placement Agent Fees	$ 85	$ 0
At the Market
Investment Company, Changes in Net Assets [Line Items]
Number of Shares Issued (in shares)	1,641,416
Gross Proceeds	$ 32,725
Placement Agent Fees	327
Net Proceeds	$ 32,398
Average Sales Price per Share (in dollars per share)	$ 19.94
Net proceeds excluding offering costs	$ 100

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Stockholders' Equity Note [Abstract]

Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Schedule of Investments [Line Items]
Derivative assets	$ 0			$ 4,910
Derivative liability at fair value	(29,316)			(47,519)
Foreign currency forward contract
Schedule of Investments [Line Items]
Derivative assets	0			4,910
Derivative liability at fair value	(2,914)			0
Interest rate swap
Schedule of Investments [Line Items]
Derivative assets	4,013			0
Derivative liability at fair value	(30,415)			(47,519)
Derivative assets (liability)	(26,402)
Interest Rate Swap Maturing 2027
Schedule of Investments [Line Items]
Derivative assets	$ (30,415)
Derivative liability at fair value				$ (40,519)
Interest rate	2.70%	2.70%	2.70%	2.70%	2.70%	2.70%
Floating interest rate	1.658%	1.658%	1.658%	1.658%	1.658%	1.658%
Notional amount	$ 350,000			$ 350,000
Interest Rate Swap Maturing 2029
Schedule of Investments [Line Items]
Derivative assets	$ 4,013
Derivative liability at fair value				$ (7,000)
Interest rate	7.10%	7.10%	7.10%	7.10%	7.10%	7.10%
Floating interest rate	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%
Notional amount	$ 300,000			$ 300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024
Schedule of Investments [Line Items]
Notional Amount to be Purchased	36,775
Notional Amount to be Sold \| €		€ 34,350
Derivative assets	0
Derivative liability at fair value	(1,227)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased				42,182
Notional Amount to be Sold \| €		€ 34,350			€ 38,026
Derivative assets				1,857
Derivative liability at fair value	(1,227)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024
Schedule of Investments [Line Items]
Notional Amount to be Purchased	47,403
Notional Amount to be Sold \| £			£ 38,500
Derivative assets	0
Derivative liability at fair value	(1,687)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased				72,098
Notional Amount to be Sold \| £						£ 56,556
Derivative assets				3,053
Derivative liability at fair value	(1,687)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Schedule of Investments [Line Items]
Derivative assets	4,013			0
Derivative liability at fair value	0			(7,000)
Notional amount	300,000			300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Schedule of Investments [Line Items]
Derivative assets	0			0
Derivative liability at fair value	(30,415)			(40,519)
Notional amount	$ 350,000			$ 350,000

Share Data and Net Assets (Tables)

3 Months Ended

Dec. 31, 2023

Schedule of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three months ended December 31, 2023 and 2022:


(Share amounts in thousands)	Three months ended December 31, 2023		Three months ended December 31, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	10,535	$	13,172
Weighted average common shares outstanding — basic and diluted	77,840		61,142
Earnings (loss) per common share — basic and diluted	$	0.14	$	0.22

Schedule of Changes in Net Assets

The following table presents the changes in net assets for the three months ended December 31, 2023:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2023	77,225	$	772	$	2,166,330	$	(651,338)	$	1,515,764
Net investment income	—	—		—		44,189		44,189
Net unrealized appreciation (depreciation)	—	—		—		(25,025)		(25,025)
Net realized gains (losses)	—	—		—		(8,453)		(8,453)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(176)		(176)
Distributions to stockholders	—	—		—		(48,897)		(48,897)
Issuance of common stock in connection with the "at the market" offering	1,641	17		32,296		—		32,313
Issuance of common stock under dividend reinvestment plan	99	1		1,935		—		1,936
Balance as of December 31, 2023	78,965	$	790	$	2,200,561	$	(689,700)	$	1,511,651

The following table presents the changes in net assets for the three months ended December 31, 2022:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2022	61,125	$	611	$	1,827,721	$	(582,769)	$	1,245,563
Net investment income	—	—		—		38,808		38,808
Net unrealized appreciation (depreciation)	—	—		—		(22,982)		(22,982)
Net realized gains (losses)	—	—		—		(3,203)		(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		549		549
Distributions to stockholders	—	—		—		(58,679)		(58,679)
Issuance of common stock under dividend reinvestment plan	95	1		1,932		—		1,933
Balance as of December 31, 2022	61,220	$	612	$	1,829,653	$	(628,276)	$	1,201,989

Schedule of Distributions


Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value
Quarterly	November 8, 2023	December 15, 2023	December 29, 2023	$	0.55	$	41.7	million	87,472	(1)	$	1.7	million
Special	November 8, 2023	December 15, 2023	December 29, 2023	$	0.07	$	5.3	million	11,133	(1)	$	0.2	million
Total for the three months ended December 31, 2023				$	0.62	$	47.0	million	98,605		$	1.9	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	$	0.42	$	24.8	million	41,510	(1)	$	0.8	million
Total for the three months ended December 31, 2022				$	0.96	$	56.8	million	94,879		$	1.9	million

__________

(1) New shares were issued and distributed.

Schedule of Common Stock Issued and Sold


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	1,641,416	$	32,725	$	327	$	32,398	$	19.94

(1) Net proceeds excludes offering costs of $0.1 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

Borrowings (Tables)

3 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Components of Debt

The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023:


	As of December 31, 2023						As of September 30, 2023
($ in millions)	2025 Notes		2027 Notes		2029 Notes		2025 Notes		2027 Notes		2029 Notes
Principal	$	300.0	$	350.0	$	300.0	$	300.0	$	350.0	$	300.0
Unamortized financing costs	(0.9)		(2.3)		(3.4)		(1.1)		(2.5)		(3.5)
Unaccreted discount	(0.6)		(0.5)		(3.2)		(0.7)		(0.6)		(3.4)
Interest rate swap fair value adjustment	—		(30.4)		4.0		—		(40.5)		(7.0)
Net carrying value	$	298.5	$	316.8	$	297.4	$	298.2	$	306.4	$	286.1
Fair Value	$	291.2	$	315.1	$	310.4	$	286.4	$	301.8	$	290.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023:


($ in millions)	2025 Notes				2027 Notes			2029 Notes
Coupon interest		$	2.6		$	2.4		$	5.3
Amortization of financing costs and discount		0.3			0.2			0.3
Effect of interest rate swap		—			4.2			1.2
Total interest expense		$	2.9		$	6.8		$	6.8
Coupon interest rate (net of effect of interest rate swaps)		3.500		%	7.455		%	8.679		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:


($ in millions)	2025 Notes				2027 Notes
Coupon interest		$	2.6		$	2.4
Amortization of financing costs and discount		0.3			0.2
Effect of interest rate swap		—			2.5
Total interest expense		$	2.9		$	5.1
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)		3.500		%	5.586		%

Organization	3 Months Ended
Organization	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams. On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”). On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Company as the surviving company (the “OSI2 Merger”).

Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
2025 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.6	$ 2.6
Amortization of financing costs and discount	0.3	0.3
Effect of interest rate swap	0.0	0.0
Total interest expense	$ 2.9	$ 2.9
Coupon interest rate	3.50%	3.50%
2027 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.4	$ 2.4
Amortization of financing costs and discount	0.2	0.2
Effect of interest rate swap	4.2	2.5
Total interest expense	$ 6.8	$ 5.1
Coupon interest rate	7.455%	5.586%
2029 Notes
Debt Instrument [Line Items]
Coupon interest	$ 5.3
Amortization of financing costs and discount	0.3
Effect of interest rate swap	1.2
Total interest expense	$ 6.8
Coupon interest rate	8.679%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482900/835-30-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Financial Highlights (Tables)

3 Months Ended

Dec. 31, 2023

Schedule of Financial Highlights


	December 31, 2023				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,703,890	84.82	%	$	2,594,640	85.24	%
Debt investments in the JVs	163,277		5.12	%	162,986		5.35	%
Preferred equity	102,877		3.23	%	99,597		3.27	%
Common equity and warrants	87,328		2.74	%	72,261		2.37	%
Subordinated debt	75,587		2.37	%	59,844		1.97	%
LLC equity interests of the JVs	54,791		1.72	%	54,791		1.80	%
Total	$	3,187,750	100.00	%	$	3,044,119	100.00	%


	December 31, 2023						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,605,288	86.31	%	172.36	%	$	2,501,385	86.47	%	165.01	%
Debt investments in the JVs	163,613		5.42	%	10.82	%	162,673		5.62	%	10.73	%
Common equity and warrants	75,637		2.51	%	5.00	%	57,710		2.00	%	3.81	%
Subordinated debt	75,166		2.49	%	4.97	%	55,717		1.93	%	3.68	%
Preferred equity	69,261		2.29	%	4.58	%	86,057		2.98	%	5.68	%
LLC equity interests of the JVs	29,587		0.98	%	1.96	%	28,878		1.00	%	1.91	%
Total	$	3,018,552	100.00	%	199.69	%	$	2,892,420	100.00	%	190.82	%


	December 31, 2023				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Northeast	$	1,054,445	33.08	%	$	1,012,955	33.27	%
West	417,364		13.09	%	393,390		12.92	%
Southeast	412,397		12.94	%	375,247		12.33	%
International	370,987		11.64	%	418,595		13.75	%
Midwest	365,262		11.46	%	360,506		11.84	%
South	222,299		6.97	%	202,374		6.65	%
Southwest	216,429		6.79	%	153,318		5.04	%
Northwest	128,567		4.03	%	127,734		4.20	%
Total	$	3,187,750	100.00	%	$	3,044,119	100.00	%


	December 31, 2023						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	964,560	31.95	%	63.80	%	$	945,422	32.69	%	62.37	%
West	398,128		13.19	%	26.34	%	384,055		13.28	%	25.34	%
Southeast	385,269		12.76	%	25.49	%	354,444		12.25	%	23.38	%
International	374,156		12.40	%	24.75	%	414,079		14.32	%	27.32	%
Midwest	357,502		11.84	%	23.65	%	350,620		12.12	%	23.13	%
South	216,121		7.16	%	14.30	%	188,541		6.52	%	12.44	%
Southwest	196,779		6.52	%	13.02	%	130,455		4.51	%	8.61	%
Northwest	126,037		4.18	%	8.34	%	124,804		4.31	%	8.23	%
Total	$	3,018,552	100.00	%	199.69	%	$	2,892,420	100.00	%	190.82	%

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2023 and September 30, 2023:


	December 31, 2023	September 30, 2023
Senior secured loans (1)	$334,754	$332,637
Weighted average interest rate on senior secured loans (2)	10.57%	10.62%
Number of borrowers in SLF JV I	52	48
Largest exposure to a single borrower (1)	$11,220	$11,286
Total of five largest loan exposures to borrowers (1)	$51,354	$54,051

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 2023 and September 30, 2023:


	December 31, 2023	September 30, 2023
Senior secured loans (1)	$130,946	$130,589
Weighted average current interest rate on senior secured loans (2)	10.58%	10.77%
Number of borrowers in the Glick JV	42	38
Largest loan exposure to a single borrower (1)	$6,147	$6,230
Total of five largest loan exposures to borrowers (1)	$27,867	$28,396

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


(Share amounts in thousands)	Three months ended December 31, 2023	Three months ended December 31, 2022 (6)
Net asset value per share at beginning of period	$19.63	$20.38
Net investment income (1)	0.57	0.63
Net unrealized appreciation (depreciation) (1)	(0.33)	(0.38)
Net realized gains (losses) (1)	(0.11)	(0.05)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	0.01
Distributions of net investment income to stockholders	(0.62)	(0.96)
Net asset value per share at end of period	$19.14	$19.63
Per share market value at beginning of period	$20.12	$18.00
Per share market value at end of period	$20.42	$20.61
Total return (2)	4.70%	19.90%
Common shares outstanding at beginning of period	77,225	61,125
Common shares outstanding at end of period	78,965	61,220
Net assets at beginning of period	$1,515,764	$1,245,563
Net assets at end of period	$1,511,651	$1,201,989
Average net assets (3)	$1,524,243	$1,241,806
Ratio of net investment income to average net assets (7)	11.50%	12.40%
Ratio of total expenses to average net assets (7)	14.39%	13.11%
Ratio of net expenses to average net assets (7)	14.00%	12.87%
Ratio of portfolio turnover to average investments at fair value	7.36%	4.24%
Weighted average outstanding debt (4)	$1,660,435	$1,441,326
Average debt per share (1)	$21.33	$23.57
Asset coverage ratio at end of period (5)	188.66%	176.31%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			Interim periods are annualized.

Schedule 12-14

3 Months Ended

Dec. 31, 2023

Investments in and Advances to Affiliates [Abstract]

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Three months ended December 31, 2023


Portfolio Company (1)	Industry	Investment Type	Index	Spread		Cash		PIK Rate		Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2023		Gross Additions (3)		Gross Reductions (4)		Fair Value at December 31, 2023		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock									829				$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity									34,984,460				—		—		27,638		—		—		27,638		1.8	%
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	Common Stock									22,267,661				—		—		—		16,173		—		16,173		1.1	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.50	%			8/28/2025			$	14,033	—		391		14,068		—		(35)		14,033		0.9	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.46	%			8/28/2025			1,393		—		58		2,090		—		(696)		1,394		0.1	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00	%	10.50	%			8/28/2025			5,574		—		150		5,574		—		—		5,574		0.4	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock									30,031				—		—		2,711		—		—		2,711		0.2	%
First Star Speir Aviation Limited	Airlines	Equity Interest													786		—		—		—		—		—		—	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	SOFR+	4.50	%	9.94	%			10/20/2028			58,349		—		1,773		50,017		940		—		50,957		3.4	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest									87.50	%			—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	SOFR+	7.00	%	12.44	%			12/29/2028			112,656		—		3,581		112,656		—		—		112,656		7.5	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest									87.50	%			—		1,400		28,878		709		—		29,587		2.0	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			16,355		—		540		15,874		534		(53)		16,355		1.1	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			3,005		—		69		1,359		1,646		—		3,005		0.2	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Common Stock									1,184,630				—		—		36,226		—		—		36,226		2.4	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Warrants									66,686				—		—		—		—		—		—		—	%
Total Control Investments													$	211,365	$	786	$	7,962	$	297,091	$	20,002	$	(784)	$	316,309	20.9	%

Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver													—		329		21,823		33		(21,856)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock									12,463,242				—		—		89		1,159		(251)		997		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity													—		—		1,005		154		(1,159)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Warrants									78,045				—		—		—		—		—		—		—	%
The Avery	Real Estate Operating Companies	First Lien Term Loan						10.00	%	12/15/2024			5,065		—		—		—		4,657		(367)		4,290		0.3	%
The Avery	Real Estate Operating Companies	First Lien Term Loan						10.00	%	12/15/2024			20,871		—		—		—		19,217		(494)		18,723		1.2	%
The Avery	Real Estate Operating Companies	Membership Interest									6.40	%	—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity									1,080,398				—		—		432		—		—		432		—	%
Total Affiliate Investments													$	25,936	$	—	$	329	$	23,349	$	25,220	$	(24,127)	$	24,442	1.6	%
Total Control & Affiliate Investments													$	237,301	$	786	$	8,291	$	320,440	$	45,222	$	(24,911)	$	340,751	22.5	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Three months ended December 31, 2022


Portfolio Company (1)	Industry	Investment Type	Index	Spread		Cash		PIK Rate	Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2022		Gross Additions (3)		Gross Reductions (4)		Fair Value at December 31, 2022		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock								829		$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity								34,984,460		—		—		—		27,638		—		—		27,638		2.3	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	LIBOR+	5.00	%	9.73	%		2/28/2024			14,297		—		331		14,333		—		(36)		14,297		1.2	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	LIBOR+	5.00	%				2/28/2024			—		—		14		—		—		—		—		—	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock								30,031		—		—		—		4,946		—		(719)		4,227		0.4	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	LIBOR+	4.50	%	7.67	%		10/20/2028			59,049		—		1,624		50,283		380		(1,127)		49,536		4.1	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	LIBOR+	7.00	%	10.17	%		12/29/2028			112,656		—		2,611		96,250		16,406		—		112,656		9.4	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		1,050		20,715		5,469		(2,076)		24,108		2.0	%
Total Control Investments												$	186,002	$	—	$	5,630	$	214,165	$	22,255	$	(3,958)	$	232,462	19.3	%

Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	LIBOR+	6.75	%	11.48	%		10/17/2023			21,464		—		646		24,225		55		(3,028)		21,252		1.8	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock								1,609,201		—		—		—		370		—		(16)		354		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity								1,019,169		—		—		—		1,223		20		—		1,243		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants								70,425		—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity								1,080,399		—		—		—		378		—		(54)		324		—	%
Total Affiliate Investments												$	21,464	$	—	$	646	$	26,196	$	75	$	(3,098)	$	23,173	1.9	%
Total Control & Affiliate Investments												$	207,466	$	—	$	6,276	$	240,361	$	22,330	$	(7,056)	$	255,635	21.2	%

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments, included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2022.

Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Carrying Value	$ 1,622,717	$ 1,600,731
Fair Value	1,626,776	1,588,201
Syndicated Facility
Schedule of Investments [Line Items]
Carrying Value	430,000	430,000
Fair Value	430,000	430,000
OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Carrying Value	280,000	280,000
Fair Value	280,000	280,000
2025 Notes
Schedule of Investments [Line Items]
Carrying Value	298,554	298,241
Fair Value	291,204	286,437
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	316,745	306,412
Fair Value	315,147	301,784
2029 Notes
Schedule of Investments [Line Items]
Carrying Value	297,418	286,078
Fair Value	310,425	289,980
Level 1
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Fair Value	916,776	878,201
Level 2 \| Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	291,204	286,437
Level 2 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	315,147	301,784
Level 2 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	310,425	289,980
Level 3
Schedule of Investments [Line Items]
Fair Value	710,000	710,000
Level 3 \| Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	430,000	430,000
Level 3 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	280,000	280,000
Level 3 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	$ 0	$ 0

Financial Highlights - Portfolio Composition (Details)
$ / shares in Units, shares in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

USD ($)

$ / shares

Dec. 31, 2022

USD ($)

$ / shares

Investment Company, Financial Highlights [Roll Forward]

Net asset value per share at beginning of period (in dollars per share)

$ 19.63

$ 20.38

Net investment income (in dollars per share)

^[1]

0.57

0.63

Net unrealized appreciation (depreciation) (in dollars per share)

(0.33)

(0.38)

Net realized gains (losses) (in dollars per share)

(0.11)

(0.05)

(Provision) benefit for taxes on realized and unrealized gains (losses) (in dollars per share)

0.01

Distributions of net investment income to stockholders (dollars per share)

(0.62)

(0.96)

Net asset value per share at end of period (in dollars per share)

^[2]

19.14

19.63

Per share market value at beginning of period (in dollars per share)

20.12

18.00

Per share market value at end of period (in dollars per share)

$ 20.42

$ 20.61

Total return

4.70%

19.90%

Common shares outstanding at beginning of period (in shares) | shares

77,225

61,125

Common shares outstanding at end of period (in shares) | shares

^[2]

78,965

61,220

Net assets at beginning of period | $

$ 1,515,764

$ 1,245,563

Net assets at end of period | $

1,511,651

1,201,989

Average net assets | $

$ 1,524,243

$ 1,241,806

Ratio of net investment income to average net assets

11.50%

12.40%

Ratio of total expenses to average net assets

14.39%

13.11%

Ratio of net expenses to average net assets

14.00%

12.87%

Ratio of portfolio turnover to average investments at fair value

7.36%

4.24%

Weighted average outstanding debt | $

$ 1,660,435

$ 1,441,326

Average debt per share (dollars per share)

$ 21.33

$ 23.57

Asset coverage ratio

188.66%

176.31%

Investment Company, Nonconsolidated Subsidiary [Line Items]

0.3333

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.
[2]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Cash equivalents	8,722	83,262
Derivative assets	0	4,910
Total assets at fair value	3,027,274	2,980,592
Derivative liability	29,316	47,519
Total liabilities at fair value	29,316	47,519
Carrying Value	1,622,717	1,600,731
Fair Value	1,626,776	1,588,201
Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,605,288	2,501,385
Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	238,779	218,390
Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	69,261	86,057
Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	105,224	86,588
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	316,745	306,412
Fair Value	315,147	301,784
Level 1
Schedule of Investments [Line Items]
Investments at fair value	4,416	4,317
Cash equivalents	8,722	83,262
Derivative assets		0
Total assets at fair value	13,138	87,579
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value	0	0
Level 1 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	4,416	4,317
Level 1 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Investments at fair value	258,426	239,313
Cash equivalents	0	0
Derivative assets		4,910
Total assets at fair value	258,426	244,223
Derivative liability	29,316	47,519
Total liabilities at fair value	29,316	47,519
Fair Value	916,776	878,201
Level 2 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	212,113	208,694
Level 2 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	42,419	28,666
Level 2 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	3,894	1,953
Level 2 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	315,147	301,784
Level 3
Schedule of Investments [Line Items]
Investments at fair value	2,726,123	2,619,912
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	2,726,123	2,619,912
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value	710,000	710,000
Level 3 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,393,175	2,292,691
Level 3 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	196,360	189,724
Level 3 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	69,261	86,057
Level 3 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	67,327	51,440
Level 3 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Fair Value Measured at Net Asset Value Per Share
Schedule of Investments [Line Items]
Investments at fair value	29,587	28,878
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	29,587	28,878
Derivative liability	0	0
Total liabilities at fair value	0	0
Fair Value Measured at Net Asset Value Per Share \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	$ 29,587	$ 28,878

Fee Income	3 Months Ended
Fee Income	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Fee Income	Fee Income For the three months ended December 31, 2023 and 2022, the Company recorded total fee income of $1.3 million and $2.0 million, respectively, of which $0.2 million and $0.2 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees.

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 226,613	$ 232,740
Debt and Equity Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	199,500	205,600
Amount which can be drawn immediately	$ 165,900	154,200
JV Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments		$ 27,100

Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Northeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,054,445	$ 1,012,955
Investments at fair value	$ 964,560	$ 945,422
Investment owned, percent of net assets	63.80%	62.37%
West
Schedule of Investments [Line Items]
Investment owned, at cost	$ 417,364	$ 393,390
Investments at fair value	$ 398,128	$ 384,055
Investment owned, percent of net assets	26.34%	25.34%
Southeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 412,397	$ 375,247
Investments at fair value	$ 385,269	$ 354,444
Investment owned, percent of net assets	25.49%	23.38%
International
Schedule of Investments [Line Items]
Investment owned, at cost	$ 370,987	$ 418,595
Investments at fair value	$ 374,156	$ 414,079
Investment owned, percent of net assets	24.75%	27.32%
Midwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 365,262	$ 360,506
Investments at fair value	$ 357,502	$ 350,620
Investment owned, percent of net assets	23.65%	23.13%
South
Schedule of Investments [Line Items]
Investment owned, at cost	$ 222,299	$ 202,374
Investments at fair value	$ 216,121	$ 188,541
Investment owned, percent of net assets	14.30%	12.44%
Southwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 216,429	$ 153,318
Investments at fair value	$ 196,779	$ 130,455
Investment owned, percent of net assets	13.02%	8.61%
Northwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 128,567	$ 127,734
Investments at fair value	$ 126,037	$ 124,804
Investment owned, percent of net assets	8.34%	8.23%
Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Cost \| Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Cost \| Geographic Concentration Risk \| Northeast
Schedule of Investments [Line Items]
Concentration risk	33.08%	33.27%
Investment Owned, At Cost \| Geographic Concentration Risk \| West
Schedule of Investments [Line Items]
Concentration risk	13.09%	12.92%
Investment Owned, At Cost \| Geographic Concentration Risk \| Southeast
Schedule of Investments [Line Items]
Concentration risk	12.94%	12.33%
Investment Owned, At Cost \| Geographic Concentration Risk \| International
Schedule of Investments [Line Items]
Concentration risk	11.64%	13.75%
Investment Owned, At Cost \| Geographic Concentration Risk \| Midwest
Schedule of Investments [Line Items]
Concentration risk	11.46%	11.84%
Investment Owned, At Cost \| Geographic Concentration Risk \| South
Schedule of Investments [Line Items]
Concentration risk	6.97%	6.65%
Investment Owned, At Cost \| Geographic Concentration Risk \| Southwest
Schedule of Investments [Line Items]
Concentration risk	6.79%	5.04%
Investment Owned, At Cost \| Geographic Concentration Risk \| Northwest
Schedule of Investments [Line Items]
Concentration risk	4.03%	4.20%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Fair Value \| Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Northeast
Schedule of Investments [Line Items]
Concentration risk	31.95%	32.69%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| West
Schedule of Investments [Line Items]
Concentration risk	13.19%	13.28%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Southeast
Schedule of Investments [Line Items]
Concentration risk	12.76%	12.25%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| International
Schedule of Investments [Line Items]
Concentration risk	12.40%	14.32%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Midwest
Schedule of Investments [Line Items]
Concentration risk	11.84%	12.12%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| South
Schedule of Investments [Line Items]
Concentration risk	7.16%	6.52%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Southwest
Schedule of Investments [Line Items]
Concentration risk	6.52%	4.51%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Northwest
Schedule of Investments [Line Items]
Concentration risk	4.18%	4.31%
Senior secured debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,703,890	$ 2,594,640
Investments at fair value	$ 2,605,288	$ 2,501,385
Investment owned, percent of net assets	172.36%	165.01%
Senior secured debt \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	84.82%	85.24%
Senior secured debt \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	86.31%	86.47%
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 163,277	$ 162,986
Investments at fair value	$ 163,613	$ 162,673
Investment owned, percent of net assets	10.82%	10.73%
Debt investments in the JVs \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.12%	5.35%
Debt investments in the JVs \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.42%	5.62%
Preferred equity
Schedule of Investments [Line Items]
Investment owned, at cost	$ 102,877	$ 99,597
Investments at fair value	$ 69,261	$ 86,057
Investment owned, percent of net assets	4.58%	5.68%
Preferred equity \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.23%	3.27%
Preferred equity \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.29%	2.98%
Common equity and warrants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 87,328	$ 72,261
Investments at fair value	$ 75,637	$ 57,710
Investment owned, percent of net assets	5.00%	3.81%
Common equity and warrants \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.74%	2.37%
Common equity and warrants \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.51%	2.00%
Subordinated debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 75,587	$ 59,844
Investments at fair value	$ 75,166	$ 55,717
Investment owned, percent of net assets	4.97%	3.68%
Subordinated debt \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.37%	1.97%
Subordinated debt \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.49%	1.93%
LLC equity interests of the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,791	$ 54,791
Investments at fair value	$ 29,587	$ 28,878
Investment owned, percent of net assets	1.96%	1.91%
LLC equity interests of the JVs \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.72%	1.80%
LLC equity interests of the JVs \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.98%	1.00%

Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			$ 558,300
Valuation allowance	$ 8,200
Deferred tax assets	8,200
(Provision) benefit for taxes on realized and unrealized gains (losses)	$ 176	$ (549)
Cost of investments			3,070,000
Unrealized appreciation			529,500
Unrealized depreciation			704,500
Unrealized appreciation (depreciation)			175,000
Short-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			70,300
Long-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net			$ 488,000

Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Total investment income	$ 97,985	$ 79,179
Interest expense	32,170	20,719
Total expenses	55,296	41,043
Net investment income before taxes	44,189	38,886
Net increase (decrease) in net assets resulting from operations	10,535	13,172
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	9,708	8,781
Fee income	57	0
Total investment income	9,765	8,781
Other expenses	71	69
Total expenses	8,070	6,760
Net investment income before taxes	1,695	2,021
Net unrealized appreciation (depreciation)	947	(2,207)
Realized gain (loss)	(322)	(992)
Net increase (decrease) in net assets resulting from operations	2,320	(1,178)
SLF JV I \| Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	3,906	3,709
SLF JV I \| SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	4,093	2,982
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	3,798	3,403
Fee income	25	0
Total investment income	3,823	3,403
Other expenses	37	53
Total expenses	3,183	2,662
Net investment income before taxes	640	741
Net unrealized appreciation (depreciation)	(453)	(651)
Realized gain (loss)	(187)	(90)
Net increase (decrease) in net assets resulting from operations	0	0
OCSI Glick JV LLC \| Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,452	1,285
OCSI Glick JV LLC \| Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	$ 1,694	$ 1,324

Consolidated Schedule of Investments - Parenthetical	12 Months Ended
Consolidated Schedule of Investments - Parenthetical	Sep. 30, 2023 $ / shares
Schedule of Investments [Line Items]
Percentage of total assets representing qualifying assets	74.30%
Percentage of total assets representing non-qualifying assets	25.70%
Minimum
Schedule of Investments [Line Items]
Debt instrument, floor interest rate	0.00%
Maximum
Schedule of Investments [Line Items]
Debt instrument, floor interest rate	2.75%
Share-Based Payment Arrangement, Tranche One
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 15.00
Investment owned, balance, shares, VWAP number of trading days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days
Share-Based Payment Arrangement, Tranche Two
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)	$ 20.00
Investment owned, balance, shares, VWAP number of trading days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days

Portfolio Investments - Portfolio Listing (Details)
€ in Thousands, £ in Thousands, $ in Thousands

Dec. 31, 2023

USD ($)

Dec. 31, 2023

EUR (€)

Dec. 31, 2023

GBP (£)

Sep. 30, 2023

USD ($)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

Dec. 31, 2022

USD ($)

Sep. 30, 2022

USD ($)

$ 3,187,750

$ 3,044,119

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 3,018,552

$ 2,892,420

Minimum

Investment Company, Nonconsolidated Subsidiary [Line Items]

0.00%

Maximum

Investment Company, Nonconsolidated Subsidiary [Line Items]

2.75%

SLF JV I

$ 334,754

$ 332,637

334,451

331,808

Investment Company, Nonconsolidated Subsidiary [Line Items]

$ 325,769

$ 322,179

SLF JV I | Minimum

Investment Company, Nonconsolidated Subsidiary [Line Items]

0.00%

SLF JV I | Maximum

Investment Company, Nonconsolidated Subsidiary [Line Items]

1.00%

OCSI Glick JV LLC

$ 130,946

$ 130,589

128,333

127,788

OCSI Glick JV LLC | Minimum

$ 124,492

$ 123,343

Investment Company, Nonconsolidated Subsidiary [Line Items]

OCSI Glick JV LLC | Maximum

0.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

1.00%

Investment Company, Nonconsolidated Subsidiary [Line Items]

12.50%

^{[1],[2],[3],[4],[5]}

12.50%

^{[1],[2],[3],[4],[5]}

12.50%

^{[1],[2],[3],[4],[5]}

12.50%

^{[6],[7],[8],[9],[10]}

12.50%

^{[6],[7],[8],[9],[10]}

12.50%

^{[6],[7],[8],[9],[10]}

$ 1,269

^{[1],[2],[3],[11]}

$ 1,269

^{[6],[7],[9],[12]}

1,251

^[1],[2],[3]

1,240

^[6],[7],[9]

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

$ 1,228

^[1],[2],[3]

$ 1,214

^[6],[7],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.00%

^{[1],[2],[4],[5]}

11.00%

^{[1],[2],[4],[5]}

11.00%

^{[1],[2],[4],[5]}

11.00%

^{[6],[8],[9],[10]}

11.00%

^{[6],[8],[9],[10]}

11.00%

^{[6],[8],[9],[10]}

$ 18,869

^[1],[2],[11]

$ 18,869

^[6],[9],[12]

18,691

^[1],[2]

18,687

^[6],[9]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

$ 18,443

^[1],[2]

$ 18,443

^[6],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12.00%

^{[1],[2],[3],[4],[5]}

12.00%

^{[1],[2],[3],[4],[5]}

12.00%

^{[1],[2],[3],[4],[5]}

12.00%

^{[6],[7],[8],[9],[10]}

12.00%

^{[6],[7],[8],[9],[10]}

12.00%

^{[6],[7],[8],[9],[10]}

$ 4,274

^{[1],[2],[3],[11]}

$ 4,070

^{[6],[7],[9],[12]}

4,256

^[1],[2],[3]

4,038

^[6],[7],[9]

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

$ 4,210

^[1],[2],[3]

$ 4,022

^[6],[7],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

14.25%

^{[1],[4],[5],[13],[14]}

14.25%

^{[1],[4],[5],[13],[14]}

14.25%

^{[1],[4],[5],[13],[14]}

14.25%

^{[8],[9],[10],[15],[16]}

14.25%

^{[8],[9],[10],[15],[16]}

14.25%

^{[8],[9],[10],[15],[16]}

$ 21,434

^{[1],[11],[13],[14]}

$ 21,434

^{[9],[12],[15],[16]}

21,604

^{[1],[13],[14]}

21,612

^{[9],[15],[16]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

$ 21,273

^{[1],[13],[14]}

$ 21,220

^{[9],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

22.50%

^[1],[13]

22.50%

^[1],[13]

22.50%

^[1],[13]

20.00%

^[9],[15]

20.00%

^[9],[15]

20.00%

^[9],[15]

$ 6,329

^{[1],[11],[13]}

$ 6,021

^{[9],[12],[15]}

6,295

^[1],[13]

6,013

^[9],[15]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

$ 6,219

^[1],[13]

$ 5,900

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

12.11%

^[1],[4],[5]

12.11%

^[1],[4],[5]

12.11%

^[1],[4],[5]

11.90%

^[8],[9],[10]

11.90%

^[8],[9],[10]

11.90%

^[8],[9],[10]

$ 3,373

^[1],[5],[11]

$ 3,446

^[8],[9],[12]

3,343

^[1],[5]

3,411

^[8],[9]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

$ 3,295

^[1],[5]

$ 3,383

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

12.14%

^[1],[4],[5]

12.14%

^[1],[4],[5]

12.14%

^[1],[4],[5]

12.15%

^[8],[9],[10]

12.15%

^[8],[9],[10]

12.15%

^[8],[9],[10]

$ 944

^[1],[5],[11]

$ 17,901

^[8],[9],[12]

931

^[1],[5]

17,743

^[8],[9]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

$ 922

^[1],[5]

$ 17,575

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

12.11%

^[1],[4],[5]

12.11%

^[1],[4],[5]

12.11%

^[1],[4],[5]

12.13%

^[8],[9],[10]

12.13%

^[8],[9],[10]

12.13%

^[8],[9],[10]

$ 17,532

^[1],[5],[11]

$ 963

^[8],[9],[12]

17,394

^[1],[5]

948

^[8],[9]

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | SLF JV I

$ 17,130

^[1],[5]

$ 945

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

12.11%

11.90%

$ 1,124

$ 1,149

1,112

1,135

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

$ 1,098

$ 1,128

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

12.11%

11.90%

$ 562

$ 574

557

568

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | SLF JV I

$ 549

$ 564

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

12.11%

12.15%

$ 6,631

$ 6,771

6,571

6,701

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC

$ 6,479

$ 6,648

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

12.11%

12.15%

$ 3,669

$ 3,746

3,637

3,709

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

$ 3,585

$ 3,678

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5],[13]

7.50%

^[1],[5],[13]

7.50%

^[1],[5],[13]

7.50%

^[8],[9],[15]

7.50%

^[8],[9],[15]

7.50%

^[8],[9],[15]

^{[8],[9],[10],[15]}

13.04%

$ 0

^{[1],[2],[5],[11],[13]}

$ 6,589

^{[8],[9],[12],[15]}

(38)

^{[1],[2],[5],[13]}

6,305

^[8],[9],[15]

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

$ (38)

^{[1],[2],[5],[13]}

$ 6,276

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5],[13]

7.50%

^[1],[5],[13]

7.50%

^[1],[5],[13]

7.50%

^{[6],[8],[9],[15]}

7.50%

^{[6],[8],[9],[15]}

7.50%

^{[6],[8],[9],[15]}

^[4],[5]

13.00%

$ 6,589

^{[1],[5],[11],[13]}

$ 0

^{[6],[8],[9],[12],[15]}

6,317

^[1],[5],[13]

(38)

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

$ 6,276

^[1],[5],[13]

$ (38)

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

28,948

^[1],[13]

28,948

^[1],[13]

28,948

^[1],[13]

28,948

^[9],[15]

28,948

^[9],[15]

28,948

^[9],[15]

$ 174

^[1],[13]

$ 174

^[9],[15]

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

$ 13

^[1],[13]

$ 6

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[15]

5.00%

^{[8],[10],[15]}

8.86%

^{[8],[12],[15]}

€ 5,500

^[8],[15]

$ 6,024

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

^[8],[15]

$ 5,825

Investment Company, Nonconsolidated Subsidiary [Line Items]

17,870

^[1]

17,870

^[1]

17,870

^[1]

17,870

^[9]

17,870

^[9]

17,870

^[9]

$ 1,733

^[1]

$ 1,733

^[9]

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

$ 2,494

^[1]

$ 2,826

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.75%

^[1],[5]

7.75%

^[1],[5]

7.75%

^[1],[5]

7.75%

^[8],[9]

7.75%

^[8],[9]

7.75%

^[8],[9]

13.21%

^[1],[4],[5]

13.21%

^[1],[4],[5]

13.21%

^[1],[4],[5]

13.17%

^[8],[9],[10]

13.17%

^[8],[9],[10]

13.17%

^[8],[9],[10]

$ 16,032

^[1],[5],[11]

$ 17,873

^[8],[9],[12]

15,844

^[1],[5]

17,655

^[8],[9]

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I

$ 15,743

^[1],[5]

$ 17,687

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

$ 0

(7)

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC

$ (30)

$ (29)

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

$ 0

(3)

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I

$ (12)

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.64%

11.63%

$ 4,124

$ 4,134

4,069

4,076

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 3,876

$ 3,892

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.64%

11.63%

$ 1,712

$ 1,716

1,689

1,692

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

$ 1,609

$ 1,616

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^{[1],[2],[5],[13]}

6.00%

^{[1],[2],[5],[13]}

6.00%

^{[1],[2],[5],[13]}

6.00%

^{[6],[8],[9],[15]}

6.00%

^{[6],[8],[9],[15]}

6.00%

^{[6],[8],[9],[15]}

$ 0

^{[1],[2],[5],[11],[13]}

$ 0

^{[6],[8],[9],[12],[15]}

(12)

^{[1],[2],[5],[13]}

(13)

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

$ (24)

^{[1],[2],[5],[13]}

$ (23)

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

6.00%

^[8],[9],[15]

6.00%

^[8],[9],[15]

6.00%

^[8],[9],[15]

11.64%

^[4],[5]

11.64%

^[4],[5]

11.64%

^[4],[5]

11.63%

^{[8],[9],[10],[15]}

11.63%

^{[8],[9],[10],[15]}

11.63%

^{[8],[9],[10],[15]}

$ 3,268

^{[1],[5],[11],[13]}

$ 3,276

^{[8],[9],[12],[15]}

3,259

^[1],[5],[13]

3,267

^[8],[9],[15]

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

3,072

^[1],[5],[13]

3,084

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12,583

^{[1],[11],[13],[14]}

12,222

^{[9],[12],[15],[16]}

12,618

^{[1],[13],[14]}

12,260

^{[9],[15],[16]}

Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I

$ 12,268

^{[1],[13],[14]}

$ 11,795

^{[9],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

12.11%

10.32%

$ 8,575

$ 8,596

8,486

8,503

Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 8,600

$ 8,499

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.39%

10.32%

$ 1,995

$ 2,000

1,957

1,960

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

$ 2,001

$ 1,978

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

11.52%

^{[1],[2],[4],[5]}

11.52%

^{[1],[2],[4],[5]}

11.52%

^{[1],[2],[4],[5]}

11.55%

^{[6],[8],[9],[10]}

11.55%

^{[6],[8],[9],[10]}

11.55%

^{[6],[8],[9],[10]}

$ 2,033

^{[1],[2],[5],[11]}

$ 2,033

^{[6],[8],[9],[12]}

2,015

^[1],[2],[5]

2,013

^[6],[8],[9]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

$ 2,027

^[1],[2],[5]

$ 2,027

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

^[8],[9],[10]

11.55%

$ 0

^{[1],[2],[5],[11]}

$ 20,234

^[8],[9],[12]

(2)

^[1],[2],[5]

20,150

^[8],[9]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

$ (8)

^[1],[2],[5]

$ 20,194

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

11.52%

^[1],[4],[5]

11.52%

^[1],[4],[5]

11.52%

^[1],[4],[5]

^{[6],[8],[9],[10]}

$ 20,182

^[1],[5],[11]

$ 0

^{[6],[8],[9],[12]}

20,107

^[1],[5]

(2)

^[6],[8],[9]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

$ 20,141

^[1],[5]

$ (8)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

12.72%

^{[1],[2],[4],[5]}

12.72%

^{[1],[2],[4],[5]}

12.72%

^{[1],[2],[4],[5]}

12.72%

^{[6],[8],[9],[10]}

12.72%

^{[6],[8],[9],[10]}

12.72%

^{[6],[8],[9],[10]}

$ 1,333

^{[1],[2],[5],[11]}

$ 1,333

^{[6],[8],[9],[12]}

1,324

^[1],[2],[5]

1,322

^[6],[8],[9]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

$ 1,333

^[1],[2],[5]

$ 1,324

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.74%

^[1],[4],[5]

12.74%

^[1],[4],[5]

12.74%

^[1],[4],[5]

12.34%

^[8],[9],[10]

12.34%

^[8],[9],[10]

12.34%

^[8],[9],[10]

$ 6,400

^[1],[5],[11]

$ 6,400

^[8],[9],[12]

6,343

^[1],[5]

6,335

^[8],[9]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

$ 6,406

^[1],[5]

$ 6,380

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.74%

^{[1],[2],[4],[5]}

12.74%

^{[1],[2],[4],[5]}

12.74%

^{[1],[2],[4],[5]}

12.34%

^[8],[9],[10]

12.34%

^[8],[9],[10]

12.34%

^[8],[9],[10]

$ 25,332

^{[1],[2],[5],[11]}

$ 25,332

^[8],[9],[12]

25,293

^[1],[2],[5]

25,288

^[8],[9]

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

$ 25,357

^[1],[2],[5]

$ 25,253

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5,715

^[1]

5,715

^[1]

5,715

^[1]

5,715

^[9]

5,715

^[9]

5,715

^[9]

$ 90

^[1]

$ 90

^[9]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^[1],[5],[17]

8.50%

^[1],[5],[17]

8.50%

^[1],[5],[17]

8.50%

^[8],[9],[18]

8.50%

^[8],[9],[18]

8.50%

^[8],[9],[18]

$ 23,562

^{[1],[5],[11],[17]}

$ 23,562

^{[8],[9],[12],[18]}

22,795

^[1],[5],[17]

22,795

^[8],[9],[18]

Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I

$ 9,797

^[1],[5],[17]

$ 9,797

^[8],[9],[18]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.64%

9.63%

$ 1,786

$ 2,969

1,722

2,853

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

$ 1,670

$ 2,810

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[4],[5],[13]

5.50%

^[4],[5],[13]

5.50%

^[4],[5],[13]

5.50%

^{[8],[10],[15]}

5.50%

^{[8],[10],[15]}

5.50%

^{[8],[10],[15]}

$ 4,050

^[11],[13]

$ 4,050

^[12],[15]

3,592

^[13]

3,577

^[15]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

$ 3,181

^[13]

$ 2,918

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.50%

^[1],[5]

11.50%

^[1],[5]

11.50%

^[1],[5]

11.50%

^[8],[9]

11.50%

^[8],[9]

11.50%

^[8],[9]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

5.00%

^[8],[9],[10]

5.00%

^[8],[9],[10]

5.00%

^[8],[9],[10]

11.95%

^[1],[5]

11.95%

^[1],[5]

11.95%

^[1],[5]

11.99%

^[8],[9]

11.99%

^[8],[9]

11.99%

^[8],[9]

$ 9,331

^[1],[5],[11]

$ 9,057

^[8],[9],[12]

8,748

^[1],[5]

8,434

^[8],[9]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

$ 8,585

^[1],[5]

$ 8,332

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

598,283

^[9]

598,283

^[9]

598,283

^[9]

$ 642

^[1],[5]

$ 642

^[9]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I

$ 1,562

^[1],[5]

$ 1,915

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

13.00%

13.04%

$ 8,681

$ 8,798

8,629

8,737

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 8,117

$ 8,218

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

13.00%

13.04%

$ 6,147

$ 6,230

6,110

6,185

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

$ 5,747

$ 5,819

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[8],[9]

7.50%

^[8],[9]

7.50%

^[8],[9]

13.00%

^[1],[4],[5]

13.00%

^[1],[4],[5]

13.00%

^[1],[4],[5]

13.04%

^[8],[9],[10]

13.04%

^[8],[9],[10]

13.04%

^[8],[9],[10]

$ 16,825

^[1],[5],[11]

$ 17,053

^[8],[9],[12]

16,766

^[1],[5]

16,982

^[8],[9]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

$ 15,732

^[1],[5]

$ 15,929

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

382,275

^[13]

382,275

^[13]

382,275

^[13]

471,253

^[15]

471,253

^[15]

471,253

^[15]

$ 689

^[13]

$ 849

^[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

$ 4,389

^[13]

$ 4,298

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

141,640

^{[1],[13],[19]}

141,640

^{[1],[13],[19]}

141,640

^{[1],[13],[19]}

141,640

^{[9],[15],[20]}

141,640

^{[9],[15],[20]}

141,640

^{[9],[15],[20]}

$ 566

^{[1],[13],[19]}

$ 566

^{[9],[15],[20]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

$ 446

^{[1],[13],[19]}

$ 368

^{[9],[15],[20]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[9],[15]

3.50%

^[9],[15]

3.50%

^[9],[15]

$ 28,964

^{[1],[11],[13]}

$ 28,464

^{[9],[12],[15]}

28,838

^[1],[13]

28,329

^[9],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

$ 28,167

^[1],[13]

$ 27,687

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[9],[15]

3.50%

^[9],[15]

3.50%

^[9],[15]

$ 28,178

^{[1],[11],[13]}

$ 2,121

^{[9],[12],[15]}

28,076

^[1],[13]

1,945

^[9],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

$ 27,403

^[1],[13]

$ 2,063

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[9],[15]

3.50%

^[9],[15]

3.50%

^[9],[15]

$ 2,159

^{[1],[11],[13]}

$ 27,692

^{[9],[12],[15]}

1,982

^[1],[13]

27,582

^[9],[15]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

$ 2,099

^[1],[13]

$ 26,936

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[1],[4],[5],[13]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

8.50%

^{[8],[9],[10],[15]}

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[1],[13]

3.50%

^[9],[15]

3.50%

^[9],[15]

3.50%

^[9],[15]

$ 2,100

^{[1],[11],[13]}

$ 2,064

^{[9],[12],[15]}

1,927

^[1],[13]

1,891

^[9],[15]

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

$ 2,042

^[1],[13]

$ 2,007

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

8.75%

^[8],[9],[10]

14.14%

^[8],[9],[12]

$ 17,048

^[8],[9]

16,440

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

^[8],[9]

$ 15,087

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

8.75%

^[1],[4],[5]

14.25%

^[1],[5],[11]

$ 17,048

^[1],[5]

16,469

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | SLF JV I

^[1],[5]

$ 15,940

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.43%

$ 4,957

4,734

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 4,614

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

9.43%

$ 3,270

$ 2,478

3,111

2,367

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 1 | SLF JV I

$ 3,100

$ 2,307

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

$ 1,596

1,488

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan 2 | SLF JV I

$ 1,513

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

$ 4,944

4,734

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

$ 4,688

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

^[5]

6.25%

^[5]

6.25%

^[5]

6.25%

^[8]

6.25%

^[8]

6.25%

^[8]

11.91%

^[4],[5]

11.91%

^[4],[5]

11.91%

^[4],[5]

11.81%

^[8],[10]

11.81%

^[8],[10]

11.81%

^[8],[10]

$ 14,907

^[5],[11]

$ 19,115

^[8],[12]

14,189

^[5]

18,278

^[8]

Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I

$ 12,548

^[5]

$ 16,798

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

11.91%

11.81%

$ 4,811

$ 4,824

4,751

4,763

Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 4,050

$ 4,239

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

11.91%

11.81%

$ 2,853

$ 2,860

2,818

2,825

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I

$ 2,402

$ 2,514

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.15%

9.54%

$ 7,720

7,643

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC

$ 7,720

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.15%

9.54%

$ 2,895

2,866

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

$ 2,895

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[15]

8.00%

^{[8],[10],[15]}

13.54%

^{[8],[12],[15]}

$ 12,500

^[8],[15]

12,188

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

^[8],[15]

$ 11,865

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

5.75%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(112)

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

^[1],[2],[5]

$ (113)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

5.75%

^[1],[4],[5]

11.10%

^[1],[5],[11]

$ 33,558

^[1],[5]

32,728

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

^[1],[5]

$ 32,719

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

5.75%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(60)

Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC

^[1],[2],[5]

$ (60)

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.45%

10.42%

$ 2,993

2,917

2,913

Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I

$ 3,000

$ 2,997

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.36%

9.40%

$ 1,519

$ 1,523

1,187

1,191

Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 929

$ 1,099

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.36%

9.40%

$ 905

$ 907

703

705

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

$ 554

$ 654

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

^[5]

3.75%

^[5]

3.75%

^[5]

3.75%

^[8]

3.75%

^[8]

3.75%

^[8]

9.36%

^[4],[5]

9.36%

^[4],[5]

9.36%

^[4],[5]

9.40%

^[8],[10]

9.40%

^[8],[10]

9.40%

^[8],[10]

$ 3,691

^[5],[11]

$ 3,700

^[8],[12]

3,059

^[5]

3,067

^[8]

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

$ 2,257

^[5]

$ 2,669

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

5.50%

^[1],[4],[5]

10.86%

^[1],[5],[11]

$ 47,810

^[1],[5]

47,095

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

^[1],[5]

$ 47,093

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

10.95%

^{[8],[9],[10],[15]}

10.95%

^{[8],[9],[10],[15]}

10.95%

^{[8],[9],[10],[15]}

€ 4,949

^{[1],[5],[11],[13]}

€ 3,017

^{[8],[9],[12],[15]}

$ 6,253

^[1],[5],[13]

$ 3,331

^[8],[9],[15]

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

$ 6,372

^[1],[5],[13]

$ 3,226

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

11.82%

^{[1],[4],[5],[13]}

11.82%

^{[1],[4],[5],[13]}

11.82%

^{[1],[4],[5],[13]}

11.57%

^{[8],[9],[10],[15]}

11.57%

^{[8],[9],[10],[15]}

11.57%

^{[8],[9],[10],[15]}

$ 10,519

^{[1],[5],[11],[13]}

$ 10,519

^{[8],[9],[12],[15]}

10,411

^[1],[5],[13]

10,400

^[8],[9],[15]

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

$ 10,624

^[1],[5],[13]

$ 10,624

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

6.00%

^[1],[5],[13]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

9.95%

^{[1],[4],[5],[13]}

9.95%

^{[1],[4],[5],[13]}

9.95%

^{[1],[4],[5],[13]}

12.46%

^{[8],[9],[10],[15]}

12.46%

^{[8],[9],[10],[15]}

12.46%

^{[8],[9],[10],[15]}

£ 3,649

^{[1],[5],[11],[13]}

£ 4,949

^{[8],[9],[12],[15]}

$ 4,094

^[1],[5],[13]

$ 6,318

^[8],[9],[15]

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

$ 4,083

^[1],[5],[13]

$ 6,101

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

7.00%

^[8],[9],[15]

11.20%

^{[1],[4],[5],[13]}

11.20%

^{[1],[4],[5],[13]}

11.20%

^{[1],[4],[5],[13]}

12.46%

^{[8],[9],[10],[15]}

12.46%

^{[8],[9],[10],[15]}

12.46%

^{[8],[9],[10],[15]}

£ 3,017

^{[1],[5],[11],[13]}

£ 23,675

^{[8],[9],[12],[15]}

$ 3,319

^[1],[5],[13]

$ 28,713

^[8],[9],[15]

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

$ 3,366

^[1],[5],[13]

$ 29,185

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

9.70%

^{[8],[9],[10],[15]}

9.70%

^{[8],[9],[10],[15]}

9.70%

^{[8],[9],[10],[15]}

£ 23,675

^{[1],[5],[11],[13]}

£ 3,649

^{[8],[9],[12],[15]}

$ 28,395

^[1],[5],[13]

$ 4,094

^[8],[9],[15]

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

$ 30,482

^[1],[5],[13]

$ 3,914

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12,463,242

^[1]

12,463,242

^[1]

12,463,242

^[1]

1,783,332

^[9]

1,783,332

^[9]

1,783,332

^[9]

1,609,201

$ 1,963

^[1]

$ 804

^[9]

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

997

^[1]

$ 89

^[9]

$ 354

$ 370

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[6],[8],[9]

6.75%

^[6],[8],[9]

6.75%

^[6],[8],[9]

6.75%

12.14%

^{[6],[8],[9],[10]}

12.14%

^{[6],[8],[9],[10]}

12.14%

^{[6],[8],[9],[10]}

11.48%

$ 21,852

^{[6],[8],[9],[12]}

$ 21,464

^[6],[8],[9]

21,855

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

$ 21,823

^[6],[8],[9]

$ 21,252

24,225

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,129,453

^[9]

1,129,453

^[9]

1,129,453

^[9]

1,019,169

^[9]

$ 1,159

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

$ 0

$ 1,005

^[9]

$ 1,243

1,223

Investment Company, Nonconsolidated Subsidiary [Line Items]

78,045

^[1]

78,045

^[1]

78,045

^[1]

78,045

^[9]

78,045

^[9]

78,045

^[9]

70,425

$ 0

^[1]

$ 0

^[9]

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

$ 0

^[1]

$ 0

^[9]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

^[5]

5.25%

^[5]

5.25%

^[5]

5.25%

^[8]

5.25%

^[8]

5.25%

^[8]

10.86%

^[4],[5]

10.86%

^[4],[5]

10.86%

^[4],[5]

10.90%

^[8],[10]

10.90%

^[8],[10]

10.90%

^[8],[10]

$ 15,688

^[5],[11]

$ 8,490

^[8],[12]

13,112

^[5]

8,168

^[8]

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I

$ 10,230

^[5]

$ 6,414

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.86%

10.90%

$ 5,052

4,895

4,888

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC

$ 3,294

$ 3,817

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.86%

10.90%

$ 2,078

2,040

2,039

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | SLF JV I

$ 1,355

$ 1,570

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.46%

9.42%

$ 5,920

$ 4,950

5,734

4,747

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

$ 5,904

$ 4,809

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.25%

4.00%

9.71%

9.42%

$ 993

$ 1,980

942

1,899

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | SLF JV I

$ 990

$ 1,924

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

4.25%

9.46%

9.67%

$ 613

$ 1,990

589

1,884

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC

$ 612

$ 1,937

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

4.25%

9.46%

9.67%

$ 2,773

$ 995

2,687

942

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3 | SLF JV I

$ 2,765

$ 968

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.25%

9.71%

$ 1,985

1,884

Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I

$ 1,981

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.68%

$ 4,346

4,036

Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC

$ 3,871

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.68%

$ 2,423

2,244

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

$ 2,158

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5],[13]

7.00%

^[1],[5],[13]

7.00%

^[1],[5],[13]

6.00%

^[8],[9],[15]

6.00%

^[8],[9],[15]

6.00%

^[8],[9],[15]

8.45%

^{[1],[4],[5],[13]}

8.45%

^{[1],[4],[5],[13]}

8.45%

^{[1],[4],[5],[13]}

11.49%

^{[8],[9],[10],[15]}

11.49%

^{[8],[9],[10],[15]}

11.49%

^{[8],[9],[10],[15]}

4.00%

$ 29,801

^{[1],[5],[11],[13]}

$ 29,509

^{[8],[9],[12],[15]}

29,483

^[1],[5],[13]

29,164

^[8],[9],[15]

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I

$ 28,311

^[1],[5],[13]

$ 28,284

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

6.00%

8.45%

11.49%

4.00%

$ 6,351

$ 6,289

6,284

6,216

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC

$ 6,033

$ 6,028

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

6.00%

8.45%

11.49%

4.00%

$ 3,664

$ 3,628

3,625

3,586

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

$ 3,481

$ 3,478

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(102)

^[1],[2],[5]

(108)

^[6],[8],[9]

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

$ (63)

^[1],[2],[5]

$ (78)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[8],[9]

7.25%

^[8],[9]

7.25%

^[8],[9]

12.60%

^[4],[5]

12.60%

^[4],[5]

12.60%

^[4],[5]

12.64%

^[8],[9],[10]

12.64%

^[8],[9],[10]

12.64%

^[8],[9],[10]

$ 50,470

^[1],[5],[11]

$ 50,470

^[8],[9],[12]

49,718

^[1],[5]

49,679

^[8],[9]

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I

$ 49,839

^[1],[5]

$ 49,688

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.61%

10.65%

$ 1,749

$ 1,753

1,737

1,742

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC

$ 1,684

$ 1,711

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.61%

10.65%

$ 3,355

$ 3,363

3,323

3,332

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I

$ 3,230

$ 3,282

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.61%

10.65%

$ 6,290

$ 6,306

6,231

6,247

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC

$ 6,057

$ 6,155

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.61%

10.65%

$ 798

$ 800

793

795

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

$ 768

$ 780

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

^[8],[9]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

$ 3,239

^[1],[5],[11]

$ 3,247

^[8],[9],[12]

3,208

^[1],[5]

3,216

^[8],[9]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

$ 3,119

^[1],[5]

$ 3,169

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

^[8],[9]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

$ 1,258

^[1],[5],[11]

$ 1,261

^[8],[9],[12]

1,265

^[1],[5]

1,269

^[8],[9]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

$ 1,211

^[1],[5]

$ 1,231

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[8],[9]

8.50%

^[8],[9]

8.50%

^[8],[9]

14.15%

^[1],[4],[5]

14.15%

^[1],[4],[5]

14.15%

^[1],[4],[5]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

$ 2,091

^[1],[5],[11]

$ 8,920

^[8],[9],[12]

2,070

^[1],[5]

8,819

^[8],[9]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

$ 1,842

^[1],[5]

$ 8,492

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[8],[9]

8.50%

^[8],[9]

8.50%

^[8],[9]

14.11%

^[1],[4],[5]

14.11%

^[1],[4],[5]

14.11%

^[1],[4],[5]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

$ 4,361

^[1],[5],[11]

$ 2,091

^[8],[9],[12]

4,298

^[1],[5]

2,068

^[8],[9]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

$ 3,842

^[1],[5]

$ 1,991

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[8],[9]

8.50%

^[8],[9]

8.50%

^[8],[9]

14.11%

^[1],[4],[5]

14.11%

^[1],[4],[5]

14.11%

^[1],[4],[5]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

14.15%

^[8],[9],[10]

$ 8,920

^[1],[5],[11]

$ 4,361

^[8],[9],[12]

8,818

^[1],[5]

4,297

^[8],[9]

Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | SLF JV I

$ 7,859

^[1],[5]

$ 4,152

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.71%

$ 3,990

3,884

Investment, Identifier [Axis]: Bausch + Lomb Corp, First Lien Term Loan | OCSI Glick JV LLC

$ 3,957

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.71%

$ 1,995

1,942

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

$ 1,979

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

^[1],[2],[5]

4.50%

^[1],[2],[5]

4.50%

^[1],[2],[5]

4.50%

^[6],[8],[9]

4.50%

^[6],[8],[9]

4.50%

^[6],[8],[9]

13.00%

^{[1],[2],[4],[5]}

13.00%

^{[1],[2],[4],[5]}

13.00%

^{[1],[2],[4],[5]}

13.00%

^{[6],[8],[9],[10]}

13.00%

^{[6],[8],[9],[10]}

13.00%

^{[6],[8],[9],[10]}

$ 1,836

^{[1],[2],[5],[11]}

$ 2,221

^{[6],[8],[9],[12]}

1,806

^[1],[2],[5]

2,188

^[6],[8],[9]

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

$ 1,798

^[1],[2],[5]

$ 2,178

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[8],[9]

5.50%

^[8],[9]

5.50%

^[8],[9]

11.03%

^[1],[4],[5]

11.03%

^[1],[4],[5]

11.03%

^[1],[4],[5]

11.02%

^[8],[9],[10]

11.02%

^[8],[9],[10]

11.02%

^[8],[9],[10]

$ 40,557

^[1],[5],[11]

$ 40,660

^[8],[9],[12]

40,352

^[1],[5]

40,440

^[8],[9]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

$ 40,070

^[1],[5]

$ 40,213

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[2],[5],[13]}

7.50%

^{[8],[9],[10],[15]}

8.00%

^[9],[15]

2.25%

$ 0

^{[1],[2],[5],[11],[13]}

$ 6,757

^{[9],[12],[15]}

^{[1],[2],[5],[13]}

6,560

^[9],[15]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

$ 0

^{[1],[2],[5],[13]}

6,225

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5],[13]

7.50%

^{[1],[4],[5],[13]}

12.89%

$ 2,815

^{[1],[5],[11],[13]}

3,316

^{[6],[9],[12],[15],[16]}

2,815

^[1],[5],[13]

3,335

^{[6],[9],[15],[16]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 2,625

^[1],[5],[13]

$ 3,169

^{[6],[9],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[6],[8],[9],[10],[15]}

8.00%

^{[6],[8],[9],[10],[15]}

8.00%

^{[6],[8],[9],[10],[15]}

2.25%

^[1],[13]

2.25%

^[1],[13]

2.25%

^[1],[13]

2.25%

^[6],[9],[15]

2.25%

^[6],[9],[15]

2.25%

^[6],[9],[15]

$ 0

^{[1],[2],[11],[13]}

$ 0

^{[6],[9],[12],[15]}

^[1],[2],[13]

^[6],[9],[15]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

$ 0

^[1],[2],[13]

$ 0

^[6],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[1],[2],[4],[5],[13]}

8.00%

^{[6],[8],[9],[10],[15]}

8.00%

^{[6],[8],[9],[10],[15]}

8.00%

^{[6],[8],[9],[10],[15]}

2.25%

^[1],[2],[13]

2.25%

^[1],[2],[13]

2.25%

^[1],[2],[13]

2.25%

^[6],[9],[15]

2.25%

^[6],[9],[15]

2.25%

^[6],[9],[15]

$ 0

^{[1],[2],[11],[13]}

$ 0

^{[6],[9],[12],[15]}

^[1],[2],[13]

^[6],[9],[15]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

$ 0

^[1],[2],[13]

^[6],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[1],[4],[5],[13]}

8.00%

^[1],[13]

2.25%

$ 6,785

^{[1],[11],[13]}

^{[6],[9],[12],[15],[16]}

6,602

^[1],[13]

^{[6],[9],[15],[16]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

$ 6,327

^[1],[13]

^{[6],[9],[15],[16]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[6],[9],[12],[15],[16]}

^{[6],[9],[15],[16]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

^{[6],[9],[15],[16]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

32,664

^[1],[13]

32,664

^[1],[13]

32,664

^[1],[13]

26,131

^[9],[15]

26,131

^[9],[15]

26,131

^[9],[15]

$ 225

^[1],[13]

$ 225

^[9],[15]

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

$ 46

^[1],[13]

$ 3

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[5]

7.00%

^[5]

7.00%

^[5]

7.00%

^[8]

7.00%

^[8]

7.00%

^[8]

12.46%

^[4],[5]

12.46%

^[4],[5]

12.46%

^[4],[5]

12.43%

^[8],[10]

12.43%

^[8],[10]

12.43%

^[8],[10]

$ 30,625

^[5],[11]

$ 30,625

^[8],[12]

30,394

^[5]

30,370

^[8]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

$ 30,319

^[5]

$ 29,989

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

394,297

^[1]

394,297

^[1]

394,297

^[1]

394,297

^[9]

394,297

^[9]

394,297

^[9]

$ 424

^[1]

$ 424

^[9]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

$ 95

^[1]

$ 158

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.00%

^[1],[4],[5]

9.00%

^[1],[4],[5]

9.00%

^[1],[4],[5]

9.00%

^[8],[9],[10]

9.00%

^[8],[9],[10]

9.00%

^[8],[9],[10]

$ 5,257

^[1],[11]

$ 5,257

^[9],[12]

5,263

^[1]

5,258

^[9]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

$ 5,205

^[1]

$ 5,251

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,708,618

^[1]

1,708,618

^[1]

1,708,618

^[1]

1,708,618

^[9]

1,708,618

^[9]

1,708,618

^[9]

$ 1,711

^[1]

$ 1,711

^[9]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

$ 1,982

^[1]

$ 1,999

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

394,297

^[1]

394,297

^[1]

394,297

^[1]

394,297

^[9]

394,297

^[9]

394,297

^[9]

$ 395

^[1]

$ 395

^[9]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I

$ 434

^[1]

$ 442

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

171

$ 0

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

829

^[1]

829

^[1]

829

^[1]

829

^[9]

829

^[9]

829

^[9]

829

$ 0

$ 0

^[1]

$ 0

^[9]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

$ 0

^[1]

$ 0

^[9]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

34,984,460

^[1]

34,984,460

^[1]

34,984,460

^[1]

34,984,460

^[9]

34,984,460

^[9]

34,984,460

^[9]

34,984,460

$ 0

$ 34,984

^[1]

$ 34,984

^[9]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I

$ 27,638

^[1]

$ 27,638

^[9]

$ 27,638

27,638

Investment Company, Nonconsolidated Subsidiary [Line Items]

7,193,540

$ 7,194

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan

$ 5,683

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[5],[13]

6.00%

^[4],[5],[13]

11.29%

^{[5],[11],[13]}

$ 16,185

^[5],[13]

20,053

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

^[5],[13]

$ 20,281

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.75%

^[1],[5],[17]

7.75%

^[1],[5],[17]

7.75%

^[1],[5],[17]

7.75%

^[8],[9],[18]

7.75%

^[8],[9],[18]

7.75%

^[8],[9],[18]

$ 727

^{[1],[5],[11],[17]}

$ 727

^{[8],[9],[12],[18]}

413

^[1],[5],[17]

462

^[8],[9],[18]

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

$ 365

^[1],[5],[17]

$ 396

^[8],[9],[18]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

6.50%

^[8],[9],[10]

12.07%

^[8],[9],[12]

$ 37

^[8],[9]

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

^[8],[9]

$ 37

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

6.50%

^[8],[9],[10]

12.07%

^[8],[9],[12]

$ 3,031

^[8],[9]

2,899

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

^[8],[9]

$ 3,031

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

6.50%

^[8],[9],[10]

12.07%

^[8],[9],[12]

$ 1,557

^[8],[9]

1,489

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

^[8],[9]

$ 1,557

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

6.50%

^[8],[9],[10]

12.07%

^[8],[9],[12]

$ 1,024

^[8],[9]

994

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

^[8],[9]

$ 1,024

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,080,398

^[1]

1,080,398

^[1]

1,080,398

^[1]

1,080,399

^[9]

1,080,399

^[9]

1,080,399

^[9]

1,080,399

$ 1,079

^[1]

$ 1,080

^[9]

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I

$ 432

^[1]

$ 432

^[9]

$ 324

378

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.54%

11.57%

$ 600

593

592

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I

$ 543

$ 581

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.53%

11.55%

$ 2,348

$ 2,354

2,318

2,322

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I

$ 2,125

$ 2,281

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.53%

11.55%

$ 1,978

$ 1,983

1,951

1,954

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3 | SLF JV I

$ 1,790

$ 1,921

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.53%

11.55%

$ 1,955

$ 1,960

1,932

1,935

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

$ 1,769

$ 1,899

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[4],[5],[13]

7.50%

^[4],[5],[13]

7.50%

^[4],[5],[13]

7.50%

^{[8],[10],[15]}

7.50%

^{[8],[10],[15]}

7.50%

^{[8],[10],[15]}

$ 2,632

^[11],[13]

$ 2,632

^[12],[15]

2,632

^[13]

2,632

^[15]

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

$ 2,191

^[13]

$ 2,017

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.75%

^[4],[5],[13]

7.75%

^[4],[5],[13]

7.75%

^[4],[5],[13]

7.75%

^{[8],[10],[15]}

7.75%

^{[8],[10],[15]}

7.75%

^{[8],[10],[15]}

$ 176

^[11],[13]

$ 176

^[12],[15]

170

^[13]

170

^[15]

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

$ 152

^[13]

$ 141

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.38%

^[4],[5]

7.38%

^[4],[5]

7.38%

^[4],[5]

7.38%

^[8],[10]

7.38%

^[8],[10]

7.38%

^[8],[10]

$ 10,720

^[11]

$ 8,420

^[12]

10,282

8,261

Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond

$ 9,804

7,059

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5],[13]

6.75%

^[11],[13]

$ 1,670

^[13]

1,625

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

^[13]

$ 1,661

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1]

22,267,661

^[1]

$ 16,172

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

$ 16,173

^[1]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[18]

8.50%

^{[8],[9],[12],[18]}

$ 22,084

^[8],[9],[18]

21,336

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

^[8],[9],[18]

16,040

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[9]

706

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

^[9]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

417,851

^[1]

417,851

^[1]

417,851

^[1]

417,851

^[9]

417,851

^[9]

417,851

^[9]

$ 605

^[1]

$ 605

^[9]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

$ 894

^[1]

$ 894

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(19)

^[1],[2],[5]

(20)

^[6],[8],[9]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

$ (19)

^[1],[2],[5]

$ (20)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[8],[9]

7.50%

^[8],[9]

7.50%

^[8],[9]

^[8],[9],[10]

12.82%

$ 0

^{[1],[2],[5],[11]}

$ 13,157

^[8],[9],[12]

(15)

^[1],[2],[5]

12,855

^[8],[9]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

$ (11)

^[1],[2],[5]

$ 12,858

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

^[1],[4],[5]

12.86%

$ 13,157

^[1],[5],[11]

$ 0

^{[6],[8],[9],[12]}

12,867

^[1],[5]

(15)

^[6],[8],[9]

Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I

$ 12,883

^[1],[5]

$ (13)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.35%

10.39%

$ 6,327

$ 6,343

5,985

5,983

Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 6,332

$ 6,285

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.35%

10.39%

$ 2,759

$ 2,766

2,607

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

$ 2,762

$ 2,741

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[5]

5.00%

^[5]

5.00%

^[5]

5.00%

^[8]

5.00%

^[8]

5.00%

^[8]

10.35%

^[4],[5]

10.35%

^[4],[5]

10.35%

^[4],[5]

10.39%

^[8],[10]

10.39%

^[8],[10]

10.39%

^[8],[10]

$ 14,713

^[5],[11]

$ 14,750

^[8],[12]

14,160

^[5]

14,173

^[8]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

$ 14,724

^[5]

$ 14,616

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

^{[6],[8],[9],[10]}

11.47%

$ 0

^[1],[5],[11]

$ 933

^{[6],[8],[9],[12]}

(13)

^[1],[5]

920

^[6],[8],[9]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

$ (15)

^[1],[5]

$ 918

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.53%

^[4],[5]

11.53%

^[4],[5]

11.53%

^[4],[5]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

$ 17,967

^[1],[5],[11]

$ 18,013

^[8],[9],[12]

17,666

^[1],[5]

17,690

^[8],[9]

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

$ 17,765

^[1],[5]

$ 17,812

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

6.75%

^[1],[5],[11]

$ 0

^[1],[5]

(53)

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

^[1],[5]

$ (52)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1]

6.75%

^[4],[5]

12.10%

^[1],[11]

$ 20,924

^[1]

20,412

Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I

^[1]

$ 20,422

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.85%

9.89%

$ 8,708

$ 8,730

8,621

8,642

Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC

$ 8,714

$ 8,730

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.85%

9.89%

$ 2,834

$ 2,841

2,813

2,820

Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I

$ 2,836

$ 2,841

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

10.13%

10.12%

$ 8,698

$ 7,920

8,563

7,792

Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 8,619

$ 7,729

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

10.13%

10.12%

$ 3,361

$ 2,970

3,309

2,922

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

$ 3,331

$ 2,899

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

^[5]

4.75%

^[5]

4.75%

^[5]

4.75%

^[8]

4.75%

^[8]

4.75%

^[8]

10.13%

^[4],[5]

10.13%

^[4],[5]

10.13%

^[4],[5]

10.12%

^[8],[10]

10.12%

^[8],[10]

10.12%

^[8],[10]

$ 4,938

^[5],[11]

$ 4,950

^[8],[12]

4,862

^[5]

4,871

^[8]

Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond

$ 4,893

^[5]

$ 4,831

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

8.00%

^[11]

$ 440

423

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

$ 436

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[13]

^[9],[15]

$ 2

^[1],[13]

$ 2

^[9],[15]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

$ 2

^[1],[13]

$ 2

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

419

^[1],[13]

419

^[1],[13]

419

^[1],[13]

419

^[9],[15]

419

^[9],[15]

419

^[9],[15]

$ 419

^[1],[13]

$ 419

^[9],[15]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

$ 419

^[1],[13]

$ 419

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

7.00%

^[1],[13]

7.00%

^[1],[13]

7.00%

^[1],[13]

7.00%

^[6],[9],[15]

7.00%

^[6],[9],[15]

7.00%

^[6],[9],[15]

$ 32,104

^{[1],[11],[13]}

$ 17,465

^{[6],[9],[12],[15]}

32,104

^[1],[13]

17,465

^[6],[9],[15]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

$ 32,104

^[1],[13]

$ 17,465

^[6],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[13]

^[9],[15]

$ 0

^[1],[13]

$ 0

^[9],[15]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

$ 0

^[1],[13]

$ 0

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.00%

^[1],[5]

9.00%

^[1],[5]

9.00%

^[1],[5]

9.00%

^[8],[9]

9.00%

^[8],[9]

9.00%

^[8],[9]

14.50%

^[1],[4],[5]

14.50%

^[1],[4],[5]

14.50%

^[1],[4],[5]

14.54%

^[8],[9],[10]

14.54%

^[8],[9],[10]

14.54%

^[8],[9],[10]

$ 20,757

^[1],[5],[11]

$ 20,757

^[8],[9],[12]

20,201

^[1],[5]

20,146

^[8],[9]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

$ 20,639

^[1],[5]

$ 20,653

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1]

8.00%

^[1]

8.00%

^[1]

8.00%

^[9]

8.00%

^[9]

8.00%

^[9]

$ 667

^[1],[11]

$ 654

^[9],[12]

666

^[1]

653

^[9]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

$ 643

^[1]

$ 631

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6,397,254

^[1]

6,397,254

^[1]

6,397,254

^[1]

6,397,254

^[9]

6,397,254

^[9]

6,397,254

^[9]

$ 1,642

^[1]

$ 1,642

^[9]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

$ 128

^[1]

$ 1,152

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

12.45%

^{[1],[2],[4],[5]}

12.45%

^{[1],[2],[4],[5]}

12.45%

^{[1],[2],[4],[5]}

12.49%

^{[6],[8],[9],[10]}

12.49%

^{[6],[8],[9],[10]}

12.49%

^{[6],[8],[9],[10]}

$ 578

^{[1],[2],[5],[11]}

$ 284

^{[6],[8],[9],[12]}

561

^[1],[2],[5]

265

^[6],[8],[9]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

$ 550

^[1],[2],[5]

$ 252

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.45%

^[1],[4],[5]

12.45%

^[1],[4],[5]

12.45%

^[1],[4],[5]

12.49%

^[8],[9],[10]

12.49%

^[8],[9],[10]

12.49%

^[8],[9],[10]

$ 12,355

^[1],[5],[11]

$ 12,386

^[8],[9],[12]

12,191

^[1],[5]

12,208

^[8],[9]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

$ 12,083

^[1],[5]

$ 12,101

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[8]

5.00%

^[8]

5.00%

^[8]

10.65%

^[4],[5]

10.65%

^[4],[5]

10.65%

^[4],[5]

10.43%

^[8],[10]

10.43%

^[8],[10]

10.43%

^[8],[10]

$ 4,514

^[5],[11]

$ 4,641

^[8],[12]

4,491

^[5]

4,619

^[8]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond

$ 4,522

^[5]

$ 4,546

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

5.88%

^[11]

$ 5,090

4,455

Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I

$ 4,787

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.65%

10.43%

$ 7,196

$ 5,799

7,110

5,715

Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 7,209

$ 5,681

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.65%

10.43%

$ 3,171

$ 2,460

3,144

2,435

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

$ 3,176

$ 2,410

Investment Company, Nonconsolidated Subsidiary [Line Items]

30,031

^[1]

30,031

^[1]

30,031

^[1]

30,031

^[9]

30,031

^[9]

30,031

^[9]

30,031

$ 0

$ 15,222

^[1]

$ 15,222

^[9]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

$ 2,711

^[1]

$ 2,711

^[9]

$ 4,227

4,946

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

10.50%

^[1],[4],[5]

10.50%

^[1],[4],[5]

10.50%

^[1],[4],[5]

10.54%

^[8],[9],[10]

10.54%

^[8],[9],[10]

10.54%

^[8],[9],[10]

$ 5,574

^[1],[5],[11]

$ 5,574

^[8],[9],[12]

$ 0

5,574

^[1],[5]

5,574

^[8],[9]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan

$ 5,574

^[1],[5]

$ 5,574

^[8],[9]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

9.73%

$ 14,297

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

14,297

14,333

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

^[8],[9]

10.50%

^[1],[4],[5]

10.50%

^[1],[4],[5]

10.50%

^[1],[4],[5]

10.54%

^[8],[9],[10]

10.54%

^[8],[9],[10]

10.54%

^[8],[9],[10]

$ 14,033

^[1],[5],[11]

$ 14,068

^[8],[9],[12]

14,032

^[1],[5]

14,068

^[8],[9]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

$ 14,033

^[1],[5]

$ 14,068

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[2],[5]

5.00%

^[1],[2],[5]

5.00%

^[1],[2],[5]

5.00%

^[6],[8],[9]

5.00%

^[6],[8],[9]

5.00%

^[6],[8],[9]

10.46%

^{[1],[2],[4],[5]}

10.46%

^{[1],[2],[4],[5]}

10.46%

^{[1],[2],[4],[5]}

10.42%

^{[6],[8],[9],[10]}

10.42%

^{[6],[8],[9],[10]}

10.42%

^{[6],[8],[9],[10]}

$ 1,393

^{[1],[2],[5],[11]}

$ 2,090

^{[6],[8],[9],[12]}

1,393

^[1],[2],[5]

2,090

^[6],[8],[9]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

$ 1,394

^[1],[2],[5]

$ 2,090

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12,500

^[1]

12,500

^[1]

12,500

^[1]

12,500

^[9]

12,500

^[9]

12,500

^[9]

$ 0

^[1]

$ 0

^[9]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

488

^[1]

488

^[1]

488

^[1]

488

^[9]

488

^[9]

488

^[9]

$ 488

^[1]

$ 488

^[9]

Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I

$ 1,345

^[1]

$ 1,345

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.25%

9.60%

$ 2,992

2,948

Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC

$ 2,971

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.25%

9.60%

$ 1,496

1,474

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

$ 1,486

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[8],[9]

7.50%

^[8],[9]

7.50%

^[8],[9]

13.00%

^[1],[4],[5]

13.00%

^[1],[4],[5]

13.00%

^[1],[4],[5]

13.04%

^[8],[9],[10]

13.04%

^[8],[9],[10]

13.04%

^[8],[9],[10]

$ 8,974

^[1],[5],[11]

$ 8,974

^[8],[9],[12]

8,884

^[1],[5]

8,884

^[8],[9]

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

$ 8,032

^[1],[5]

$ 7,987

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

5.50%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(28)

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

^[1],[2],[5]

$ (28)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

5.50%

^[1],[4],[5]

10.84%

^[1],[5],[11]

$ 24,865

^[1],[5]

24,492

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

^[1],[5]

$ 24,492

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

5.50%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(19)

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

^[1],[2],[5]

$ (19)

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[8],[9],[10],[15]}

3.00%

^{[8],[9],[10],[15]}

3.00%

^{[8],[9],[10],[15]}

6.00%

^[1],[13]

6.00%

^[1],[13]

6.00%

^[1],[13]

6.00%

^[9],[15]

6.00%

^[9],[15]

6.00%

^[9],[15]

$ 1,799

^{[1],[11],[13]}

$ 11,065

^{[9],[12],[15]}

1,777

^[1],[13]

10,953

^[9],[15]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

$ 1,718

^[1],[13]

$ 10,677

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[8],[9],[10],[15]}

3.00%

^{[8],[9],[10],[15]}

3.00%

^{[8],[9],[10],[15]}

6.00%

^[1],[2],[13]

6.00%

^[1],[2],[13]

6.00%

^[1],[2],[13]

6.00%

^[9],[15]

6.00%

^[9],[15]

6.00%

^[9],[15]

$ 0

^{[1],[2],[11],[13]}

$ 1,772

^{[9],[12],[15]}

^[1],[2],[13]

1,748

^[9],[15]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

$ 0

^[1],[2],[13]

$ 1,710

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[1],[2],[4],[5],[13]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

6.00%

^[1],[2],[13]

6.00%

^[1],[2],[13]

6.00%

^[1],[2],[13]

6.00%

^[6],[9],[15]

6.00%

^[6],[9],[15]

6.00%

^[6],[9],[15]

$ 0

^{[1],[2],[11],[13]}

$ 0

^{[6],[9],[12],[15]}

^[1],[2],[13]

^[6],[9],[15]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

$ 0

^[1],[2],[13]

$ 0

^[6],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[1],[4],[5],[13]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

3.00%

^{[6],[8],[9],[10],[15]}

6.00%

^[1],[13]

6.00%

^[1],[13]

6.00%

^[1],[13]

6.00%

^[6],[9],[15]

6.00%

^[6],[9],[15]

6.00%

^[6],[9],[15]

$ 11,232

^{[1],[11],[13]}

$ 0

^{[6],[9],[12],[15]}

11,129

^[1],[13]

^[6],[9],[15]

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

$ 10,727

^[1],[13]

$ 0

^[6],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(39)

^[1],[2],[5]

(41)

^[6],[8],[9]

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

$ (37)

^[1],[2],[5]

$ (41)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.35%

^[4],[5]

11.35%

^[4],[5]

11.35%

^[4],[5]

11.32%

^[8],[9],[10]

11.32%

^[8],[9],[10]

11.32%

^[8],[9],[10]

$ 14,736

^{[1],[2],[5],[11]}

$ 14,736

^[8],[9],[12]

14,381

^[1],[2],[5]

14,368

^[8],[9]

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

$ 14,394

^[1],[2],[5]

$ 14,368

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[5]

4.00%

^[4],[5]

9.47%

^[5],[11]

$ 4,324

^[5]

3,497

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

^[5]

$ 3,457

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[5]

6.75%

^[5]

6.75%

^[5]

6.75%

^[8],[15]

6.75%

^[8],[15]

6.75%

^[8],[15]

12.22%

^[4],[5]

12.22%

^[4],[5]

12.22%

^[4],[5]

12.18%

^{[8],[10],[15]}

12.18%

^{[8],[10],[15]}

12.18%

^{[8],[10],[15]}

$ 31,074

^[5],[11]

$ 31,074

^{[8],[12],[15]}

29,191

^[5]

29,127

^[8],[15]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

$ 18,745

^[5]

$ 19,917

^[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.00%

^{[1],[2],[4],[5]}

9.00%

^{[1],[2],[4],[5]}

9.00%

^{[1],[2],[4],[5]}

9.00%

^{[6],[8],[9],[10]}

9.00%

^{[6],[8],[9],[10]}

9.00%

^{[6],[8],[9],[10]}

$ 61,500

^[1],[2],[11]

$ 59,950

^[6],[9],[12]

61,500

^[1],[2]

59,950

^[6],[9]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

$ 61,500

^[1],[2]

$ 59,950

^[6],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3,750

^{[1],[13],[21]}

3,750

^{[1],[13],[21]}

3,750

^{[1],[13],[21]}

3,750

^[9],[15]

3,750

^[9],[15]

3,750

^[9],[15]

$ 0

^{[1],[13],[21]}

$ 0

^[9],[15]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

$ 4

^{[1],[13],[21]}

$ 3

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^{[1],[2],[5],[13]}

7.25%

^{[1],[2],[5],[13]}

7.25%

^{[1],[2],[5],[13]}

7.25%

^{[6],[8],[9],[15]}

7.25%

^{[6],[8],[9],[15]}

7.25%

^{[6],[8],[9],[15]}

12.61%

^{[1],[2],[4],[5],[13]}

12.61%

^{[1],[2],[4],[5],[13]}

12.61%

^{[1],[2],[4],[5],[13]}

12.55%

^{[6],[8],[9],[10],[15]}

12.55%

^{[6],[8],[9],[10],[15]}

12.55%

^{[6],[8],[9],[10],[15]}

$ 322

^{[1],[2],[5],[11],[13]}

$ 258

^{[6],[8],[9],[12],[15]}

299

^{[1],[2],[5],[13]}

234

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

$ 301

^{[1],[2],[5],[13]}

$ 234

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.25%

^[1],[5],[13]

7.25%

^[8],[9],[15]

7.25%

^[8],[9],[15]

7.25%

^[8],[9],[15]

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

12.71%

^{[1],[4],[5],[13]}

12.55%

^{[8],[9],[10],[15]}

12.55%

^{[8],[9],[10],[15]}

12.55%

^{[8],[9],[10],[15]}

$ 11,742

^{[1],[5],[11],[13]}

$ 11,742

^{[8],[9],[12],[15]}

11,519

^[1],[5],[13]

11,509

^[8],[9],[15]

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

11,538

^[1],[5],[13]

11,511

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC

51,354

54,051

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

$ 27,867

$ 28,396

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.00%

^{[1],[4],[5],[13]}

11.00%

^{[1],[4],[5],[13]}

11.00%

^{[1],[4],[5],[13]}

11.00%

^{[8],[9],[10],[15]}

11.00%

^{[8],[9],[10],[15]}

11.00%

^{[8],[9],[10],[15]}

$ 11,918

^{[1],[11],[13]}

$ 11,918

^{[9],[12],[15]}

11,653

^[1],[13]

11,612

^[9],[15]

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

$ 11,173

^[1],[13]

$ 11,144

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

417,011

^[1],[13]

417,011

^[1],[13]

417,011

^[1],[13]

417,011

^[9],[15]

417,011

^[9],[15]

417,011

^[9],[15]

$ 427

^[1],[13]

$ 427

^[9],[15]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | SLF JV I

$ 354

^[1],[13]

$ 42

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.22%

$ 2,992

2,955

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 2,981

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.22%

$ 1,496

1,477

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

$ 1,491

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[4],[5],[13]

6.00%

^[4],[5],[13]

6.00%

^[4],[5],[13]

6.00%

^{[8],[10],[15]}

6.00%

^{[8],[10],[15]}

6.00%

^{[8],[10],[15]}

$ 4,881

^[11],[13]

$ 4,881

^[12],[15]

4,482

^[13]

4,469

^[15]

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

$ 4,170

^[13]

$ 3,577

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

12.60%

^{[1],[2],[4],[5]}

12.60%

^{[1],[2],[4],[5]}

12.60%

^{[1],[2],[4],[5]}

12.64%

^{[6],[8],[9],[10]}

12.64%

^{[6],[8],[9],[10]}

12.64%

^{[6],[8],[9],[10]}

$ 1,215

^{[1],[2],[5],[11]}

$ 1,638

^{[6],[8],[9],[12]}

1,117

^[1],[2],[5]

1,535

^[6],[8],[9]

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

$ 1,152

^[1],[2],[5]

$ 1,535

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[8],[9]

7.25%

^[8],[9]

7.25%

^[8],[9]

12.60%

^[1],[4],[5]

12.60%

^[1],[4],[5]

12.60%

^[1],[4],[5]

12.64%

^[8],[9],[10]

12.64%

^[8],[9],[10]

12.64%

^[8],[9],[10]

$ 23,714

^[1],[5],[11]

$ 23,774

^[8],[9],[12]

23,082

^[1],[5]

23,110

^[8],[9]

Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I

$ 23,306

^[1],[5]

$ 23,110

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.66%

10.57%

$ 7,350

$ 7,369

7,277

7,295

Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 6,590

$ 6,190

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.66%

10.57%

$ 3,920

$ 3,930

3,881

3,891

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

$ 3,515

$ 3,301

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8]

5.00%

^[8]

5.00%

^[8]

10.66%

^[1],[4],[5]

10.66%

^[1],[4],[5]

10.66%

^[1],[4],[5]

10.57%

^[8],[10]

10.57%

^[8],[10]

10.57%

^[8],[10]

$ 2,450

^[1],[5],[11]

$ 2,456

^[8],[12]

2,070

^[1],[5]

2,055

^[8]

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

$ 2,197

^[1],[5]

$ 2,063

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

2.85%

^[5],[13]

2.85%

^[5],[13]

2.85%

^[5],[13]

2.85%

^[8],[15]

2.85%

^[8],[15]

2.85%

^[8],[15]

6.84%

^[4],[5],[13]

6.84%

^[4],[5],[13]

6.84%

^[4],[5],[13]

6.56%

^{[8],[10],[15]}

6.56%

^{[8],[10],[15]}

6.56%

^{[8],[10],[15]}

€ 1,000

^{[5],[11],[13]}

€ 1,000

^{[8],[12],[15]}

$ 880

^[5],[13]

$ 876

^[8],[15]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

$ 1,033

^[5],[13]

$ 963

^[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(25)

^[1],[2],[5]

(27)

^[6],[8],[9]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

$ (29)

^[1],[2],[5]

$ (35)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[8],[9]

8.00%

^[8],[9]

8.00%

^[8],[9]

^[8],[9],[10]

13.42%

$ 0

^{[1],[2],[5],[11]}

$ 17,444

^[8],[9],[12]

(50)

^[1],[2],[5]

17,276

^[8],[9]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

$ (59)

^[1],[2],[5]

$ 17,096

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

^[1],[4],[5]

13.46%

$ 17,400

^[1],[5],[11]

$ 0

^{[6],[8],[9],[12]}

17,244

^[1],[5]

(54)

^[6],[8],[9]

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

$ 17,112

^[1],[5]

$ (70)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

^[5]

5.25%

^[5]

5.25%

^[5]

5.25%

^[8]

5.25%

^[8]

5.25%

^[8]

10.71%

^[4],[5]

10.71%

^[4],[5]

10.71%

^[4],[5]

10.67%

^[8],[10]

10.67%

^[8],[10]

10.67%

^[8],[10]

$ 8,538

^[5],[11]

$ 14,347

^[8],[12]

8,257

^[5]

13,871

^[8]

Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I

$ 8,396

^[5]

$ 13,618

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.71%

10.67%

$ 7,900

$ 7,920

7,720

7,731

Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 7,769

$ 7,517

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.71%

10.67%

$ 3,950

$ 3,960

3,860

3,865

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan

$ 3,884

$ 3,759

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5],[13]

6.50%

^{[1],[4],[5],[13]}

12.00%

^{[1],[5],[11],[13]}

$ 7,448

^[1],[5],[13]

7,313

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

^[1],[5],[13]

$ 7,355

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^{[1],[2],[5],[13]}

6.50%

^{[1],[2],[5],[13]}

6.50%

^{[1],[2],[5],[13]}

6.50%

^[8],[9],[15]

6.50%

^[8],[9],[15]

6.50%

^[8],[9],[15]

^{[8],[9],[10],[15]}

11.89%

$ 0

^{[1],[2],[5],[11],[13]}

$ 7,448

^{[8],[9],[12],[15]}

(73)

^{[1],[2],[5],[13]}

7,296

^[8],[9],[15]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

$ (50)

^{[1],[2],[5],[13]}

$ 7,301

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5],[13]

6.50%

^[1],[5],[13]

6.50%

^[1],[5],[13]

6.50%

^{[6],[8],[9],[15]}

6.50%

^{[6],[8],[9],[15]}

6.50%

^{[6],[8],[9],[15]}

^[4],[5]

12.00%

$ 1,432

^{[1],[5],[11],[13]}

$ 0

^{[6],[8],[9],[12],[15]}

1,403

^[1],[5],[13]

(82)

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 1,414

^[1],[5],[13]

$ (79)

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[15]

6.50%

^{[8],[9],[10],[15]}

12.04%

^{[8],[9],[12],[15]}

$ 1,432

^[8],[9],[15]

1,399

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

^[8],[9],[15]

$ 1,404

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.46%

^[4],[5],[13]

4.46%

^[4],[5],[13]

4.46%

^[4],[5],[13]

4.46%

^{[8],[9],[10],[15]}

4.46%

^{[8],[9],[10],[15]}

4.46%

^{[8],[9],[10],[15]}

$ 9,406

^[11],[13]

$ 6,808

^{[9],[12],[15]}

7,727

^[13]

5,490

^[9],[15]

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

$ 8,155

^[13]

$ 5,873

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

13.63%

^{[1],[4],[5],[13]}

13.63%

^{[1],[4],[5],[13]}

13.63%

^{[1],[4],[5],[13]}

13.62%

^{[8],[9],[10],[15]}

13.62%

^{[8],[9],[10],[15]}

13.62%

^{[8],[9],[10],[15]}

$ 23,975

^{[1],[5],[11],[13]}

$ 23,975

^{[8],[9],[12],[15]}

23,347

^[1],[5],[13]

23,310

^[8],[9],[15]

Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I

$ 23,519

^[1],[5],[13]

$ 23,328

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

11.36%

11.40%

$ 8,875

$ 9,000

8,728

8,839

Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 7,100

$ 7,080

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

11.36%

11.40%

$ 2,219

$ 2,250

2,182

2,210

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

$ 1,775

$ 1,770

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

^[1],[5]

5.75%

^[1],[5]

5.75%

^[1],[5]

5.75%

^[8],[9]

5.75%

^[8],[9]

5.75%

^[8],[9]

11.36%

^[1],[4],[5]

11.36%

^[1],[4],[5]

11.36%

^[1],[4],[5]

11.40%

^[8],[9],[10]

11.40%

^[8],[9],[10]

11.40%

^[8],[9],[10]

$ 43,931

^[1],[5],[11]

$ 44,550

^[8],[9],[12]

42,440

^[1],[5]

42,918

^[8],[9]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

$ 35,145

^[1],[5]

$ 35,046

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

12.06%

^[1],[4],[5]

12.06%

^[1],[4],[5]

12.06%

^[1],[4],[5]

11.92%

^[8],[9],[10]

11.92%

^[8],[9],[10]

11.92%

^[8],[9],[10]

$ 40,587

^[1],[5],[11]

$ 40,587

^[8],[9],[12]

39,991

^[1],[5]

39,935

^[8],[9]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

$ 38,963

^[1],[5]

$ 38,963

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.75%

^[1],[17]

10.75%

^[1],[17]

10.75%

^[1],[17]

10.75%

^[8],[9]

10.75%

^[8],[9]

10.75%

^[8],[9]

^[8],[9]

16.06%

$ 1,001

^{[1],[11],[17]}

$ 26,613

^[8],[9],[12]

983

^[1],[17]

26,492

^[8],[9]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

$ 793

^[1],[17]

$ 24,484

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.75%

^[1],[5],[17]

10.75%

^[1],[5],[17]

10.75%

^[1],[5],[17]

10.75%

^[8],[9]

10.75%

^[8],[9]

10.75%

^[8],[9]

^[8],[9]

16.05%

$ 2,232

^{[1],[5],[11],[17]}

$ 787

^[8],[9],[12]

2,163

^[1],[5],[17]

771

^[8],[9]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

$ 1,768

^[1],[5],[17]

$ 787

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.75%

^[1],[5],[17]

10.75%

^[1],[5],[17]

10.75%

^[1],[5],[17]

10.75%

^[6],[8],[9]

10.75%

^[6],[8],[9]

10.75%

^[6],[8],[9]

^[6],[8],[9]

16.06%

$ 839

^{[1],[5],[11],[17]}

$ 688

^{[6],[8],[9],[12]}

785

^[1],[5],[17]

688

^[6],[8],[9]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4

$ 664

^[1],[5],[17]

$ 688

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5],[17]

10.75%

^{[1],[5],[11],[17]}

$ 28,010

^[1],[5],[17]

26,687

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

^[1],[5],[17]

$ 14,817

Investment Company, Nonconsolidated Subsidiary [Line Items]

350,241

$ 0

Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I

$ 0

$ 147

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.86%

10.90%

$ 7,313

$ 7,331

7,238

7,249

Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC

$ 7,313

$ 7,340

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.86%

10.90%

$ 3,900

$ 3,910

3,860

3,866

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

$ 3,900

$ 3,915

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[15]

5.75%

^{[8],[9],[10],[15]}

11.14%

^[8],[9],[15]

2.75%

^{[8],[9],[12],[15]}

$ 7,179

^[8],[9],[15]

6,969

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

^[8],[9],[15]

$ 6,568

Investment Company, Nonconsolidated Subsidiary [Line Items]

112,990

^[1],[13]

112,990

^[1],[13]

112,990

^[1],[13]

112,990

^[9],[15]

112,990

^[9],[15]

112,990

^[9],[15]

$ 300

^[1],[13]

$ 300

^[9],[15]

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

$ 0

^[1],[13]

$ 105

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,078,284

^[1]

1,078,284

^[1]

1,078,284

^[1]

1,078,284

^[9]

1,078,284

^[9]

1,078,284

^[9]

$ 113

^[1]

$ 113

^[9]

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(85)

^[1],[2],[5]

(99)

^[6],[8],[9]

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

$ (86)

^[1],[2],[5]

$ (86)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[8],[9]

7.50%

^[8],[9]

7.50%

^[8],[9]

12.97%

^[1],[4],[5]

12.97%

^[1],[4],[5]

12.97%

^[1],[4],[5]

12.93%

^[8],[9],[10]

12.93%

^[8],[9],[10]

12.93%

^[8],[9],[10]

$ 33,331

^[1],[5],[11]

$ 33,414

^[8],[9],[12]

32,585

^[1],[5]

32,539

^[8],[9]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

$ 32,577

^[1],[5]

$ 32,659

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[5]

7.25%

^[5]

7.25%

^[5]

7.25%

^[8]

7.25%

^[8]

7.25%

^[8]

12.91%

^[4],[5]

12.91%

^[4],[5]

12.91%

^[4],[5]

12.78%

^[8],[10]

12.78%

^[8],[10]

12.78%

^[8],[10]

$ 13,939

^[5],[11]

$ 13,939

^[8],[12]

12,721

^[5]

12,661

^[8]

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

11,314

^[5]

10,094

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8,722

83,262

Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | SLF JV I

$ 8,722

$ 83,262

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.36%

10.32%

$ 7,910

$ 10,000

7,658

9,666

Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | OCSI Glick JV LLC

$ 7,857

$ 9,665

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.36%

10.32%

$ 3,560

$ 4,500

3,447

4,350

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

$ 3,536

$ 4,349

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

^{[6],[8],[9],[10]}

11.84%

$ 0

^{[1],[2],[5],[11]}

$ 272

^{[6],[8],[9],[12]}

(44)

^[1],[2],[5]

246

^[6],[8],[9]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

$ (47)

^[1],[2],[5]

$ 238

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(26)

^[1],[2],[5]

(47)

^[6],[8],[9]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

$ (35)

^[1],[2],[5]

$ (47)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

11.99%

^[4],[5]

11.99%

^[4],[5]

11.99%

^[4],[5]

11.84%

^[8],[9],[10]

11.84%

^[8],[9],[10]

11.84%

^[8],[9],[10]

$ 38,015

^[1],[5],[11]

$ 16,752

^[8],[9],[12]

37,482

^[1],[5]

16,623

^[8],[9]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

$ 37,445

^[1],[5]

$ 16,500

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

11.84%

^[1],[4],[5]

11.84%

^[1],[4],[5]

11.84%

^[1],[4],[5]

11.80%

^[8],[9],[10]

11.80%

^[8],[9],[10]

11.80%

^[8],[9],[10]

$ 16,722

^[1],[5],[11]

$ 38,015

^[8],[9],[12]

16,593

^[1],[5]

37,447

^[8],[9]

Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | SLF JV I

$ 16,471

^[1],[5]

$ 37,445

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.46%

10.42%

$ 3,952

$ 3,962

3,813

3,815

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

$ 3,801

$ 3,955

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(39)

^[1],[2],[5]

(41)

^[6],[8],[9]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

$ (199)

^[1],[2],[5]

$ (172)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.46%

^[1],[4],[5]

11.46%

^[1],[4],[5]

11.46%

^[1],[4],[5]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

$ 2,729

^[1],[5],[11]

$ 2,736

^[8],[9],[12]

2,597

^[1],[5]

2,595

^[8],[9]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

$ 2,524

^[1],[5]

$ 2,558

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.46%

^[4],[5]

11.46%

^[4],[5]

11.46%

^[4],[5]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

$ 23,435

^[1],[5],[11]

$ 23,494

^[8],[9],[12]

23,091

^[1],[5]

23,128

^[8],[9]

Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I

21,677

^[1],[5]

21,967

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC

11,220

11,286

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I

$ 6,147

$ 6,230

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

11.41%

11.32%

$ 7,350

$ 7,369

7,257

7,269

Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 7,267

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

11.41%

11.32%

$ 3,920

$ 3,930

3,870

3,877

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

$ 3,876

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.50%

^[5],[13]

9.50%

^[5],[13]

9.50%

^[5],[13]

9.50%

^[8],[15]

9.50%

^[8],[15]

9.50%

^[8],[15]

15.08%

^[4],[5],[13]

15.08%

^[4],[5],[13]

15.08%

^[4],[5],[13]

14.95%

^{[8],[10],[15]}

14.95%

^{[8],[10],[15]}

14.95%

^{[8],[10],[15]}

$ 26,356

^{[5],[11],[13]}

$ 26,422

^{[8],[12],[15]}

24,952

^[5],[13]

24,920

^[8],[15]

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

$ 27,163

^[5],[13]

$ 27,512

^[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[9]

2,000,000

^[9]

$ 1,399

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I

^[9]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.61%

10.65%

$ 11,220

$ 11,249

11,091

11,106

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

$ 10,883

$ 10,912

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[1],[5]

5.00%

^[8],[9]

5.00%

^[8],[9]

5.00%

^[8],[9]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.61%

^[1],[4],[5]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

10.65%

^[8],[9],[10]

$ 45,125

^[1],[5],[11]

$ 45,243

^[8],[9],[12]

44,652

^[1],[5]

44,717

^[8],[9]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

$ 43,771

^[1],[5]

$ 43,886

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

559

^[1]

559

^[1]

559

^[1]

559

^[9]

559

^[9]

559

^[9]

^[9],[12]

$ 563

^[1]

563

^[9]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

$ 268

^[1]

$ 372

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.50%

^[1],[5]

9.50%

^[1],[5]

9.50%

^[1],[5]

8.50%

^[8],[9]

8.50%

^[8],[9]

8.50%

^[8],[9]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

13.99%

^[8],[9],[10]

13.99%

^[8],[9],[10]

13.99%

^[8],[9],[10]

9.95%

$ 3,012

^[1],[5],[11]

$ 5,403

^[8],[9],[12]

2,968

^[1],[5]

5,348

^[8],[9]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

$ 2,846

^[1],[5]

$ 5,160

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.50%

^[1],[5]

9.50%

^[1],[5]

9.50%

^[1],[5]

8.50%

^[6],[8],[9]

8.50%

^[6],[8],[9]

8.50%

^[6],[8],[9]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

5.00%

^[1],[4],[5]

13.99%

^{[6],[8],[9],[10]}

13.99%

^{[6],[8],[9],[10]}

13.99%

^{[6],[8],[9],[10]}

9.95%

$ 5,536

^[1],[5],[11]

$ 2,939

^{[6],[8],[9],[12]}

5,486

^[1],[5]

2,884

^[6],[8],[9]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

$ 5,232

^[1],[5]

$ 2,745

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

6.00%

^[6],[8],[9]

^{[6],[8],[9],[10]}

11.42%

$ 0

^{[1],[2],[5],[11]}

$ 964

^{[6],[8],[9],[12]}

(26)

^[1],[2],[5]

936

^[6],[8],[9]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

$ (27)

^[1],[2],[5]

$ 938

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.53%

^[1],[4],[5]

11.53%

^[1],[4],[5]

11.53%

^[1],[4],[5]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

$ 2,624

^[1],[5],[11]

$ 20,125

^[8],[9],[12]

2,581

^[1],[5]

19,912

^[8],[9]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

$ 2,585

^[1],[5]

$ 19,823

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[1],[2],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.53%

^[4],[5]

11.53%

^[4],[5]

11.53%

^[4],[5]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

11.52%

^[8],[9],[10]

$ 11,802

^{[1],[2],[5],[11]}

$ 2,631

^[8],[9],[12]

11,685

^[1],[2],[5]

2,587

^[8],[9]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

$ 11,625

^[1],[2],[5]

$ 2,591

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[1],[2],[5]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

7.50%

^[6],[8],[9]

12.86%

^{[1],[2],[4],[5]}

12.86%

^{[1],[2],[4],[5]}

12.86%

^{[1],[2],[4],[5]}

12.83%

^{[6],[8],[9],[10]}

12.83%

^{[6],[8],[9],[10]}

12.83%

^{[6],[8],[9],[10]}

$ 8,308

^{[1],[2],[5],[11]}

$ 1,466

^{[6],[8],[9],[12]}

8,070

^[1],[2],[5]

1,215

^[6],[8],[9]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

$ 8,308

^[1],[2],[5]

$ 1,282

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[1],[5]

7.50%

^[8],[9]

7.50%

^[8],[9]

7.50%

^[8],[9]

12.89%

^[1],[4],[5]

12.89%

^[1],[4],[5]

12.89%

^[1],[4],[5]

12.89%

^[8],[9],[10]

12.89%

^[8],[9],[10]

12.89%

^[8],[9],[10]

$ 40,538

^[1],[5],[11]

$ 40,538

^[8],[9],[12]

39,910

^[1],[5]

39,873

^[8],[9]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

$ 40,944

^[1],[5]

$ 39,833

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[1],[2],[5]

5.50%

^[1],[2],[5]

5.50%

^[1],[2],[5]

5.50%

^[6],[8],[9]

5.50%

^[6],[8],[9]

5.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(55)

^[1],[2],[5]

(28)

^[6],[8],[9]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

$ (27)

^[1],[2],[5]

$ (47)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[8],[9]

5.50%

^[8],[9]

5.50%

^[8],[9]

10.95%

^[4],[5]

10.95%

^[4],[5]

10.95%

^[4],[5]

10.99%

^[8],[9],[10]

10.99%

^[8],[9],[10]

10.99%

^[8],[9],[10]

$ 21,272

^[1],[5],[11]

$ 13,973

^[8],[9],[12]

20,949

^[1],[5]

13,936

^[8],[9]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

$ 21,060

^[1],[5]

$ 13,685

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[1],[5]

5.50%

^[8],[9]

5.50%

^[8],[9]

5.50%

^[8],[9]

10.95%

^[1],[4],[5]

10.95%

^[1],[4],[5]

10.95%

^[1],[4],[5]

10.99%

^[8],[9],[10]

10.99%

^[8],[9],[10]

10.99%

^[8],[9],[10]

$ 13,937

^[1],[5],[11]

$ 21,328

^[8],[9],[12]

13,897

^[1],[5]

21,021

^[8],[9]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

$ 13,797

^[1],[5]

$ 20,888

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

5.50%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I

^[1],[2],[5]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

$ 0

(3)

Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC

$ (2)

$ (7)

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

$ 0

(1)

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC

$ (1)

$ (3)

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

10.95%

10.99%

$ 1,625

$ 1,630

1,612

1,616

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | SLF JV I

$ 1,609

$ 1,596

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

10.95%

10.99%

$ 8,297

$ 8,319

8,143

8,164

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | SLF JV I

$ 8,215

$ 8,147

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

10.95%

10.99%

$ 2,205

$ 2,211

2,205

2,210

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

$ 2,183

$ 2,165

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

$ 8,568

^{[1],[11],[13]}

$ 8,568

^{[9],[12],[15]}

8,502

^[1],[13]

8,495

^[9],[15]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

$ 8,139

^[1],[13]

$ 8,132

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

$ 8,568

^{[1],[11],[13]}

$ 4,284

^{[9],[12],[15]}

8,502

^[1],[13]

4,247

^[9],[15]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 8,139

^[1],[13]

$ 4,066

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[1],[4],[5],[13]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

11.50%

^{[8],[9],[10],[15]}

$ 4,284

^{[1],[11],[13]}

$ 8,568

^{[9],[12],[15]}

4,251

^[1],[13]

8,495

^[9],[15]

Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | SLF JV I

$ 4,070

^[1],[13]

$ 8,132

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.19%

9.18%

$ 5,925

$ 5,940

5,653

5,654

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

$ 5,916

$ 5,812

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^{[1],[4],[5],[13]}

8.00%

^{[1],[4],[5],[13]}

8.00%

^{[1],[4],[5],[13]}

8.00%

^{[8],[9],[10],[15]}

8.00%

^{[8],[9],[10],[15]}

8.00%

^{[8],[9],[10],[15]}

1.75%

^[1],[13]

1.75%

^[1],[13]

1.75%

^[1],[13]

1.75%

^[9],[15]

1.75%

^[9],[15]

1.75%

^[9],[15]

$ 9,129

^{[1],[11],[13]}

$ 9,106

^{[9],[12],[15]}

8,644

^[1],[13]

8,580

^[9],[15]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

$ 8,147

^[1],[13]

$ 8,013

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

66,817

^[1],[13]

66,817

^[1],[13]

66,817

^[1],[13]

259,877

^[9],[15]

259,877

^[9],[15]

259,877

^[9],[15]

^{[9],[12],[15]}

$ 23

^[1],[13]

545

^[9],[15]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

$ 27

^[1],[13]

$ 78

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

259,877

^[1],[13]

259,877

^[1],[13]

259,877

^[1],[13]

66,817

^[9],[15]

66,817

^[9],[15]

66,817

^[9],[15]

^{[9],[12],[15]}

$ 545

^[1],[13]

^[9],[15]

Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I

$ 65

^[1],[13]

$ 33

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

$ 0

(2)

Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I

$ (7)

$ (8)

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

12.53%

12.52%

$ 4,669

4,652

4,648

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

$ 4,603

$ 4,594

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(35)

^[1],[2],[5]

(43)

^[6],[8],[9]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

$ (67)

^[1],[2],[5]

$ (76)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.53%

^[4],[5]

12.53%

^[4],[5]

12.53%

^[4],[5]

12.52%

^[8],[9],[10]

12.52%

^[8],[9],[10]

12.52%

^[8],[9],[10]

$ 46,687

^[1],[5],[11]

$ 5,248

^[8],[9],[12]

46,322

^[1],[5]

5,220

^[8],[9]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

$ 46,033

^[1],[5]

$ 5,164

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.53%

^[1],[4],[5]

12.53%

^[1],[4],[5]

12.53%

^[1],[4],[5]

12.52%

^[8],[9],[10]

12.52%

^[8],[9],[10]

12.52%

^[8],[9],[10]

$ 5,248

^[1],[5],[11]

$ 46,687

^[8],[9],[12]

5,225

^[1],[5]

46,239

^[8],[9]

Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | SLF JV I

$ 5,175

^[1],[5]

$ 45,940

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.40%

9.18%

$ 2,977

$ 2,985

2,845

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

$ 2,980

$ 2,941

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[1],[5]

6.75%

^[1],[5]

6.75%

^[1],[5]

6.75%

^[8],[9]

6.75%

^[8],[9]

6.75%

^[8],[9]

13.60%

^[1],[4],[5]

13.60%

^[1],[4],[5]

13.60%

^[1],[4],[5]

12.51%

^[8],[9],[10]

12.51%

^[8],[9],[10]

12.51%

^[8],[9],[10]

$ 49,266

^[1],[5],[11]

$ 54,559

^[8],[9],[12]

49,001

^[1],[5]

54,236

^[8],[9]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

$ 48,034

^[1],[5]

$ 53,168

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.88%

^[4],[5]

6.88%

^[4],[5]

6.88%

^[4],[5]

6.88%

^[8],[10]

6.88%

^[8],[10]

6.88%

^[8],[10]

$ 10,191

^[11]

$ 10,191

^[12]

9,846

9,831

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

$ 10,368

$ 8,743

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.88%

^[1],[5],[13]

6.88%

^[1],[5],[13]

6.88%

^[1],[5],[13]

6.88%

^[8],[9],[15]

6.88%

^[8],[9],[15]

6.88%

^[8],[9],[15]

12.33%

^{[1],[4],[5],[13]}

12.33%

^{[1],[4],[5],[13]}

12.33%

^{[1],[4],[5],[13]}

12.29%

^{[8],[9],[10],[15]}

12.29%

^{[8],[9],[10],[15]}

12.29%

^{[8],[9],[10],[15]}

2.00%

^[1],[5],[13]

2.00%

^[1],[5],[13]

2.00%

^[1],[5],[13]

2.00%

^[8],[9],[15]

2.00%

^[8],[9],[15]

2.00%

^[8],[9],[15]

$ 73,547

^{[1],[5],[11],[13]}

$ 73,362

^{[8],[9],[12],[15]}

72,724

^[1],[5],[13]

72,459

^[8],[9],[15]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

$ 70,201

^[1],[5],[13]

$ 69,694

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

487,870

^[13]

487,870

^[13]

487,870

^[13]

487,870

^[15]

487,870

^[15]

487,870

^[15]

$ 0

^[13]

$ 0

^[15]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

$ 1,947

^[13]

$ 903

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

487,870

^[13]

487,870

^[13]

487,870

^[13]

487,870

^[15]

487,870

^[15]

487,870

^[15]

$ 0

^[13]

$ 0

^[15]

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

$ 1,947

^[13]

$ 903

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[1],[5]

8.50%

^[8],[9]

8.50%

^[8],[9]

8.50%

^[8],[9]

13.93%

^[1],[4],[5]

13.93%

^[1],[4],[5]

13.93%

^[1],[4],[5]

13.99%

^[8],[9],[10]

13.99%

^[8],[9],[10]

13.99%

^[8],[9],[10]

$ 30,339

^[1],[5],[11]

$ 30,339

^[8],[9],[12]

30,040

^[1],[5]

30,021

^[8],[9]

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

$ 30,166

^[1],[5]

$ 29,007

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.50%

^[1],[5]

9.50%

^[1],[5]

9.50%

^[1],[5]

9.50%

^[8],[9]

9.50%

^[8],[9]

9.50%

^[8],[9]

14.83%

^[1],[4],[5]

14.83%

^[1],[4],[5]

14.83%

^[1],[4],[5]

14.89%

^[8],[9],[10]

14.89%

^[8],[9],[10]

14.89%

^[8],[9],[10]

$ 64,606

^[1],[5],[11]

$ 64,606

^[8],[9],[12]

64,689

^[1],[5]

64,720

^[8],[9]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

$ 63,185

^[1],[5]

$ 63,185

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

6.00%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(28)

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

^[1],[2],[5]

$ (23)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

6.00%

^[1],[4],[5]

11.37%

^[1],[5],[11]

$ 19,995

^[1],[5]

19,695

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

^[1],[5]

$ 19,751

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

6.00%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(38)

Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I

^[1],[2],[5]

(38)

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.76%

10.15%

$ 6,615

6,608

Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 6,565

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.76%

10.15%

$ 5,198

5,192

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

5,159

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[2],[13],[22],[23]}

^{[6],[15],[24],[25]}

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

$ 0

^{[2],[13],[22],[23]}

$ 0

^{[6],[15],[24],[25]}

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

^{[1],[2],[5],[13],[22]}

4.50%

^{[1],[2],[5],[13],[22]}

4.50%

^{[1],[2],[5],[13],[22]}

4.50%

^{[6],[9],[15],[24]}

4.50%

^{[6],[9],[15],[24]}

4.50%

^{[6],[9],[15],[24]}

4.50%

9.94%

^{[1],[2],[4],[5],[13],[22]}

9.94%

^{[1],[2],[4],[5],[13],[22]}

9.94%

^{[1],[2],[4],[5],[13],[22]}

9.76%

^{[6],[8],[9],[10],[15],[24]}

9.76%

^{[6],[8],[9],[10],[15],[24]}

9.76%

^{[6],[8],[9],[10],[15],[24]}

7.67%

$ 58,349

^{[1],[2],[5],[11],[13],[22]}

$ 58,349

^{[6],[9],[12],[15],[24]}

$ 59,049

50,621

^{[1],[2],[5],[13],[22]}

50,330

^{[6],[9],[15],[24]}

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

$ 50,957

^{[1],[2],[5],[13],[22]}

$ 50,017

^{[6],[9],[15],[24]}

49,536

50,283

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.46%

^[1],[4],[5]

12.46%

^[1],[4],[5]

12.46%

^[1],[4],[5]

12.49%

^[8],[9],[10]

12.49%

^[8],[9],[10]

12.49%

^[8],[9],[10]

$ 9,323

^[1],[5],[11]

$ 9,323

^[8],[9],[12]

9,216

^[1],[5]

9,210

^[8],[9]

Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I

$ 9,183

^[1],[5]

$ 9,183

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.46%

9.43%

$ 10,958

$ 10,987

10,810

10,827

Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 10,954

$ 10,971

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.46%

9.43%

$ 3,839

$ 3,849

3,821

3,830

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

$ 3,837

$ 3,843

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.00%

^[1],[5],[17]

10.00%

^[1],[5],[17]

10.00%

^[1],[5],[17]

10.00%

^[8],[9]

10.00%

^[8],[9]

10.00%

^[8],[9]

^[8],[9]

15.67%

$ 1,303

^{[1],[5],[11],[17]}

$ 25,712

^[8],[9],[12]

1,202

^[1],[5],[17]

25,615

^[8],[9]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

$ 1,074

^[1],[5],[17]

$ 25,069

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.00%

^[1],[5],[17]

10.00%

^[1],[5],[17]

10.00%

^[1],[5],[17]

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

$ 31,515

^{[1],[5],[11],[17]}

$ 0

^{[6],[8],[9],[12]}

26,979

^[1],[5],[17]

(11)

^[6],[8],[9]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

$ 25,959

^[1],[5],[17]

$ (69)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12.00%

^{[1],[2],[5],[17]}

12.00%

^{[1],[2],[5],[17]}

12.00%

^{[1],[2],[5],[17]}

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

^[6],[8],[9]

15.64%

$ 233

^{[1],[2],[5],[11],[17]}

$ 1,210

^{[6],[8],[9],[12]}

233

^{[1],[2],[5],[17]}

1,193

^[6],[8],[9]

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

$ 233

^{[1],[2],[5],[17]}

$ 1,169

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.75%

^[1],[2],[5]

7.75%

^[1],[2],[5]

7.75%

^[1],[2],[5]

7.75%

^[6],[8],[9]

7.75%

^[6],[8],[9]

7.75%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(40)

^[1],[2],[5]

(42)

^[6],[8],[9]

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

$ (29)

^[1],[2],[5]

$ (36)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.75%

^[1],[5]

7.75%

^[1],[5]

7.75%

^[1],[5]

7.75%

^[8],[9]

7.75%

^[8],[9]

7.75%

^[8],[9]

13.13%

^[1],[4],[5]

13.13%

^[1],[4],[5]

13.13%

^[1],[4],[5]

13.12%

^[8],[9],[10]

13.12%

^[8],[9],[10]

13.12%

^[8],[9],[10]

$ 15,231

^[1],[5],[11]

$ 15,231

^[8],[9],[12]

14,908

^[1],[5]

14,892

^[8],[9]

Investment, Identifier [Axis]: Other cash accounts

15,003

^[1],[5]

14,945

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

122,975

62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

$ 122,975

$ 62,277

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[10]

7.75%

^[12]

$ 4,519

4,550

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

$ 3,305

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[1],[2],[5]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

7.00%

^[6],[8],[9]

^{[1],[2],[4],[5]}

12.35%

$ 98

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

^[1],[2],[5]

(53)

^[6],[8],[9]

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

$ 44

^[1],[2],[5]

$ (54)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

12.36%

^[1],[4],[5]

12.36%

^[1],[4],[5]

12.36%

^[1],[4],[5]

12.32%

^[8],[9],[10]

12.32%

^[8],[9],[10]

12.32%

^[8],[9],[10]

$ 10,868

^[1],[5],[11]

$ 10,895

^[8],[9],[12]

10,497

^[1],[5]

10,505

^[8],[9]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

$ 10,469

^[1],[5]

$ 10,495

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

100,000

^[1]

100,000

^[1]

100,000

^[1]

100,000

^[9]

100,000

^[9]

100,000

^[9]

$ 109

^[1]

$ 109

^[9]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

$ 300

^[1]

$ 248

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(30)

^[1],[2],[5]

(34)

^[6],[8],[9]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

$ 0

^[1],[2],[5]

$ (3)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

12.04%

^[1],[4],[5]

12.04%

^[1],[4],[5]

12.04%

^[1],[4],[5]

12.01%

^[8],[9],[10]

12.01%

^[8],[9],[10]

12.01%

^[8],[9],[10]

$ 38,308

^[1],[5],[11]

$ 38,414

^[8],[9],[12]

37,902

^[1],[5]

37,960

^[8],[9]

Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I

$ 38,308

^[1],[5]

$ 38,380

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.46%

10.42%

$ 9,799

$ 9,825

9,488

9,492

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

$ 9,778

$ 9,698

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[5]

5.00%

^[5]

5.00%

^[5]

5.00%

^[8]

5.00%

^[8]

5.00%

^[8]

10.46%

^[4],[5]

10.46%

^[4],[5]

10.46%

^[4],[5]

10.42%

^[8],[10]

10.42%

^[8],[10]

10.42%

^[8],[10]

$ 9,651

^[5],[11]

$ 9,676

^[8],[12]

9,500

^[5]

9,518

^[8]

Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | SLF JV I

$ 9,630

^[5]

$ 9,551

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.21%

$ 1,995

1,994

Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | OCSI Glick JV LLC

$ 2,002

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.21%

$ 997

997

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

$ 1,001

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.75%

^[1],[5]

5.75%

^[1],[5]

5.75%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.32%

^[1],[4],[5]

11.32%

^[1],[4],[5]

11.32%

^[1],[4],[5]

11.57%

^[8],[9],[10]

11.57%

^[8],[9],[10]

11.57%

^[8],[9],[10]

$ 22,375

^[1],[5],[11]

$ 22,375

^[8],[9],[12]

22,201

^[1],[5]

22,189

^[8],[9]

Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | SLF JV I

$ 21,928

^[1],[5]

$ 21,896

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.21%

$ 4,000

3,930

Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 3,962

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.21%

$ 2,000

1,965

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

$ 1,981

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

6.00%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(134)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

^[1],[2],[5]

$ (133)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

6.00%

^[1],[4],[5]

11.36%

^[1],[5],[11]

$ 52,639

^[1],[5]

51,606

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

^[1],[5]

$ 51,618

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

6.00%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(69)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

^[1],[2],[5]

$ (69)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1]

4,531,000

^[1]

$ 4,440

Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond

^[1]

$ 4,444

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

6.50%

^[11]

$ 2,300

2,122

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

$ 2,192

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[8],[9]

7.25%

^[8],[9]

7.25%

^[8],[9]

12.70%

^[1],[4],[5]

12.70%

^[1],[4],[5]

12.70%

^[1],[4],[5]

12.74%

^[8],[9],[10]

12.74%

^[8],[9],[10]

12.74%

^[8],[9],[10]

$ 36,499

^[1],[5],[11]

$ 36,499

^[8],[9],[12]

35,490

^[1],[5]

35,458

^[8],[9]

Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | SLF JV I

$ 33,397

^[1],[5]

$ 33,214

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.61%

9.65%

$ 2,410

$ 2,416

2,299

2,298

Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 2,395

$ 2,390

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.61%

9.65%

$ 681

$ 683

650

Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I

$ 677

$ 676

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

12.70%

12.74%

$ 4,503

4,435

Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC

$ 4,120

$ 4,098

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

12.70%

12.74%

$ 2,842

2,799

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

$ 2,600

$ 2,586

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[1],[2],[5]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

8.00%

^[6],[8],[9]

13.56%

^{[1],[2],[4],[5]}

13.56%

^{[1],[2],[4],[5]}

13.56%

^{[1],[2],[4],[5]}

13.45%

^{[6],[8],[9],[10]}

13.45%

^{[6],[8],[9],[10]}

13.45%

^{[6],[8],[9],[10]}

$ 3,722

^{[1],[2],[5],[11]}

$ 3,003

^{[6],[8],[9],[12]}

3,649

^[1],[2],[5]

2,926

^[6],[8],[9]

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

$ 3,540

^[1],[2],[5]

$ 2,801

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[8],[9]

8.00%

^[8],[9]

8.00%

^[8],[9]

13.56%

^[1],[4],[5]

13.56%

^[1],[4],[5]

13.56%

^[1],[4],[5]

13.45%

^[8],[9],[10]

13.45%

^[8],[9],[10]

13.45%

^[8],[9],[10]

$ 67,244

^[1],[5],[11]

$ 67,244

^[8],[9],[12]

66,418

^[1],[5]

66,353

^[8],[9]

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I

$ 64,689

^[1],[5]

$ 64,406

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

13.56%

13.45%

$ 394

$ 318

379

301

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC

$ 375

$ 297

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

13.56%

13.45%

$ 281

$ 226

271

216

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I

$ 266

$ 211

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

13.56%

13.45%

$ 8,116

7,869

7,850

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 7,807

$ 7,773

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

13.56%

13.45%

$ 5,182

5,040

5,029

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

$ 4,985

$ 4,964

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5],[13]

7.25%

^{[1],[4],[5],[13]}

12.60%

^{[1],[5],[11],[13]}

$ 28,818

^[1],[5],[13]

28,530

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

^[1],[5],[13]

$ 28,530

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

7.25%

^[8],[9],[10]

12.78%

^[8],[9],[12]

$ 24,503

^[8],[9]

24,255

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

^[8],[9]

$ 24,081

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

7.25%

^[8],[9],[10]

12.78%

^[8],[9],[12]

$ 2,819

^[8],[9]

2,797

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

^[8],[9]

$ 2,771

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.50%

^[1],[5],[13]

5.50%

^[1],[5],[13]

5.50%

^[1],[5],[13]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

5.75%

^[8],[9],[15]

10.96%

^{[1],[4],[5],[13]}

10.96%

^{[1],[4],[5],[13]}

10.96%

^{[1],[4],[5],[13]}

11.21%

^{[8],[9],[10],[15]}

11.21%

^{[8],[9],[10],[15]}

11.21%

^{[8],[9],[10],[15]}

£ 6,136

^{[1],[5],[11],[13]}

£ 4,626

^{[8],[9],[12],[15]}

$ 7,677

^[1],[5],[13]

$ 5,897

^[8],[9],[15]

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

$ 7,353

^[1],[5],[13]

$ 5,166

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

64,887,669

^[1]

64,887,669

^[1]

64,887,669

^[1]

64,887,669

^[9]

64,887,669

^[9]

64,887,669

^[9]

$ 375

^[1]

$ 375

^[9]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[1],[2],[5]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

6.50%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(40)

^[1],[2],[5]

(43)

^[6],[8],[9]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

$ (35)

^[1],[2],[5]

$ (47)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[1],[5]

6.50%

^[8],[9]

6.50%

^[8],[9]

6.50%

^[8],[9]

11.96%

^[1],[4],[5]

11.96%

^[1],[4],[5]

11.96%

^[1],[4],[5]

11.92%

^[8],[9],[10]

11.92%

^[8],[9],[10]

11.92%

^[8],[9],[10]

$ 32,329

^[1],[5],[11]

$ 32,329

^[8],[9],[12]

32,089

^[1],[5]

32,070

^[8],[9]

Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | SLF JV I

$ 31,915

^[1],[5]

$ 31,779

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

10.11%

9.99%

$ 4,988

$ 5,000

4,853

4,860

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

$ 5,012

$ 4,969

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

13.86%

^{[1],[4],[5],[13]}

13.86%

^{[1],[4],[5],[13]}

13.86%

^{[1],[4],[5],[13]}

13.90%

^{[8],[9],[10],[15]}

13.90%

^{[8],[9],[10],[15]}

13.90%

^{[8],[9],[10],[15]}

0.50%

^[1],[5],[13]

0.50%

^[1],[5],[13]

0.50%

^[1],[5],[13]

0.50%

^[8],[9],[15]

0.50%

^[8],[9],[15]

0.50%

^[8],[9],[15]

$ 9,697

^{[1],[5],[11],[13]}

$ 36,707

^{[8],[9],[12],[15]}

9,405

^[1],[5],[13]

35,548

^[8],[9],[15]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

$ 9,115

^[1],[5],[13]

$ 34,505

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

8.25%

^[8],[9],[15]

13.86%

^{[1],[4],[5],[13]}

13.86%

^{[1],[4],[5],[13]}

13.86%

^{[1],[4],[5],[13]}

13.90%

^{[8],[9],[10],[15]}

13.90%

^{[8],[9],[10],[15]}

13.90%

^{[8],[9],[10],[15]}

0.50%

^[1],[5],[13]

0.50%

^[1],[5],[13]

0.50%

^[1],[5],[13]

0.50%

^[8],[9],[15]

0.50%

^[8],[9],[15]

0.50%

^[8],[9],[15]

$ 32,133

^{[1],[5],[11],[13]}

$ 13,504

^{[8],[9],[12],[15]}

31,203

^[1],[5],[13]

13,058

^[8],[9],[15]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

$ 30,205

^[1],[5],[13]

$ 12,694

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

204,454

^[1],[13]

204,454

^[1],[13]

204,454

^[1],[13]

204,454

^[9],[15]

204,454

^[9],[15]

204,454

^[9],[15]

$ 1,202

^[1],[13]

$ 1,202

^[9],[15]

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond

$ 1,073

^[1],[13]

$ 756

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

4.88%

^[11]

$ 1,680

1,539

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | SLF JV I

$ 1,573

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

$ 2,991

2,991

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 2,999

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

$ 1,495

1,495

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

$ 1,500

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,037

^[1]

1,037

^[1]

1,037

^[1]

1,037

^[9]

1,037

^[9]

1,037

^[9]

$ 1,037

^[1]

$ 1,037

^[9]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

$ 1,024

^[1]

$ 951

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[8],[9]

8.75%

^[8],[9]

8.75%

^[8],[9]

14.20%

^{[1],[2],[4],[5]}

14.20%

^{[1],[2],[4],[5]}

14.20%

^{[1],[2],[4],[5]}

14.18%

^[8],[9],[10]

14.18%

^[8],[9],[10]

14.18%

^[8],[9],[10]

$ 990

^{[1],[2],[5],[11]}

$ 8,010

^[8],[9],[12]

954

^[1],[2],[5]

7,799

^[8],[9]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

$ 921

^[1],[2],[5]

$ 7,778

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.75%

^[1],[5]

8.75%

^[1],[5]

8.75%

^[1],[5]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

^[1],[4],[5]

14.21%

$ 8,010

^[1],[5],[11]

$ 0

^{[6],[8],[9],[12]}

7,807

^[1],[5]

(35)

^[6],[8],[9]

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I

$ 7,778

^[1],[5]

$ (68)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.23%

10.61%

10.86%

$ 158

$ 138

158

138

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC

$ 107

$ 94

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.63%

10.88%

$ 6,012

$ 6,029

6,010

6,025

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I

$ 4,073

$ 4,110

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.63%

10.88%

$ 8,091

$ 8,113

8,090

8,111

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC

$ 5,482

$ 5,531

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.23%

10.61%

10.86%

$ 117

$ 103

117

102

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

$ 79

$ 70

Investment Company, Nonconsolidated Subsidiary [Line Items]

1,184,630

^[1]

1,184,630

^[1]

1,184,630

^[1]

1,184,630

^[9]

1,184,630

^[9]

1,184,630

^[9]

$ 40,094

^[1]

$ 40,093

^[9]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

$ 36,226

^[1]

$ 36,226

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12.00%

^[1]

12.00%

^[1]

12.00%

^[1]

12.00%

^[9]

12.00%

^[9]

12.00%

^[9]

$ 16,355

^[1],[11]

$ 15,874

^[9],[12]

14,634

^[1]

14,100

^[9]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

$ 16,355

^[1]

$ 15,874

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

12.00%

^[1],[2]

12.00%

^[1],[2]

12.00%

^[1],[2]

12.00%

^[6],[9]

12.00%

^[6],[9]

12.00%

^[6],[9]

$ 3,005

^[1],[2],[11]

$ 1,359

^[6],[9],[12]

2,951

^[1],[2]

1,337

^[6],[9]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

$ 3,005

^[1],[2]

$ 1,359

^[6],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

66,686

^[1]

66,686

^[1]

66,686

^[1]

66,686

^[9]

66,686

^[9]

66,686

^[9]

$ 0

^[1]

$ 0

^[9]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | SLF JV I

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

10.39%

10.38%

$ 2,970

$ 2,977

2,595

2,580

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

$ 2,881

$ 2,799

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

^[1],[5]

4.75%

^[1],[5]

4.75%

^[1],[5]

4.75%

^[8],[9]

4.75%

^[8],[9]

4.75%

^[8],[9]

10.39%

^[1],[4],[5]

10.39%

^[1],[4],[5]

10.39%

^[1],[4],[5]

10.38%

^[8],[9],[10]

10.38%

^[8],[9],[10]

10.38%

^[8],[9],[10]

$ 4,440

^[1],[5],[11]

$ 4,452

^[8],[9],[12]

3,833

^[1],[5]

3,806

^[8],[9]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

$ 4,307

^[1],[5]

$ 4,184

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[8],[9]

8.00%

^[8],[9]

8.00%

^[8],[9]

13.64%

^[1],[4],[5]

13.64%

^[1],[4],[5]

13.64%

^[1],[4],[5]

13.63%

^[8],[9],[10]

13.63%

^[8],[9],[10]

13.63%

^[8],[9],[10]

$ 12,034

^[1],[5],[11]

$ 12,034

^[8],[9],[12]

11,280

^[1],[5]

11,250

^[8],[9]

Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I

$ 10,169

^[1],[5]

$ 9,928

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.96%

9.92%

$ 8,801

8,459

8,442

Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 8,842

$ 8,794

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.96%

9.92%

$ 5,228

$ 5,227

5,041

5,032

Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond

$ 5,252

$ 5,224

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

8.75%

^[11]

$ 1,590

1,531

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

$ 1,592

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[1],[5],[17]

6.75%

^[1],[5],[17]

6.75%

^[1],[5],[17]

6.75%

^[8],[9]

6.75%

^[8],[9]

6.75%

^[8],[9]

^[8],[9],[10]

12.40%

$ 25,462

^{[1],[5],[11],[17]}

$ 25,527

^[8],[9],[12]

23,085

^[1],[5],[17]

23,859

^[8],[9]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

$ 14,131

^[1],[5],[17]

$ 19,954

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.00%

^[1],[2],[5]

10.00%

^[1],[2],[5]

10.00%

^[1],[2],[5]

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

10.00%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

(87)

^[1],[2],[5]

(95)

^[6],[8],[9]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

$ (85)

^[1],[2],[5]

$ (93)

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10.00%

^[1],[5]

10.00%

^[1],[5]

10.00%

^[1],[5]

10.00%

^[8],[9]

10.00%

^[8],[9]

10.00%

^[8],[9]

15.36%

^[1],[4],[5]

15.36%

^[1],[4],[5]

15.36%

^[1],[4],[5]

15.24%

^[8],[9],[10]

15.24%

^[8],[9],[10]

15.24%

^[8],[9],[10]

$ 25,418

^[1],[5],[11]

$ 25,558

^[8],[9],[12]

24,707

^[1],[5]

24,777

^[8],[9]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

$ 24,719

^[1],[5]

$ 24,791

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

991,019

^[1]

991,019

^[1]

991,019

^[1]

991,019

^[9]

991,019

^[9]

991,019

^[9]

$ 327

^[1]

$ 327

^[9]

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

$ 1,536

^[1]

$ 1,625

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9,307

^[13]

9,307

^[13]

9,307

^[13]

9,307

^[15]

9,307

^[15]

9,307

^[15]

$ 78

^[13]

$ 78

^[15]

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

^[13]

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

54,791

^{[2],[13],[21],[22],[23]}

54,791

^{[6],[15],[24],[25],[26]}

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

$ 29,587

^{[2],[13],[21],[22],[23]}

$ 28,878

^{[6],[15],[24],[25],[26]}

$ 24,108

20,715

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^{[1],[2],[5],[13],[22]}

7.00%

^{[1],[2],[5],[13],[22]}

7.00%

^{[1],[2],[5],[13],[22]}

7.00%

^{[6],[9],[15],[24]}

7.00%

^{[6],[9],[15],[24]}

7.00%

^{[6],[9],[15],[24]}

7.00%

12.44%

^{[1],[2],[4],[5],[13],[22]}

12.44%

^{[1],[2],[4],[5],[13],[22]}

12.44%

^{[1],[2],[4],[5],[13],[22]}

12.26%

^{[6],[8],[9],[10],[15],[24]}

12.26%

^{[6],[8],[9],[10],[15],[24]}

12.26%

^{[6],[8],[9],[10],[15],[24]}

10.17%

$ 112,656

^{[1],[2],[5],[11],[13],[22]}

$ 112,656

^{[6],[9],[12],[15],[24]}

$ 112,656

112,656

^{[1],[2],[5],[13],[22]}

112,656

^{[6],[9],[15],[24]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

$ 112,656

^{[1],[2],[5],[13],[22]}

$ 112,656

^{[6],[9],[15],[24]}

$ 112,656

$ 96,250

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.88%

^{[1],[2],[5],[13]}

7.88%

^{[1],[2],[5],[13]}

7.88%

^{[1],[2],[5],[13]}

7.88%

^[8],[9],[15]

7.88%

^[8],[9],[15]

7.88%

^[8],[9],[15]

^{[8],[9],[10],[15]}

12.88%

$ 0

^{[1],[2],[5],[11],[13]}

$ 7,191

^{[8],[9],[12],[15]}

^{[1],[2],[5],[13]}

6,934

^[8],[9],[15]

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

$ 0

^{[1],[2],[5],[13]}

$ 6,937

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.88%

^{[1],[2],[5],[13]}

7.88%

^{[1],[2],[5],[13]}

7.88%

^{[1],[2],[5],[13]}

7.88%

^[8],[9],[15]

7.88%

^[8],[9],[15]

7.88%

^[8],[9],[15]

^{[8],[9],[10],[15]}

12.88%

$ 0

^{[1],[2],[5],[11],[13]}

$ 2,697

^{[8],[9],[12],[15]}

^{[1],[2],[5],[13]}

2,601

^[8],[9],[15]

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

$ 0

^{[1],[2],[5],[13]}

$ 2,602

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.88%

^[1],[5],[13]

7.88%

^[1],[5],[13]

7.88%

^[1],[5],[13]

7.88%

^{[6],[8],[9],[15]}

7.88%

^{[6],[8],[9],[15]}

7.88%

^{[6],[8],[9],[15]}

^{[1],[4],[5],[13]}

12.88%

$ 7,191

^{[1],[5],[11],[13]}

$ 0

^{[6],[8],[9],[12],[15]}

6,946

^[1],[5],[13]

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

$ 6,880

^[1],[5],[13]

$ 0

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.88%

^[1],[5],[13]

7.88%

^[1],[5],[13]

7.88%

^[1],[5],[13]

7.88%

^{[6],[8],[9],[15]}

7.88%

^{[6],[8],[9],[15]}

7.88%

^{[6],[8],[9],[15]}

^{[1],[4],[5],[13]}

12.88%

$ 2,697

^{[1],[5],[11],[13]}

$ 0

^{[6],[8],[9],[12],[15]}

2,605

^[1],[5],[13]

^{[6],[8],[9],[15]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

$ 2,580

^[1],[5],[13]

$ 0

^{[6],[8],[9],[15]}

Investment Company, Nonconsolidated Subsidiary [Line Items]

58,210

^[1],[13]

58,210

^[1],[13]

58,210

^[1],[13]

58,210

^[9],[15]

58,210

^[9],[15]

58,210

^[9],[15]

$ 182

^[1],[13]

$ 182

^[9],[15]

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

$ 44

^[1],[13]

$ 87

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

345,452

^[1]

345,452

^[1]

345,452

^[1]

345,452

^[9]

345,452

^[9]

345,452

^[9]

$ 367

^[1]

$ 367

^[9]

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

7.50%

^[8],[9],[10]

13.04%

^[8],[9],[12]

$ 821

^[8],[9]

813

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

^[8],[9]

$ 776

Investment Company, Nonconsolidated Subsidiary [Line Items]

66,000

^[13]

66,000

^[13]

66,000

^[13]

66,000

^[15]

66,000

^[15]

66,000

^[15]

$ 139

^[13]

$ 139

^[15]

Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | SLF JV I

$ 8

^[13]

$ 6

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

9.43%

$ 7,661

$ 7,680

7,622

7,642

Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 7,646

$ 7,643

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.47%

9.43%

$ 3,283

$ 3,292

3,267

3,275

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

$ 3,277

$ 3,276

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

^[1],[2],[5]

5.00%

^[1],[2],[5]

5.00%

^[1],[2],[5]

5.00%

^[6],[8],[9]

5.00%

^[6],[8],[9]

5.00%

^[6],[8],[9]

^{[6],[8],[9],[10]}

10.42%

$ 0

^{[1],[2],[5],[11]}

$ 618

^{[6],[8],[9],[12]}

(40)

^[1],[2],[5]

576

^[6],[8],[9]

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

$ (19)

^[1],[2],[5]

$ 577

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

^[1],[5]

5.25%

^[1],[5]

5.25%

^[1],[5]

5.25%

^[8],[9]

5.25%

^[8],[9]

5.25%

^[8],[9]

10.71%

^[4],[5]

10.71%

^[4],[5]

10.71%

^[4],[5]

10.67%

^[8],[9],[10]

10.67%

^[8],[9],[10]

10.67%

^[8],[9],[10]

$ 4,477

^[1],[5],[11]

$ 4,488

^[8],[9],[12]

4,415

^[1],[5]

4,423

^[8],[9]

Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I

$ 4,438

^[1],[5]

$ 4,425

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.71%

10.67%

$ 8,820

$ 8,843

8,697

8,713

Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 8,743

$ 8,717

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.25%

10.71%

10.67%

$ 4,900

$ 4,913

4,832

4,840

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

$ 4,857

$ 4,843

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

7.50%

^[11]

$ 4,700

4,162

Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | SLF JV I

$ 4,377

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.35%

9.33%

$ 8,000

7,880

Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 7,926

$ 7,834

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.35%

9.33%

$ 4,000

3,940

3,939

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

$ 3,963

$ 3,916

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.25%

^[1],[5],[13]

8.50%

^[8],[9],[15]

8.50%

^[8],[9],[15]

8.50%

^[8],[9],[15]

12.21%

^{[1],[4],[5],[13]}

12.21%

^{[1],[4],[5],[13]}

12.21%

^{[1],[4],[5],[13]}

12.32%

^{[8],[9],[10],[15]}

12.32%

^{[8],[9],[10],[15]}

12.32%

^{[8],[9],[10],[15]}

€ 23,731

^{[1],[5],[11],[13]}

€ 23,731

^{[8],[9],[12],[15]}

$ 26,702

^[1],[5],[13]

$ 26,772

^[8],[9],[15]

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

$ 26,149

^[1],[5],[13]

$ 24,937

^[8],[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[8],[9]

8.00%

^[8],[9]

8.00%

^[8],[9]

13.36%

^[1],[4],[5]

13.36%

^[1],[4],[5]

13.36%

^[1],[4],[5]

13.32%

^[8],[9],[10]

13.32%

^[8],[9],[10]

13.32%

^[8],[9],[10]

$ 49,395

^[1],[5],[11]

$ 49,520

^[8],[9],[12]

48,462

^[1],[5]

48,536

^[8],[9]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

$ 48,901

^[1],[5]

$ 49,148

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

12.66%

^[1],[4],[5]

12.66%

^[1],[4],[5]

12.66%

^[1],[4],[5]

12.44%

^{[8],[9],[10],[27]}

12.44%

^{[8],[9],[10],[27]}

12.44%

^{[8],[9],[10],[27]}

$ 1,552

^[1],[5],[11]

$ 1,552

^{[8],[9],[12],[27]}

1,541

^[1],[5]

1,540

^[8],[9],[27]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

$ 1,476

^[1],[5]

$ 1,478

^[8],[9],[27]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[6],[8],[9],[27]}

7.00%

^{[6],[8],[9],[10],[27]}

12.51%

^{[6],[8],[9],[12],[27]}

$ 1,099

^{[6],[8],[9],[27]}

1,062

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

^{[6],[8],[9],[27]}

$ 943

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[1],[5]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

12.66%

^[1],[4],[5]

12.66%

^[1],[4],[5]

12.66%

^[1],[4],[5]

12.51%

^{[8],[9],[10],[27]}

12.51%

^{[8],[9],[10],[27]}

12.51%

^{[8],[9],[10],[27]}

$ 2,742

^[1],[5],[11]

$ 32,104

^{[8],[9],[12],[27]}

2,721

^[1],[5]

31,861

^[8],[9],[27]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

$ 2,608

^[1],[5]

$ 30,579

^[8],[9],[27]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

7.00%

^[8],[9],[27]

14.50%

^[1],[4],[5]

14.50%

^[1],[4],[5]

14.50%

^[1],[4],[5]

12.51%

^{[8],[9],[10],[27]}

12.51%

^{[8],[9],[10],[27]}

12.51%

^{[8],[9],[10],[27]}

$ 3,298

^[1],[5],[11]

$ 2,749

^{[8],[9],[12],[27]}

3,175

^[1],[5]

2,726

^[8],[9],[27]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

$ 3,137

^[1],[5]

$ 2,618

^[8],[9],[27]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

7.00%

^[1],[4],[5]

12.66%

^[1],[5],[11]

$ 32,022

^[1],[5]

31,799

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

^[1],[5]

$ 30,456

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[7],[8],[9],[10],[15]}

11.50%

^{[7],[9],[12],[15]}

$ 4,984

^[7],[9],[15]

4,894

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

^[7],[9],[15]

$ 4,785

Investment Company, Nonconsolidated Subsidiary [Line Items]

13.00%

^{[1],[4],[5],[13]}

13.00%

^{[1],[4],[5],[13]}

13.00%

^{[1],[4],[5],[13]}

13.00%

^{[8],[9],[10],[15]}

13.00%

^{[8],[9],[10],[15]}

13.00%

^{[8],[9],[10],[15]}

$ 50,419

^{[1],[11],[13]}

$ 50,419

^{[9],[12],[15]}

49,898

^[1],[13]

49,842

^[9],[15]

Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I

$ 49,869

^[1],[13]

$ 49,869

^[9],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.95%

9.99%

$ 8,194

$ 8,215

7,570

7,559

Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 8,025

$ 7,913

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.50%

9.95%

9.99%

$ 2,634

$ 2,641

2,442

2,439

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

$ 2,580

$ 2,544

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[1],[5]

8.00%

^[8]

8.00%

^[8]

8.00%

^[8]

13.47%

^[1],[4],[5]

13.47%

^[1],[4],[5]

13.47%

^[1],[4],[5]

13.43%

^[8],[10]

13.43%

^[8],[10]

13.43%

^[8],[10]

$ 12,843

^[1],[5],[11]

$ 12,843

^[8],[12]

12,617

^[1],[5]

12,603

^[8]

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

$ 12,847

^[1],[5]

$ 12,464

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^{[6],[8],[9],[15]}

6.00%

^{[6],[8],[9],[12],[15]}

$ 0

^{[6],[8],[9],[15]}

(29)

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

^{[6],[8],[9],[15]}

$ (22)

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[15]

6.00%

^{[8],[9],[10],[15]}

11.42%

^{[8],[9],[12],[15]}

$ 28,826

^[8],[9],[15]

28,595

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

^[8],[9],[15]

$ 28,537

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.75%

^[1],[2],[5]

9.75%

^[1],[2],[5]

9.75%

^[1],[2],[5]

9.75%

^[6],[8],[9]

9.75%

^[6],[8],[9]

9.75%

^[6],[8],[9]

15.21%

^{[1],[2],[4],[5]}

15.21%

^{[1],[2],[4],[5]}

15.21%

^{[1],[2],[4],[5]}

15.17%

^{[6],[8],[9],[10]}

15.17%

^{[6],[8],[9],[10]}

15.17%

^{[6],[8],[9],[10]}

$ 2,119

^{[1],[2],[5],[11]}

$ 1,861

^{[6],[8],[9],[12]}

2,105

^[1],[2],[5]

1,845

^[6],[8],[9]

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

$ 2,040

^[1],[2],[5]

$ 1,802

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.75%

^[1],[5]

9.75%

^[1],[5]

9.75%

^[1],[5]

9.75%

^[8],[9]

9.75%

^[8],[9]

9.75%

^[8],[9]

15.28%

^[1],[4],[5]

15.28%

^[1],[4],[5]

15.28%

^[1],[4],[5]

15.26%

^[8],[9],[10]

15.26%

^[8],[9],[10]

15.26%

^[8],[9],[10]

$ 23,363

^[1],[5],[11]

$ 23,423

^[8],[9],[12]

23,174

^[1],[5]

23,207

^[8],[9]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

$ 22,545

^[1],[5]

$ 22,814

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.36%

^[1],[4],[5]

11.36%

^[1],[4],[5]

11.36%

^[1],[4],[5]

11.32%

^[8],[9],[10]

11.32%

^[8],[9],[10]

11.32%

^[8],[9],[10]

$ 19,894

^[1],[5],[11]

$ 19,947

^[8],[9],[12]

19,014

^[1],[5]

19,013

^[8],[9]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

$ 19,211

^[1],[5]

$ 19,199

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[18]

7.30%

^{[8],[9],[12],[18]}

$ 19,163

^[8],[9],[18]

19,163

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

^[8],[9],[18]

18,340

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[17]

10.00%

^{[1],[11],[17]}

$ 5,065

^[1],[17]

4,657

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

$ 4,290

^[1],[17]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[17]

10.00%

^{[1],[11],[17]}

$ 20,871

^[1],[17]

19,217

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

18,723

^[1],[17]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

$ 0

^[1]

$ 0

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[18]

12.50%

^{[8],[9],[12],[18]}

$ 4,641

^[8],[9],[18]

4,641

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

^[8],[9],[18]

$ 4,170

Investment Company, Nonconsolidated Subsidiary [Line Items]

9.00%

^[1],[5],[17]

9.00%

^[1],[5],[17]

9.00%

^[1],[5],[17]

7.00%

^[8],[9]

7.00%

^[8],[9]

7.00%

^[8],[9]

^[8],[9]

12.65%

$ 46,832

^{[1],[5],[11],[17]}

$ 46,832

^[8],[9],[12]

45,698

^[1],[5],[17]

45,698

^[8],[9]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

$ 28,099

^[1],[5],[17]

$ 37,231

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

358,299

^[1]

358,299

^[1]

358,299

^[1]

10,616

^[9]

10,616

^[9]

10,616

^[9]

$ 2,912

^[1]

$ 120

^[9]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

10,616

^[1]

10,616

^[1]

10,616

^[1]

358,299

^[9]

358,299

^[9]

358,299

^[9]

$ 120

^[1]

$ 2,912

^[9]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

$ 0

^[1]

$ 0

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

60,862

^[1]

60,862

^[1]

60,862

^[1]

60,862

^[9]

60,862

^[9]

60,862

^[9]

$ 1,207

^[1]

$ 1,207

^[9]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

$ 0

^[1]

$ 108

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

32,447

^[1]

32,447

^[1]

32,447

^[1]

32,447

^[9]

32,447

^[9]

32,447

^[9]

$ 33,353

^[1],[5]

$ 33,353

^[9]

Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan | SLF JV I

$ 11,131

^[1],[5]

31,701

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

332,637

331,808

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I

$ 322,179

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.48%

11.42%

$ 7,194

$ 7,212

7,091

7,103

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 6,996

$ 7,022

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

11.48%

11.42%

$ 2,986

$ 2,993

2,943

2,948

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

$ 2,904

$ 2,914

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[1],[5]

6.00%

^[8],[9]

6.00%

^[8],[9]

6.00%

^[8],[9]

11.48%

^[1],[4],[5]

11.48%

^[1],[4],[5]

11.48%

^[1],[4],[5]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

11.42%

^[8],[9],[10]

$ 11,642

^[1],[5],[11]

$ 11,671

^[8],[9],[12]

11,618

^[1],[5]

11,646

^[8],[9]

Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | SLF JV I

$ 11,321

^[1],[5]

$ 11,363

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.61%

$ 2,992

2,944

Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 2,987

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

9.61%

$ 1,496

1,472

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

$ 1,494

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.71%

^[5],[13]

7.71%

^[5],[13]

7.71%

^[5],[13]

7.71%

^[8],[15]

7.71%

^[8],[15]

7.71%

^[8],[15]

13.12%

^[4],[5],[13]

13.12%

^[4],[5],[13]

13.12%

^[4],[5],[13]

13.06%

^{[8],[10],[15]}

13.06%

^{[8],[10],[15]}

13.06%

^{[8],[10],[15]}

$ 1,000

^{[5],[11],[13]}

$ 1,000

^{[8],[12],[15]}

818

^[5],[13]

816

^[8],[15]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

$ 930

^[5],[13]

$ 917

^[8],[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.75%

^[4],[5],[13]

4.75%

^[4],[5],[13]

4.75%

^[4],[5],[13]

6.50%

^{[8],[10],[15]}

6.50%

^{[8],[10],[15]}

6.50%

^{[8],[10],[15]}

$ 300

^[11],[13]

$ 4,500

^[12],[15]

266

^[13]

4,115

^[15]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

$ 259

^[13]

$ 2,953

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.50%

^[4],[5],[13]

6.50%

^[4],[5],[13]

6.50%

^[4],[5],[13]

4.75%

^{[8],[10],[15]}

4.75%

^{[8],[10],[15]}

4.75%

^{[8],[10],[15]}

$ 4,500

^[11],[13]

$ 300

^[12],[15]

4,129

^[13]

264

^[15]

Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond

$ 3,252

^[13]

$ 245

^[15]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

9.50%

^[5],[11]

$ 6,620

^[5]

6,620

Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I

^[5]

$ 7,009

Investment Company, Nonconsolidated Subsidiary [Line Items]

5.00%

10.47%

10.43%

$ 6,289

$ 6,305

6,247

6,257

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

$ 5,248

$ 5,500

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

7.25%

^[8],[9],[10]

12.68%

^[8],[9],[12]

$ 1,140

^[8],[9]

927

Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[8],[9]

$ 1,139

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

15.00%

^[1],[4],[5]

21.66%

^[1],[5],[11]

$ 1,290

^[1],[5]

1,278

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

^[1],[5]

$ 1,203

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[2],[5]

6.75%

^{[1],[2],[5],[11]}

$ 0

^[1],[2],[5]

(81)

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

^[1],[2],[5]

$ (82)

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[1],[5]

6.75%

^[1],[5]

6.75%

^[1],[5]

3.75%

^[8]

3.75%

^[8]

3.75%

^[8]

12.06%

^[1],[4],[5]

12.06%

^[1],[4],[5]

12.06%

^[1],[4],[5]

9.27%

^[8],[10]

9.27%

^[8],[10]

9.27%

^[8],[10]

$ 29,838

^[1],[5],[11]

$ 11,792

^[8],[12]

29,105

^[1],[5]

11,281

^[8]

Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I

$ 29,092

^[1],[5]

$ 11,127

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.27%

$ 1,965

1,920

Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 1,855

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.75%

9.27%

$ 983

960

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

$ 927

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

7.00%

^[8],[9],[10]

12.65%

^[8],[9],[12]

$ 5,000

^[8],[9]

4,925

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[8],[9]

$ 4,263

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[1],[5]

15.00%

^[1],[4],[5]

21.66%

^[1],[5],[11]

$ 1,543

^[1],[5]

1,530

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

^[1],[5]

$ 1,439

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

15.00%

^[8],[9],[10]

21.68%

^[8],[9],[12]

$ 1,565

^[8],[9]

1,551

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

^[8],[9]

$ 1,464

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9]

15.00%

^[8],[9],[10]

21.68%

^[8],[9],[12]

$ 1,323

^[8],[9]

1,311

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

^[8],[9]

$ 1,237

Investment Company, Nonconsolidated Subsidiary [Line Items]

4,871

^[1]

4,871

^[1]

4,871

^[1]

4,871

^[9]

4,871

^[9]

4,871

^[9]

$ 46

^[1]

$ 46

^[9]

Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I

$ 42

^[1]

$ 107

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

11.71%

11.67%

$ 3,249

$ 6,148

3,180

6,008

Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC

$ 3,083

$ 5,939

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

11.71%

11.67%

$ 2,035

$ 3,843

1,992

3,756

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

$ 1,931

$ 3,712

Investment Company, Nonconsolidated Subsidiary [Line Items]

127,452

^[1]

127,452

^[1]

127,452

^[1]

127,452

^[9]

127,452

^[9]

127,452

^[9]

$ 2,057

^[1]

$ 2,057

^[9]

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

$ 1,485

^[1]

$ 1,319

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.25%

^[5]

6.25%

^[5]

6.25%

^[5]

6.25%

^[8]

6.25%

^[8]

6.25%

^[8]

11.71%

^[4],[5]

11.71%

^[4],[5]

11.71%

^[4],[5]

11.67%

^[8],[10]

11.67%

^[8],[10]

11.67%

^[8],[10]

$ 4,664

^[5],[11]

$ 8,983

^[8],[12]

4,526

^[5]

8,698

^[8]

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

$ 4,425

^[5]

$ 8,678

^[8]

Investment Company, Nonconsolidated Subsidiary [Line Items]

4.00%

^[1],[5]

4.00%

^[1],[5]

4.00%

^[1],[5]

4.00%

^[8],[9]

4.00%

^[8],[9]

4.00%

^[8],[9]

9.35%

^[1],[4],[5]

9.35%

^[1],[4],[5]

9.35%

^[1],[4],[5]

9.32%

^[8],[9],[10]

9.32%

^[8],[9],[10]

9.32%

^[8],[9],[10]

$ 19,578

^[1],[5],[11]

$ 19,578

^[8],[9],[12]

19,556

^[1],[5]

19,568

^[8],[9]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

$ 19,577

^[1],[5]

$ 19,489

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[8],[9],[15]

7.50%

^{[8],[9],[10],[15]}

12.72%

^{[8],[9],[12],[15]}

£ 20,000

^[8],[9],[15]

$ 25,841

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | SLF JV I

^[8],[9],[15]

$ 22,914

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.57%

$ 4,320

4,080

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | OCSI Glick JV LLC

$ 4,251

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.61%

8.57%

$ 2,965

$ 1,772

2,856

1,674

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1 | SLF JV I

$ 2,956

$ 1,744

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.61%

$ 2,394

2,364

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2 | SLF JV I

$ 2,387

Investment Company, Nonconsolidated Subsidiary [Line Items]

3.25%

8.61%

$ 4,309

4,081

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond

$ 4,296

Investment Company, Nonconsolidated Subsidiary [Line Items]

^[4],[5]

6.50%

^[11]

$ 4,960

4,379

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

$ 4,506

Investment Company, Nonconsolidated Subsidiary [Line Items]

21,523

^[1]

21,523

^[1]

21,523

^[1]

21,523

^[9]

21,523

^[9]

21,523

^[9]

$ 20,789

^[1]

$ 20,789

^[9]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

$ 20,542

^[1]

$ 20,074

^[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

6.75%

^[1],[2],[5]

6.75%

^[1],[2],[5]

6.75%

^[1],[2],[5]

6.75%

^[6],[8],[9]

6.75%

^[6],[8],[9]

6.75%

^[6],[8],[9]

12.10%

^[4],[5]

12.10%

^[4],[5]

12.10%

^[4],[5]

12.14%

^{[6],[8],[9],[10]}

12.14%

^{[6],[8],[9],[10]}

12.14%

^{[6],[8],[9],[10]}

$ 377

^{[1],[2],[5],[11]}

$ 377

^{[6],[8],[9],[12]}

336

^[1],[2],[5]

334

^[6],[8],[9]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

$ 276

^[1],[2],[5]

$ 296

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[8],[9]

7.25%

^[8],[9]

7.25%

^[8],[9]

12.62%

^[1],[4],[5]

12.62%

^[1],[4],[5]

12.62%

^[1],[4],[5]

12.63%

^[8],[9],[10]

12.63%

^[8],[9],[10]

12.63%

^[8],[9],[10]

^[8],[9]

$ 24,427

^[1],[5],[11]

$ 24,427

^[8],[9],[12]

24,151

^[1],[5]

24,135

^[8],[9]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

$ 23,531

^[1],[5]

$ 23,548

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[1],[5]

7.25%

^[8],[9]

7.25%

^[8],[9]

7.25%

^[8],[9]

12.62%

^[1],[4],[5]

12.62%

^[1],[4],[5]

12.62%

^[1],[4],[5]

12.63%

^[8],[9],[10]

12.63%

^[8],[9],[10]

12.63%

^[8],[9],[10]

$ 3,636

^[1],[5],[11]

$ 3,636

^[8],[9],[12]

3,604

^[1],[5]

3,602

^[8],[9]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

$ 3,537

^[1],[5]

$ 3,574

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[1],[2],[5]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

7.25%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

^[1],[2],[5]

^[6],[8],[9]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

$ 0

^[1],[2],[5]

$ 0

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[8],[9]

8.75%

^[8],[9]

8.75%

^[8],[9]

^[8],[9],[10]

11.75%

$ 0

^{[1],[2],[5],[11]}

$ 5,212

^[8],[9],[12]

^[1],[2],[5]

4,987

^[8],[9]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

$ 0

^[1],[2],[5]

$ 4,990

^[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[1],[2],[5]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

$ 0

^{[1],[2],[5],[11]}

$ 0

^{[6],[8],[9],[12]}

^[1],[2],[5]

^[6],[8],[9]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

$ 0

^[1],[2],[5]

$ 0

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

8.75%

^[1],[5]

8.75%

^[1],[5]

8.75%

^[1],[5]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

8.75%

^[6],[8],[9]

^[1],[4],[5]

11.75%

$ 5,212

^[1],[5],[11]

$ 0

^{[6],[8],[9],[12]}

5,001

^[1],[5]

^[6],[8],[9]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

$ 5,043

^[1],[5]

$ 0

^[6],[8],[9]

Investment Company, Nonconsolidated Subsidiary [Line Items]

53,700

^[1]

53,700

^[1]

53,700

^[1]

53,700

^[9]

53,700

^[9]

53,700

^[9]

^[11]

$ 0

175

^[1]

$ 175

^[9]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 212

^[1]

$ 258

^[9]

[1]	As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[2]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[3]	This investment represents a participation interest in the underlying securities shown.
[4]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[5]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[6]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[7]	This investment represents a participation interest in the underlying securities shown.
[8]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[9]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[10]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[11]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[12]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[13]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[14]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[15]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[16]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[17]	This investment was on non-accrual status as of December 31, 2023.
[18]	This investment was on non-accrual status as of September 30, 2023.
[19]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[20]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[21]	Income producing through payment of dividends or distributions.
[22]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[23]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[24]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[25]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[26]	Income producing through payment of dividends or distributions.
[27]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details)
€ in Thousands, £ in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

USD ($)

Dec. 31, 2022

USD ($)

Dec. 31, 2023

EUR (€)

Dec. 31, 2023

GBP (£)

Sep. 30, 2023

USD ($)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

$ 2,892,420

$ 3,018,552

199.69%

190.82%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,349

24,442

211,365

$ 186,002

Amount of Interest, Fees or Dividends Credited in Income

786

7,962

5,630

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

297,091

^[1],[2]

214,165

20,002

22,255

(784)

(3,958)

$ 316,309

^[3],[4]

$ 232,462

20.90%

19.30%

20.90%

^[3],[4]

20.90%

^[3],[4]

20.90%

^[3],[4]

Affiliate Investments

$ 25,936

$ 21,464

Amount of Interest, Fees or Dividends Credited in Income

329

646

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

23,349

^[5]

26,196

25,220

(24,127)

(3,098)

$ 24,442

^[6]

$ 23,173

Investment, Affiliated Issuer, Control and Affiliate

1.60%

1.90%

1.60%

^[6]

1.60%

^[6]

1.60%

^[6]

$ 237,301

$ 207,466

Amount of Interest, Fees or Dividends Credited in Income

786

8,291

6,276

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

320,440

240,361

45,222

22,330

(24,911)

(7,056)

$ 340,751

$ 255,635

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

22.50%

21.20%

22.50%

12.50%

^{[7],[8],[9],[10],[11]}

12.50%

^{[7],[8],[9],[10],[11]}

12.50%

^{[7],[8],[9],[10],[11]}

12.50%

^{[12],[13],[14],[15],[16]}

12.50%

^{[12],[13],[14],[15],[16]}

12.50%

^{[12],[13],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,269

^{[7],[8],[9],[17]}

$ 1,269

^{[12],[13],[15],[18]}

^{[12],[13],[15]}

1,214

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

^[7],[8],[9]

$ 1,228

11.00%

^{[7],[8],[10],[11]}

11.00%

^{[7],[8],[10],[11]}

11.00%

^{[7],[8],[10],[11]}

11.00%

^{[12],[14],[15],[16]}

11.00%

^{[12],[14],[15],[16]}

11.00%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 18,869

^[7],[8],[17]

$ 18,869

^{[12],[15],[18]}

^[12],[15]

18,443

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

^[7],[8]

$ 18,443

12.00%

^{[7],[8],[9],[10],[11]}

12.00%

^{[7],[8],[9],[10],[11]}

12.00%

^{[7],[8],[9],[10],[11]}

12.00%

^{[12],[13],[14],[15],[16]}

12.00%

^{[12],[13],[14],[15],[16]}

12.00%

^{[12],[13],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,274

^{[7],[8],[9],[17]}

$ 4,070

^{[12],[13],[15],[18]}

^{[12],[13],[15]}

4,022

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

^[7],[8],[9]

$ 4,210

14.25%

^{[7],[10],[11],[19],[20]}

14.25%

^{[7],[10],[11],[19],[20]}

14.25%

^{[7],[10],[11],[19],[20]}

14.25%

^{[14],[15],[16],[21],[22]}

14.25%

^{[14],[15],[16],[21],[22]}

14.25%

^{[14],[15],[16],[21],[22]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 21,434

^{[7],[17],[19],[20]}

$ 21,434

^{[15],[18],[21],[22]}

^{[15],[21],[22]}

21,220

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

^{[7],[19],[20]}

$ 21,273

22.50%

^[7],[19]

22.50%

^[7],[19]

22.50%

^[7],[19]

20.00%

^[15],[21]

20.00%

^[15],[21]

20.00%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 6,329

^{[7],[17],[19]}

$ 6,021

^{[15],[18],[21]}

^[15],[21]

5,900

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

^[7],[19]

$ 6,219

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

12.11%

^{[7],[10],[11]}

12.11%

^{[7],[10],[11]}

12.11%

^{[7],[10],[11]}

11.90%

^{[14],[15],[16]}

11.90%

^{[14],[15],[16]}

11.90%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,373

^{[7],[11],[17]}

$ 3,446

^{[14],[15],[18]}

^[14],[15]

3,383

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

^[7],[11]

$ 3,295

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

12.14%

^{[7],[10],[11]}

12.14%

^{[7],[10],[11]}

12.14%

^{[7],[10],[11]}

12.15%

^{[14],[15],[16]}

12.15%

^{[14],[15],[16]}

12.15%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 944

^{[7],[11],[17]}

$ 17,901

^{[14],[15],[18]}

^[14],[15]

17,575

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

^[7],[11]

$ 922

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

12.11%

^{[7],[10],[11]}

12.11%

^{[7],[10],[11]}

12.11%

^{[7],[10],[11]}

12.13%

^{[14],[15],[16]}

12.13%

^{[14],[15],[16]}

12.13%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 17,532

^{[7],[11],[17]}

$ 963

^{[14],[15],[18]}

^[14],[15]

945

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

^[7],[11]

$ 17,130

7.50%

^{[7],[11],[19]}

7.50%

^{[7],[11],[19]}

7.50%

^{[7],[11],[19]}

7.50%

^{[14],[15],[21]}

7.50%

^{[14],[15],[21]}

7.50%

^{[14],[15],[21]}

^{[14],[15],[16],[21]}

13.04%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 6,589

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

6,276

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

^{[7],[8],[11],[19]}

$ (38)

7.50%

^{[7],[11],[19]}

7.50%

^{[7],[11],[19]}

7.50%

^{[7],[11],[19]}

7.50%

^{[12],[14],[15],[21]}

7.50%

^{[12],[14],[15],[21]}

7.50%

^{[12],[14],[15],[21]}

^[10],[11]

13.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 6,589

^{[7],[11],[17],[19]}

$ 0

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

(38)

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

^{[7],[11],[19]}

$ 6,276

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

28,948

^[7],[19]

28,948

^[7],[19]

28,948

^[7],[19]

28,948

^[15],[21]

28,948

^[15],[21]

28,948

^[15],[21]

^[15],[21]

$ 6

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

^[7],[19]

^[14],[21]

5.00%

^{[14],[16],[21]}

8.86%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[18],[21]}

€ 5,500

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

^[14],[21]

$ 5,825

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

17,870

^[7]

17,870

^[7]

17,870

^[7]

17,870

^[15]

17,870

^[15]

17,870

^[15]

^[15]

$ 2,826

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

^[7]

$ 2,494

7.75%

^[7],[11]

7.75%

^[7],[11]

7.75%

^[7],[11]

7.75%

^[14],[15]

7.75%

^[14],[15]

7.75%

^[14],[15]

13.21%

^{[7],[10],[11]}

13.21%

^{[7],[10],[11]}

13.21%

^{[7],[10],[11]}

13.17%

^{[14],[15],[16]}

13.17%

^{[14],[15],[16]}

13.17%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 16,032

^{[7],[11],[17]}

$ 17,873

^{[14],[15],[18]}

^[14],[15]

17,687

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

^[7],[11]

$ 15,743

6.00%

^{[7],[8],[11],[19]}

6.00%

^{[7],[8],[11],[19]}

6.00%

^{[7],[8],[11],[19]}

6.00%

^{[12],[14],[15],[21]}

6.00%

^{[12],[14],[15],[21]}

6.00%

^{[12],[14],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 0

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

(23)

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

^{[7],[8],[11],[19]}

$ (24)

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

6.00%

^{[14],[15],[21]}

6.00%

^{[14],[15],[21]}

6.00%

^{[14],[15],[21]}

11.64%

^[10],[11]

11.64%

^[10],[11]

11.64%

^[10],[11]

11.63%

^{[14],[15],[16],[21]}

11.63%

^{[14],[15],[16],[21]}

11.63%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,268

^{[7],[11],[17],[19]}

$ 3,276

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

3,084

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

^{[7],[11],[19]}

3,072

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

12,583

^{[7],[17],[19],[20]}

$ 12,222

^{[15],[18],[21],[22]}

^{[15],[21],[22]}

11,795

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

^{[7],[19],[20]}

$ 12,268

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

11.52%

^{[7],[8],[10],[11]}

11.52%

^{[7],[8],[10],[11]}

11.52%

^{[7],[8],[10],[11]}

11.55%

^{[12],[14],[15],[16]}

11.55%

^{[12],[14],[15],[16]}

11.55%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,033

^{[7],[8],[11],[17]}

$ 2,033

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

2,027

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

^[7],[8],[11]

$ 2,027

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

^{[14],[15],[16]}

11.55%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 20,234

^{[14],[15],[18]}

^[14],[15]

20,194

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

^[7],[8],[11]

$ (8)

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

11.52%

^{[7],[10],[11]}

11.52%

^{[7],[10],[11]}

11.52%

^{[7],[10],[11]}

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 20,182

^{[7],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(8)

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

^[7],[11]

$ 20,141

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

12.72%

^{[7],[8],[10],[11]}

12.72%

^{[7],[8],[10],[11]}

12.72%

^{[7],[8],[10],[11]}

12.72%

^{[12],[14],[15],[16]}

12.72%

^{[12],[14],[15],[16]}

12.72%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,333

^{[7],[8],[11],[17]}

$ 1,333

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

1,324

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

^[7],[8],[11]

$ 1,333

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.74%

^{[7],[10],[11]}

12.74%

^{[7],[10],[11]}

12.74%

^{[7],[10],[11]}

12.34%

^{[14],[15],[16]}

12.34%

^{[14],[15],[16]}

12.34%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 6,400

^{[7],[11],[17]}

$ 6,400

^{[14],[15],[18]}

^[14],[15]

6,380

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

^[7],[11]

$ 6,406

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.74%

^{[7],[8],[10],[11]}

12.74%

^{[7],[8],[10],[11]}

12.74%

^{[7],[8],[10],[11]}

12.34%

^{[14],[15],[16]}

12.34%

^{[14],[15],[16]}

12.34%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 25,332

^{[7],[8],[11],[17]}

$ 25,332

^{[14],[15],[18]}

^[14],[15]

25,253

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

^[7],[8],[11]

$ 25,357

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

5,715

^[7]

5,715

^[7]

5,715

^[7]

5,715

^[15]

5,715

^[15]

5,715

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

^[7]

$ 0

8.50%

^{[7],[11],[23]}

8.50%

^{[7],[11],[23]}

8.50%

^{[7],[11],[23]}

8.50%

^{[14],[15],[24]}

8.50%

^{[14],[15],[24]}

8.50%

^{[14],[15],[24]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,562

^{[7],[11],[17],[23]}

$ 23,562

^{[14],[15],[18],[24]}

^{[14],[15],[24]}

9,797

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

^{[7],[11],[23]}

$ 9,797

5.50%

^{[10],[11],[19]}

5.50%

^{[10],[11],[19]}

5.50%

^{[10],[11],[19]}

5.50%

^{[14],[16],[21]}

5.50%

^{[14],[16],[21]}

5.50%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,050

^[17],[19]

$ 4,050

^[18],[21]

^[21]

2,918

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

^[19]

$ 3,181

11.50%

^[7],[11]

11.50%

^[7],[11]

11.50%

^[7],[11]

11.50%

^[14],[15]

11.50%

^[14],[15]

11.50%

^[14],[15]

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

5.00%

^{[14],[15],[16]}

5.00%

^{[14],[15],[16]}

5.00%

^{[14],[15],[16]}

11.95%

^[7],[11]

11.95%

^[7],[11]

11.95%

^[7],[11]

11.99%

^[14],[15]

11.99%

^[14],[15]

11.99%

^[14],[15]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,331

^{[7],[11],[17]}

$ 9,057

^{[14],[15],[18]}

^[14],[15]

8,332

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

^[7],[11]

$ 8,585

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

598,283

^[15]

598,283

^[15]

598,283

^[15]

^[15]

$ 1,915

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

^[7],[11]

$ 1,562

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[14],[15]

7.50%

^[14],[15]

7.50%

^[14],[15]

13.00%

^{[7],[10],[11]}

13.00%

^{[7],[10],[11]}

13.00%

^{[7],[10],[11]}

13.04%

^{[14],[15],[16]}

13.04%

^{[14],[15],[16]}

13.04%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 16,825

^{[7],[11],[17]}

$ 17,053

^{[14],[15],[18]}

^[14],[15]

15,929

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

^[7],[11]

$ 15,732

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

382,275

^[19]

382,275

^[19]

382,275

^[19]

471,253

^[21]

471,253

^[21]

471,253

^[21]

^[21]

$ 4,298

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

^[19]

$ 4,389

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

141,640

^{[7],[19],[25]}

141,640

^{[7],[19],[25]}

141,640

^{[7],[19],[25]}

141,640

^{[15],[21],[26]}

141,640

^{[15],[21],[26]}

141,640

^{[15],[21],[26]}

^{[15],[21],[26]}

$ 368

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

^{[7],[19],[25]}

$ 446

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[15],[21]

3.50%

^[15],[21]

3.50%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 28,964

^{[7],[17],[19]}

$ 28,464

^{[15],[18],[21]}

^[15],[21]

27,687

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

^[7],[19]

$ 28,167

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[15],[21]

3.50%

^[15],[21]

3.50%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 28,178

^{[7],[17],[19]}

$ 2,121

^{[15],[18],[21]}

^[15],[21]

2,063

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

^[7],[19]

$ 27,403

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[15],[21]

3.50%

^[15],[21]

3.50%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,159

^{[7],[17],[19]}

$ 27,692

^{[15],[18],[21]}

^[15],[21]

26,936

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

^[7],[19]

$ 2,099

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[7],[10],[11],[19]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

8.50%

^{[14],[15],[16],[21]}

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[7],[19]

3.50%

^[15],[21]

3.50%

^[15],[21]

3.50%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,100

^{[7],[17],[19]}

$ 2,064

^{[15],[18],[21]}

^[15],[21]

2,007

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

^[7],[19]

2,042

^[14],[15]

8.75%

^{[14],[15],[16]}

14.14%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 17,048

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

^[14],[15]

$ 15,087

^[7],[11]

8.75%

^{[7],[10],[11]}

14.25%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 17,048

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

^[7],[11]

$ 15,940

6.25%

^[11]

6.25%

^[11]

6.25%

^[11]

6.25%

^[14]

6.25%

^[14]

6.25%

^[14]

11.91%

^[10],[11]

11.91%

^[10],[11]

11.91%

^[10],[11]

11.81%

^[14],[16]

11.81%

^[14],[16]

11.81%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 14,907

^[11],[17]

$ 19,115

^[14],[18]

^[14]

16,798

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

^[11]

12,548

^[14],[21]

8.00%

^{[14],[16],[21]}

13.54%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[18],[21]}

$ 12,500

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

^[14],[21]

$ 11,865

^[7],[8],[11]

5.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

^[7],[8],[11]

$ (113)

^[7],[11]

5.75%

^{[7],[10],[11]}

11.10%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 33,558

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

^[7],[11]

$ 32,719

^[7],[8],[11]

5.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

^[7],[8],[11]

$ (60)

3.75%

^[11]

3.75%

^[11]

3.75%

^[11]

3.75%

^[14]

3.75%

^[14]

3.75%

^[14]

9.36%

^[10],[11]

9.36%

^[10],[11]

9.36%

^[10],[11]

9.40%

^[14],[16]

9.40%

^[14],[16]

9.40%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,691

^[11],[17]

$ 3,700

^[14],[18]

^[14]

2,669

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

^[11]

$ 2,257

^[7],[11]

5.50%

^{[7],[10],[11]}

10.86%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 47,810

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

^[7],[11]

$ 47,093

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

10.95%

^{[14],[15],[16],[21]}

10.95%

^{[14],[15],[16],[21]}

10.95%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

€ 4,949

^{[7],[11],[17],[19]}

€ 3,017

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 3,226

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

^{[7],[11],[19]}

$ 6,372

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

11.82%

^{[7],[10],[11],[19]}

11.82%

^{[7],[10],[11],[19]}

11.82%

^{[7],[10],[11],[19]}

11.57%

^{[14],[15],[16],[21]}

11.57%

^{[14],[15],[16],[21]}

11.57%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 10,519

^{[7],[11],[17],[19]}

$ 10,519

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

10,624

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

^{[7],[11],[19]}

$ 10,624

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

6.00%

^{[7],[11],[19]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

9.95%

^{[7],[10],[11],[19]}

9.95%

^{[7],[10],[11],[19]}

9.95%

^{[7],[10],[11],[19]}

12.46%

^{[14],[15],[16],[21]}

12.46%

^{[14],[15],[16],[21]}

12.46%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

£ 3,649

^{[7],[11],[17],[19]}

£ 4,949

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 6,101

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

^{[7],[11],[19]}

$ 4,083

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

7.00%

^{[14],[15],[21]}

11.20%

^{[7],[10],[11],[19]}

11.20%

^{[7],[10],[11],[19]}

11.20%

^{[7],[10],[11],[19]}

12.46%

^{[14],[15],[16],[21]}

12.46%

^{[14],[15],[16],[21]}

12.46%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

£ 3,017

^{[7],[11],[17],[19]}

£ 23,675

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 29,185

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

^{[7],[11],[19]}

$ 3,366

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

9.70%

^{[14],[15],[16],[21]}

9.70%

^{[14],[15],[16],[21]}

9.70%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

£ 23,675

^{[7],[11],[17],[19]}

£ 3,649

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 3,914

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

^{[7],[11],[19]}

$ 30,482

12,463,242

^[7]

1,609,201

12,463,242

^[7]

12,463,242

^[7]

1,783,332

^[15]

1,783,332

^[15]

1,783,332

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

370

1,159

(251)

(16)

$ 997

^[7]

$ 354

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

0.10%

0.00%

0.10%

6.75%

^{[12],[14],[15]}

6.75%

^{[12],[14],[15]}

6.75%

^{[12],[14],[15]}

11.48%

12.14%

^{[12],[14],[15],[16]}

12.14%

^{[12],[14],[15],[16]}

12.14%

^{[12],[14],[15],[16]}

$ 21,464

$ 21,852

^{[12],[14],[15],[18]}

Amount of Interest, Fees or Dividends Credited in Income

$ 0

329

646

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

21,823

^{[12],[14],[15]}

24,225

(21,856)

(3,028)

$ 0

$ 21,252

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

0.00%

1.80%

0.00%

1,019,169

1,129,453

^[15]

1,129,453

^[15]

1,129,453

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

1,005

^[15]

1,223

154

(1,159)

$ 0

$ 1,243

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

0.00%

0.10%

0.00%

78,045

^[7]

70,425

78,045

^[7]

78,045

^[7]

78,045

^[15]

78,045

^[15]

78,045

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

$ 0

^[7]

$ 0

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

0.00%

5.25%

^[11]

5.25%

^[11]

5.25%

^[11]

5.25%

^[14]

5.25%

^[14]

5.25%

^[14]

10.86%

^[10],[11]

10.86%

^[10],[11]

10.86%

^[10],[11]

10.90%

^[14],[16]

10.90%

^[14],[16]

10.90%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 15,688

^[11],[17]

$ 8,490

^[14],[18]

^[14]

6,414

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

^[11]

$ 10,230

7.00%

^{[7],[11],[19]}

7.00%

^{[7],[11],[19]}

7.00%

^{[7],[11],[19]}

6.00%

^{[14],[15],[21]}

6.00%

^{[14],[15],[21]}

6.00%

^{[14],[15],[21]}

8.45%

^{[7],[10],[11],[19]}

8.45%

^{[7],[10],[11],[19]}

8.45%

^{[7],[10],[11],[19]}

11.49%

^{[14],[15],[16],[21]}

11.49%

^{[14],[15],[16],[21]}

11.49%

^{[14],[15],[16],[21]}

4.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 29,801

^{[7],[11],[17],[19]}

$ 29,509

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

28,284

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

^{[7],[11],[19]}

$ 28,311

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(78)

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

^[7],[8],[11]

$ (63)

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[14],[15]

7.25%

^[14],[15]

7.25%

^[14],[15]

12.60%

^[10],[11]

12.60%

^[10],[11]

12.60%

^[10],[11]

12.64%

^{[14],[15],[16]}

12.64%

^{[14],[15],[16]}

12.64%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 50,470

^{[7],[11],[17]}

$ 50,470

^{[14],[15],[18]}

^[14],[15]

49,688

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

^[7],[11]

$ 49,839

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14],[15]

5.00%

^[14],[15]

5.00%

^[14],[15]

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,239

^{[7],[11],[17]}

$ 3,247

^{[14],[15],[18]}

^[14],[15]

3,169

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

^[7],[11]

$ 3,119

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14],[15]

5.00%

^[14],[15]

5.00%

^[14],[15]

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,258

^{[7],[11],[17]}

$ 1,261

^{[14],[15],[18]}

^[14],[15]

1,231

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

^[7],[11]

$ 1,211

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[14],[15]

8.50%

^[14],[15]

8.50%

^[14],[15]

14.15%

^{[7],[10],[11]}

14.15%

^{[7],[10],[11]}

14.15%

^{[7],[10],[11]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,091

^{[7],[11],[17]}

$ 8,920

^{[14],[15],[18]}

^[14],[15]

8,492

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

^[7],[11]

$ 1,842

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[14],[15]

8.50%

^[14],[15]

8.50%

^[14],[15]

14.11%

^{[7],[10],[11]}

14.11%

^{[7],[10],[11]}

14.11%

^{[7],[10],[11]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,361

^{[7],[11],[17]}

$ 2,091

^{[14],[15],[18]}

^[14],[15]

1,991

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

^[7],[11]

$ 3,842

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[14],[15]

8.50%

^[14],[15]

8.50%

^[14],[15]

14.11%

^{[7],[10],[11]}

14.11%

^{[7],[10],[11]}

14.11%

^{[7],[10],[11]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

14.15%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,920

^{[7],[11],[17]}

$ 4,361

^{[14],[15],[18]}

^[14],[15]

4,152

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

^[7],[11]

$ 7,859

4.50%

^[7],[8],[11]

4.50%

^[7],[8],[11]

4.50%

^[7],[8],[11]

4.50%

^{[12],[14],[15]}

4.50%

^{[12],[14],[15]}

4.50%

^{[12],[14],[15]}

13.00%

^{[7],[8],[10],[11]}

13.00%

^{[7],[8],[10],[11]}

13.00%

^{[7],[8],[10],[11]}

13.00%

^{[12],[14],[15],[16]}

13.00%

^{[12],[14],[15],[16]}

13.00%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,836

^{[7],[8],[11],[17]}

$ 2,221

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

2,178

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

^[7],[8],[11]

$ 1,798

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[14],[15]

5.50%

^[14],[15]

5.50%

^[14],[15]

11.03%

^{[7],[10],[11]}

11.03%

^{[7],[10],[11]}

11.03%

^{[7],[10],[11]}

11.02%

^{[14],[15],[16]}

11.02%

^{[14],[15],[16]}

11.02%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 40,557

^{[7],[11],[17]}

$ 40,660

^{[14],[15],[18]}

^[14],[15]

40,213

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

^[7],[11]

$ 40,070

^{[7],[8],[11],[19]}

7.50%

^{[14],[15],[16],[21]}

8.00%

^[15],[21]

2.25%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 6,757

^{[15],[18],[21]}

^[15],[21]

6,225

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

^{[7],[8],[11],[19]}

$ 0

^{[7],[11],[19]}

7.50%

^{[7],[10],[11],[19]}

12.89%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,815

^{[7],[11],[17],[19]}

$ 3,316

^{[12],[15],[18],[21],[22]}

^{[12],[15],[21],[22]}

3,169

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

^{[7],[11],[19]}

$ 2,625

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[12],[14],[15],[16],[21]}

8.00%

^{[12],[14],[15],[16],[21]}

8.00%

^{[12],[14],[15],[16],[21]}

2.25%

^[7],[19]

2.25%

^[7],[19]

2.25%

^[7],[19]

2.25%

^{[12],[15],[21]}

2.25%

^{[12],[15],[21]}

2.25%

^{[12],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[17],[19]}

$ 0

^{[12],[15],[18],[21]}

^{[12],[15],[21]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

^[7],[8],[19]

$ 0

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[7],[8],[10],[11],[19]}

8.00%

^{[12],[14],[15],[16],[21]}

8.00%

^{[12],[14],[15],[16],[21]}

8.00%

^{[12],[14],[15],[16],[21]}

2.25%

^[7],[8],[19]

2.25%

^[7],[8],[19]

2.25%

^[7],[8],[19]

2.25%

^{[12],[15],[21]}

2.25%

^{[12],[15],[21]}

2.25%

^{[12],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[17],[19]}

$ 0

^{[12],[15],[18],[21]}

^{[12],[15],[21]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

^[7],[8],[19]

$ 0

^{[7],[10],[11],[19]}

8.00%

^[7],[19]

2.25%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 6,785

^{[7],[17],[19]}

^{[12],[15],[18],[21],[22]}

^{[12],[15],[21],[22]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

^[7],[19]

6,327

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[12],[15],[18],[21],[22]}

$ 0

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

^{[12],[15],[21],[22]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

32,664

^[7],[19]

32,664

^[7],[19]

32,664

^[7],[19]

26,131

^[15],[21]

26,131

^[15],[21]

26,131

^[15],[21]

^[15],[21]

$ 3

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

^[7],[19]

$ 46

7.00%

^[11]

7.00%

^[11]

7.00%

^[11]

7.00%

^[14]

7.00%

^[14]

7.00%

^[14]

12.46%

^[10],[11]

12.46%

^[10],[11]

12.46%

^[10],[11]

12.43%

^[14],[16]

12.43%

^[14],[16]

12.43%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 30,625

^[11],[17]

$ 30,625

^[14],[18]

^[14]

29,989

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

^[11]

$ 30,319

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

394,297

^[7]

394,297

^[7]

394,297

^[7]

394,297

^[15]

394,297

^[15]

394,297

^[15]

^[15]

$ 158

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

^[7]

$ 95

9.00%

^{[7],[10],[11]}

9.00%

^{[7],[10],[11]}

9.00%

^{[7],[10],[11]}

9.00%

^{[14],[15],[16]}

9.00%

^{[14],[15],[16]}

9.00%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 5,257

^[7],[17]

$ 5,257

^[15],[18]

^[15]

5,251

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

^[7]

$ 5,205

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

1,708,618

^[7]

1,708,618

^[7]

1,708,618

^[7]

1,708,618

^[15]

1,708,618

^[15]

1,708,618

^[15]

^[15]

$ 1,999

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

^[7]

$ 1,982

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

394,297

^[7]

394,297

^[7]

394,297

^[7]

394,297

^[15]

394,297

^[15]

394,297

^[15]

^[15]

$ 442

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

^[7]

$ 434

829

^[7]

829

^[7]

829

^[7]

829

^[15]

829

^[15]

829

^[15]

$ 0

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

$ 0

^[7]

$ 0

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

0.00%

34,984,460

^[7]

34,984,460

^[7]

34,984,460

^[7]

34,984,460

^[15]

34,984,460

^[15]

34,984,460

^[15]

$ 0

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

27,638

^[15]

27,638

$ 27,638

^[7]

$ 27,638

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan

1.80%

2.30%

1.80%

^[11],[19]

6.00%

^{[10],[11],[19]}

11.29%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[11],[17],[19]}

$ 16,185

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

^[11],[19]

$ 20,281

7.75%

^{[7],[11],[23]}

7.75%

^{[7],[11],[23]}

7.75%

^{[7],[11],[23]}

7.75%

^{[14],[15],[24]}

7.75%

^{[14],[15],[24]}

7.75%

^{[14],[15],[24]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 727

^{[7],[11],[17],[23]}

$ 727

^{[14],[15],[18],[24]}

^{[14],[15],[24]}

396

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

^{[7],[11],[23]}

365

^[14],[15]

6.50%

^{[14],[15],[16]}

12.07%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 37

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

^[14],[15]

^[14],[15]

6.50%

^{[14],[15],[16]}

12.07%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 3,031

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

^[14],[15]

3,031

^[14],[15]

6.50%

^{[14],[15],[16]}

12.07%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 1,557

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

^[14],[15]

1,557

^[14],[15]

6.50%

^{[14],[15],[16]}

12.07%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 1,024

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

^[14],[15]

$ 1,024

1,080,398

^[7]

1,080,399

1,080,398

^[7]

1,080,398

^[7]

1,080,399

^[15]

1,080,399

^[15]

1,080,399

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

432

^[15]

378

(54)

$ 432

^[7]

$ 324

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

0.00%

7.50%

^{[10],[11],[19]}

7.50%

^{[10],[11],[19]}

7.50%

^{[10],[11],[19]}

7.50%

^{[14],[16],[21]}

7.50%

^{[14],[16],[21]}

7.50%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,632

^[17],[19]

$ 2,632

^[18],[21]

^[21]

2,017

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

^[19]

$ 2,191

7.75%

^{[10],[11],[19]}

7.75%

^{[10],[11],[19]}

7.75%

^{[10],[11],[19]}

7.75%

^{[14],[16],[21]}

7.75%

^{[14],[16],[21]}

7.75%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 176

^[17],[19]

$ 176

^[18],[21]

^[21]

141

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

^[19]

$ 152

7.38%

^[10],[11]

7.38%

^[10],[11]

7.38%

^[10],[11]

7.38%

^[14],[16]

7.38%

^[14],[16]

7.38%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 10,720

^[17]

$ 8,420

^[18]

7,059

Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond

$ 9,804

^{[10],[11],[19]}

6.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17],[19]

$ 1,670

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

^[19]

$ 1,661

^[7]

22,267,661

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

16,173

^[7]

$ 16,173

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

1.10%

^{[14],[15],[24]}

8.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[24]}

$ 22,084

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

^{[14],[15],[24]}

$ 16,040

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

^[15]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

417,851

^[7]

417,851

^[7]

417,851

^[7]

417,851

^[15]

417,851

^[15]

417,851

^[15]

^[15]

$ 894

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

^[7]

$ 894

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(20)

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

^[7],[8],[11]

$ (19)

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^[14],[15]

7.50%

^[14],[15]

7.50%

^[14],[15]

^{[14],[15],[16]}

12.82%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 13,157

^{[14],[15],[18]}

^[14],[15]

12,858

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

^[7],[8],[11]

$ (11)

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

^{[7],[10],[11]}

12.86%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 13,157

^{[7],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(13)

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

^[7],[11]

$ 12,883

5.00%

^[11]

5.00%

^[11]

5.00%

^[11]

5.00%

^[14]

5.00%

^[14]

5.00%

^[14]

10.35%

^[10],[11]

10.35%

^[10],[11]

10.35%

^[10],[11]

10.39%

^[14],[16]

10.39%

^[14],[16]

10.39%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 14,713

^[11],[17]

$ 14,750

^[14],[18]

^[14]

14,616

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

^[11]

$ 14,724

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

^{[12],[14],[15],[16]}

11.47%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[11],[17]}

$ 933

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

918

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

^[7],[11]

$ (15)

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.53%

^[10],[11]

11.53%

^[10],[11]

11.53%

^[10],[11]

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 17,967

^{[7],[11],[17]}

$ 18,013

^{[14],[15],[18]}

^[14],[15]

17,812

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

^[7],[11]

$ 17,765

^[7],[11]

6.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 0

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

^[7],[11]

$ (52)

^[7]

6.75%

^[10],[11]

12.10%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[7],[17]

$ 20,924

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

^[7]

$ 20,422

4.75%

^[11]

4.75%

^[11]

4.75%

^[11]

4.75%

^[14]

4.75%

^[14]

4.75%

^[14]

10.13%

^[10],[11]

10.13%

^[10],[11]

10.13%

^[10],[11]

10.12%

^[14],[16]

10.12%

^[14],[16]

10.12%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,938

^[11],[17]

$ 4,950

^[14],[18]

^[14]

4,831

Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond

^[11]

$ 4,893

^[10],[11]

8.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 440

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

$ 436

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[7],[19]

^[15],[21]

^[15],[21]

$ 2

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

^[7],[19]

$ 2

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

419

^[7],[19]

419

^[7],[19]

419

^[7],[19]

419

^[15],[21]

419

^[15],[21]

419

^[15],[21]

^[15],[21]

$ 419

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

^[7],[19]

$ 419

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

7.00%

^[7],[19]

7.00%

^[7],[19]

7.00%

^[7],[19]

7.00%

^{[12],[15],[21]}

7.00%

^{[12],[15],[21]}

7.00%

^{[12],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 32,104

^{[7],[17],[19]}

$ 17,465

^{[12],[15],[18],[21]}

^{[12],[15],[21]}

17,465

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

^[7],[19]

$ 32,104

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[7],[19]

^[15],[21]

^[15],[21]

$ 0

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

^[7],[19]

$ 0

9.00%

^[7],[11]

9.00%

^[7],[11]

9.00%

^[7],[11]

9.00%

^[14],[15]

9.00%

^[14],[15]

9.00%

^[14],[15]

14.50%

^{[7],[10],[11]}

14.50%

^{[7],[10],[11]}

14.50%

^{[7],[10],[11]}

14.54%

^{[14],[15],[16]}

14.54%

^{[14],[15],[16]}

14.54%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 20,757

^{[7],[11],[17]}

$ 20,757

^{[14],[15],[18]}

^[14],[15]

20,653

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

^[7],[11]

$ 20,639

8.00%

^[7]

8.00%

^[7]

8.00%

^[7]

8.00%

^[15]

8.00%

^[15]

8.00%

^[15]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 667

^[7],[17]

$ 654

^[15],[18]

^[15]

631

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

^[7]

$ 643

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

6,397,254

^[7]

6,397,254

^[7]

6,397,254

^[7]

6,397,254

^[15]

6,397,254

^[15]

6,397,254

^[15]

^[15]

$ 1,152

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

^[7]

$ 128

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

12.45%

^{[7],[8],[10],[11]}

12.45%

^{[7],[8],[10],[11]}

12.45%

^{[7],[8],[10],[11]}

12.49%

^{[12],[14],[15],[16]}

12.49%

^{[12],[14],[15],[16]}

12.49%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 578

^{[7],[8],[11],[17]}

$ 284

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

252

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

^[7],[8],[11]

$ 550

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.45%

^{[7],[10],[11]}

12.45%

^{[7],[10],[11]}

12.45%

^{[7],[10],[11]}

12.49%

^{[14],[15],[16]}

12.49%

^{[14],[15],[16]}

12.49%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 12,355

^{[7],[11],[17]}

$ 12,386

^{[14],[15],[18]}

^[14],[15]

12,101

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

^[7],[11]

$ 12,083

5.00%

^[14]

5.00%

^[14]

5.00%

^[14]

10.65%

^[10],[11]

10.65%

^[10],[11]

10.65%

^[10],[11]

10.43%

^[14],[16]

10.43%

^[14],[16]

10.43%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,514

^[11],[17]

$ 4,641

^[14],[18]

^[14]

4,546

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond

^[11]

$ 4,522

^[10],[11]

5.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 5,090

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

$ 4,787

30,031

^[7]

30,031

^[7]

30,031

^[7]

30,031

^[15]

30,031

^[15]

30,031

^[15]

$ 0

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

2,711

^[15]

4,946

(719)

$ 2,711

^[7]

$ 4,227

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

0.20%

0.40%

0.20%

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14],[15]

5.00%

^[14],[15]

5.00%

^[14],[15]

10.50%

^{[7],[10],[11]}

10.50%

^{[7],[10],[11]}

10.50%

^{[7],[10],[11]}

10.54%

^{[14],[15],[16]}

10.54%

^{[14],[15],[16]}

10.54%

^{[14],[15],[16]}

$ 5,574

^{[7],[11],[17]}

$ 0

$ 5,574

^{[14],[15],[18]}

Amount of Interest, Fees or Dividends Credited in Income

150

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

5,574

^[14],[15]

$ 5,574

^[7],[11]

$ 0

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan

0.40%

0.00%

0.40%

5.00%

9.73%

$ 14,297

Amount of Interest, Fees or Dividends Credited in Income

331

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

14,333

(36)

$ 14,297

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

1.20%

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14],[15]

5.00%

^[14],[15]

5.00%

^[14],[15]

10.50%

^{[7],[10],[11]}

10.50%

^{[7],[10],[11]}

10.50%

^{[7],[10],[11]}

10.54%

^{[14],[15],[16]}

10.54%

^{[14],[15],[16]}

10.54%

^{[14],[15],[16]}

$ 14,033

^{[7],[11],[17]}

$ 14,068

^{[14],[15],[18]}

Amount of Interest, Fees or Dividends Credited in Income

391

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[14],[15]

14,068

(35)

^[7],[11]

$ 14,033

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

0.90%

5.00%

^[7],[8],[11]

5.00%

^[7],[8],[11]

5.00%

^[7],[8],[11]

5.00%

^{[12],[14],[15]}

5.00%

^{[12],[14],[15]}

5.00%

^{[12],[14],[15]}

10.46%

^{[7],[8],[10],[11]}

10.46%

^{[7],[8],[10],[11]}

10.46%

^{[7],[8],[10],[11]}

10.42%

^{[12],[14],[15],[16]}

10.42%

^{[12],[14],[15],[16]}

10.42%

^{[12],[14],[15],[16]}

$ 1,393

^{[7],[8],[11],[17]}

$ 2,090

^{[12],[14],[15],[18]}

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[12],[14],[15]}

2,090

(696)

^[7],[8],[11]

$ 1,394

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

0.10%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

12,500

^[7]

12,500

^[7]

12,500

^[7]

12,500

^[15]

12,500

^[15]

12,500

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

^[7]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

488

^[7]

488

^[7]

488

^[7]

488

^[15]

488

^[15]

488

^[15]

^[15]

$ 1,345

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

^[7]

$ 1,345

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[14],[15]

7.50%

^[14],[15]

7.50%

^[14],[15]

13.00%

^{[7],[10],[11]}

13.00%

^{[7],[10],[11]}

13.00%

^{[7],[10],[11]}

13.04%

^{[14],[15],[16]}

13.04%

^{[14],[15],[16]}

13.04%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,974

^{[7],[11],[17]}

$ 8,974

^{[14],[15],[18]}

^[14],[15]

7,987

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

^[7],[11]

$ 8,032

^[7],[8],[11]

5.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

^[7],[8],[11]

$ (28)

^[7],[11]

5.50%

^{[7],[10],[11]}

10.84%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 24,865

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

^[7],[11]

$ 24,492

^[7],[8],[11]

5.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

^[7],[8],[11]

$ (19)

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[14],[15],[16],[21]}

3.00%

^{[14],[15],[16],[21]}

3.00%

^{[14],[15],[16],[21]}

6.00%

^[7],[19]

6.00%

^[7],[19]

6.00%

^[7],[19]

6.00%

^[15],[21]

6.00%

^[15],[21]

6.00%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,799

^{[7],[17],[19]}

$ 11,065

^{[15],[18],[21]}

^[15],[21]

10,677

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

^[7],[19]

$ 1,718

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[14],[15],[16],[21]}

3.00%

^{[14],[15],[16],[21]}

3.00%

^{[14],[15],[16],[21]}

6.00%

^[7],[8],[19]

6.00%

^[7],[8],[19]

6.00%

^[7],[8],[19]

6.00%

^[15],[21]

6.00%

^[15],[21]

6.00%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[17],[19]}

$ 1,772

^{[15],[18],[21]}

^[15],[21]

1,710

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

^[7],[8],[19]

$ 0

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[7],[8],[10],[11],[19]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

6.00%

^[7],[8],[19]

6.00%

^[7],[8],[19]

6.00%

^[7],[8],[19]

6.00%

^{[12],[15],[21]}

6.00%

^{[12],[15],[21]}

6.00%

^{[12],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[17],[19]}

$ 0

^{[12],[15],[18],[21]}

^{[12],[15],[21]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

^[7],[8],[19]

$ 0

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[7],[10],[11],[19]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

3.00%

^{[12],[14],[15],[16],[21]}

6.00%

^[7],[19]

6.00%

^[7],[19]

6.00%

^[7],[19]

6.00%

^{[12],[15],[21]}

6.00%

^{[12],[15],[21]}

6.00%

^{[12],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 11,232

^{[7],[17],[19]}

$ 0

^{[12],[15],[18],[21]}

^{[12],[15],[21]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

^[7],[19]

$ 10,727

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(41)

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

^[7],[8],[11]

$ (37)

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.35%

^[10],[11]

11.35%

^[10],[11]

11.35%

^[10],[11]

11.32%

^{[14],[15],[16]}

11.32%

^{[14],[15],[16]}

11.32%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 14,736

^{[7],[8],[11],[17]}

$ 14,736

^{[14],[15],[18]}

^[14],[15]

14,368

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

^[7],[8],[11]

$ 14,394

^[11]

4.00%

^[10],[11]

9.47%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[11],[17]

$ 4,324

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

^[11]

$ 3,457

6.75%

^[11]

6.75%

^[11]

6.75%

^[11]

6.75%

^[14],[21]

6.75%

^[14],[21]

6.75%

^[14],[21]

12.22%

^[10],[11]

12.22%

^[10],[11]

12.22%

^[10],[11]

12.18%

^{[14],[16],[21]}

12.18%

^{[14],[16],[21]}

12.18%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 31,074

^[11],[17]

$ 31,074

^{[14],[18],[21]}

^[14],[21]

19,917

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

^[11]

$ 18,745

9.00%

^{[7],[8],[10],[11]}

9.00%

^{[7],[8],[10],[11]}

9.00%

^{[7],[8],[10],[11]}

9.00%

^{[12],[14],[15],[16]}

9.00%

^{[12],[14],[15],[16]}

9.00%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 61,500

^[7],[8],[17]

$ 59,950

^{[12],[15],[18]}

^[12],[15]

59,950

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

^[7],[8]

$ 61,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

3,750

^{[7],[19],[27]}

3,750

^{[7],[19],[27]}

3,750

^{[7],[19],[27]}

3,750

^[15],[21]

3,750

^[15],[21]

3,750

^[15],[21]

^[15],[21]

$ 3

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

^{[7],[19],[27]}

$ 4

7.25%

^{[7],[8],[11],[19]}

7.25%

^{[7],[8],[11],[19]}

7.25%

^{[7],[8],[11],[19]}

7.25%

^{[12],[14],[15],[21]}

7.25%

^{[12],[14],[15],[21]}

7.25%

^{[12],[14],[15],[21]}

12.61%

^{[7],[8],[10],[11],[19]}

12.61%

^{[7],[8],[10],[11],[19]}

12.61%

^{[7],[8],[10],[11],[19]}

12.55%

^{[12],[14],[15],[16],[21]}

12.55%

^{[12],[14],[15],[16],[21]}

12.55%

^{[12],[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 322

^{[7],[8],[11],[17],[19]}

$ 258

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

234

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

^{[7],[8],[11],[19]}

$ 301

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.25%

^{[7],[11],[19]}

7.25%

^{[14],[15],[21]}

7.25%

^{[14],[15],[21]}

7.25%

^{[14],[15],[21]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

12.71%

^{[7],[10],[11],[19]}

12.55%

^{[14],[15],[16],[21]}

12.55%

^{[14],[15],[16],[21]}

12.55%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 11,742

^{[7],[11],[17],[19]}

$ 11,742

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

11,511

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

^{[7],[11],[19]}

11,538

Amount of Interest, Fees or Dividends Credited in Income

786

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

0.00%

11.00%

^{[7],[10],[11],[19]}

11.00%

^{[7],[10],[11],[19]}

11.00%

^{[7],[10],[11],[19]}

11.00%

^{[14],[15],[16],[21]}

11.00%

^{[14],[15],[16],[21]}

11.00%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 11,918

^{[7],[17],[19]}

$ 11,918

^{[15],[18],[21]}

^[15],[21]

11,144

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

^[7],[19]

$ 11,173

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

417,011

^[7],[19]

417,011

^[7],[19]

417,011

^[7],[19]

417,011

^[15],[21]

417,011

^[15],[21]

417,011

^[15],[21]

^[15],[21]

$ 42

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

^[7],[19]

$ 354

6.00%

^{[10],[11],[19]}

6.00%

^{[10],[11],[19]}

6.00%

^{[10],[11],[19]}

6.00%

^{[14],[16],[21]}

6.00%

^{[14],[16],[21]}

6.00%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,881

^[17],[19]

$ 4,881

^[18],[21]

^[21]

3,577

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

^[19]

$ 4,170

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

12.60%

^{[7],[8],[10],[11]}

12.60%

^{[7],[8],[10],[11]}

12.60%

^{[7],[8],[10],[11]}

12.64%

^{[12],[14],[15],[16]}

12.64%

^{[12],[14],[15],[16]}

12.64%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,215

^{[7],[8],[11],[17]}

$ 1,638

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

1,535

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

^[7],[8],[11]

$ 1,152

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[14],[15]

7.25%

^[14],[15]

7.25%

^[14],[15]

12.60%

^{[7],[10],[11]}

12.60%

^{[7],[10],[11]}

12.60%

^{[7],[10],[11]}

12.64%

^{[14],[15],[16]}

12.64%

^{[14],[15],[16]}

12.64%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,714

^{[7],[11],[17]}

$ 23,774

^{[14],[15],[18]}

^[14],[15]

23,110

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

^[7],[11]

$ 23,306

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14]

5.00%

^[14]

5.00%

^[14]

10.66%

^{[7],[10],[11]}

10.66%

^{[7],[10],[11]}

10.66%

^{[7],[10],[11]}

10.57%

^[14],[16]

10.57%

^[14],[16]

10.57%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,450

^{[7],[11],[17]}

$ 2,456

^[14],[18]

^[14]

2,063

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

^[7],[11]

$ 2,197

2.85%

^[11],[19]

2.85%

^[11],[19]

2.85%

^[11],[19]

2.85%

^[14],[21]

2.85%

^[14],[21]

2.85%

^[14],[21]

6.84%

^{[10],[11],[19]}

6.84%

^{[10],[11],[19]}

6.84%

^{[10],[11],[19]}

6.56%

^{[14],[16],[21]}

6.56%

^{[14],[16],[21]}

6.56%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

€ 1,000

^{[11],[17],[19]}

€ 1,000

^{[14],[18],[21]}

^[14],[21]

$ 963

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

^[11],[19]

$ 1,033

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(35)

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

^[7],[8],[11]

$ (29)

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^[14],[15]

8.00%

^[14],[15]

8.00%

^[14],[15]

^{[14],[15],[16]}

13.42%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 17,444

^{[14],[15],[18]}

^[14],[15]

17,096

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

^[7],[8],[11]

$ (59)

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

^{[7],[10],[11]}

13.46%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 17,400

^{[7],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(70)

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

^[7],[11]

$ 17,112

5.25%

^[11]

5.25%

^[11]

5.25%

^[11]

5.25%

^[14]

5.25%

^[14]

5.25%

^[14]

10.71%

^[10],[11]

10.71%

^[10],[11]

10.71%

^[10],[11]

10.67%

^[14],[16]

10.67%

^[14],[16]

10.67%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,538

^[11],[17]

$ 14,347

^[14],[18]

^[14]

13,618

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan

^[11]

$ 8,396

^{[7],[11],[19]}

6.50%

^{[7],[10],[11],[19]}

12.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17],[19]}

$ 7,448

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

^{[7],[11],[19]}

$ 7,355

6.50%

^{[7],[8],[11],[19]}

6.50%

^{[7],[8],[11],[19]}

6.50%

^{[7],[8],[11],[19]}

6.50%

^{[14],[15],[21]}

6.50%

^{[14],[15],[21]}

6.50%

^{[14],[15],[21]}

^{[14],[15],[16],[21]}

11.89%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 7,448

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

7,301

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

^{[7],[8],[11],[19]}

$ (50)

6.50%

^{[7],[11],[19]}

6.50%

^{[7],[11],[19]}

6.50%

^{[7],[11],[19]}

6.50%

^{[12],[14],[15],[21]}

6.50%

^{[12],[14],[15],[21]}

6.50%

^{[12],[14],[15],[21]}

^[10],[11]

12.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,432

^{[7],[11],[17],[19]}

$ 0

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

(79)

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

^{[7],[11],[19]}

1,414

^{[14],[15],[21]}

6.50%

^{[14],[15],[16],[21]}

12.04%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[21]}

$ 1,432

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

^{[14],[15],[21]}

$ 1,404

4.46%

^{[10],[11],[19]}

4.46%

^{[10],[11],[19]}

4.46%

^{[10],[11],[19]}

4.46%

^{[14],[15],[16],[21]}

4.46%

^{[14],[15],[16],[21]}

4.46%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,406

^[17],[19]

$ 6,808

^{[15],[18],[21]}

^[15],[21]

5,873

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

^[19]

$ 8,155

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

13.63%

^{[7],[10],[11],[19]}

13.63%

^{[7],[10],[11],[19]}

13.63%

^{[7],[10],[11],[19]}

13.62%

^{[14],[15],[16],[21]}

13.62%

^{[14],[15],[16],[21]}

13.62%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,975

^{[7],[11],[17],[19]}

$ 23,975

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

23,328

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

^{[7],[11],[19]}

$ 23,519

5.75%

^[7],[11]

5.75%

^[7],[11]

5.75%

^[7],[11]

5.75%

^[14],[15]

5.75%

^[14],[15]

5.75%

^[14],[15]

11.36%

^{[7],[10],[11]}

11.36%

^{[7],[10],[11]}

11.36%

^{[7],[10],[11]}

11.40%

^{[14],[15],[16]}

11.40%

^{[14],[15],[16]}

11.40%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 43,931

^{[7],[11],[17]}

$ 44,550

^{[14],[15],[18]}

^[14],[15]

35,046

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

^[7],[11]

$ 35,145

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

12.06%

^{[7],[10],[11]}

12.06%

^{[7],[10],[11]}

12.06%

^{[7],[10],[11]}

11.92%

^{[14],[15],[16]}

11.92%

^{[14],[15],[16]}

11.92%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 40,587

^{[7],[11],[17]}

$ 40,587

^{[14],[15],[18]}

^[14],[15]

38,963

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

^[7],[11]

$ 38,963

10.75%

^[7],[23]

10.75%

^[7],[23]

10.75%

^[7],[23]

10.75%

^[14],[15]

10.75%

^[14],[15]

10.75%

^[14],[15]

^[14],[15]

16.06%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,001

^{[7],[17],[23]}

$ 26,613

^{[14],[15],[18]}

^[14],[15]

24,484

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

^[7],[23]

$ 793

10.75%

^{[7],[11],[23]}

10.75%

^{[7],[11],[23]}

10.75%

^{[7],[11],[23]}

10.75%

^[14],[15]

10.75%

^[14],[15]

10.75%

^[14],[15]

^[14],[15]

16.05%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,232

^{[7],[11],[17],[23]}

$ 787

^{[14],[15],[18]}

^[14],[15]

787

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

^{[7],[11],[23]}

$ 1,768

10.75%

^{[7],[11],[23]}

10.75%

^{[7],[11],[23]}

10.75%

^{[7],[11],[23]}

10.75%

^{[12],[14],[15]}

10.75%

^{[12],[14],[15]}

10.75%

^{[12],[14],[15]}

^{[12],[14],[15]}

16.06%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 839

^{[7],[11],[17],[23]}

$ 688

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

688

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4

^{[7],[11],[23]}

$ 664

^{[7],[11],[23]}

10.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17],[23]}

$ 28,010

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

^{[7],[11],[23]}

$ 14,817

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

350,241

$ 147

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

^{[14],[15],[21]}

5.75%

^{[14],[15],[16],[21]}

11.14%

^{[14],[15],[21]}

2.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[21]}

$ 7,179

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

^{[14],[15],[21]}

$ 6,568

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

112,990

^[7],[19]

112,990

^[7],[19]

112,990

^[7],[19]

112,990

^[15],[21]

112,990

^[15],[21]

112,990

^[15],[21]

^[15],[21]

$ 105

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

^[7],[19]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

1,078,284

^[7]

1,078,284

^[7]

1,078,284

^[7]

1,078,284

^[15]

1,078,284

^[15]

1,078,284

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

^[7]

$ 0

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(86)

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

^[7],[8],[11]

$ (86)

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[14],[15]

7.50%

^[14],[15]

7.50%

^[14],[15]

12.97%

^{[7],[10],[11]}

12.97%

^{[7],[10],[11]}

12.97%

^{[7],[10],[11]}

12.93%

^{[14],[15],[16]}

12.93%

^{[14],[15],[16]}

12.93%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 33,331

^{[7],[11],[17]}

$ 33,414

^{[14],[15],[18]}

^[14],[15]

32,659

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

^[7],[11]

$ 32,577

7.25%

^[11]

7.25%

^[11]

7.25%

^[11]

7.25%

^[14]

7.25%

^[14]

7.25%

^[14]

12.91%

^[10],[11]

12.91%

^[10],[11]

12.91%

^[10],[11]

12.78%

^[14],[16]

12.78%

^[14],[16]

12.78%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 13,939

^[11],[17]

$ 13,939

^[14],[18]

^[14]

10,094

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

^[11]

11,314

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

83,262

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

$ 8,722

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

^{[12],[14],[15],[16]}

11.84%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 272

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

238

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

^[7],[8],[11]

$ (47)

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(47)

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

^[7],[8],[11]

$ (35)

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

11.99%

^[10],[11]

11.99%

^[10],[11]

11.99%

^[10],[11]

11.84%

^{[14],[15],[16]}

11.84%

^{[14],[15],[16]}

11.84%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 38,015

^{[7],[11],[17]}

$ 16,752

^{[14],[15],[18]}

^[14],[15]

16,500

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

^[7],[11]

$ 37,445

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

11.84%

^{[7],[10],[11]}

11.84%

^{[7],[10],[11]}

11.84%

^{[7],[10],[11]}

11.80%

^{[14],[15],[16]}

11.80%

^{[14],[15],[16]}

11.80%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 16,722

^{[7],[11],[17]}

$ 38,015

^{[14],[15],[18]}

^[14],[15]

37,445

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

^[7],[11]

$ 16,471

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(172)

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

^[7],[8],[11]

$ (199)

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.46%

^{[7],[10],[11]}

11.46%

^{[7],[10],[11]}

11.46%

^{[7],[10],[11]}

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,729

^{[7],[11],[17]}

$ 2,736

^{[14],[15],[18]}

^[14],[15]

2,558

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

^[7],[11]

$ 2,524

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.46%

^[10],[11]

11.46%

^[10],[11]

11.46%

^[10],[11]

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,435

^{[7],[11],[17]}

$ 23,494

^{[14],[15],[18]}

^[14],[15]

21,967

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

^[7],[11]

$ 21,677

9.50%

^[11],[19]

9.50%

^[11],[19]

9.50%

^[11],[19]

9.50%

^[14],[21]

9.50%

^[14],[21]

9.50%

^[14],[21]

15.08%

^{[10],[11],[19]}

15.08%

^{[10],[11],[19]}

15.08%

^{[10],[11],[19]}

14.95%

^{[14],[16],[21]}

14.95%

^{[14],[16],[21]}

14.95%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 26,356

^{[11],[17],[19]}

$ 26,422

^{[14],[18],[21]}

^[14],[21]

27,512

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

^[11],[19]

27,163

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

2,000,000

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

^[15]

$ 0

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[7],[11]

5.00%

^[14],[15]

5.00%

^[14],[15]

5.00%

^[14],[15]

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.61%

^{[7],[10],[11]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

10.65%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 45,125

^{[7],[11],[17]}

$ 45,243

^{[14],[15],[18]}

^[14],[15]

43,886

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

^[7],[11]

$ 43,771

559

^[7]

559

^[7]

559

^[7]

559

^[15]

559

^[15]

559

^[15]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15],[18]

^[15]

$ 372

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

^[7]

$ 268

9.50%

^[7],[11]

9.50%

^[7],[11]

9.50%

^[7],[11]

8.50%

^[14],[15]

8.50%

^[14],[15]

8.50%

^[14],[15]

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

13.99%

^{[14],[15],[16]}

13.99%

^{[14],[15],[16]}

13.99%

^{[14],[15],[16]}

9.95%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,012

^{[7],[11],[17]}

$ 5,403

^{[14],[15],[18]}

^[14],[15]

5,160

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

^[7],[11]

$ 2,846

9.50%

^[7],[11]

9.50%

^[7],[11]

9.50%

^[7],[11]

8.50%

^{[12],[14],[15]}

8.50%

^{[12],[14],[15]}

8.50%

^{[12],[14],[15]}

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

5.00%

^{[7],[10],[11]}

13.99%

^{[12],[14],[15],[16]}

13.99%

^{[12],[14],[15],[16]}

13.99%

^{[12],[14],[15],[16]}

9.95%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 5,536

^{[7],[11],[17]}

$ 2,939

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

2,745

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

^[7],[11]

$ 5,232

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

6.00%

^{[12],[14],[15]}

^{[12],[14],[15],[16]}

11.42%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 964

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

938

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

^[7],[8],[11]

$ (27)

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.53%

^{[7],[10],[11]}

11.53%

^{[7],[10],[11]}

11.53%

^{[7],[10],[11]}

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,624

^{[7],[11],[17]}

$ 20,125

^{[14],[15],[18]}

^[14],[15]

19,823

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

^[7],[11]

$ 2,585

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[7],[8],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.53%

^[10],[11]

11.53%

^[10],[11]

11.53%

^[10],[11]

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

11.52%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 11,802

^{[7],[8],[11],[17]}

$ 2,631

^{[14],[15],[18]}

^[14],[15]

2,591

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

^[7],[8],[11]

$ 11,625

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^[7],[8],[11]

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

7.50%

^{[12],[14],[15]}

12.86%

^{[7],[8],[10],[11]}

12.86%

^{[7],[8],[10],[11]}

12.86%

^{[7],[8],[10],[11]}

12.83%

^{[12],[14],[15],[16]}

12.83%

^{[12],[14],[15],[16]}

12.83%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,308

^{[7],[8],[11],[17]}

$ 1,466

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

1,282

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

^[7],[8],[11]

$ 8,308

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[7],[11]

7.50%

^[14],[15]

7.50%

^[14],[15]

7.50%

^[14],[15]

12.89%

^{[7],[10],[11]}

12.89%

^{[7],[10],[11]}

12.89%

^{[7],[10],[11]}

12.89%

^{[14],[15],[16]}

12.89%

^{[14],[15],[16]}

12.89%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 40,538

^{[7],[11],[17]}

$ 40,538

^{[14],[15],[18]}

^[14],[15]

39,833

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

^[7],[11]

$ 40,944

5.50%

^[7],[8],[11]

5.50%

^[7],[8],[11]

5.50%

^[7],[8],[11]

5.50%

^{[12],[14],[15]}

5.50%

^{[12],[14],[15]}

5.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(47)

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

^[7],[8],[11]

$ (27)

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[14],[15]

5.50%

^[14],[15]

5.50%

^[14],[15]

10.95%

^[10],[11]

10.95%

^[10],[11]

10.95%

^[10],[11]

10.99%

^{[14],[15],[16]}

10.99%

^{[14],[15],[16]}

10.99%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 21,272

^{[7],[11],[17]}

$ 13,973

^{[14],[15],[18]}

^[14],[15]

13,685

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

^[7],[11]

$ 21,060

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[7],[11]

5.50%

^[14],[15]

5.50%

^[14],[15]

5.50%

^[14],[15]

10.95%

^{[7],[10],[11]}

10.95%

^{[7],[10],[11]}

10.95%

^{[7],[10],[11]}

10.99%

^{[14],[15],[16]}

10.99%

^{[14],[15],[16]}

10.99%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 13,937

^{[7],[11],[17]}

$ 21,328

^{[14],[15],[18]}

^[14],[15]

20,888

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

^[7],[11]

$ 13,797

^[7],[8],[11]

5.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

^[7],[8],[11]

$ 0

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,568

^{[7],[17],[19]}

$ 8,568

^{[15],[18],[21]}

^[15],[21]

8,132

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

^[7],[19]

$ 8,139

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,568

^{[7],[17],[19]}

$ 4,284

^{[15],[18],[21]}

^[15],[21]

4,066

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

^[7],[19]

$ 8,139

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[7],[10],[11],[19]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

11.50%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,284

^{[7],[17],[19]}

$ 8,568

^{[15],[18],[21]}

^[15],[21]

8,132

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

^[7],[19]

$ 4,070

8.00%

^{[7],[10],[11],[19]}

8.00%

^{[7],[10],[11],[19]}

8.00%

^{[7],[10],[11],[19]}

8.00%

^{[14],[15],[16],[21]}

8.00%

^{[14],[15],[16],[21]}

8.00%

^{[14],[15],[16],[21]}

1.75%

^[7],[19]

1.75%

^[7],[19]

1.75%

^[7],[19]

1.75%

^[15],[21]

1.75%

^[15],[21]

1.75%

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,129

^{[7],[17],[19]}

$ 9,106

^{[15],[18],[21]}

^[15],[21]

8,013

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

^[7],[19]

$ 8,147

66,817

^[7],[19]

66,817

^[7],[19]

66,817

^[7],[19]

259,877

^[15],[21]

259,877

^[15],[21]

259,877

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[15],[18],[21]}

^[15],[21]

$ 78

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

^[7],[19]

$ 27

259,877

^[7],[19]

259,877

^[7],[19]

259,877

^[7],[19]

66,817

^[15],[21]

66,817

^[15],[21]

66,817

^[15],[21]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[15],[18],[21]}

^[15],[21]

$ 33

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

^[7],[19]

$ 65

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(76)

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

^[7],[8],[11]

$ (67)

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.53%

^[10],[11]

12.53%

^[10],[11]

12.53%

^[10],[11]

12.52%

^{[14],[15],[16]}

12.52%

^{[14],[15],[16]}

12.52%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 46,687

^{[7],[11],[17]}

$ 5,248

^{[14],[15],[18]}

^[14],[15]

5,164

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

^[7],[11]

$ 46,033

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.53%

^{[7],[10],[11]}

12.53%

^{[7],[10],[11]}

12.53%

^{[7],[10],[11]}

12.52%

^{[14],[15],[16]}

12.52%

^{[14],[15],[16]}

12.52%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 5,248

^{[7],[11],[17]}

$ 46,687

^{[14],[15],[18]}

^[14],[15]

45,940

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

^[7],[11]

$ 5,175

6.75%

^[7],[11]

6.75%

^[7],[11]

6.75%

^[7],[11]

6.75%

^[14],[15]

6.75%

^[14],[15]

6.75%

^[14],[15]

13.60%

^{[7],[10],[11]}

13.60%

^{[7],[10],[11]}

13.60%

^{[7],[10],[11]}

12.51%

^{[14],[15],[16]}

12.51%

^{[14],[15],[16]}

12.51%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 49,266

^{[7],[11],[17]}

$ 54,559

^{[14],[15],[18]}

^[14],[15]

53,168

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

^[7],[11]

$ 48,034

6.88%

^[10],[11]

6.88%

^[10],[11]

6.88%

^[10],[11]

6.88%

^[14],[16]

6.88%

^[14],[16]

6.88%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 10,191

^[17]

$ 10,191

^[18]

8,743

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

$ 10,368

6.88%

^{[7],[11],[19]}

6.88%

^{[7],[11],[19]}

6.88%

^{[7],[11],[19]}

6.88%

^{[14],[15],[21]}

6.88%

^{[14],[15],[21]}

6.88%

^{[14],[15],[21]}

12.33%

^{[7],[10],[11],[19]}

12.33%

^{[7],[10],[11],[19]}

12.33%

^{[7],[10],[11],[19]}

12.29%

^{[14],[15],[16],[21]}

12.29%

^{[14],[15],[16],[21]}

12.29%

^{[14],[15],[16],[21]}

2.00%

^{[7],[11],[19]}

2.00%

^{[7],[11],[19]}

2.00%

^{[7],[11],[19]}

2.00%

^{[14],[15],[21]}

2.00%

^{[14],[15],[21]}

2.00%

^{[14],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 73,547

^{[7],[11],[17],[19]}

$ 73,362

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

69,694

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

^{[7],[11],[19]}

$ 70,201

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

487,870

^[19]

487,870

^[19]

487,870

^[19]

487,870

^[21]

487,870

^[21]

487,870

^[21]

^[21]

$ 903

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

^[19]

$ 1,947

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

487,870

^[19]

487,870

^[19]

487,870

^[19]

487,870

^[21]

487,870

^[21]

487,870

^[21]

^[21]

$ 903

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

^[19]

$ 1,947

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[7],[11]

8.50%

^[14],[15]

8.50%

^[14],[15]

8.50%

^[14],[15]

13.93%

^{[7],[10],[11]}

13.93%

^{[7],[10],[11]}

13.93%

^{[7],[10],[11]}

13.99%

^{[14],[15],[16]}

13.99%

^{[14],[15],[16]}

13.99%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 30,339

^{[7],[11],[17]}

$ 30,339

^{[14],[15],[18]}

^[14],[15]

29,007

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

^[7],[11]

$ 30,166

9.50%

^[7],[11]

9.50%

^[7],[11]

9.50%

^[7],[11]

9.50%

^[14],[15]

9.50%

^[14],[15]

9.50%

^[14],[15]

14.83%

^{[7],[10],[11]}

14.83%

^{[7],[10],[11]}

14.83%

^{[7],[10],[11]}

14.89%

^{[14],[15],[16]}

14.89%

^{[14],[15],[16]}

14.89%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 64,606

^{[7],[11],[17]}

$ 64,606

^{[14],[15],[18]}

^[14],[15]

63,185

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

^[7],[11]

$ 63,185

^[7],[8],[11]

6.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

^[7],[8],[11]

$ (23)

^[7],[11]

6.00%

^{[7],[10],[11]}

11.37%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 19,995

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

^[7],[11]

$ 19,751

^[7],[8],[11]

6.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

^[7],[8],[11]

$ (38)

87.50%

^{[8],[19],[28],[29]}

87.50%

^{[8],[19],[28],[29]}

87.50%

^{[8],[19],[28],[29]}

87.50%

^{[12],[21],[30],[31]}

87.50%

^{[12],[21],[30],[31]}

87.50%

^{[12],[21],[30],[31]}

$ 0

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[12],[21],[30],[31]}

$ 0

^{[8],[19],[28],[29]}

$ 0

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

0.00%

4.50%

^{[7],[8],[11],[19],[28]}

4.50%

^{[7],[8],[11],[19],[28]}

4.50%

^{[7],[8],[11],[19],[28]}

4.50%

^{[12],[15],[21],[30]}

4.50%

^{[12],[15],[21],[30]}

4.50%

^{[12],[15],[21],[30]}

9.94%

^{[7],[8],[10],[11],[19],[28]}

7.67%

9.94%

^{[7],[8],[10],[11],[19],[28]}

9.94%

^{[7],[8],[10],[11],[19],[28]}

9.76%

^{[12],[14],[15],[16],[21],[30]}

9.76%

^{[12],[14],[15],[16],[21],[30]}

9.76%

^{[12],[14],[15],[16],[21],[30]}

$ 58,349

^{[7],[8],[11],[17],[19],[28]}

$ 59,049

$ 58,349

^{[12],[15],[18],[21],[30]}

Amount of Interest, Fees or Dividends Credited in Income

1,773

1,624

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

50,017

^{[12],[15],[21],[30]}

50,283

940

380

(1,127)

$ 50,957

^{[7],[8],[11],[19],[28]}

$ 49,536

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

3.40%

4.10%

3.40%

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.46%

^{[7],[10],[11]}

12.46%

^{[7],[10],[11]}

12.46%

^{[7],[10],[11]}

12.49%

^{[14],[15],[16]}

12.49%

^{[14],[15],[16]}

12.49%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,323

^{[7],[11],[17]}

$ 9,323

^{[14],[15],[18]}

^[14],[15]

9,183

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

^[7],[11]

$ 9,183

10.00%

^{[7],[11],[23]}

10.00%

^{[7],[11],[23]}

10.00%

^{[7],[11],[23]}

10.00%

^[14],[15]

10.00%

^[14],[15]

10.00%

^[14],[15]

^[14],[15]

15.67%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,303

^{[7],[11],[17],[23]}

$ 25,712

^{[14],[15],[18]}

^[14],[15]

25,069

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

^{[7],[11],[23]}

$ 1,074

10.00%

^{[7],[11],[23]}

10.00%

^{[7],[11],[23]}

10.00%

^{[7],[11],[23]}

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 31,515

^{[7],[11],[17],[23]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(69)

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

^{[7],[11],[23]}

$ 25,959

12.00%

^{[7],[8],[11],[23]}

12.00%

^{[7],[8],[11],[23]}

12.00%

^{[7],[8],[11],[23]}

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

^{[12],[14],[15]}

15.64%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 233

^{[7],[8],[11],[17],[23]}

$ 1,210

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

1,169

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

^{[7],[8],[11],[23]}

$ 233

7.75%

^[7],[8],[11]

7.75%

^[7],[8],[11]

7.75%

^[7],[8],[11]

7.75%

^{[12],[14],[15]}

7.75%

^{[12],[14],[15]}

7.75%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(36)

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

^[7],[8],[11]

$ (29)

7.75%

^[7],[11]

7.75%

^[7],[11]

7.75%

^[7],[11]

7.75%

^[14],[15]

7.75%

^[14],[15]

7.75%

^[14],[15]

13.13%

^{[7],[10],[11]}

13.13%

^{[7],[10],[11]}

13.13%

^{[7],[10],[11]}

13.12%

^{[14],[15],[16]}

13.12%

^{[14],[15],[16]}

13.12%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 15,231

^{[7],[11],[17]}

$ 15,231

^{[14],[15],[18]}

^[14],[15]

14,945

Investment, Identifier [Axis]: Other cash accounts

^[7],[11]

15,003

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

122,975

^[14],[16]

7.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[18]

$ 4,519

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

$ 3,305

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^[7],[8],[11]

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

7.00%

^{[12],[14],[15]}

^{[7],[8],[10],[11]}

12.35%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 98

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(54)

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

^[7],[8],[11]

$ 44

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

12.36%

^{[7],[10],[11]}

12.36%

^{[7],[10],[11]}

12.36%

^{[7],[10],[11]}

12.32%

^{[14],[15],[16]}

12.32%

^{[14],[15],[16]}

12.32%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 10,868

^{[7],[11],[17]}

$ 10,895

^{[14],[15],[18]}

^[14],[15]

10,495

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

^[7],[11]

$ 10,469

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

100,000

^[7]

100,000

^[7]

100,000

^[7]

100,000

^[15]

100,000

^[15]

100,000

^[15]

^[15]

$ 248

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

^[7]

$ 300

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(3)

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

^[7],[8],[11]

$ 0

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

12.04%

^{[7],[10],[11]}

12.04%

^{[7],[10],[11]}

12.04%

^{[7],[10],[11]}

12.01%

^{[14],[15],[16]}

12.01%

^{[14],[15],[16]}

12.01%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 38,308

^{[7],[11],[17]}

$ 38,414

^{[14],[15],[18]}

^[14],[15]

38,380

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

^[7],[11]

$ 38,308

5.00%

^[11]

5.00%

^[11]

5.00%

^[11]

5.00%

^[14]

5.00%

^[14]

5.00%

^[14]

10.46%

^[10],[11]

10.46%

^[10],[11]

10.46%

^[10],[11]

10.42%

^[14],[16]

10.42%

^[14],[16]

10.42%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,651

^[11],[17]

$ 9,676

^[14],[18]

^[14]

9,551

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

^[11]

$ 9,630

5.75%

^[7],[11]

5.75%

^[7],[11]

5.75%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.32%

^{[7],[10],[11]}

11.32%

^{[7],[10],[11]}

11.32%

^{[7],[10],[11]}

11.57%

^{[14],[15],[16]}

11.57%

^{[14],[15],[16]}

11.57%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 22,375

^{[7],[11],[17]}

$ 22,375

^{[14],[15],[18]}

^[14],[15]

21,896

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

^[7],[11]

$ 21,928

^[7],[8],[11]

6.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

^[7],[8],[11]

$ (133)

^[7],[11]

6.00%

^{[7],[10],[11]}

11.36%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 52,639

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

^[7],[11]

$ 51,618

^[7],[8],[11]

6.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

^[7],[8],[11]

$ (69)

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[7]

4,531,000

Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond

^[7]

$ 4,444

^[10],[11]

6.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 2,300

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

$ 2,192

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[14],[15]

7.25%

^[14],[15]

7.25%

^[14],[15]

12.70%

^{[7],[10],[11]}

12.70%

^{[7],[10],[11]}

12.70%

^{[7],[10],[11]}

12.74%

^{[14],[15],[16]}

12.74%

^{[14],[15],[16]}

12.74%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 36,499

^{[7],[11],[17]}

$ 36,499

^{[14],[15],[18]}

^[14],[15]

33,214

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

^[7],[11]

$ 33,397

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^[7],[8],[11]

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

8.00%

^{[12],[14],[15]}

13.56%

^{[7],[8],[10],[11]}

13.56%

^{[7],[8],[10],[11]}

13.56%

^{[7],[8],[10],[11]}

13.45%

^{[12],[14],[15],[16]}

13.45%

^{[12],[14],[15],[16]}

13.45%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,722

^{[7],[8],[11],[17]}

$ 3,003

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

2,801

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

^[7],[8],[11]

$ 3,540

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[14],[15]

8.00%

^[14],[15]

8.00%

^[14],[15]

13.56%

^{[7],[10],[11]}

13.56%

^{[7],[10],[11]}

13.56%

^{[7],[10],[11]}

13.45%

^{[14],[15],[16]}

13.45%

^{[14],[15],[16]}

13.45%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 67,244

^{[7],[11],[17]}

$ 67,244

^{[14],[15],[18]}

^[14],[15]

64,406

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

^[7],[11]

$ 64,689

^{[7],[11],[19]}

7.25%

^{[7],[10],[11],[19]}

12.60%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17],[19]}

$ 28,818

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

^{[7],[11],[19]}

28,530

^[14],[15]

7.25%

^{[14],[15],[16]}

12.78%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 24,503

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

^[14],[15]

24,081

^[14],[15]

7.25%

^{[14],[15],[16]}

12.78%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 2,819

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

^[14],[15]

$ 2,771

5.50%

^{[7],[11],[19]}

5.50%

^{[7],[11],[19]}

5.50%

^{[7],[11],[19]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

5.75%

^{[14],[15],[21]}

10.96%

^{[7],[10],[11],[19]}

10.96%

^{[7],[10],[11],[19]}

10.96%

^{[7],[10],[11],[19]}

11.21%

^{[14],[15],[16],[21]}

11.21%

^{[14],[15],[16],[21]}

11.21%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

£ 6,136

^{[7],[11],[17],[19]}

£ 4,626

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 5,166

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

^{[7],[11],[19]}

$ 7,353

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

64,887,669

^[7]

64,887,669

^[7]

64,887,669

^[7]

64,887,669

^[15]

64,887,669

^[15]

64,887,669

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

^[7]

$ 0

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^[7],[8],[11]

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

6.50%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(47)

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

^[7],[8],[11]

$ (35)

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[7],[11]

6.50%

^[14],[15]

6.50%

^[14],[15]

6.50%

^[14],[15]

11.96%

^{[7],[10],[11]}

11.96%

^{[7],[10],[11]}

11.96%

^{[7],[10],[11]}

11.92%

^{[14],[15],[16]}

11.92%

^{[14],[15],[16]}

11.92%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 32,329

^{[7],[11],[17]}

$ 32,329

^{[14],[15],[18]}

^[14],[15]

31,779

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

^[7],[11]

$ 31,915

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

13.86%

^{[7],[10],[11],[19]}

13.86%

^{[7],[10],[11],[19]}

13.86%

^{[7],[10],[11],[19]}

13.90%

^{[14],[15],[16],[21]}

13.90%

^{[14],[15],[16],[21]}

13.90%

^{[14],[15],[16],[21]}

0.50%

^{[7],[11],[19]}

0.50%

^{[7],[11],[19]}

0.50%

^{[7],[11],[19]}

0.50%

^{[14],[15],[21]}

0.50%

^{[14],[15],[21]}

0.50%

^{[14],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 9,697

^{[7],[11],[17],[19]}

$ 36,707

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

34,505

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

^{[7],[11],[19]}

$ 9,115

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

8.25%

^{[14],[15],[21]}

13.86%

^{[7],[10],[11],[19]}

13.86%

^{[7],[10],[11],[19]}

13.86%

^{[7],[10],[11],[19]}

13.90%

^{[14],[15],[16],[21]}

13.90%

^{[14],[15],[16],[21]}

13.90%

^{[14],[15],[16],[21]}

0.50%

^{[7],[11],[19]}

0.50%

^{[7],[11],[19]}

0.50%

^{[7],[11],[19]}

0.50%

^{[14],[15],[21]}

0.50%

^{[14],[15],[21]}

0.50%

^{[14],[15],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 32,133

^{[7],[11],[17],[19]}

$ 13,504

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

12,694

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

^{[7],[11],[19]}

$ 30,205

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

204,454

^[7],[19]

204,454

^[7],[19]

204,454

^[7],[19]

204,454

^[15],[21]

204,454

^[15],[21]

204,454

^[15],[21]

^[15],[21]

$ 756

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond

^[7],[19]

$ 1,073

^[10],[11]

4.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 1,680

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

$ 1,573

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

1,037

^[7]

1,037

^[7]

1,037

^[7]

1,037

^[15]

1,037

^[15]

1,037

^[15]

^[15]

$ 951

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

^[7]

$ 1,024

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^[14],[15]

8.75%

^[14],[15]

8.75%

^[14],[15]

14.20%

^{[7],[8],[10],[11]}

14.20%

^{[7],[8],[10],[11]}

14.20%

^{[7],[8],[10],[11]}

14.18%

^{[14],[15],[16]}

14.18%

^{[14],[15],[16]}

14.18%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 990

^{[7],[8],[11],[17]}

$ 8,010

^{[14],[15],[18]}

^[14],[15]

7,778

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

^[7],[8],[11]

$ 921

8.75%

^[7],[11]

8.75%

^[7],[11]

8.75%

^[7],[11]

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

^{[7],[10],[11]}

14.21%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 8,010

^{[7],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(68)

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

^[7],[11]

$ 7,778

1,184,630

^[7]

1,184,630

^[7]

1,184,630

^[7]

1,184,630

^[15]

1,184,630

^[15]

1,184,630

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

36,226

^[7]

$ 36,226

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

2.40%

12.00%

^[7]

12.00%

^[7]

12.00%

^[7]

12.00%

^[15]

12.00%

^[15]

12.00%

^[15]

$ 16,355

^[7],[17]

$ 15,874

^[15],[18]

Amount of Interest, Fees or Dividends Credited in Income

540

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

15,874

534

(53)

^[7]

$ 16,355

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

1.10%

12.00%

^[7],[8]

12.00%

^[7],[8]

12.00%

^[7],[8]

12.00%

^[12],[15]

12.00%

^[12],[15]

12.00%

^[12],[15]

$ 3,005

^[7],[8],[17]

$ 1,359

^{[12],[15],[18]}

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[12],[15]

1,359

1,646

^[7],[8]

$ 3,005

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

0.20%

66,686

^[7]

66,686

^[7]

66,686

^[7]

66,686

^[15]

66,686

^[15]

66,686

^[15]

Amount of Interest, Fees or Dividends Credited in Income

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[15]

^[7]

$ 0

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

0.00%

4.75%

^[7],[11]

4.75%

^[7],[11]

4.75%

^[7],[11]

4.75%

^[14],[15]

4.75%

^[14],[15]

4.75%

^[14],[15]

10.39%

^{[7],[10],[11]}

10.39%

^{[7],[10],[11]}

10.39%

^{[7],[10],[11]}

10.38%

^{[14],[15],[16]}

10.38%

^{[14],[15],[16]}

10.38%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,440

^{[7],[11],[17]}

$ 4,452

^{[14],[15],[18]}

^[14],[15]

4,184

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

^[7],[11]

$ 4,307

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[14],[15]

8.00%

^[14],[15]

8.00%

^[14],[15]

13.64%

^{[7],[10],[11]}

13.64%

^{[7],[10],[11]}

13.64%

^{[7],[10],[11]}

13.63%

^{[14],[15],[16]}

13.63%

^{[14],[15],[16]}

13.63%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 12,034

^{[7],[11],[17]}

$ 12,034

^{[14],[15],[18]}

^[14],[15]

9,928

Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond

^[7],[11]

$ 10,169

^[10],[11]

8.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 1,590

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

$ 1,592

6.75%

^{[7],[11],[23]}

6.75%

^{[7],[11],[23]}

6.75%

^{[7],[11],[23]}

6.75%

^[14],[15]

6.75%

^[14],[15]

6.75%

^[14],[15]

^{[14],[15],[16]}

12.40%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 25,462

^{[7],[11],[17],[23]}

$ 25,527

^{[14],[15],[18]}

^[14],[15]

19,954

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

^{[7],[11],[23]}

$ 14,131

10.00%

^[7],[8],[11]

10.00%

^[7],[8],[11]

10.00%

^[7],[8],[11]

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

10.00%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

(93)

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

^[7],[8],[11]

$ (85)

10.00%

^[7],[11]

10.00%

^[7],[11]

10.00%

^[7],[11]

10.00%

^[14],[15]

10.00%

^[14],[15]

10.00%

^[14],[15]

15.36%

^{[7],[10],[11]}

15.36%

^{[7],[10],[11]}

15.36%

^{[7],[10],[11]}

15.24%

^{[14],[15],[16]}

15.24%

^{[14],[15],[16]}

15.24%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 25,418

^{[7],[11],[17]}

$ 25,558

^{[14],[15],[18]}

^[14],[15]

24,791

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

^[7],[11]

$ 24,719

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

991,019

^[7]

991,019

^[7]

991,019

^[7]

991,019

^[15]

991,019

^[15]

991,019

^[15]

^[15]

$ 1,625

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

^[7]

$ 1,536

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

9,307

^[19]

9,307

^[19]

9,307

^[19]

9,307

^[21]

9,307

^[21]

9,307

^[21]

^[21]

$ 13

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

^[19]

$ 19

87.50%

^{[8],[19],[27],[28],[29]}

87.50%

^{[8],[19],[27],[28],[29]}

87.50%

^{[8],[19],[27],[28],[29]}

87.50%

^{[12],[21],[30],[31],[32]}

87.50%

^{[12],[21],[30],[31],[32]}

87.50%

^{[12],[21],[30],[31],[32]}

$ 0

Amount of Interest, Fees or Dividends Credited in Income

$ 0

1,400

1,050

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

28,878

^{[12],[21],[30],[31],[32]}

20,715

709

5,469

(2,076)

$ 29,587

^{[8],[19],[27],[28],[29]}

$ 24,108

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

2.00%

7.00%

^{[7],[8],[11],[19],[28]}

7.00%

^{[7],[8],[11],[19],[28]}

7.00%

^{[7],[8],[11],[19],[28]}

7.00%

^{[12],[15],[21],[30]}

7.00%

^{[12],[15],[21],[30]}

7.00%

^{[12],[15],[21],[30]}

12.44%

^{[7],[8],[10],[11],[19],[28]}

10.17%

12.44%

^{[7],[8],[10],[11],[19],[28]}

12.44%

^{[7],[8],[10],[11],[19],[28]}

12.26%

^{[12],[14],[15],[16],[21],[30]}

12.26%

^{[12],[14],[15],[16],[21],[30]}

12.26%

^{[12],[14],[15],[16],[21],[30]}

$ 112,656

^{[7],[8],[11],[17],[19],[28]}

$ 112,656

^{[12],[15],[18],[21],[30]}

Amount of Interest, Fees or Dividends Credited in Income

3,581

2,611

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

112,656

^{[12],[15],[21],[30]}

96,250

16,406

$ 112,656

^{[7],[8],[11],[19],[28]}

$ 112,656

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

7.50%

9.40%

7.50%

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[14],[15],[21]}

7.88%

^{[14],[15],[21]}

7.88%

^{[14],[15],[21]}

^{[14],[15],[16],[21]}

12.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 7,191

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

6,937

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

^{[7],[8],[11],[19]}

$ 0

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[7],[8],[11],[19]}

7.88%

^{[14],[15],[21]}

7.88%

^{[14],[15],[21]}

7.88%

^{[14],[15],[21]}

^{[14],[15],[16],[21]}

12.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17],[19]}

$ 2,697

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

2,602

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

^{[7],[8],[11],[19]}

$ 0

7.88%

^{[7],[11],[19]}

7.88%

^{[7],[11],[19]}

7.88%

^{[7],[11],[19]}

7.88%

^{[12],[14],[15],[21]}

7.88%

^{[12],[14],[15],[21]}

7.88%

^{[12],[14],[15],[21]}

^{[7],[10],[11],[19]}

12.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 7,191

^{[7],[11],[17],[19]}

$ 0

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

^{[7],[11],[19]}

$ 6,880

7.88%

^{[7],[11],[19]}

7.88%

^{[7],[11],[19]}

7.88%

^{[7],[11],[19]}

7.88%

^{[12],[14],[15],[21]}

7.88%

^{[12],[14],[15],[21]}

7.88%

^{[12],[14],[15],[21]}

^{[7],[10],[11],[19]}

12.88%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,697

^{[7],[11],[17],[19]}

$ 0

^{[12],[14],[15],[18],[21]}

^{[12],[14],[15],[21]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

^{[7],[11],[19]}

$ 2,580

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

58,210

^[7],[19]

58,210

^[7],[19]

58,210

^[7],[19]

58,210

^[15],[21]

58,210

^[15],[21]

58,210

^[15],[21]

^[15],[21]

$ 87

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

^[7],[19]

$ 44

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

345,452

^[7]

345,452

^[7]

345,452

^[7]

345,452

^[15]

345,452

^[15]

345,452

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

^[7]

^[14],[15]

7.50%

^{[14],[15],[16]}

13.04%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 821

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

^[14],[15]

$ 776

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

66,000

^[19]

66,000

^[19]

66,000

^[19]

66,000

^[21]

66,000

^[21]

66,000

^[21]

^[21]

$ 6

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

^[19]

$ 8

5.00%

^[7],[8],[11]

5.00%

^[7],[8],[11]

5.00%

^[7],[8],[11]

5.00%

^{[12],[14],[15]}

5.00%

^{[12],[14],[15]}

5.00%

^{[12],[14],[15]}

^{[12],[14],[15],[16]}

10.42%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 618

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

577

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

^[7],[8],[11]

$ (19)

5.25%

^[7],[11]

5.25%

^[7],[11]

5.25%

^[7],[11]

5.25%

^[14],[15]

5.25%

^[14],[15]

5.25%

^[14],[15]

10.71%

^[10],[11]

10.71%

^[10],[11]

10.71%

^[10],[11]

10.67%

^{[14],[15],[16]}

10.67%

^{[14],[15],[16]}

10.67%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,477

^{[7],[11],[17]}

$ 4,488

^{[14],[15],[18]}

^[14],[15]

4,425

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

^[7],[11]

$ 4,438

^[10],[11]

7.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 4,700

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

$ 4,377

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.25%

^{[7],[11],[19]}

8.50%

^{[14],[15],[21]}

8.50%

^{[14],[15],[21]}

8.50%

^{[14],[15],[21]}

12.21%

^{[7],[10],[11],[19]}

12.21%

^{[7],[10],[11],[19]}

12.21%

^{[7],[10],[11],[19]}

12.32%

^{[14],[15],[16],[21]}

12.32%

^{[14],[15],[16],[21]}

12.32%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

€ 23,731

^{[7],[11],[17],[19]}

€ 23,731

^{[14],[15],[18],[21]}

^{[14],[15],[21]}

$ 24,937

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

^{[7],[11],[19]}

$ 26,149

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[14],[15]

8.00%

^[14],[15]

8.00%

^[14],[15]

13.36%

^{[7],[10],[11]}

13.36%

^{[7],[10],[11]}

13.36%

^{[7],[10],[11]}

13.32%

^{[14],[15],[16]}

13.32%

^{[14],[15],[16]}

13.32%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 49,395

^{[7],[11],[17]}

$ 49,520

^{[14],[15],[18]}

^[14],[15]

49,148

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

^[7],[11]

$ 48,901

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

12.66%

^{[7],[10],[11]}

12.66%

^{[7],[10],[11]}

12.66%

^{[7],[10],[11]}

12.44%

^{[14],[15],[16],[33]}

12.44%

^{[14],[15],[16],[33]}

12.44%

^{[14],[15],[16],[33]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,552

^{[7],[11],[17]}

$ 1,552

^{[14],[15],[18],[33]}

^{[14],[15],[33]}

1,478

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

^[7],[11]

1,476

^{[12],[14],[15],[33]}

7.00%

^{[12],[14],[15],[16],[33]}

12.51%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[12],[14],[15],[18],[33]}

$ 1,099

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

^{[12],[14],[15],[33]}

$ 943

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^[7],[11]

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

12.66%

^{[7],[10],[11]}

12.66%

^{[7],[10],[11]}

12.66%

^{[7],[10],[11]}

12.51%

^{[14],[15],[16],[33]}

12.51%

^{[14],[15],[16],[33]}

12.51%

^{[14],[15],[16],[33]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,742

^{[7],[11],[17]}

$ 32,104

^{[14],[15],[18],[33]}

^{[14],[15],[33]}

30,579

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

^[7],[11]

$ 2,608

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

7.00%

^{[14],[15],[33]}

14.50%

^{[7],[10],[11]}

14.50%

^{[7],[10],[11]}

14.50%

^{[7],[10],[11]}

12.51%

^{[14],[15],[16],[33]}

12.51%

^{[14],[15],[16],[33]}

12.51%

^{[14],[15],[16],[33]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,298

^{[7],[11],[17]}

$ 2,749

^{[14],[15],[18],[33]}

^{[14],[15],[33]}

2,618

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

^[7],[11]

$ 3,137

^[7],[11]

7.00%

^{[7],[10],[11]}

12.66%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 32,022

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

^[7],[11]

30,456

^{[13],[14],[15],[16],[21]}

11.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[13],[15],[18],[21]}

$ 4,984

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

^{[13],[15],[21]}

$ 4,785

13.00%

^{[7],[10],[11],[19]}

13.00%

^{[7],[10],[11],[19]}

13.00%

^{[7],[10],[11],[19]}

13.00%

^{[14],[15],[16],[21]}

13.00%

^{[14],[15],[16],[21]}

13.00%

^{[14],[15],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 50,419

^{[7],[17],[19]}

$ 50,419

^{[15],[18],[21]}

^[15],[21]

49,869

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

^[7],[19]

$ 49,869

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[7],[11]

8.00%

^[14]

8.00%

^[14]

8.00%

^[14]

13.47%

^{[7],[10],[11]}

13.47%

^{[7],[10],[11]}

13.47%

^{[7],[10],[11]}

13.43%

^[14],[16]

13.43%

^[14],[16]

13.43%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 12,843

^{[7],[11],[17]}

$ 12,843

^[14],[18]

^[14]

12,464

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

^[7],[11]

12,847

^{[12],[14],[15],[21]}

6.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[12],[14],[15],[18],[21]}

$ 0

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

^{[12],[14],[15],[21]}

(22)

^{[14],[15],[21]}

6.00%

^{[14],[15],[16],[21]}

11.42%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[21]}

$ 28,826

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

^{[14],[15],[21]}

$ 28,537

9.75%

^[7],[8],[11]

9.75%

^[7],[8],[11]

9.75%

^[7],[8],[11]

9.75%

^{[12],[14],[15]}

9.75%

^{[12],[14],[15]}

9.75%

^{[12],[14],[15]}

15.21%

^{[7],[8],[10],[11]}

15.21%

^{[7],[8],[10],[11]}

15.21%

^{[7],[8],[10],[11]}

15.17%

^{[12],[14],[15],[16]}

15.17%

^{[12],[14],[15],[16]}

15.17%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 2,119

^{[7],[8],[11],[17]}

$ 1,861

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

1,802

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

^[7],[8],[11]

$ 2,040

9.75%

^[7],[11]

9.75%

^[7],[11]

9.75%

^[7],[11]

9.75%

^[14],[15]

9.75%

^[14],[15]

9.75%

^[14],[15]

15.28%

^{[7],[10],[11]}

15.28%

^{[7],[10],[11]}

15.28%

^{[7],[10],[11]}

15.26%

^{[14],[15],[16]}

15.26%

^{[14],[15],[16]}

15.26%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 23,363

^{[7],[11],[17]}

$ 23,423

^{[14],[15],[18]}

^[14],[15]

22,814

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

^[7],[11]

$ 22,545

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.36%

^{[7],[10],[11]}

11.36%

^{[7],[10],[11]}

11.36%

^{[7],[10],[11]}

11.32%

^{[14],[15],[16]}

11.32%

^{[14],[15],[16]}

11.32%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 19,894

^{[7],[11],[17]}

$ 19,947

^{[14],[15],[18]}

^[14],[15]

19,199

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

^[7],[11]

19,211

^{[14],[15],[24]}

7.30%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[24]}

$ 19,163

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

^{[14],[15],[24]}

$ 18,340

^[7],[23]

10.00%

^{[7],[17],[23]}

$ 5,065

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

4,657

(367)

^[7],[23]

$ 4,290

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

0.30%

^[7],[23]

10.00%

^{[7],[17],[23]}

$ 20,871

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

19,217

(494)

^[7],[23]

$ 18,723

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

1.20%

^[7]

6.40%

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[7]

$ 0

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

0.00%

^{[14],[15],[24]}

12.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[24]}

$ 4,641

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

^{[14],[15],[24]}

$ 4,170

9.00%

^{[7],[11],[23]}

9.00%

^{[7],[11],[23]}

9.00%

^{[7],[11],[23]}

7.00%

^[14],[15]

7.00%

^[14],[15]

7.00%

^[14],[15]

^[14],[15]

12.65%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 46,832

^{[7],[11],[17],[23]}

$ 46,832

^{[14],[15],[18]}

^[14],[15]

37,231

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

^{[7],[11],[23]}

$ 28,099

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

358,299

^[7]

358,299

^[7]

358,299

^[7]

10,616

^[15]

10,616

^[15]

10,616

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

^[7]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

10,616

^[7]

10,616

^[7]

10,616

^[7]

358,299

^[15]

358,299

^[15]

358,299

^[15]

^[15]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

^[7]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

60,862

^[7]

60,862

^[7]

60,862

^[7]

60,862

^[15]

60,862

^[15]

60,862

^[15]

^[15]

$ 108

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

^[7]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

32,447

^[7]

32,447

^[7]

32,447

^[7]

32,447

^[15]

32,447

^[15]

32,447

^[15]

^[15]

$ 31,701

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

^[7],[11]

$ 11,131

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[7],[11]

6.00%

^[14],[15]

6.00%

^[14],[15]

6.00%

^[14],[15]

11.48%

^{[7],[10],[11]}

11.48%

^{[7],[10],[11]}

11.48%

^{[7],[10],[11]}

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

11.42%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 11,642

^{[7],[11],[17]}

$ 11,671

^{[14],[15],[18]}

^[14],[15]

11,363

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

^[7],[11]

$ 11,321

7.71%

^[11],[19]

7.71%

^[11],[19]

7.71%

^[11],[19]

7.71%

^[14],[21]

7.71%

^[14],[21]

7.71%

^[14],[21]

13.12%

^{[10],[11],[19]}

13.12%

^{[10],[11],[19]}

13.12%

^{[10],[11],[19]}

13.06%

^{[14],[16],[21]}

13.06%

^{[14],[16],[21]}

13.06%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 1,000

^{[11],[17],[19]}

$ 1,000

^{[14],[18],[21]}

^[14],[21]

917

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

^[11],[19]

$ 930

4.75%

^{[10],[11],[19]}

4.75%

^{[10],[11],[19]}

4.75%

^{[10],[11],[19]}

6.50%

^{[14],[16],[21]}

6.50%

^{[14],[16],[21]}

6.50%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 300

^[17],[19]

$ 4,500

^[18],[21]

^[21]

2,953

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

^[19]

$ 259

6.50%

^{[10],[11],[19]}

6.50%

^{[10],[11],[19]}

6.50%

^{[10],[11],[19]}

4.75%

^{[14],[16],[21]}

4.75%

^{[14],[16],[21]}

4.75%

^{[14],[16],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,500

^[17],[19]

$ 300

^[18],[21]

^[21]

245

Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond

^[19]

$ 3,252

^[10],[11]

9.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[11],[17]

$ 6,620

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

^[11]

7,009

^[14],[15]

7.25%

^{[14],[15],[16]}

12.68%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 1,140

Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[14],[15]

$ 1,139

^[7],[11]

15.00%

^{[7],[10],[11]}

21.66%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 1,290

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

^[7],[11]

$ 1,203

^[7],[8],[11]

6.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[8],[11],[17]}

$ 0

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

^[7],[8],[11]

$ (82)

6.75%

^[7],[11]

6.75%

^[7],[11]

6.75%

^[7],[11]

3.75%

^[14]

3.75%

^[14]

3.75%

^[14]

12.06%

^{[7],[10],[11]}

12.06%

^{[7],[10],[11]}

12.06%

^{[7],[10],[11]}

9.27%

^[14],[16]

9.27%

^[14],[16]

9.27%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 29,838

^{[7],[11],[17]}

$ 11,792

^[14],[18]

^[14]

11,127

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

^[7],[11]

29,092

^[14],[15]

7.00%

^{[14],[15],[16]}

12.65%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 5,000

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[14],[15]

$ 4,263

^[7],[11]

15.00%

^{[7],[10],[11]}

21.66%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[7],[11],[17]}

$ 1,543

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

^[7],[11]

1,439

^[14],[15]

15.00%

^{[14],[15],[16]}

21.68%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 1,565

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

^[14],[15]

1,464

^[14],[15]

15.00%

^{[14],[15],[16]}

21.68%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18]}

$ 1,323

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

^[14],[15]

$ 1,237

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

4,871

^[7]

4,871

^[7]

4,871

^[7]

4,871

^[15]

4,871

^[15]

4,871

^[15]

^[15]

$ 107

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

^[7]

$ 42

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

127,452

^[7]

127,452

^[7]

127,452

^[7]

127,452

^[15]

127,452

^[15]

127,452

^[15]

^[15]

$ 1,319

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

^[7]

$ 1,485

6.25%

^[11]

6.25%

^[11]

6.25%

^[11]

6.25%

^[14]

6.25%

^[14]

6.25%

^[14]

11.71%

^[10],[11]

11.71%

^[10],[11]

11.71%

^[10],[11]

11.67%

^[14],[16]

11.67%

^[14],[16]

11.67%

^[14],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 4,664

^[11],[17]

$ 8,983

^[14],[18]

^[14]

8,678

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

^[11]

$ 4,425

4.00%

^[7],[11]

4.00%

^[7],[11]

4.00%

^[7],[11]

4.00%

^[14],[15]

4.00%

^[14],[15]

4.00%

^[14],[15]

9.35%

^{[7],[10],[11]}

9.35%

^{[7],[10],[11]}

9.35%

^{[7],[10],[11]}

9.32%

^{[14],[15],[16]}

9.32%

^{[14],[15],[16]}

9.32%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 19,578

^{[7],[11],[17]}

$ 19,578

^{[14],[15],[18]}

^[14],[15]

19,489

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

^[7],[11]

19,577

^{[14],[15],[21]}

7.50%

^{[14],[15],[16],[21]}

12.72%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^{[14],[15],[18],[21]}

£ 20,000

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond

^{[14],[15],[21]}

$ 22,914

^[10],[11]

6.50%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 4,960

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

$ 4,506

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

21,523

^[7]

21,523

^[7]

21,523

^[7]

21,523

^[15]

21,523

^[15]

21,523

^[15]

^[15]

$ 20,074

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

^[7]

$ 20,542

6.75%

^[7],[8],[11]

6.75%

^[7],[8],[11]

6.75%

^[7],[8],[11]

6.75%

^{[12],[14],[15]}

6.75%

^{[12],[14],[15]}

6.75%

^{[12],[14],[15]}

12.10%

^[10],[11]

12.10%

^[10],[11]

12.10%

^[10],[11]

12.14%

^{[12],[14],[15],[16]}

12.14%

^{[12],[14],[15],[16]}

12.14%

^{[12],[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 377

^{[7],[8],[11],[17]}

$ 377

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

296

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

^[7],[8],[11]

$ 276

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[14],[15]

7.25%

^[14],[15]

7.25%

^[14],[15]

12.62%

^{[7],[10],[11]}

12.62%

^{[7],[10],[11]}

12.62%

^{[7],[10],[11]}

12.63%

^{[14],[15],[16]}

12.63%

^{[14],[15],[16]}

12.63%

^{[14],[15],[16]}

^[14],[15]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 24,427

^{[7],[11],[17]}

$ 24,427

^{[14],[15],[18]}

^[14],[15]

23,548

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

^[7],[11]

$ 23,531

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[7],[11]

7.25%

^[14],[15]

7.25%

^[14],[15]

7.25%

^[14],[15]

12.62%

^{[7],[10],[11]}

12.62%

^{[7],[10],[11]}

12.62%

^{[7],[10],[11]}

12.63%

^{[14],[15],[16]}

12.63%

^{[14],[15],[16]}

12.63%

^{[14],[15],[16]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 3,636

^{[7],[11],[17]}

$ 3,636

^{[14],[15],[18]}

^[14],[15]

3,574

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

^[7],[11]

$ 3,537

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^[7],[8],[11]

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

7.25%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

^[7],[8],[11]

$ 0

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^[14],[15]

8.75%

^[14],[15]

8.75%

^[14],[15]

^{[14],[15],[16]}

11.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 5,212

^{[14],[15],[18]}

^[14],[15]

4,990

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

^[7],[8],[11]

$ 0

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^[7],[8],[11]

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 0

^{[7],[8],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

^[7],[8],[11]

$ 0

8.75%

^[7],[11]

8.75%

^[7],[11]

8.75%

^[7],[11]

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

8.75%

^{[12],[14],[15]}

^{[7],[10],[11]}

11.75%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

$ 5,212

^{[7],[11],[17]}

$ 0

^{[12],[14],[15],[18]}

^{[12],[14],[15]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

^[7],[11]

$ 5,043

53,700

^[7]

53,700

^[7]

53,700

^[7]

53,700

^[15]

53,700

^[15]

53,700

^[15]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

^[17]

$ 0

^[15]

258

^[7]

$ 212

[1]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[2]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[3]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[4]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[5]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[6]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[7]	As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[8]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[9]	This investment represents a participation interest in the underlying securities shown.
[10]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[11]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[12]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[13]	This investment represents a participation interest in the underlying securities shown.
[14]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[15]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[16]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[17]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[18]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[19]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[20]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[21]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[22]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[23]	This investment was on non-accrual status as of December 31, 2023.
[24]	This investment was on non-accrual status as of September 30, 2023.
[25]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[26]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[27]	Income producing through payment of dividends or distributions.
[28]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[29]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[30]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[31]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[32]	Income producing through payment of dividends or distributions.
[33]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Share Data and Net Assets - Narrative (Details) $ in Millions			3 Months Ended
	Feb. 08, 2023 USD ($)	Feb. 07, 2022 USD ($)	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 shares
Investment Company, Changes in Net Assets [Line Items]
Stock split, conversion ratio			0.3333
Issuance of common stock under dividend reinvestment plan (shares)			98,605,000	94,879,000
Aggregate offering price \| $	$ 125.0	$ 125.0
At the Market
Investment Company, Changes in Net Assets [Line Items]
Dividend reinvestment plan, percent of current market price			95.00%
Number of shares issued (in shares)			1,641,416
Net proceeds \| $			$ 32.3
Common Stock
Investment Company, Changes in Net Assets [Line Items]
Issuance of common stock under dividend reinvestment plan (shares)			98,605	94,879

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,619,912	$ 2,169,475
Purchases	300,357	203,463
Sales and repayments	(178,365)	(56,632)
Transfers in	34,451	19,075
Transfers out	(21,988)
Capitalized PIK interest income	3,848	5,769
Accretion of OID	4,303	4,512
Fair value, ending balance	$ 2,726,123	2,334,740
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	$ (39,473)	(9,936)
Transfers in	$ 34,451	19,075
Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Net unrealized appreciation (depreciation)
Total gains or losses included in earnings	$ (26,090)	(9,809)
Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Realized gain (loss)
Total gains or losses included in earnings	$ (10,305)	(1,113)
Senior secured debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	2,292,691	1,910,606
Purchases	281,278	177,599
Sales and repayments	(172,647)	(55,885)
Transfers in	17,121	19,075
Transfers out	(16,172)
Capitalized PIK interest income	3,835	5,763
Accretion of OID	4,005	4,114
Fair value, ending balance	2,393,175	2,047,842
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(18,446)	(12,398)
Transfers in	17,121	19,075
Investment exchanged, cost	16,200
Senior secured debt \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(7,904)	(12,271)
Senior secured debt \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(9,032)	(1,159)
Subordinated debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	189,724	159,388
Purchases	14,639	21,104
Sales and repayments	(4,932)	(699)
Transfers in	0	0
Transfers out	(4,657)
Capitalized PIK interest income	13	6
Accretion of OID	298	398
Fair value, ending balance	196,360	179,631
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	648	(566)
Transfers in	0	0
Investment exchanged, cost	4,700
Subordinated debt \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	1,229	(566)
Subordinated debt \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	46	0
Preferred equity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	86,057	79,523
Purchases	4,440	2,579
Sales and repayments	0	0
Transfers in	0	0
Transfers out	(1,159)
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	69,261	80,625
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(20,231)	(1,477)
Transfers in	0	0
Investment exchanged, cost	1,200
Preferred equity \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(20,077)	(1,477)
Preferred equity \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0
Common equity and warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	51,440	19,958
Purchases	0	2,181
Sales and repayments	(786)	(48)
Transfers in	17,330	0
Transfers out	0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	67,327	26,642
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(1,444)	4,505
Transfers in	17,330	0
Common equity and warrants \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	662	4,505
Common equity and warrants \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,319)	$ 46
Investment, Change in Market Quotes or Liquidity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers in	12,400
Transfers in	$ 12,400

Related Party Transactions	3 Months Ended
Related Party Transactions	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of December 31, 2023 and September 30, 2023, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $19.0 million and $19.5 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. The investment advisory agreement with Oaktree was amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. For the three months ended December 31, 2023 and 2022, the base management fee incurred under the Investment Advisory Agreement was $10.0 million (net of waiver) and $9.2 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: •No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; •100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and •For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the three months ended December 31, 2023 and 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.0 million and $7.7 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2023 and 2022, there were no accrued capital gains incentive fees. As of December 31, 2023, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the three months ended December 31, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.4 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. As of December 31, 2023 and September 30, 2023, $3.8 million and $4.3 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Concentration of Credit Risks	3 Months Ended
Concentration of Credit Risks	Dec. 31, 2023
Risks and Uncertainties [Abstract]
Concentration of Credit Risks	Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Significant Accounting Policies (Policies)	3 Months Ended
Significant Accounting Policies (Policies)	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates	Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
Consolidation	Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.
Fair Value Measurements	Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; •Preliminary valuations are then reviewed and discussed with management of Oaktree; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; •Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and •Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.
Foreign Currency Translation	Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments	Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income	Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash	Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
Due From Portfolio Companies	Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions	Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs	Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.
Deferred Offering Costs	Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes	Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)

3 Months Ended

Dec. 31, 2023

Schedule of Aggregate Net Realized Gains

During the three months ended December 31, 2023, the Company recorded an aggregate net realized loss of $8.5 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Continental Intermodal Group LP	$	(6.8)
P&L Development LLC	(1.9)
Zephyr Bidco Limited (1)	(1.7)
Lift Brands Holdings, Inc.	(1.4)
Foreign currency forward contracts	4.1
Other, net	(0.8)
Total, net	$	(8.5)

__________

During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	4.4
Carvana Co.	(2.8)
ASP Unifrax Holdings Inc.	(2.1)
Global Medical Response Inc.	(1.0)
Other, net	(1.7)
Total, net	$	(3.2)

Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	$ 0			$ 4,910
Derivative liability at fair value	29,316			47,519
Foreign currency forward contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	0			4,910
Derivative liability at fair value	2,914			0
Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	4,013			0
Derivative liability at fair value	30,415			47,519
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing February 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	36,775
Notional Amount to be Sold \| €		€ 34,350
Derivative assets at fair value	0
Derivative liability at fair value	1,227
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				42,182
Notional Amount to be Sold \| €		€ 34,350			€ 38,026
Derivative assets at fair value				1,857
Derivative liability at fair value	1,227			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing February 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	47,403
Notional Amount to be Sold \| £			£ 38,500
Derivative assets at fair value	0
Derivative liability at fair value	1,687
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				72,098
Notional Amount to be Sold \| £						£ 56,556
Derivative assets at fair value				3,053
Derivative liability at fair value	1,687			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	300,000			300,000
Derivative assets at fair value	4,013			0
Derivative liability at fair value	0			7,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	350,000			350,000
Derivative assets at fair value	0			0
Derivative liability at fair value	$ 30,415			$ 40,519

Derivative Instruments (Tables)

3 Months Ended

Dec. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Foreign Currency Forward Contracts and Interest Rate Swap

Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	36,775	€	34,350	2/8/2024	$	—	$	1,227	Derivative liability
Foreign currency forward contract	$	47,403	£	38,500	2/8/2024	—		1,687		Derivative liability
						$	—	$	2,914

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	42,182	€	38,026	11/9/2023	$	1,857	$	—	Derivative asset
Foreign currency forward contract	$	72,098	£	56,556	11/9/2023	3,053		—		Derivative asset
						$	4,910	$	—

Certain information related to the Company’s interest rate swaps is presented below as of December 31, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	30,415	Derivative liability
Interest rate swap	300,000		2/15/2029	4,013		—		Derivative liability
				$	4,013	$	30,415

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	40,519	Derivative liability
Interest rate swap	300,000		2/15/2029	—		7,000		Derivative liability
				$	—	$	47,519

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

Commitments and Contingencies Disclosure [Abstract]

Related Party Transactions (Details)			3 Months Ended
Related Party Transactions (Details)	May 03, 2019	May 02, 2019	Dec. 31, 2023 USD ($) component	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)
Related Party Transaction [Line Items]
Base management fee and incentive fee payable			$ 19,004,000		$ 19,547,000
Base management fee rate (as a percent)	1.00%	1.50%
Base management fee, threshold (as a percent)	200.00%
Base management fee			11,477,000	$ 9,917,000
Part I incentive fee			9,028,000	7,703,000
Due to affiliate			$ 3,815,000		4,310,000
Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, termination, notice period			60 days
Administrator expense			$ 400,000	400,000
General and administrative expenses			100,000	100,000
Due to affiliate			3,800,000		$ 4,300,000
Oaktree Strategic Income Corporation Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived			$ 6,000,000
Contractual fee waived, period otherwise receivable (in years)			2 years
Contractual fee waived, per quarter			$ 750,000
Oaktree Strategic Income II, Inc. Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived			9,000,000
Oaktree Strategic Income II, Inc Merger, Year One
Related Party Transaction [Line Items]
Investment company, contractual fee waived			6,000,000
Contractual fee waived, per quarter			1,500,000
Oaktree Strategic Income II, Inc Merger, Year Two
Related Party Transaction [Line Items]
Investment company, contractual fee waived			3,000,000
Contractual fee waived, per quarter			$ 750,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Number of components \| component			2
Related party transaction, termination, notice period			60 days
Base management fee			$ 10,000,000	9,200,000
Management incentive rate			1.50%
Investment Advisory Agreement \| Affiliated Entity
Related Party Transaction [Line Items]
Part I incentive fee			$ 9,000,000	7,700,000
Incentive fee expense			9,600,000
Accrued capital gains incentive fees expensed (reversed)			$ 0	$ 0
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up
Related Party Transaction [Line Items]
Management incentive rate			100.00%
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold
Related Party Transaction [Line Items]
Management incentive rate			1.8182%
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income
Related Party Transaction [Line Items]
Management incentive rate			17.50%
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains \| Affiliated Entity
Related Party Transaction [Line Items]
Management incentive rate			17.50%

Significant Accounting Policies (Details) $ in Thousands	3 Months Ended		12 Months Ended
Significant Accounting Policies (Details) $ in Thousands	Dec. 31, 2023 USD ($) investment	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) investment	Dec. 31, 2022 USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 19,328		$ 9,089
Excise tax	0	$ 78		$ 100
Deutsche Bank Trust Company Americas
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 19,300
Wells Fargo Bank, N.A.
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash			$ 9,100
Investment Owned, Cost \| Non-Accrual Status, Debt Securities \| Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Concentration risk	5.90%		2.40%
Investment Owned, Fair Value \| Non-Accrual Status, Debt Securities \| Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Number of investments \| investment	7		4
Concentration risk	4.20%		1.80%

Borrowings - Narrative (Details) - USD ($)				3 Months Ended
Borrowings - Narrative (Details) - USD ($)	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023
Line of Credit Facility [Line Items]
Borrowings outstanding				$ 710,000,000		$ 710,000,000
Interest expense				32,170,000	$ 20,719,000
Fair Value				$ 1,626,776,000		1,588,201,000
Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate		2.70%
Notional amount		$ 350,000,000
Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Interest rate				2.00%
Secured Overnight Financing Rate \| Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				0.11448%
Secured Overnight Financing Rate \| Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				0.26161%
London Interbank Offered Rate (LIBOR) \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		1.658%
Base Rate
Line of Credit Facility [Line Items]
Interest rate				1.00%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		0.26161%
2025 Notes
Line of Credit Facility [Line Items]
Principal amount			$ 300,000,000	$ 300,000,000.0		300,000,000.0
Net proceeds			293,800,000
Unaccreted discount			2,500,000	$ 600,000		700,000
Underwriting commissions			3,000,000
Offering costs			$ 700,000
Interest rate, percentage			3.50%	3.50%
Redemption price			100.00%
2027 Notes
Line of Credit Facility [Line Items]
Principal amount		$ 350,000,000		$ 350,000,000.0		350,000,000.0
Net proceeds		344,800,000
Unaccreted discount		1,000,000		$ 500,000		600,000
Underwriting commissions		3,500,000
Offering costs		$ 700,000
Interest rate, percentage		2.70%		2.70%
Redemption price		100.00%
2029 Notes
Line of Credit Facility [Line Items]
Principal amount	$ 300,000,000			$ 300,000,000.0		300,000,000.0
Net proceeds	292,900,000
Unaccreted discount	3,500,000			$ 3,200,000		3,400,000
Underwriting commissions	3,000,000
Offering costs	$ 600,000
Interest rate, percentage	7.10%			7.10%
Redemption price	100.00%
2029 Notes \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate		7.10%
Notional amount		$ 300,000,000
2029 Notes \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate		3.1255%
Line of Credit \| Revolving Credit Facility \| Syndicated Facility
Line of Credit Facility [Line Items]
Borrowing capacity				$ 1,218,000,000
Accordion feature, increase limit				1,250,000,000
Borrowing capacity subject to expiration				$ 1,035,000,000.000
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold				1.50
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold				2.25
Borrowings outstanding				$ 430,000,000		430,000,000
Fair value				$ 430,000,000		430,000,000
Weighted average interest rate				7.621%	5.849%
Interest expense inclusive of fees				$ 9,600,000	$ 10,000,000
Line of Credit \| Revolving Credit Facility \| Citibank Facility
Line of Credit Facility [Line Items]
Weighted average interest rate					6.508%
Interest expense inclusive of fees					$ 2,700,000
Line of Credit \| Revolving Credit Facility \| OSI2 Citibank Facility payable
Line of Credit Facility [Line Items]
Borrowing capacity				400,000,000
Borrowings outstanding				$ 280,000,000		280,000,000
Weighted average interest rate				8.204%
Interest expense inclusive of fees				$ 6,100,000
Unused capacity, commitment fee				0.50%
Commitment fee, unused capacity threshold percentage				30.00%
Fair Value				$ 280,000,000		$ 280,000,000
Line of Credit \| Revolving Credit Facility \| OSI2 Citibank Facility payable \| Secured Overnight Financing Rate \| After Reinvestment Period
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				4.00%
Line of Credit \| Revolving Credit Facility \| OSI2 Citibank Facility payable \| Secured Overnight Financing Rate \| Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2.50%
Line of Credit \| Revolving Credit Facility \| OSI2 Citibank Facility, Syndicated Loans \| Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2.00%
Line of Credit \| Revolving Credit Facility \| OSI2 Citibank Facility, All Other Loans \| Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate				2.75%

Commitments and Contingencies

3 Months Ended

Dec. 31, 2023

Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2023, the Company's only off-balance sheet arrangements consisted of $226.6 million of unfunded commitments, which was comprised of $199.5 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $199.5 million, approximately $165.9 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. As of September 30, 2023, the Company's only off-balance sheet arrangements consisted of $232.7 million of unfunded commitments, which was comprised of $205.6 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $205.6 million, approximately $154.2 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.

A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of December 31, 2023 and September 30, 2023 is shown in the table below:


	December 31, 2023		September 30, 2023
107-109 Beech OAK22 LLC	$	26,969	$	26,969
OCSI Glick JV LLC	13,998		13,998
PetVet Care Centers, LLC	13,732		—
Senior Loan Fund JV I, LLC	13,125		13,125
Fairbridge Strategic Capital Funding LLC	9,465		13,090
BioXcel Therapeutics, Inc.	9,383		14,547
Amspec Parent LLC	9,372		—
Seres Therapeutics, Inc.	8,090		8,090
MRI Software LLC	7,260		2,261
Next Holdco, LLC	7,051		—
iCIMs, Inc.	6,924		7,466
Kings Buyer, LLC	5,462		5,189
Grove Hotel Parcel Owner, LLC	5,286		5,286
scPharmaceuticals Inc.	5,212		5,212
Avalara, Inc.	5,047		5,047
Mindbody, Inc.	4,762		4,762
Accupac, Inc.	4,500		4,500
107 Fair Street LLC	4,227		4,227
Harrow, Inc.	4,011		4,011
Inventus Power, Inc.	3,792		3,792
Dominion Diagnostics, LLC	3,484		3,484
Establishment Labs Holdings Inc.	3,384		3,384
WP CPP Holdings, LLC	3,272		—
Enverus Holdings, Inc.	3,135		—
PRGX Global, Inc.	3,127		3,127
Salus Workers' Compensation, LLC	3,102		3,102
Spanx, LLC	3,092		2,473
ADC Therapeutics SA	3,020		3,020
Relativity ODA LLC	2,762		2,762
LSL Holdco, LLC	2,650		2,650
Galileo Parent, Inc.	2,484		2,061
MND Holdings III Corp	2,280		9,122
Crewline Buyer, Inc.	2,180		—
112-126 Van Houten Real22 LLC	2,139		2,343
Coupa Holdings, LLC	2,075		2,075
Berner Food & Beverage, LLC	2,005		1,622
Oranje Holdco, Inc.	1,904		1,904
MHE Intermediate Holdings, LLC	1,786		821
Evergreen IX Borrower 2023, LLC	1,626		1,626
Acquia Inc.	1,376		1,376
PPW Aero Buyer, Inc.	1,368		1,466
SCP Eye Care Services, LLC	1,366		2,356
Coyote Buyer, LLC	1,333		400
Pluralsight, LLC	1,068		1,787
Finastra USA, Inc.	896		960
Digital.AI Software Holdings, Inc.	782		1,078
OTG Management, LLC	467		3,190
ASP-R-PAC Acquisition Co LLC	396		396
SIO2 Medical Products, Inc.	238		1,821
Telestream Holdings Corporation	148		407
Delta Leasing SPV II LLC	—		14,639
Assembled Brands Capital LLC	—		7,514
Impel Pharmaceuticals Inc.	—		2,458
Supreme Fitness Group NY Holdings, LLC	—		2,199
Tahoe Bidco B.V.	—		2,162
Liquid Environmental Solutions Corporation	—		1,383
Total	$	226,613	$	232,740

Consolidated Statements of Changes in Net Assets
shares in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

USD ($)

$ / shares

Dec. 31, 2022

USD ($)

$ / shares

Operations:

Net investment income

$ 44,189

$ 38,808

Net realized gains (losses)

(25,025)

(22,982)

(8,453)

(3,203)

(Provision) benefit for taxes on realized and unrealized gains (losses)

(176)

549

Net increase (decrease) in net assets resulting from operations

10,535

13,172

Stockholder transactions:

Net increase (decrease) in net assets from stockholder transactions

(48,897)

(58,679)

Capital share transactions:

Issuance of common stock under dividend reinvestment plan

1,936

1,933

Issuance of common stock in connection with the "at the market" offering

32,313

Net increase (decrease) in net assets from capital share transactions

34,249

1,933

Total increase (decrease) in net assets

(4,113)

(43,574)

Net assets

$ 1,511,651

$ 1,201,989

Net asset value per common share (in dollars per share) | $ / shares

^[1]

$ 19.14

$ 19.63

Common shares outstanding at end of period (in shares) | shares

^[1]

78,965

61,220

0.3333

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (8,453)	$ (3,203)
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Investments in equity securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(18,800)	2,800
Investments in debt securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(13,700)	18,700
Foreign currency forward contract
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(7,800)	11,000
Exited Investments
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ 15,300	$ 3,900

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column D))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 12))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 13))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 49: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 53: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 54: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 55: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 56: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 57: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 58: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 59: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 60: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 61: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 62: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 63: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 64: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19

Reference 65: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19

Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations

Taxable/Distributable Income and Dividend Distributions (Tables)

3 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022.


	Three months ended December 31, 2023		Three months ended December 31, 2022
Net increase (decrease) in net assets resulting from operations	$	10,535	$	13,172
Net unrealized (appreciation) depreciation	25,025		22,982
Book/tax difference due to capital losses suspended (utilized)	6,540		8,013
Other book/tax differences	(7,178)		(12,910)
Taxable/Distributable Income (1)	$	34,922	$	31,257

__________

(1) The Company's taxable income for the three months ended December 31, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate.

Components of Accumulated Overdistributed Earnings

As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:


Undistributed ordinary income, net	$	33,525
Net realized capital losses	(509,832)
Unrealized losses, net	(175,031)
Accumulated overdistributed earnings	$	(651,338)

Cover - shares	3 Months Ended
Cover - shares	Dec. 31, 2023	Jan. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Securities Act File Number	1-33901
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1219283
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	OCSL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		78,965,350
Entity Central Index Key	0001414932
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--09-30

Subsequent Events (Details)	Jan. 26, 2024 $ / shares
Subsequent Event \| Quarterly
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.55

Commitments and Contingencies (Tables)

3 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments


	December 31, 2023		September 30, 2023
107-109 Beech OAK22 LLC	$	26,969	$	26,969
OCSI Glick JV LLC	13,998		13,998
PetVet Care Centers, LLC	13,732		—
Senior Loan Fund JV I, LLC	13,125		13,125
Fairbridge Strategic Capital Funding LLC	9,465		13,090
BioXcel Therapeutics, Inc.	9,383		14,547
Amspec Parent LLC	9,372		—
Seres Therapeutics, Inc.	8,090		8,090
MRI Software LLC	7,260		2,261
Next Holdco, LLC	7,051		—
iCIMs, Inc.	6,924		7,466
Kings Buyer, LLC	5,462		5,189
Grove Hotel Parcel Owner, LLC	5,286		5,286
scPharmaceuticals Inc.	5,212		5,212
Avalara, Inc.	5,047		5,047
Mindbody, Inc.	4,762		4,762
Accupac, Inc.	4,500		4,500
107 Fair Street LLC	4,227		4,227
Harrow, Inc.	4,011		4,011
Inventus Power, Inc.	3,792		3,792
Dominion Diagnostics, LLC	3,484		3,484
Establishment Labs Holdings Inc.	3,384		3,384
WP CPP Holdings, LLC	3,272		—
Enverus Holdings, Inc.	3,135		—
PRGX Global, Inc.	3,127		3,127
Salus Workers' Compensation, LLC	3,102		3,102
Spanx, LLC	3,092		2,473
ADC Therapeutics SA	3,020		3,020
Relativity ODA LLC	2,762		2,762
LSL Holdco, LLC	2,650		2,650
Galileo Parent, Inc.	2,484		2,061
MND Holdings III Corp	2,280		9,122
Crewline Buyer, Inc.	2,180		—
112-126 Van Houten Real22 LLC	2,139		2,343
Coupa Holdings, LLC	2,075		2,075
Berner Food & Beverage, LLC	2,005		1,622
Oranje Holdco, Inc.	1,904		1,904
MHE Intermediate Holdings, LLC	1,786		821
Evergreen IX Borrower 2023, LLC	1,626		1,626
Acquia Inc.	1,376		1,376
PPW Aero Buyer, Inc.	1,368		1,466
SCP Eye Care Services, LLC	1,366		2,356
Coyote Buyer, LLC	1,333		400
Pluralsight, LLC	1,068		1,787
Finastra USA, Inc.	896		960
Digital.AI Software Holdings, Inc.	782		1,078
OTG Management, LLC	467		3,190
ASP-R-PAC Acquisition Co LLC	396		396
SIO2 Medical Products, Inc.	238		1,821
Telestream Holdings Corporation	148		407
Delta Leasing SPV II LLC	—		14,639
Assembled Brands Capital LLC	—		7,514
Impel Pharmaceuticals Inc.	—		2,458
Supreme Fitness Group NY Holdings, LLC	—		2,199
Tahoe Bidco B.V.	—		2,162
Liquid Environmental Solutions Corporation	—		1,383
Total	$	226,613	$	232,740

Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)	77,225,000
Net assets at beginning of period	$ 1,515,764	$ 1,245,563
Net investment income	44,189	38,808
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Net realized gains (losses)	(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	(176)	549
Distributions to stockholders	(48,897)	(58,679)
Issuance of common stock in connection with the "at the market" offering	$ 32,313	$ 0
Issuance of common stock under dividend reinvestment plan (shares)	98,605,000	94,879,000
Issuance of common stock under dividend reinvestment plan	$ 1,936	$ 1,933
End of period (shares)	78,965,000
Net assets at end of period	$ 1,511,651	$ 1,201,989
Common Stock
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)	77,225,000	61,125,000
Net assets at beginning of period	$ 772	$ 611
Issuance of common stock in connection with the "at the market" offering (shares)	1,641,000
Issuance of common stock in connection with the "at the market" offering	$ 17
Issuance of common stock under dividend reinvestment plan (shares)	99,000	95,000
Issuance of common stock under dividend reinvestment plan	$ 1	$ 1
End of period (shares)	78,965,000	61,220,000
Net assets at end of period	$ 790	$ 612
Additional paid-in-capital
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period	2,166,330	1,827,721
Issuance of common stock in connection with the "at the market" offering	32,296
Issuance of common stock under dividend reinvestment plan	1,935	1,932
Net assets at end of period	2,200,561	1,829,653
Accumulated Overdistributed Earnings
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period	(651,338)	(582,769)
Net investment income	44,189	38,808
Net unrealized appreciation (depreciation)	(25,025)	(22,982)
Net realized gains (losses)	(8,453)	(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	(176)	549
Distributions to stockholders	(48,897)	(58,679)
Net assets at end of period	$ (689,700)	$ (628,276)

Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Investment owned, percent of net assets	199.69%	190.82%
Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Application Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 472,016	$ 468,483
Application Software \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	14.82%	15.39%
Application Software \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 460,072	$ 455,719
Investment owned, percent of net assets	30.41%	30.03%
Application Software \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	15.23%	15.73%
Multi-Sector Holdings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 219,766	$ 219,469
Multi-Sector Holdings \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.89%	7.21%
Multi-Sector Holdings \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 195,163	$ 193,431
Investment owned, percent of net assets	12.91%	12.76%
Multi-Sector Holdings \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.47%	6.69%
Health Care Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 137,713	$ 81,560
Health Care Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.32%	2.68%
Health Care Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 122,076	$ 66,683
Investment owned, percent of net assets	8.08%	4.40%
Health Care Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.04%	2.31%
Data Processing & Outsourced Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 133,399	$ 133,410
Data Processing & Outsourced Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.18%	4.38%
Data Processing & Outsourced Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 126,731	$ 125,259
Investment owned, percent of net assets	8.38%	8.26%
Data Processing & Outsourced Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.20%	4.33%
Health Care Technology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 130,701	$ 106,915
Health Care Technology \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.10%	3.51%
Health Care Technology \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 107,574	$ 95,404
Investment owned, percent of net assets	7.12%	6.29%
Health Care Technology \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.56%	3.30%
Biotechnology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 127,672	$ 126,349
Biotechnology \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.01%	4.15%
Biotechnology \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 127,586	$ 125,678
Investment owned, percent of net assets	8.44%	8.29%
Biotechnology \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.23%	4.35%
Industrial Machinery & Supplies & Components
Schedule of Investments [Line Items]
Investment owned, at cost	$ 102,785	$ 99,511
Industrial Machinery & Supplies & Components \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.22%	3.27%
Industrial Machinery & Supplies & Components \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 104,217	$ 98,352
Investment owned, percent of net assets	6.89%	6.49%
Industrial Machinery & Supplies & Components \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.45%	3.40%
Real Estate Operating Companies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 85,374	$ 83,754
Real Estate Operating Companies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.68%	2.75%
Real Estate Operating Companies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 84,517	$ 82,463
Investment owned, percent of net assets	5.59%	5.44%
Real Estate Operating Companies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.80%	2.85%
Broadline Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 83,290	$ 83,290
Broadline Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.61%	2.74%
Broadline Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,230	$ 69,040
Investment owned, percent of net assets	2.60%	4.55%
Broadline Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.30%	2.39%
Pharmaceuticals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 74,100	$ 84,948
Pharmaceuticals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.32%	2.79%
Pharmaceuticals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 71,320	$ 80,455
Investment owned, percent of net assets	4.72%	5.31%
Pharmaceuticals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.36%	2.78%
Other Specialty Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 68,033	$ 41,088
Other Specialty Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.13%	1.35%
Other Specialty Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 69,533	$ 41,115
Investment owned, percent of net assets	4.60%	2.71%
Other Specialty Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.30%	1.42%
Personal Care Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 67,619	$ 68,146
Personal Care Products \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.12%	2.24%
Personal Care Products \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 59,562	$ 59,928
Investment owned, percent of net assets	3.94%	3.95%
Personal Care Products \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.97%	2.07%
Interactive Media & Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 66,109	$ 19,013
Interactive Media & Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.07%	0.62%
Interactive Media & Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 66,304	$ 19,199
Investment owned, percent of net assets	4.39%	1.27%
Interactive Media & Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.20%	0.66%
Fertilizers & Agricultural Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 64,689	$ 64,720
Fertilizers & Agricultural Chemicals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.03%	2.13%
Fertilizers & Agricultural Chemicals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 63,185	$ 63,185
Investment owned, percent of net assets	4.18%	4.17%
Fertilizers & Agricultural Chemicals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.09%	2.18%
Aerospace & Defense
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,768	$ 51,797
Aerospace & Defense \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.00%	1.70%
Aerospace & Defense \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 63,981	$ 51,862
Investment owned, percent of net assets	4.23%	3.42%
Aerospace & Defense \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.12%	1.79%
Diversified Support Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,265	$ 23,435
Diversified Support Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%	0.77%
Diversified Support Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,669	$ 23,352
Investment owned, percent of net assets	4.15%	1.54%
Diversified Support Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%	0.81%
Environmental & Facilities Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,022	$ 63,064
Environmental & Facilities Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%	2.07%
Environmental & Facilities Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,180	$ 62,413
Investment owned, percent of net assets	4.11%	4.12%
Environmental & Facilities Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.06%	2.16%
Health Care Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 62,010	$ 62,044
Health Care Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.95%	2.04%
Health Care Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,654	$ 60,865
Investment owned, percent of net assets	4.01%	4.02%
Health Care Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.01%	2.10%
Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,608	$ 61,725
Diversified Financial Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.93%	2.03%
Diversified Financial Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,687	$ 60,003
Investment owned, percent of net assets	4.15%	3.96%
Diversified Financial Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%	2.07%
Internet Services & Infrastructure
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,012	$ 60,934
Internet Services & Infrastructure \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.91%	2.00%
Internet Services & Infrastructure \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,771	$ 60,579
Investment owned, percent of net assets	4.02%	4.00%
Internet Services & Infrastructure \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.01%	2.09%
Airport Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,897	$ 55,961
Airport Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.82%	1.84%
Airport Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,577	$ 54,453
Investment owned, percent of net assets	3.68%	3.59%
Airport Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.84%	1.88%
Metal, Glass & Plastic Containers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,679	$ 55,530
Metal, Glass & Plastic Containers \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.81%	1.82%
Metal, Glass & Plastic Containers \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,586	$ 53,459
Investment owned, percent of net assets	3.68%	3.53%
Metal, Glass & Plastic Containers \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.84%	1.85%
Insurance Brokers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 52,472	$ 52,856
Insurance Brokers \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.65%	1.74%
Insurance Brokers \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,927	$ 53,050
Investment owned, percent of net assets	3.63%	3.50%
Insurance Brokers \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.82%	1.83%
Diversified Metals & Mining
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,898	$ 49,842
Diversified Metals & Mining \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.57%	1.64%
Diversified Metals & Mining \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 49,869	$ 49,869
Investment owned, percent of net assets	3.30%	3.29%
Diversified Metals & Mining \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.65%	1.72%
Automotive Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,603	$ 57,596
Automotive Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.56%	1.89%
Automotive Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,109	$ 55,805
Investment owned, percent of net assets	3.18%	3.68%
Automotive Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.59%	1.93%
Home Improvement Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,001	$ 54,236
Home Improvement Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.54%	1.78%
Home Improvement Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,034	$ 53,168
Investment owned, percent of net assets	3.18%	3.51%
Home Improvement Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.59%	1.84%
Auto Parts & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 48,462	$ 48,536
Auto Parts & Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.52%	1.59%
Auto Parts & Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,901	$ 49,148
Investment owned, percent of net assets	3.23%	3.24%
Auto Parts & Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.62%	1.70%
Systems Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 45,509	$ 23,111
Systems Software \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.43%	0.76%
Systems Software \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 45,148	$ 21,968
Investment owned, percent of net assets	2.99%	1.45%
Systems Software \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.50%	0.76%
Real Estate Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 44,652	$ 44,717
Real Estate Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.40%	1.47%
Real Estate Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 43,771	$ 43,886
Investment owned, percent of net assets	2.90%	2.90%
Real Estate Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.45%	1.52%
Specialized Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,215	$ 73,035
Specialized Finance \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%	2.40%
Specialized Finance \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,677	$ 69,590
Investment owned, percent of net assets	2.76%	4.59%
Specialized Finance \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.38%	2.41%
Soft Drinks & Non-alcoholic Beverages
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,158	$ 42,628
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%	1.40%
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,868	$ 42,391
Investment owned, percent of net assets	2.77%	2.80%
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.39%	1.47%
Leisure Facilities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 39,724	$ 39,076
Leisure Facilities \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%	1.28%
Leisure Facilities \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,022	$ 36,963
Investment owned, percent of net assets	2.58%	2.44%
Leisure Facilities \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.29%	1.28%
Specialty Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,622	$ 38,640
Specialty Chemicals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.18%	1.27%
Specialty Chemicals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 37,692	$ 38,615
Investment owned, percent of net assets	2.49%	2.55%
Specialty Chemicals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.25%	1.34%
Electrical Components & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,500	$ 32,440
Electrical Components & Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.02%	1.07%
Electrical Components & Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 32,491	$ 32,573
Investment owned, percent of net assets	2.15%	2.15%
Electrical Components & Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.08%	1.13%
Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,189	$ 37,666
Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.01%	1.24%
Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 31,221	$ 37,311
Investment owned, percent of net assets	2.07%	2.46%
Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.03%	1.29%
Advertising
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,597	$ 25,597
Advertising \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.80%	0.84%
Advertising \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,140	$ 11,955
Investment owned, percent of net assets	0.80%	0.79%
Advertising \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.40%	0.41%
Passenger Airlines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,952	$ 24,920
Passenger Airlines \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%	0.82%
Passenger Airlines \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 27,163	$ 27,512
Investment owned, percent of net assets	1.80%	1.82%
Passenger Airlines \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.90%	0.95%
Real Estate Development
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,198	$ 23,965
Real Estate Development \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.76%	0.79%
Real Estate Development \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 23,881	$ 23,679
Investment owned, percent of net assets	1.58%	1.56%
Real Estate Development \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.79%	0.82%
Gold
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,347	$ 23,310
Gold \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.73%	0.77%
Gold \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 23,519	$ 23,328
Investment owned, percent of net assets	1.56%	1.54%
Gold \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%	0.81%
Home Furnishings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,085	$ 23,859
Home Furnishings \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.72%	0.78%
Home Furnishings \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 14,131	$ 19,954
Investment owned, percent of net assets	0.93%	1.32%
Home Furnishings \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.47%	0.69%
Health Care Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 22,509	$ 22,441
Health Care Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.74%
Health Care Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 21,410	$ 22,436
Investment owned, percent of net assets	1.42%	1.48%
Health Care Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.78%
Construction & Engineering
Schedule of Investments [Line Items]
Investment owned, at cost	$ 21,668	$ 22,102
Construction & Engineering \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.68%	0.73%
Construction & Engineering \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 21,347	$ 21,903
Investment owned, percent of net assets	1.41%	1.45%
Construction & Engineering \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.76%
Hotels, Resorts & Cruise Lines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 17,169	$ 17,195
Hotels, Resorts & Cruise Lines \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.54%	0.56%
Hotels, Resorts & Cruise Lines \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 17,024	$ 16,991
Investment owned, percent of net assets	1.13%	1.12%
Hotels, Resorts & Cruise Lines \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.56%	0.59%
Oil & Gas Storage & Transportation
Schedule of Investments [Line Items]
Investment owned, at cost	$ 16,172	$ 22,042
Oil & Gas Storage & Transportation \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.51%	0.72%
Oil & Gas Storage & Transportation \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 16,173	$ 16,040
Investment owned, percent of net assets	1.07%	1.06%
Oil & Gas Storage & Transportation \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.54%	0.55%
Integrated Telecommunication Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,657	$ 18,801
Integrated Telecommunication Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.46%	0.62%
Integrated Telecommunication Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 13,261	$ 16,492
Investment owned, percent of net assets	0.88%	1.09%
Integrated Telecommunication Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.44%	0.57%
Restaurants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 12,617	$ 12,603
Restaurants \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.40%	0.41%
Restaurants \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,847	$ 12,464
Investment owned, percent of net assets	0.85%	0.82%
Restaurants \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.43%	0.43%
Health Care Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 11,618	$ 11,646
Health Care Supplies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.36%	0.38%
Health Care Supplies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,321	$ 11,363
Investment owned, percent of net assets	0.75%	0.75%
Health Care Supplies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.38%	0.39%
Cable & Satellite
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,946	$ 4,619
Cable & Satellite \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.28%	0.15%
Cable & Satellite \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 9,309	$ 4,546
Investment owned, percent of net assets	0.62%	0.30%
Cable & Satellite \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.31%	0.16%
Education Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,257	$ 13,871
Education Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.26%	0.46%
Education Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 8,396	$ 13,618
Investment owned, percent of net assets	0.56%	0.90%
Education Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.28%	0.47%
Food Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 7,677	$ 5,897
Food Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.24%	0.19%
Food Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 7,353	$ 5,166
Investment owned, percent of net assets	0.49%	0.34%
Food Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.24%	0.18%
Oil & Gas Refining & Marketing
Schedule of Investments [Line Items]
Investment owned, at cost	$ 6,620	$ 0
Oil & Gas Refining & Marketing \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.21%	0.00%
Oil & Gas Refining & Marketing \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 7,009	$ 0
Investment owned, percent of net assets	0.46%	0.00%
Oil & Gas Refining & Marketing \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.23%	0.00%
Research & Consulting Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,862	$ 4,871
Research & Consulting Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.16%
Research & Consulting Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,893	$ 4,831
Investment owned, percent of net assets	0.32%	0.32%
Research & Consulting Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%	0.17%
Other Specialized REITs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,395	$ 4,379
Other Specialized REITs \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%	0.14%
Other Specialized REITs \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,511	$ 3,198
Investment owned, percent of net assets	0.23%	0.21%
Other Specialized REITs \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.12%	0.11%
Apparel Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,375	$ 4,999
Apparel Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%	0.16%
Apparel Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,419	$ 5,002
Investment owned, percent of net assets	0.29%	0.33%
Apparel Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.17%
Office Services & Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,162	$ 0
Office Services & Supplies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%	0.00%
Office Services & Supplies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,377	$ 0
Investment owned, percent of net assets	0.29%	0.00%
Office Services & Supplies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.00%
Paper & Plastic Packaging Products & Materials
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,247	$ 3,254
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.11%
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,048	$ 3,061
Investment owned, percent of net assets	0.20%	0.20%
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.11%
Housewares & Specialties
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,854	$ 2,908
Housewares & Specialties \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.10%
Housewares & Specialties \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,684	$ 2,808
Investment owned, percent of net assets	0.18%	0.19%
Housewares & Specialties \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.10%
Leisure Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,070	$ 2,055
Leisure Products \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.07%
Leisure Products \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,197	$ 2,063
Investment owned, percent of net assets	0.15%	0.14%
Leisure Products \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.07%	0.07%
Alternative Carriers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,625	$ 0
Alternative Carriers \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0.00%
Alternative Carriers \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,661	$ 0
Investment owned, percent of net assets	0.11%	0.00%
Alternative Carriers \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.00%
Diversified Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,539	$ 0
Diversified Chemicals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0.00%
Diversified Chemicals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,573	$ 0
Investment owned, percent of net assets	0.10%	0.00%
Diversified Chemicals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.05%	0.00%
Consumer Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 16,440
Consumer Finance \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.54%
Consumer Finance \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 15,087
Investment owned, percent of net assets	0.00%	1.00%
Consumer Finance \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.52%
Movies & Entertainment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 12,188
Movies & Entertainment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.40%
Movies & Entertainment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 11,865
Investment owned, percent of net assets	0.00%	0.78%
Movies & Entertainment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.41%
Air Freight & Logistics
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,925
Air Freight & Logistics \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.16%
Air Freight & Logistics \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,263
Investment owned, percent of net assets	0.00%	0.28%
Air Freight & Logistics \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.15%
Integrated Oil & Gas
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,894
Integrated Oil & Gas \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.16%
Integrated Oil & Gas \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,785
Investment owned, percent of net assets	0.00%	0.32%
Integrated Oil & Gas \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.17%
Technology Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 813
Technology Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.03%
Technology Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 776
Investment owned, percent of net assets	0.00%	0.05%
Technology Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.03%

Consolidated Schedule of Investments
€ in Thousands, £ in Thousands, $ in Thousands

Dec. 31, 2023

USD ($)

Dec. 31, 2023

EUR (€)

Dec. 31, 2023

GBP (£)

Sep. 30, 2023

USD ($)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

Dec. 31, 2022

USD ($)

Sep. 30, 2022

USD ($)

$ 3,187,750

$ 3,044,119

$ 3,018,552

$ 2,892,420

Money market funds, at carrying value

199.69%

190.82%

$ 131,697

$ 145,539

Money market funds, percent of net assets

8.70%

9.60%

Investment owned and money market funds, percent of net assets

208.40%

Total investment owned, at cost and money market funds, at carrying value

$ 3,319,447

^{[1],[2],[3],[4]}

$ 3,189,658

^{[5],[6],[7],[8]}

Total investment owned, at fair value and money market funds, at carrying value

3,150,249

^{[1],[2],[3],[4]}

3,037,959

^{[5],[6],[7],[8]}

211,365

$ 186,002

363,124

^[9],[10]

345,245

^[11],[12]

$ 316,309

^[9],[10]

$ 297,091

^[11],[12]

$ 232,462

$ 214,165

20.90%

^[9],[10]

20.90%

^[9],[10]

20.90%

^[9],[10]

19.30%

Affiliate Investments

$ 25,936

$ 21,464

26,916

^[13]

$ 24,898

^[14]

$ 24,442

^[13]

$ 23,349

^[14]

$ 23,173

26,196

1.60%

^[13]

1.60%

^[13]

1.60%

^[13]

1.90%

$ 2,797,710

^[15]

$ 2,673,976

^[12]

$ 2,677,801

^[15]

$ 2,571,980

^[12]

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

^[15]

177.10%

12.50%

^{[16],[17],[18],[19],[20]}

12.50%

^{[16],[17],[18],[19],[20]}

12.50%

^{[16],[17],[18],[19],[20]}

12.50%

^{[21],[22],[23],[24],[25]}

12.50%

^{[21],[22],[23],[24],[25]}

12.50%

^{[21],[22],[23],[24],[25]}

$ 1,269

^{[16],[17],[18],[26]}

$ 1,269

^{[21],[22],[24],[27]}

1,251

^{[16],[17],[18]}

1,240

^{[21],[22],[24]}

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

$ 1,228

^{[16],[17],[18]}

$ 1,214

^{[21],[22],[24]}

11.00%

^{[16],[17],[19],[20]}

11.00%

^{[16],[17],[19],[20]}

11.00%

^{[16],[17],[19],[20]}

11.00%

^{[21],[23],[24],[25]}

11.00%

^{[21],[23],[24],[25]}

11.00%

^{[21],[23],[24],[25]}

$ 18,869

^{[16],[17],[26]}

$ 18,869

^{[21],[24],[27]}

18,691

^[16],[17]

18,687

^[21],[24]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

$ 18,443

^[16],[17]

$ 18,443

^[21],[24]

12.00%

^{[16],[17],[18],[19],[20]}

12.00%

^{[16],[17],[18],[19],[20]}

12.00%

^{[16],[17],[18],[19],[20]}

12.00%

^{[21],[22],[23],[24],[25]}

12.00%

^{[21],[22],[23],[24],[25]}

12.00%

^{[21],[22],[23],[24],[25]}

$ 4,274

^{[16],[17],[18],[26]}

$ 4,070

^{[21],[22],[24],[27]}

4,256

^{[16],[17],[18]}

4,038

^{[21],[22],[24]}

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

$ 4,210

^{[16],[17],[18]}

$ 4,022

^{[21],[22],[24]}

14.25%

^{[16],[19],[20],[28],[29]}

14.25%

^{[16],[19],[20],[28],[29]}

14.25%

^{[16],[19],[20],[28],[29]}

14.25%

^{[23],[24],[25],[30],[31]}

14.25%

^{[23],[24],[25],[30],[31]}

14.25%

^{[23],[24],[25],[30],[31]}

$ 21,434

^{[16],[26],[28],[29]}

$ 21,434

^{[24],[27],[30],[31]}

21,604

^{[16],[28],[29]}

21,612

^{[24],[30],[31]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

$ 21,273

^{[16],[28],[29]}

$ 21,220

^{[24],[30],[31]}

22.50%

^[16],[28]

22.50%

^[16],[28]

22.50%

^[16],[28]

20.00%

^[24],[30]

20.00%

^[24],[30]

20.00%

^[24],[30]

$ 6,329

^{[16],[26],[28]}

$ 6,021

^{[24],[27],[30]}

6,295

^[16],[28]

6,013

^[24],[30]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

$ 6,219

^[16],[28]

$ 5,900

^[24],[30]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

12.11%

^{[16],[19],[20]}

12.11%

^{[16],[19],[20]}

12.11%

^{[16],[19],[20]}

11.90%

^{[23],[24],[25]}

11.90%

^{[23],[24],[25]}

11.90%

^{[23],[24],[25]}

$ 3,373

^{[16],[20],[26]}

$ 3,446

^{[23],[24],[27]}

3,343

^[16],[20]

3,411

^[23],[24]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

$ 3,295

^[16],[20]

$ 3,383

^[23],[24]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

12.14%

^{[16],[19],[20]}

12.14%

^{[16],[19],[20]}

12.14%

^{[16],[19],[20]}

12.15%

^{[23],[24],[25]}

12.15%

^{[23],[24],[25]}

12.15%

^{[23],[24],[25]}

$ 944

^{[16],[20],[26]}

$ 17,901

^{[23],[24],[27]}

931

^[16],[20]

17,743

^[23],[24]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

$ 922

^[16],[20]

$ 17,575

^[23],[24]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

12.11%

^{[16],[19],[20]}

12.11%

^{[16],[19],[20]}

12.11%

^{[16],[19],[20]}

12.13%

^{[23],[24],[25]}

12.13%

^{[23],[24],[25]}

12.13%

^{[23],[24],[25]}

$ 17,532

^{[16],[20],[26]}

$ 963

^{[23],[24],[27]}

17,394

^[16],[20]

948

^[23],[24]

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

$ 17,130

^[16],[20]

$ 945

^[23],[24]

7.50%

^{[16],[20],[28]}

7.50%

^{[16],[20],[28]}

7.50%

^{[16],[20],[28]}

7.50%

^{[23],[24],[30]}

7.50%

^{[23],[24],[30]}

7.50%

^{[23],[24],[30]}

^{[23],[24],[25],[30]}

13.04%

$ 0

^{[16],[17],[20],[26],[28]}

$ 6,589

^{[23],[24],[27],[30]}

(38)

^{[16],[17],[20],[28]}

6,305

^{[23],[24],[30]}

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

$ (38)

^{[16],[17],[20],[28]}

$ 6,276

^{[23],[24],[30]}

7.50%

^{[16],[20],[28]}

7.50%

^{[16],[20],[28]}

7.50%

^{[16],[20],[28]}

7.50%

^{[21],[23],[24],[30]}

7.50%

^{[21],[23],[24],[30]}

7.50%

^{[21],[23],[24],[30]}

^[19],[20]

13.00%

$ 6,589

^{[16],[20],[26],[28]}

$ 0

^{[21],[23],[24],[27],[30]}

6,317

^{[16],[20],[28]}

(38)

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

$ 6,276

^{[16],[20],[28]}

$ (38)

^{[21],[23],[24],[30]}

28,948

^[16],[28]

28,948

^[16],[28]

28,948

^[16],[28]

28,948

^[24],[30]

28,948

^[24],[30]

28,948

^[24],[30]

$ 174

^[16],[28]

$ 174

^[24],[30]

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

$ 13

^[16],[28]

$ 6

^[24],[30]

^[23],[30]

5.00%

^{[23],[25],[30]}

8.86%

^{[23],[27],[30]}

€ 5,500

^[23],[30]

$ 6,024

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

^[23],[30]

$ 5,825

17,870

^[16]

17,870

^[16]

17,870

^[16]

17,870

^[24]

17,870

^[24]

17,870

^[24]

$ 1,733

^[16]

$ 1,733

^[24]

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

$ 2,494

^[16]

$ 2,826

^[24]

7.75%

^[16],[20]

7.75%

^[16],[20]

7.75%

^[16],[20]

7.75%

^[23],[24]

7.75%

^[23],[24]

7.75%

^[23],[24]

13.21%

^{[16],[19],[20]}

13.21%

^{[16],[19],[20]}

13.21%

^{[16],[19],[20]}

13.17%

^{[23],[24],[25]}

13.17%

^{[23],[24],[25]}

13.17%

^{[23],[24],[25]}

$ 16,032

^{[16],[20],[26]}

$ 17,873

^{[23],[24],[27]}

15,844

^[16],[20]

17,655

^[23],[24]

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

$ 15,743

^[16],[20]

$ 17,687

^[23],[24]

6.00%

^{[16],[17],[20],[28]}

6.00%

^{[16],[17],[20],[28]}

6.00%

^{[16],[17],[20],[28]}

6.00%

^{[21],[23],[24],[30]}

6.00%

^{[21],[23],[24],[30]}

6.00%

^{[21],[23],[24],[30]}

$ 0

^{[16],[17],[20],[26],[28]}

$ 0

^{[21],[23],[24],[27],[30]}

(12)

^{[16],[17],[20],[28]}

(13)

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

$ (24)

^{[16],[17],[20],[28]}

$ (23)

^{[21],[23],[24],[30]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

6.00%

^{[23],[24],[30]}

6.00%

^{[23],[24],[30]}

6.00%

^{[23],[24],[30]}

11.64%

^[19],[20]

11.64%

^[19],[20]

11.64%

^[19],[20]

11.63%

^{[23],[24],[25],[30]}

11.63%

^{[23],[24],[25],[30]}

11.63%

^{[23],[24],[25],[30]}

$ 3,268

^{[16],[20],[26],[28]}

$ 3,276

^{[23],[24],[27],[30]}

3,259

^{[16],[20],[28]}

3,267

^{[23],[24],[30]}

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

3,072

^{[16],[20],[28]}

3,084

^{[23],[24],[30]}

12,583

^{[16],[26],[28],[29]}

12,222

^{[24],[27],[30],[31]}

12,618

^{[16],[28],[29]}

12,260

^{[24],[30],[31]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

$ 12,268

^{[16],[28],[29]}

$ 11,795

^{[24],[30],[31]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

11.52%

^{[16],[17],[19],[20]}

11.52%

^{[16],[17],[19],[20]}

11.52%

^{[16],[17],[19],[20]}

11.55%

^{[21],[23],[24],[25]}

11.55%

^{[21],[23],[24],[25]}

11.55%

^{[21],[23],[24],[25]}

$ 2,033

^{[16],[17],[20],[26]}

$ 2,033

^{[21],[23],[24],[27]}

2,015

^{[16],[17],[20]}

2,013

^{[21],[23],[24]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

$ 2,027

^{[16],[17],[20]}

$ 2,027

^{[21],[23],[24]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

^{[23],[24],[25]}

11.55%

$ 0

^{[16],[17],[20],[26]}

$ 20,234

^{[23],[24],[27]}

(2)

^{[16],[17],[20]}

20,150

^[23],[24]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

$ (8)

^{[16],[17],[20]}

$ 20,194

^[23],[24]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

11.52%

^{[16],[19],[20]}

11.52%

^{[16],[19],[20]}

11.52%

^{[16],[19],[20]}

^{[21],[23],[24],[25]}

$ 20,182

^{[16],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

20,107

^[16],[20]

(2)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

$ 20,141

^[16],[20]

$ (8)

^{[21],[23],[24]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

12.72%

^{[16],[17],[19],[20]}

12.72%

^{[16],[17],[19],[20]}

12.72%

^{[16],[17],[19],[20]}

12.72%

^{[21],[23],[24],[25]}

12.72%

^{[21],[23],[24],[25]}

12.72%

^{[21],[23],[24],[25]}

$ 1,333

^{[16],[17],[20],[26]}

$ 1,333

^{[21],[23],[24],[27]}

1,324

^{[16],[17],[20]}

1,322

^{[21],[23],[24]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

$ 1,333

^{[16],[17],[20]}

$ 1,324

^{[21],[23],[24]}

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.74%

^{[16],[19],[20]}

12.74%

^{[16],[19],[20]}

12.74%

^{[16],[19],[20]}

12.34%

^{[23],[24],[25]}

12.34%

^{[23],[24],[25]}

12.34%

^{[23],[24],[25]}

$ 6,400

^{[16],[20],[26]}

$ 6,400

^{[23],[24],[27]}

6,343

^[16],[20]

6,335

^[23],[24]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

$ 6,406

^[16],[20]

$ 6,380

^[23],[24]

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.74%

^{[16],[17],[19],[20]}

12.74%

^{[16],[17],[19],[20]}

12.74%

^{[16],[17],[19],[20]}

12.34%

^{[23],[24],[25]}

12.34%

^{[23],[24],[25]}

12.34%

^{[23],[24],[25]}

$ 25,332

^{[16],[17],[20],[26]}

$ 25,332

^{[23],[24],[27]}

25,293

^{[16],[17],[20]}

25,288

^[23],[24]

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

$ 25,357

^{[16],[17],[20]}

$ 25,253

^[23],[24]

5,715

^[16]

5,715

^[16]

5,715

^[16]

5,715

^[24]

5,715

^[24]

5,715

^[24]

$ 90

^[16]

$ 90

^[24]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

$ 0

^[16]

$ 0

^[24]

8.50%

^{[16],[20],[32]}

8.50%

^{[16],[20],[32]}

8.50%

^{[16],[20],[32]}

8.50%

^{[23],[24],[33]}

8.50%

^{[23],[24],[33]}

8.50%

^{[23],[24],[33]}

$ 23,562

^{[16],[20],[26],[32]}

$ 23,562

^{[23],[24],[27],[33]}

22,795

^{[16],[20],[32]}

22,795

^{[23],[24],[33]}

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

$ 9,797

^{[16],[20],[32]}

$ 9,797

^{[23],[24],[33]}

5.50%

^{[19],[20],[28]}

5.50%

^{[19],[20],[28]}

5.50%

^{[19],[20],[28]}

5.50%

^{[23],[25],[30]}

5.50%

^{[23],[25],[30]}

5.50%

^{[23],[25],[30]}

$ 4,050

^[26],[28]

$ 4,050

^[27],[30]

3,592

^[28]

3,577

^[30]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

$ 3,181

^[28]

$ 2,918

^[30]

11.50%

^[16],[20]

11.50%

^[16],[20]

11.50%

^[16],[20]

11.50%

^[23],[24]

11.50%

^[23],[24]

11.50%

^[23],[24]

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

5.00%

^{[23],[24],[25]}

5.00%

^{[23],[24],[25]}

5.00%

^{[23],[24],[25]}

11.95%

^[16],[20]

11.95%

^[16],[20]

11.95%

^[16],[20]

11.99%

^[23],[24]

11.99%

^[23],[24]

11.99%

^[23],[24]

$ 9,331

^{[16],[20],[26]}

$ 9,057

^{[23],[24],[27]}

8,748

^[16],[20]

8,434

^[23],[24]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

$ 8,585

^[16],[20]

$ 8,332

^[23],[24]

598,283

^[24]

598,283

^[24]

598,283

^[24]

$ 642

^[16],[20]

$ 642

^[24]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

$ 1,562

^[16],[20]

$ 1,915

^[24]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[23],[24]

7.50%

^[23],[24]

7.50%

^[23],[24]

13.00%

^{[16],[19],[20]}

13.00%

^{[16],[19],[20]}

13.00%

^{[16],[19],[20]}

13.04%

^{[23],[24],[25]}

13.04%

^{[23],[24],[25]}

13.04%

^{[23],[24],[25]}

$ 16,825

^{[16],[20],[26]}

$ 17,053

^{[23],[24],[27]}

16,766

^[16],[20]

16,982

^[23],[24]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

$ 15,732

^[16],[20]

$ 15,929

^[23],[24]

382,275

^[28]

382,275

^[28]

382,275

^[28]

471,253

^[30]

471,253

^[30]

471,253

^[30]

$ 689

^[28]

$ 849

^[30]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

$ 4,389

^[28]

$ 4,298

^[30]

141,640

^{[16],[28],[34]}

141,640

^{[16],[28],[34]}

141,640

^{[16],[28],[34]}

141,640

^{[24],[30],[35]}

141,640

^{[24],[30],[35]}

141,640

^{[24],[30],[35]}

$ 566

^{[16],[28],[34]}

$ 566

^{[24],[30],[35]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

$ 446

^{[16],[28],[34]}

$ 368

^{[24],[30],[35]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[24],[30]

3.50%

^[24],[30]

3.50%

^[24],[30]

$ 28,964

^{[16],[26],[28]}

$ 28,464

^{[24],[27],[30]}

28,838

^[16],[28]

28,329

^[24],[30]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

$ 28,167

^[16],[28]

$ 27,687

^[24],[30]

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[24],[30]

3.50%

^[24],[30]

3.50%

^[24],[30]

$ 28,178

^{[16],[26],[28]}

$ 2,121

^{[24],[27],[30]}

28,076

^[16],[28]

1,945

^[24],[30]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

$ 27,403

^[16],[28]

$ 2,063

^[24],[30]

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[24],[30]

3.50%

^[24],[30]

3.50%

^[24],[30]

$ 2,159

^{[16],[26],[28]}

$ 27,692

^{[24],[27],[30]}

1,982

^[16],[28]

27,582

^[24],[30]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

$ 2,099

^[16],[28]

$ 26,936

^[24],[30]

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[16],[19],[20],[28]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

8.50%

^{[23],[24],[25],[30]}

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[16],[28]

3.50%

^[24],[30]

3.50%

^[24],[30]

3.50%

^[24],[30]

$ 2,100

^{[16],[26],[28]}

$ 2,064

^{[24],[27],[30]}

1,927

^[16],[28]

1,891

^[24],[30]

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

$ 2,042

^[16],[28]

$ 2,007

^[24],[30]

^[23],[24]

8.75%

^{[23],[24],[25]}

14.14%

^{[23],[24],[27]}

$ 17,048

^[23],[24]

16,440

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

^[23],[24]

$ 15,087

^[16],[20]

8.75%

^{[16],[19],[20]}

14.25%

^{[16],[20],[26]}

$ 17,048

^[16],[20]

16,469

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

^[16],[20]

$ 15,940

6.25%

^[20]

6.25%

^[20]

6.25%

^[20]

6.25%

^[23]

6.25%

^[23]

6.25%

^[23]

11.91%

^[19],[20]

11.91%

^[19],[20]

11.91%

^[19],[20]

11.81%

^[23],[25]

11.81%

^[23],[25]

11.81%

^[23],[25]

$ 14,907

^[20],[26]

$ 19,115

^[23],[27]

14,189

^[20]

18,278

^[23]

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

$ 12,548

^[20]

$ 16,798

^[23]

^[23],[30]

8.00%

^{[23],[25],[30]}

13.54%

^{[23],[27],[30]}

$ 12,500

^[23],[30]

12,188

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

^[23],[30]

$ 11,865

^{[16],[17],[20]}

5.75%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(112)

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

^{[16],[17],[20]}

$ (113)

^[16],[20]

5.75%

^{[16],[19],[20]}

11.10%

^{[16],[20],[26]}

$ 33,558

^[16],[20]

32,728

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

^[16],[20]

$ 32,719

^{[16],[17],[20]}

5.75%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(60)

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

^{[16],[17],[20]}

$ (60)

3.75%

^[20]

3.75%

^[20]

3.75%

^[20]

3.75%

^[23]

3.75%

^[23]

3.75%

^[23]

9.36%

^[19],[20]

9.36%

^[19],[20]

9.36%

^[19],[20]

9.40%

^[23],[25]

9.40%

^[23],[25]

9.40%

^[23],[25]

$ 3,691

^[20],[26]

$ 3,700

^[23],[27]

3,059

^[20]

3,067

^[23]

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

$ 2,257

^[20]

$ 2,669

^[23]

^[16],[20]

5.50%

^{[16],[19],[20]}

10.86%

^{[16],[20],[26]}

$ 47,810

^[16],[20]

47,095

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

^[16],[20]

$ 47,093

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

10.95%

^{[23],[24],[25],[30]}

10.95%

^{[23],[24],[25],[30]}

10.95%

^{[23],[24],[25],[30]}

€ 4,949

^{[16],[20],[26],[28]}

€ 3,017

^{[23],[24],[27],[30]}

$ 6,253

^{[16],[20],[28]}

$ 3,331

^{[23],[24],[30]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

$ 6,372

^{[16],[20],[28]}

$ 3,226

^{[23],[24],[30]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

11.82%

^{[16],[19],[20],[28]}

11.82%

^{[16],[19],[20],[28]}

11.82%

^{[16],[19],[20],[28]}

11.57%

^{[23],[24],[25],[30]}

11.57%

^{[23],[24],[25],[30]}

11.57%

^{[23],[24],[25],[30]}

$ 10,519

^{[16],[20],[26],[28]}

$ 10,519

^{[23],[24],[27],[30]}

10,411

^{[16],[20],[28]}

10,400

^{[23],[24],[30]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

$ 10,624

^{[16],[20],[28]}

$ 10,624

^{[23],[24],[30]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

6.00%

^{[16],[20],[28]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

9.95%

^{[16],[19],[20],[28]}

9.95%

^{[16],[19],[20],[28]}

9.95%

^{[16],[19],[20],[28]}

12.46%

^{[23],[24],[25],[30]}

12.46%

^{[23],[24],[25],[30]}

12.46%

^{[23],[24],[25],[30]}

£ 3,649

^{[16],[20],[26],[28]}

£ 4,949

^{[23],[24],[27],[30]}

$ 4,094

^{[16],[20],[28]}

$ 6,318

^{[23],[24],[30]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

$ 4,083

^{[16],[20],[28]}

$ 6,101

^{[23],[24],[30]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

7.00%

^{[23],[24],[30]}

11.20%

^{[16],[19],[20],[28]}

11.20%

^{[16],[19],[20],[28]}

11.20%

^{[16],[19],[20],[28]}

12.46%

^{[23],[24],[25],[30]}

12.46%

^{[23],[24],[25],[30]}

12.46%

^{[23],[24],[25],[30]}

£ 3,017

^{[16],[20],[26],[28]}

£ 23,675

^{[23],[24],[27],[30]}

$ 3,319

^{[16],[20],[28]}

$ 28,713

^{[23],[24],[30]}

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

$ 3,366

^{[16],[20],[28]}

$ 29,185

^{[23],[24],[30]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

9.70%

^{[23],[24],[25],[30]}

9.70%

^{[23],[24],[25],[30]}

9.70%

^{[23],[24],[25],[30]}

£ 23,675

^{[16],[20],[26],[28]}

£ 3,649

^{[23],[24],[27],[30]}

$ 28,395

^{[16],[20],[28]}

$ 4,094

^{[23],[24],[30]}

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

$ 30,482

^{[16],[20],[28]}

$ 3,914

^{[23],[24],[30]}

12,463,242

^[16]

12,463,242

^[16]

12,463,242

^[16]

1,783,332

^[24]

1,783,332

^[24]

1,783,332

^[24]

1,609,201

$ 1,963

^[16]

$ 804

^[24]

$ 997

^[16]

$ 89

^[24]

$ 354

370

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

0.10%

0.00%

6.75%

^{[21],[23],[24]}

6.75%

^{[21],[23],[24]}

6.75%

^{[21],[23],[24]}

6.75%

12.14%

^{[21],[23],[24],[25]}

12.14%

^{[21],[23],[24],[25]}

12.14%

^{[21],[23],[24],[25]}

11.48%

$ 21,852

^{[21],[23],[24],[27]}

$ 21,464

^{[21],[23],[24]}

21,855

$ 0

$ 21,823

^{[21],[23],[24]}

$ 21,252

24,225

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

0.00%

1.80%

1,129,453

^[24]

1,129,453

^[24]

1,129,453

^[24]

1,019,169

^[24]

$ 1,159

$ 0

$ 1,005

^[24]

$ 1,243

1,223

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

0.00%

0.10%

78,045

^[16]

78,045

^[16]

78,045

^[16]

78,045

^[24]

78,045

^[24]

78,045

^[24]

70,425

$ 0

^[16]

$ 0

^[24]

$ 0

^[16]

$ 0

^[24]

$ 0

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

0.00%

5.25%

^[20]

5.25%

^[20]

5.25%

^[20]

5.25%

^[23]

5.25%

^[23]

5.25%

^[23]

10.86%

^[19],[20]

10.86%

^[19],[20]

10.86%

^[19],[20]

10.90%

^[23],[25]

10.90%

^[23],[25]

10.90%

^[23],[25]

$ 15,688

^[20],[26]

$ 8,490

^[23],[27]

13,112

^[20]

8,168

^[23]

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

$ 10,230

^[20]

$ 6,414

^[23]

7.00%

^{[16],[20],[28]}

7.00%

^{[16],[20],[28]}

7.00%

^{[16],[20],[28]}

6.00%

^{[23],[24],[30]}

6.00%

^{[23],[24],[30]}

6.00%

^{[23],[24],[30]}

8.45%

^{[16],[19],[20],[28]}

8.45%

^{[16],[19],[20],[28]}

8.45%

^{[16],[19],[20],[28]}

11.49%

^{[23],[24],[25],[30]}

11.49%

^{[23],[24],[25],[30]}

11.49%

^{[23],[24],[25],[30]}

4.00%

$ 29,801

^{[16],[20],[26],[28]}

$ 29,509

^{[23],[24],[27],[30]}

29,483

^{[16],[20],[28]}

29,164

^{[23],[24],[30]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

$ 28,311

^{[16],[20],[28]}

$ 28,284

^{[23],[24],[30]}

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(102)

^{[16],[17],[20]}

(108)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

$ (63)

^{[16],[17],[20]}

$ (78)

^{[21],[23],[24]}

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[23],[24]

7.25%

^[23],[24]

7.25%

^[23],[24]

12.60%

^[19],[20]

12.60%

^[19],[20]

12.60%

^[19],[20]

12.64%

^{[23],[24],[25]}

12.64%

^{[23],[24],[25]}

12.64%

^{[23],[24],[25]}

$ 50,470

^{[16],[20],[26]}

$ 50,470

^{[23],[24],[27]}

49,718

^[16],[20]

49,679

^[23],[24]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

$ 49,839

^[16],[20]

$ 49,688

^[23],[24]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

^[23],[24]

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

$ 3,239

^{[16],[20],[26]}

$ 3,247

^{[23],[24],[27]}

3,208

^[16],[20]

3,216

^[23],[24]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

$ 3,119

^[16],[20]

$ 3,169

^[23],[24]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

^[23],[24]

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

$ 1,258

^{[16],[20],[26]}

$ 1,261

^{[23],[24],[27]}

1,265

^[16],[20]

1,269

^[23],[24]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

$ 1,211

^[16],[20]

$ 1,231

^[23],[24]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[23],[24]

8.50%

^[23],[24]

8.50%

^[23],[24]

14.15%

^{[16],[19],[20]}

14.15%

^{[16],[19],[20]}

14.15%

^{[16],[19],[20]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

$ 2,091

^{[16],[20],[26]}

$ 8,920

^{[23],[24],[27]}

2,070

^[16],[20]

8,819

^[23],[24]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

$ 1,842

^[16],[20]

$ 8,492

^[23],[24]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[23],[24]

8.50%

^[23],[24]

8.50%

^[23],[24]

14.11%

^{[16],[19],[20]}

14.11%

^{[16],[19],[20]}

14.11%

^{[16],[19],[20]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

$ 4,361

^{[16],[20],[26]}

$ 2,091

^{[23],[24],[27]}

4,298

^[16],[20]

2,068

^[23],[24]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

$ 3,842

^[16],[20]

$ 1,991

^[23],[24]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[23],[24]

8.50%

^[23],[24]

8.50%

^[23],[24]

14.11%

^{[16],[19],[20]}

14.11%

^{[16],[19],[20]}

14.11%

^{[16],[19],[20]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

14.15%

^{[23],[24],[25]}

$ 8,920

^{[16],[20],[26]}

$ 4,361

^{[23],[24],[27]}

8,818

^[16],[20]

4,297

^[23],[24]

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

$ 7,859

^[16],[20]

$ 4,152

^[23],[24]

4.50%

^{[16],[17],[20]}

4.50%

^{[16],[17],[20]}

4.50%

^{[16],[17],[20]}

4.50%

^{[21],[23],[24]}

4.50%

^{[21],[23],[24]}

4.50%

^{[21],[23],[24]}

13.00%

^{[16],[17],[19],[20]}

13.00%

^{[16],[17],[19],[20]}

13.00%

^{[16],[17],[19],[20]}

13.00%

^{[21],[23],[24],[25]}

13.00%

^{[21],[23],[24],[25]}

13.00%

^{[21],[23],[24],[25]}

$ 1,836

^{[16],[17],[20],[26]}

$ 2,221

^{[21],[23],[24],[27]}

1,806

^{[16],[17],[20]}

2,188

^{[21],[23],[24]}

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

$ 1,798

^{[16],[17],[20]}

$ 2,178

^{[21],[23],[24]}

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[23],[24]

5.50%

^[23],[24]

5.50%

^[23],[24]

11.03%

^{[16],[19],[20]}

11.03%

^{[16],[19],[20]}

11.03%

^{[16],[19],[20]}

11.02%

^{[23],[24],[25]}

11.02%

^{[23],[24],[25]}

11.02%

^{[23],[24],[25]}

$ 40,557

^{[16],[20],[26]}

$ 40,660

^{[23],[24],[27]}

40,352

^[16],[20]

40,440

^[23],[24]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

$ 40,070

^[16],[20]

$ 40,213

^[23],[24]

^{[16],[17],[20],[28]}

7.50%

^{[23],[24],[25],[30]}

8.00%

^[24],[30]

2.25%

$ 0

^{[16],[17],[20],[26],[28]}

$ 6,757

^{[24],[27],[30]}

^{[16],[17],[20],[28]}

6,560

^[24],[30]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

$ 0

^{[16],[17],[20],[28]}

6,225

^[24],[30]

^{[16],[20],[28]}

7.50%

^{[16],[19],[20],[28]}

12.89%

$ 2,815

^{[16],[20],[26],[28]}

3,316

^{[21],[24],[27],[30],[31]}

2,815

^{[16],[20],[28]}

3,335

^{[21],[24],[30],[31]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 2,625

^{[16],[20],[28]}

$ 3,169

^{[21],[24],[30],[31]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[21],[23],[24],[25],[30]}

8.00%

^{[21],[23],[24],[25],[30]}

8.00%

^{[21],[23],[24],[25],[30]}

2.25%

^[16],[28]

2.25%

^[16],[28]

2.25%

^[16],[28]

2.25%

^{[21],[24],[30]}

2.25%

^{[21],[24],[30]}

2.25%

^{[21],[24],[30]}

$ 0

^{[16],[17],[26],[28]}

$ 0

^{[21],[24],[27],[30]}

^{[16],[17],[28]}

^{[21],[24],[30]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

$ 0

^{[16],[17],[28]}

$ 0

^{[21],[24],[30]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[16],[17],[19],[20],[28]}

8.00%

^{[21],[23],[24],[25],[30]}

8.00%

^{[21],[23],[24],[25],[30]}

8.00%

^{[21],[23],[24],[25],[30]}

2.25%

^{[16],[17],[28]}

2.25%

^{[16],[17],[28]}

2.25%

^{[16],[17],[28]}

2.25%

^{[21],[24],[30]}

2.25%

^{[21],[24],[30]}

2.25%

^{[21],[24],[30]}

$ 0

^{[16],[17],[26],[28]}

$ 0

^{[21],[24],[27],[30]}

^{[16],[17],[28]}

^{[21],[24],[30]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

$ 0

^{[16],[17],[28]}

^{[21],[24],[30]}

^{[16],[19],[20],[28]}

8.00%

^[16],[28]

2.25%

$ 6,785

^{[16],[26],[28]}

^{[21],[24],[27],[30],[31]}

6,602

^[16],[28]

^{[21],[24],[30],[31]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

$ 6,327

^[16],[28]

^{[21],[24],[30],[31]}

^{[21],[24],[27],[30],[31]}

^{[21],[24],[30],[31]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

^{[21],[24],[30],[31]}

$ 0

32,664

^[16],[28]

32,664

^[16],[28]

32,664

^[16],[28]

26,131

^[24],[30]

26,131

^[24],[30]

26,131

^[24],[30]

$ 225

^[16],[28]

$ 225

^[24],[30]

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

$ 46

^[16],[28]

$ 3

^[24],[30]

7.00%

^[20]

7.00%

^[20]

7.00%

^[20]

7.00%

^[23]

7.00%

^[23]

7.00%

^[23]

12.46%

^[19],[20]

12.46%

^[19],[20]

12.46%

^[19],[20]

12.43%

^[23],[25]

12.43%

^[23],[25]

12.43%

^[23],[25]

$ 30,625

^[20],[26]

$ 30,625

^[23],[27]

30,394

^[20]

30,370

^[23]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

$ 30,319

^[20]

$ 29,989

^[23]

394,297

^[16]

394,297

^[16]

394,297

^[16]

394,297

^[24]

394,297

^[24]

394,297

^[24]

$ 424

^[16]

$ 424

^[24]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

$ 95

^[16]

$ 158

^[24]

9.00%

^{[16],[19],[20]}

9.00%

^{[16],[19],[20]}

9.00%

^{[16],[19],[20]}

9.00%

^{[23],[24],[25]}

9.00%

^{[23],[24],[25]}

9.00%

^{[23],[24],[25]}

$ 5,257

^[16],[26]

$ 5,257

^[24],[27]

5,263

^[16]

5,258

^[24]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

$ 5,205

^[16]

$ 5,251

^[24]

1,708,618

^[16]

1,708,618

^[16]

1,708,618

^[16]

1,708,618

^[24]

1,708,618

^[24]

1,708,618

^[24]

$ 1,711

^[16]

$ 1,711

^[24]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

$ 1,982

^[16]

$ 1,999

^[24]

394,297

^[16]

394,297

^[16]

394,297

^[16]

394,297

^[24]

394,297

^[24]

394,297

^[24]

$ 395

^[16]

$ 395

^[24]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

$ 434

^[16]

$ 442

^[24]

829

^[16]

829

^[16]

829

^[16]

829

^[24]

829

^[24]

829

^[24]

829

$ 0

$ 0

^[16]

$ 0

^[24]

$ 0

^[16]

$ 0

^[24]

$ 0

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

0.00%

34,984,460

^[16]

34,984,460

^[16]

34,984,460

^[16]

34,984,460

^[24]

34,984,460

^[24]

34,984,460

^[24]

34,984,460

$ 0

$ 34,984

^[16]

$ 34,984

^[24]

$ 27,638

^[16]

$ 27,638

^[24]

$ 27,638

27,638

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan

1.80%

2.30%

^[20],[28]

6.00%

^{[19],[20],[28]}

11.29%

^{[20],[26],[28]}

$ 16,185

^[20],[28]

20,053

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

^[20],[28]

$ 20,281

7.75%

^{[16],[20],[32]}

7.75%

^{[16],[20],[32]}

7.75%

^{[16],[20],[32]}

7.75%

^{[23],[24],[33]}

7.75%

^{[23],[24],[33]}

7.75%

^{[23],[24],[33]}

$ 727

^{[16],[20],[26],[32]}

$ 727

^{[23],[24],[27],[33]}

413

^{[16],[20],[32]}

462

^{[23],[24],[33]}

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

$ 365

^{[16],[20],[32]}

$ 396

^{[23],[24],[33]}

^[23],[24]

6.50%

^{[23],[24],[25]}

12.07%

^{[23],[24],[27]}

$ 37

^[23],[24]

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

^[23],[24]

$ 37

^[23],[24]

6.50%

^{[23],[24],[25]}

12.07%

^{[23],[24],[27]}

$ 3,031

^[23],[24]

2,899

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

^[23],[24]

$ 3,031

^[23],[24]

6.50%

^{[23],[24],[25]}

12.07%

^{[23],[24],[27]}

$ 1,557

^[23],[24]

1,489

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

^[23],[24]

$ 1,557

^[23],[24]

6.50%

^{[23],[24],[25]}

12.07%

^{[23],[24],[27]}

$ 1,024

^[23],[24]

994

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

^[23],[24]

$ 1,024

1,080,398

^[16]

1,080,398

^[16]

1,080,398

^[16]

1,080,399

^[24]

1,080,399

^[24]

1,080,399

^[24]

1,080,399

$ 1,079

^[16]

$ 1,080

^[24]

$ 432

^[16]

$ 432

^[24]

$ 324

378

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

0.00%

7.50%

^{[19],[20],[28]}

7.50%

^{[19],[20],[28]}

7.50%

^{[19],[20],[28]}

7.50%

^{[23],[25],[30]}

7.50%

^{[23],[25],[30]}

7.50%

^{[23],[25],[30]}

$ 2,632

^[26],[28]

$ 2,632

^[27],[30]

2,632

^[28]

2,632

^[30]

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

$ 2,191

^[28]

$ 2,017

^[30]

7.75%

^{[19],[20],[28]}

7.75%

^{[19],[20],[28]}

7.75%

^{[19],[20],[28]}

7.75%

^{[23],[25],[30]}

7.75%

^{[23],[25],[30]}

7.75%

^{[23],[25],[30]}

$ 176

^[26],[28]

$ 176

^[27],[30]

170

^[28]

170

^[30]

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

$ 152

^[28]

$ 141

^[30]

7.38%

^[19],[20]

7.38%

^[19],[20]

7.38%

^[19],[20]

7.38%

^[23],[25]

7.38%

^[23],[25]

7.38%

^[23],[25]

$ 10,720

^[26]

$ 8,420

^[27]

10,282

8,261

Investment, Identifier [Axis]: Connect U.S. Finco LLC, Alternative Carriers, Fixed Rate Bond

$ 9,804

7,059

^{[19],[20],[28]}

6.75%

^[26],[28]

$ 1,670

^[28]

1,625

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

^[28]

$ 1,661

^[16]

22,267,661

^[16]

$ 16,172

$ 16,173

^[16]

$ 0

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

1.10%

^{[23],[24],[33]}

8.50%

^{[23],[24],[27],[33]}

$ 22,084

^{[23],[24],[33]}

21,336

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

^{[23],[24],[33]}

16,040

^[24]

706

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

^[24]

$ 0

417,851

^[16]

417,851

^[16]

417,851

^[16]

417,851

^[24]

417,851

^[24]

417,851

^[24]

$ 605

^[16]

$ 605

^[24]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

$ 894

^[16]

$ 894

^[24]

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(19)

^{[16],[17],[20]}

(20)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

$ (19)

^{[16],[17],[20]}

$ (20)

^{[21],[23],[24]}

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^[23],[24]

7.50%

^[23],[24]

7.50%

^[23],[24]

^{[23],[24],[25]}

12.82%

$ 0

^{[16],[17],[20],[26]}

$ 13,157

^{[23],[24],[27]}

(15)

^{[16],[17],[20]}

12,855

^[23],[24]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

$ (11)

^{[16],[17],[20]}

$ 12,858

^[23],[24]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

^{[16],[19],[20]}

12.86%

$ 13,157

^{[16],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

12,867

^[16],[20]

(15)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

$ 12,883

^[16],[20]

$ (13)

^{[21],[23],[24]}

5.00%

^[20]

5.00%

^[20]

5.00%

^[20]

5.00%

^[23]

5.00%

^[23]

5.00%

^[23]

10.35%

^[19],[20]

10.35%

^[19],[20]

10.35%

^[19],[20]

10.39%

^[23],[25]

10.39%

^[23],[25]

10.39%

^[23],[25]

$ 14,713

^[20],[26]

$ 14,750

^[23],[27]

14,160

^[20]

14,173

^[23]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

$ 14,724

^[20]

$ 14,616

^[23]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

^{[21],[23],[24],[25]}

11.47%

$ 0

^{[16],[20],[26]}

$ 933

^{[21],[23],[24],[27]}

(13)

^[16],[20]

920

^{[21],[23],[24]}

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

$ (15)

^[16],[20]

$ 918

^{[21],[23],[24]}

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.53%

^[19],[20]

11.53%

^[19],[20]

11.53%

^[19],[20]

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

$ 17,967

^{[16],[20],[26]}

$ 18,013

^{[23],[24],[27]}

17,666

^[16],[20]

17,690

^[23],[24]

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

$ 17,765

^[16],[20]

$ 17,812

^[23],[24]

^[16],[20]

6.75%

^{[16],[20],[26]}

$ 0

^[16],[20]

(53)

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

^[16],[20]

$ (52)

^[16]

6.75%

^[19],[20]

12.10%

^[16],[26]

$ 20,924

^[16]

20,412

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

^[16]

$ 20,422

4.75%

^[20]

4.75%

^[20]

4.75%

^[20]

4.75%

^[23]

4.75%

^[23]

4.75%

^[23]

10.13%

^[19],[20]

10.13%

^[19],[20]

10.13%

^[19],[20]

10.12%

^[23],[25]

10.12%

^[23],[25]

10.12%

^[23],[25]

$ 4,938

^[20],[26]

$ 4,950

^[23],[27]

4,862

^[20]

4,871

^[23]

Investment, Identifier [Axis]: Dealer Tire Financial, LLC, Distributors, Fixed Rate Bond

$ 4,893

^[20]

$ 4,831

^[23]

^[19],[20]

8.00%

^[26]

$ 440

423

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

$ 436

^[16],[28]

^[24],[30]

$ 2

^[16],[28]

$ 2

^[24],[30]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

$ 2

^[16],[28]

$ 2

^[24],[30]

419

^[16],[28]

419

^[16],[28]

419

^[16],[28]

419

^[24],[30]

419

^[24],[30]

419

^[24],[30]

$ 419

^[16],[28]

$ 419

^[24],[30]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

$ 419

^[16],[28]

$ 419

^[24],[30]

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

7.00%

^[16],[28]

7.00%

^[16],[28]

7.00%

^[16],[28]

7.00%

^{[21],[24],[30]}

7.00%

^{[21],[24],[30]}

7.00%

^{[21],[24],[30]}

$ 32,104

^{[16],[26],[28]}

$ 17,465

^{[21],[24],[27],[30]}

32,104

^[16],[28]

17,465

^{[21],[24],[30]}

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

$ 32,104

^[16],[28]

$ 17,465

^{[21],[24],[30]}

^[16],[28]

^[24],[30]

$ 0

^[16],[28]

$ 0

^[24],[30]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

$ 0

^[16],[28]

$ 0

^[24],[30]

9.00%

^[16],[20]

9.00%

^[16],[20]

9.00%

^[16],[20]

9.00%

^[23],[24]

9.00%

^[23],[24]

9.00%

^[23],[24]

14.50%

^{[16],[19],[20]}

14.50%

^{[16],[19],[20]}

14.50%

^{[16],[19],[20]}

14.54%

^{[23],[24],[25]}

14.54%

^{[23],[24],[25]}

14.54%

^{[23],[24],[25]}

$ 20,757

^{[16],[20],[26]}

$ 20,757

^{[23],[24],[27]}

20,201

^[16],[20]

20,146

^[23],[24]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

$ 20,639

^[16],[20]

$ 20,653

^[23],[24]

8.00%

^[16]

8.00%

^[16]

8.00%

^[16]

8.00%

^[24]

8.00%

^[24]

8.00%

^[24]

$ 667

^[16],[26]

$ 654

^[24],[27]

666

^[16]

653

^[24]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

$ 643

^[16]

$ 631

^[24]

6,397,254

^[16]

6,397,254

^[16]

6,397,254

^[16]

6,397,254

^[24]

6,397,254

^[24]

6,397,254

^[24]

$ 1,642

^[16]

$ 1,642

^[24]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

$ 128

^[16]

$ 1,152

^[24]

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

12.45%

^{[16],[17],[19],[20]}

12.45%

^{[16],[17],[19],[20]}

12.45%

^{[16],[17],[19],[20]}

12.49%

^{[21],[23],[24],[25]}

12.49%

^{[21],[23],[24],[25]}

12.49%

^{[21],[23],[24],[25]}

$ 578

^{[16],[17],[20],[26]}

$ 284

^{[21],[23],[24],[27]}

561

^{[16],[17],[20]}

265

^{[21],[23],[24]}

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

$ 550

^{[16],[17],[20]}

$ 252

^{[21],[23],[24]}

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.45%

^{[16],[19],[20]}

12.45%

^{[16],[19],[20]}

12.45%

^{[16],[19],[20]}

12.49%

^{[23],[24],[25]}

12.49%

^{[23],[24],[25]}

12.49%

^{[23],[24],[25]}

$ 12,355

^{[16],[20],[26]}

$ 12,386

^{[23],[24],[27]}

12,191

^[16],[20]

12,208

^[23],[24]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

$ 12,083

^[16],[20]

$ 12,101

^[23],[24]

5.00%

^[23]

5.00%

^[23]

5.00%

^[23]

10.65%

^[19],[20]

10.65%

^[19],[20]

10.65%

^[19],[20]

10.43%

^[23],[25]

10.43%

^[23],[25]

10.43%

^[23],[25]

$ 4,514

^[20],[26]

$ 4,641

^[23],[27]

4,491

^[20]

4,619

^[23]

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, Fixed Rate Bond

$ 4,522

^[20]

$ 4,546

^[23]

^[19],[20]

5.88%

^[26]

$ 5,090

4,455

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

$ 4,787

30,031

^[16]

30,031

^[16]

30,031

^[16]

30,031

^[24]

30,031

^[24]

30,031

^[24]

30,031

$ 0

$ 15,222

^[16]

$ 15,222

^[24]

$ 2,711

^[16]

$ 2,711

^[24]

$ 4,227

4,946

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

0.20%

0.40%

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

10.50%

^{[16],[19],[20]}

10.50%

^{[16],[19],[20]}

10.50%

^{[16],[19],[20]}

10.54%

^{[23],[24],[25]}

10.54%

^{[23],[24],[25]}

10.54%

^{[23],[24],[25]}

$ 5,574

^{[16],[20],[26]}

$ 5,574

^{[23],[24],[27]}

$ 0

5,574

^[16],[20]

5,574

^[23],[24]

$ 5,574

^[16],[20]

$ 5,574

^[23],[24]

$ 0

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan

0.40%

0.00%

5.00%

9.73%

$ 14,297

$ 14,297

14,333

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

1.20%

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

^[23],[24]

10.50%

^{[16],[19],[20]}

10.50%

^{[16],[19],[20]}

10.50%

^{[16],[19],[20]}

10.54%

^{[23],[24],[25]}

10.54%

^{[23],[24],[25]}

10.54%

^{[23],[24],[25]}

$ 14,033

^{[16],[20],[26]}

$ 14,068

^{[23],[24],[27]}

14,032

^[16],[20]

14,068

^[23],[24]

$ 14,033

^[16],[20]

$ 14,068

^[23],[24]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

0.90%

5.00%

^{[16],[17],[20]}

5.00%

^{[16],[17],[20]}

5.00%

^{[16],[17],[20]}

5.00%

^{[21],[23],[24]}

5.00%

^{[21],[23],[24]}

5.00%

^{[21],[23],[24]}

10.46%

^{[16],[17],[19],[20]}

10.46%

^{[16],[17],[19],[20]}

10.46%

^{[16],[17],[19],[20]}

10.42%

^{[21],[23],[24],[25]}

10.42%

^{[21],[23],[24],[25]}

10.42%

^{[21],[23],[24],[25]}

$ 1,393

^{[16],[17],[20],[26]}

$ 2,090

^{[21],[23],[24],[27]}

1,393

^{[16],[17],[20]}

2,090

^{[21],[23],[24]}

$ 1,394

^{[16],[17],[20]}

$ 2,090

^{[21],[23],[24]}

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

0.10%

12,500

^[16]

12,500

^[16]

12,500

^[16]

12,500

^[24]

12,500

^[24]

12,500

^[24]

$ 0

^[16]

$ 0

^[24]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

$ 0

^[16]

$ 0

^[24]

488

^[16]

488

^[16]

488

^[16]

488

^[24]

488

^[24]

488

^[24]

$ 488

^[16]

$ 488

^[24]

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

$ 1,345

^[16]

$ 1,345

^[24]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[23],[24]

7.50%

^[23],[24]

7.50%

^[23],[24]

13.00%

^{[16],[19],[20]}

13.00%

^{[16],[19],[20]}

13.00%

^{[16],[19],[20]}

13.04%

^{[23],[24],[25]}

13.04%

^{[23],[24],[25]}

13.04%

^{[23],[24],[25]}

$ 8,974

^{[16],[20],[26]}

$ 8,974

^{[23],[24],[27]}

8,884

^[16],[20]

8,884

^[23],[24]

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

$ 8,032

^[16],[20]

$ 7,987

^[23],[24]

^{[16],[17],[20]}

5.50%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(28)

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

^{[16],[17],[20]}

$ (28)

^[16],[20]

5.50%

^{[16],[19],[20]}

10.84%

^{[16],[20],[26]}

$ 24,865

^[16],[20]

24,492

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

^[16],[20]

$ 24,492

^{[16],[17],[20]}

5.50%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(19)

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

^{[16],[17],[20]}

$ (19)

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[23],[24],[25],[30]}

3.00%

^{[23],[24],[25],[30]}

3.00%

^{[23],[24],[25],[30]}

6.00%

^[16],[28]

6.00%

^[16],[28]

6.00%

^[16],[28]

6.00%

^[24],[30]

6.00%

^[24],[30]

6.00%

^[24],[30]

$ 1,799

^{[16],[26],[28]}

$ 11,065

^{[24],[27],[30]}

1,777

^[16],[28]

10,953

^[24],[30]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

$ 1,718

^[16],[28]

$ 10,677

^[24],[30]

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[23],[24],[25],[30]}

3.00%

^{[23],[24],[25],[30]}

3.00%

^{[23],[24],[25],[30]}

6.00%

^{[16],[17],[28]}

6.00%

^{[16],[17],[28]}

6.00%

^{[16],[17],[28]}

6.00%

^[24],[30]

6.00%

^[24],[30]

6.00%

^[24],[30]

$ 0

^{[16],[17],[26],[28]}

$ 1,772

^{[24],[27],[30]}

^{[16],[17],[28]}

1,748

^[24],[30]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

$ 0

^{[16],[17],[28]}

$ 1,710

^[24],[30]

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[16],[17],[19],[20],[28]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

6.00%

^{[16],[17],[28]}

6.00%

^{[16],[17],[28]}

6.00%

^{[16],[17],[28]}

6.00%

^{[21],[24],[30]}

6.00%

^{[21],[24],[30]}

6.00%

^{[21],[24],[30]}

$ 0

^{[16],[17],[26],[28]}

$ 0

^{[21],[24],[27],[30]}

^{[16],[17],[28]}

^{[21],[24],[30]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

$ 0

^{[16],[17],[28]}

$ 0

^{[21],[24],[30]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[16],[19],[20],[28]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

3.00%

^{[21],[23],[24],[25],[30]}

6.00%

^[16],[28]

6.00%

^[16],[28]

6.00%

^[16],[28]

6.00%

^{[21],[24],[30]}

6.00%

^{[21],[24],[30]}

6.00%

^{[21],[24],[30]}

$ 11,232

^{[16],[26],[28]}

$ 0

^{[21],[24],[27],[30]}

11,129

^[16],[28]

^{[21],[24],[30]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

$ 10,727

^[16],[28]

$ 0

^{[21],[24],[30]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(39)

^{[16],[17],[20]}

(41)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

$ (37)

^{[16],[17],[20]}

$ (41)

^{[21],[23],[24]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.35%

^[19],[20]

11.35%

^[19],[20]

11.35%

^[19],[20]

11.32%

^{[23],[24],[25]}

11.32%

^{[23],[24],[25]}

11.32%

^{[23],[24],[25]}

$ 14,736

^{[16],[17],[20],[26]}

$ 14,736

^{[23],[24],[27]}

14,381

^{[16],[17],[20]}

14,368

^[23],[24]

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

$ 14,394

^{[16],[17],[20]}

$ 14,368

^[23],[24]

^[20]

4.00%

^[19],[20]

9.47%

^[20],[26]

$ 4,324

^[20]

3,497

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

^[20]

$ 3,457

6.75%

^[20]

6.75%

^[20]

6.75%

^[20]

6.75%

^[23],[30]

6.75%

^[23],[30]

6.75%

^[23],[30]

12.22%

^[19],[20]

12.22%

^[19],[20]

12.22%

^[19],[20]

12.18%

^{[23],[25],[30]}

12.18%

^{[23],[25],[30]}

12.18%

^{[23],[25],[30]}

$ 31,074

^[20],[26]

$ 31,074

^{[23],[27],[30]}

29,191

^[20]

29,127

^[23],[30]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

$ 18,745

^[20]

$ 19,917

^[23],[30]

9.00%

^{[16],[17],[19],[20]}

9.00%

^{[16],[17],[19],[20]}

9.00%

^{[16],[17],[19],[20]}

9.00%

^{[21],[23],[24],[25]}

9.00%

^{[21],[23],[24],[25]}

9.00%

^{[21],[23],[24],[25]}

$ 61,500

^{[16],[17],[26]}

$ 59,950

^{[21],[24],[27]}

61,500

^[16],[17]

59,950

^[21],[24]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

$ 61,500

^[16],[17]

$ 59,950

^[21],[24]

3,750

^{[16],[28],[36]}

3,750

^{[16],[28],[36]}

3,750

^{[16],[28],[36]}

3,750

^[24],[30]

3,750

^[24],[30]

3,750

^[24],[30]

$ 0

^{[16],[28],[36]}

$ 0

^[24],[30]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

$ 4

^{[16],[28],[36]}

$ 3

^[24],[30]

7.25%

^{[16],[17],[20],[28]}

7.25%

^{[16],[17],[20],[28]}

7.25%

^{[16],[17],[20],[28]}

7.25%

^{[21],[23],[24],[30]}

7.25%

^{[21],[23],[24],[30]}

7.25%

^{[21],[23],[24],[30]}

12.61%

^{[16],[17],[19],[20],[28]}

12.61%

^{[16],[17],[19],[20],[28]}

12.61%

^{[16],[17],[19],[20],[28]}

12.55%

^{[21],[23],[24],[25],[30]}

12.55%

^{[21],[23],[24],[25],[30]}

12.55%

^{[21],[23],[24],[25],[30]}

$ 322

^{[16],[17],[20],[26],[28]}

$ 258

^{[21],[23],[24],[27],[30]}

299

^{[16],[17],[20],[28]}

234

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

$ 301

^{[16],[17],[20],[28]}

$ 234

^{[21],[23],[24],[30]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.25%

^{[16],[20],[28]}

7.25%

^{[23],[24],[30]}

7.25%

^{[23],[24],[30]}

7.25%

^{[23],[24],[30]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

12.71%

^{[16],[19],[20],[28]}

12.55%

^{[23],[24],[25],[30]}

12.55%

^{[23],[24],[25],[30]}

12.55%

^{[23],[24],[25],[30]}

$ 11,742

^{[16],[20],[26],[28]}

$ 11,742

^{[23],[24],[27],[30]}

11,519

^{[16],[20],[28]}

11,509

^{[23],[24],[30]}

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

11,538

^{[16],[20],[28]}

11,511

^{[23],[24],[30]}

$ 0

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

0.00%

11.00%

^{[16],[19],[20],[28]}

11.00%

^{[16],[19],[20],[28]}

11.00%

^{[16],[19],[20],[28]}

11.00%

^{[23],[24],[25],[30]}

11.00%

^{[23],[24],[25],[30]}

11.00%

^{[23],[24],[25],[30]}

$ 11,918

^{[16],[26],[28]}

$ 11,918

^{[24],[27],[30]}

11,653

^[16],[28]

11,612

^[24],[30]

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

$ 11,173

^[16],[28]

$ 11,144

^[24],[30]

417,011

^[16],[28]

417,011

^[16],[28]

417,011

^[16],[28]

417,011

^[24],[30]

417,011

^[24],[30]

417,011

^[24],[30]

$ 427

^[16],[28]

$ 427

^[24],[30]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

$ 354

^[16],[28]

$ 42

^[24],[30]

6.00%

^{[19],[20],[28]}

6.00%

^{[19],[20],[28]}

6.00%

^{[19],[20],[28]}

6.00%

^{[23],[25],[30]}

6.00%

^{[23],[25],[30]}

6.00%

^{[23],[25],[30]}

$ 4,881

^[26],[28]

$ 4,881

^[27],[30]

4,482

^[28]

4,469

^[30]

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

$ 4,170

^[28]

$ 3,577

^[30]

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

12.60%

^{[16],[17],[19],[20]}

12.60%

^{[16],[17],[19],[20]}

12.60%

^{[16],[17],[19],[20]}

12.64%

^{[21],[23],[24],[25]}

12.64%

^{[21],[23],[24],[25]}

12.64%

^{[21],[23],[24],[25]}

$ 1,215

^{[16],[17],[20],[26]}

$ 1,638

^{[21],[23],[24],[27]}

1,117

^{[16],[17],[20]}

1,535

^{[21],[23],[24]}

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

$ 1,152

^{[16],[17],[20]}

$ 1,535

^{[21],[23],[24]}

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[23],[24]

7.25%

^[23],[24]

7.25%

^[23],[24]

12.60%

^{[16],[19],[20]}

12.60%

^{[16],[19],[20]}

12.60%

^{[16],[19],[20]}

12.64%

^{[23],[24],[25]}

12.64%

^{[23],[24],[25]}

12.64%

^{[23],[24],[25]}

$ 23,714

^{[16],[20],[26]}

$ 23,774

^{[23],[24],[27]}

23,082

^[16],[20]

23,110

^[23],[24]

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

$ 23,306

^[16],[20]

$ 23,110

^[23],[24]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23]

5.00%

^[23]

5.00%

^[23]

10.66%

^{[16],[19],[20]}

10.66%

^{[16],[19],[20]}

10.66%

^{[16],[19],[20]}

10.57%

^[23],[25]

10.57%

^[23],[25]

10.57%

^[23],[25]

$ 2,450

^{[16],[20],[26]}

$ 2,456

^[23],[27]

2,070

^[16],[20]

2,055

^[23]

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

$ 2,197

^[16],[20]

$ 2,063

^[23]

2.85%

^[20],[28]

2.85%

^[20],[28]

2.85%

^[20],[28]

2.85%

^[23],[30]

2.85%

^[23],[30]

2.85%

^[23],[30]

6.84%

^{[19],[20],[28]}

6.84%

^{[19],[20],[28]}

6.84%

^{[19],[20],[28]}

6.56%

^{[23],[25],[30]}

6.56%

^{[23],[25],[30]}

6.56%

^{[23],[25],[30]}

€ 1,000

^{[20],[26],[28]}

€ 1,000

^{[23],[27],[30]}

$ 880

^[20],[28]

$ 876

^[23],[30]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

$ 1,033

^[20],[28]

$ 963

^[23],[30]

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(25)

^{[16],[17],[20]}

(27)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

$ (29)

^{[16],[17],[20]}

$ (35)

^{[21],[23],[24]}

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^[23],[24]

8.00%

^[23],[24]

8.00%

^[23],[24]

^{[23],[24],[25]}

13.42%

$ 0

^{[16],[17],[20],[26]}

$ 17,444

^{[23],[24],[27]}

(50)

^{[16],[17],[20]}

17,276

^[23],[24]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

$ (59)

^{[16],[17],[20]}

$ 17,096

^[23],[24]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

^{[16],[19],[20]}

13.46%

$ 17,400

^{[16],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

17,244

^[16],[20]

(54)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

$ 17,112

^[16],[20]

$ (70)

^{[21],[23],[24]}

5.25%

^[20]

5.25%

^[20]

5.25%

^[20]

5.25%

^[23]

5.25%

^[23]

5.25%

^[23]

10.71%

^[19],[20]

10.71%

^[19],[20]

10.71%

^[19],[20]

10.67%

^[23],[25]

10.67%

^[23],[25]

10.67%

^[23],[25]

$ 8,538

^[20],[26]

$ 14,347

^[23],[27]

8,257

^[20]

13,871

^[23]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan

$ 8,396

^[20]

$ 13,618

^[23]

^{[16],[20],[28]}

6.50%

^{[16],[19],[20],[28]}

12.00%

^{[16],[20],[26],[28]}

$ 7,448

^{[16],[20],[28]}

7,313

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

^{[16],[20],[28]}

$ 7,355

6.50%

^{[16],[17],[20],[28]}

6.50%

^{[16],[17],[20],[28]}

6.50%

^{[16],[17],[20],[28]}

6.50%

^{[23],[24],[30]}

6.50%

^{[23],[24],[30]}

6.50%

^{[23],[24],[30]}

^{[23],[24],[25],[30]}

11.89%

$ 0

^{[16],[17],[20],[26],[28]}

$ 7,448

^{[23],[24],[27],[30]}

(73)

^{[16],[17],[20],[28]}

7,296

^{[23],[24],[30]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

$ (50)

^{[16],[17],[20],[28]}

$ 7,301

^{[23],[24],[30]}

6.50%

^{[16],[20],[28]}

6.50%

^{[16],[20],[28]}

6.50%

^{[16],[20],[28]}

6.50%

^{[21],[23],[24],[30]}

6.50%

^{[21],[23],[24],[30]}

6.50%

^{[21],[23],[24],[30]}

^[19],[20]

12.00%

$ 1,432

^{[16],[20],[26],[28]}

$ 0

^{[21],[23],[24],[27],[30]}

1,403

^{[16],[20],[28]}

(82)

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 1,414

^{[16],[20],[28]}

$ (79)

^{[21],[23],[24],[30]}

^{[23],[24],[30]}

6.50%

^{[23],[24],[25],[30]}

12.04%

^{[23],[24],[27],[30]}

$ 1,432

^{[23],[24],[30]}

1,399

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

^{[23],[24],[30]}

$ 1,404

4.46%

^{[19],[20],[28]}

4.46%

^{[19],[20],[28]}

4.46%

^{[19],[20],[28]}

4.46%

^{[23],[24],[25],[30]}

4.46%

^{[23],[24],[25],[30]}

4.46%

^{[23],[24],[25],[30]}

$ 9,406

^[26],[28]

$ 6,808

^{[24],[27],[30]}

7,727

^[28]

5,490

^[24],[30]

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

$ 8,155

^[28]

$ 5,873

^[24],[30]

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

13.63%

^{[16],[19],[20],[28]}

13.63%

^{[16],[19],[20],[28]}

13.63%

^{[16],[19],[20],[28]}

13.62%

^{[23],[24],[25],[30]}

13.62%

^{[23],[24],[25],[30]}

13.62%

^{[23],[24],[25],[30]}

$ 23,975

^{[16],[20],[26],[28]}

$ 23,975

^{[23],[24],[27],[30]}

23,347

^{[16],[20],[28]}

23,310

^{[23],[24],[30]}

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

$ 23,519

^{[16],[20],[28]}

$ 23,328

^{[23],[24],[30]}

5.75%

^[16],[20]

5.75%

^[16],[20]

5.75%

^[16],[20]

5.75%

^[23],[24]

5.75%

^[23],[24]

5.75%

^[23],[24]

11.36%

^{[16],[19],[20]}

11.36%

^{[16],[19],[20]}

11.36%

^{[16],[19],[20]}

11.40%

^{[23],[24],[25]}

11.40%

^{[23],[24],[25]}

11.40%

^{[23],[24],[25]}

$ 43,931

^{[16],[20],[26]}

$ 44,550

^{[23],[24],[27]}

42,440

^[16],[20]

42,918

^[23],[24]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

$ 35,145

^[16],[20]

$ 35,046

^[23],[24]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

12.06%

^{[16],[19],[20]}

12.06%

^{[16],[19],[20]}

12.06%

^{[16],[19],[20]}

11.92%

^{[23],[24],[25]}

11.92%

^{[23],[24],[25]}

11.92%

^{[23],[24],[25]}

$ 40,587

^{[16],[20],[26]}

$ 40,587

^{[23],[24],[27]}

39,991

^[16],[20]

39,935

^[23],[24]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

$ 38,963

^[16],[20]

$ 38,963

^[23],[24]

10.75%

^[16],[32]

10.75%

^[16],[32]

10.75%

^[16],[32]

10.75%

^[23],[24]

10.75%

^[23],[24]

10.75%

^[23],[24]

^[23],[24]

16.06%

$ 1,001

^{[16],[26],[32]}

$ 26,613

^{[23],[24],[27]}

983

^[16],[32]

26,492

^[23],[24]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

$ 793

^[16],[32]

$ 24,484

^[23],[24]

10.75%

^{[16],[20],[32]}

10.75%

^{[16],[20],[32]}

10.75%

^{[16],[20],[32]}

10.75%

^[23],[24]

10.75%

^[23],[24]

10.75%

^[23],[24]

^[23],[24]

16.05%

$ 2,232

^{[16],[20],[26],[32]}

$ 787

^{[23],[24],[27]}

2,163

^{[16],[20],[32]}

771

^[23],[24]

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

$ 1,768

^{[16],[20],[32]}

$ 787

^[23],[24]

10.75%

^{[16],[20],[32]}

10.75%

^{[16],[20],[32]}

10.75%

^{[16],[20],[32]}

10.75%

^{[21],[23],[24]}

10.75%

^{[21],[23],[24]}

10.75%

^{[21],[23],[24]}

^{[21],[23],[24]}

16.06%

$ 839

^{[16],[20],[26],[32]}

$ 688

^{[21],[23],[24],[27]}

785

^{[16],[20],[32]}

688

^{[21],[23],[24]}

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 4

$ 664

^{[16],[20],[32]}

$ 688

^{[21],[23],[24]}

^{[16],[20],[32]}

10.75%

^{[16],[20],[26],[32]}

$ 28,010

^{[16],[20],[32]}

26,687

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

^{[16],[20],[32]}

$ 14,817

350,241

$ 0

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

$ 0

$ 147

^{[23],[24],[30]}

5.75%

^{[23],[24],[25],[30]}

11.14%

^{[23],[24],[30]}

2.75%

^{[23],[24],[27],[30]}

$ 7,179

^{[23],[24],[30]}

6,969

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

^{[23],[24],[30]}

$ 6,568

112,990

^[16],[28]

112,990

^[16],[28]

112,990

^[16],[28]

112,990

^[24],[30]

112,990

^[24],[30]

112,990

^[24],[30]

$ 300

^[16],[28]

$ 300

^[24],[30]

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

$ 0

^[16],[28]

$ 105

^[24],[30]

1,078,284

^[16]

1,078,284

^[16]

1,078,284

^[16]

1,078,284

^[24]

1,078,284

^[24]

1,078,284

^[24]

$ 113

^[16]

$ 113

^[24]

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

$ 0

^[16]

$ 0

^[24]

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(85)

^{[16],[17],[20]}

(99)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

$ (86)

^{[16],[17],[20]}

$ (86)

^{[21],[23],[24]}

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[23],[24]

7.50%

^[23],[24]

7.50%

^[23],[24]

12.97%

^{[16],[19],[20]}

12.97%

^{[16],[19],[20]}

12.97%

^{[16],[19],[20]}

12.93%

^{[23],[24],[25]}

12.93%

^{[23],[24],[25]}

12.93%

^{[23],[24],[25]}

$ 33,331

^{[16],[20],[26]}

$ 33,414

^{[23],[24],[27]}

32,585

^[16],[20]

32,539

^[23],[24]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

$ 32,577

^[16],[20]

$ 32,659

^[23],[24]

7.25%

^[20]

7.25%

^[20]

7.25%

^[20]

7.25%

^[23]

7.25%

^[23]

7.25%

^[23]

12.91%

^[19],[20]

12.91%

^[19],[20]

12.91%

^[19],[20]

12.78%

^[23],[25]

12.78%

^[23],[25]

12.78%

^[23],[25]

$ 13,939

^[20],[26]

$ 13,939

^[23],[27]

12,721

^[20]

12,661

^[23]

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

11,314

^[20]

10,094

^[23]

8,722

83,262

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

$ 8,722

$ 83,262

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

^{[21],[23],[24],[25]}

11.84%

$ 0

^{[16],[17],[20],[26]}

$ 272

^{[21],[23],[24],[27]}

(44)

^{[16],[17],[20]}

246

^{[21],[23],[24]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

$ (47)

^{[16],[17],[20]}

$ 238

^{[21],[23],[24]}

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(26)

^{[16],[17],[20]}

(47)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

$ (35)

^{[16],[17],[20]}

$ (47)

^{[21],[23],[24]}

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

11.99%

^[19],[20]

11.99%

^[19],[20]

11.99%

^[19],[20]

11.84%

^{[23],[24],[25]}

11.84%

^{[23],[24],[25]}

11.84%

^{[23],[24],[25]}

$ 38,015

^{[16],[20],[26]}

$ 16,752

^{[23],[24],[27]}

37,482

^[16],[20]

16,623

^[23],[24]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

$ 37,445

^[16],[20]

$ 16,500

^[23],[24]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

11.84%

^{[16],[19],[20]}

11.84%

^{[16],[19],[20]}

11.84%

^{[16],[19],[20]}

11.80%

^{[23],[24],[25]}

11.80%

^{[23],[24],[25]}

11.80%

^{[23],[24],[25]}

$ 16,722

^{[16],[20],[26]}

$ 38,015

^{[23],[24],[27]}

16,593

^[16],[20]

37,447

^[23],[24]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

$ 16,471

^[16],[20]

$ 37,445

^[23],[24]

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(39)

^{[16],[17],[20]}

(41)

^{[21],[23],[24]}

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

$ (199)

^{[16],[17],[20]}

$ (172)

^{[21],[23],[24]}

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.46%

^{[16],[19],[20]}

11.46%

^{[16],[19],[20]}

11.46%

^{[16],[19],[20]}

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

$ 2,729

^{[16],[20],[26]}

$ 2,736

^{[23],[24],[27]}

2,597

^[16],[20]

2,595

^[23],[24]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

$ 2,524

^[16],[20]

$ 2,558

^[23],[24]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.46%

^[19],[20]

11.46%

^[19],[20]

11.46%

^[19],[20]

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

$ 23,435

^{[16],[20],[26]}

$ 23,494

^{[23],[24],[27]}

23,091

^[16],[20]

23,128

^[23],[24]

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

$ 21,677

^[16],[20]

$ 21,967

^[23],[24]

9.50%

^[20],[28]

9.50%

^[20],[28]

9.50%

^[20],[28]

9.50%

^[23],[30]

9.50%

^[23],[30]

9.50%

^[23],[30]

15.08%

^{[19],[20],[28]}

15.08%

^{[19],[20],[28]}

15.08%

^{[19],[20],[28]}

14.95%

^{[23],[25],[30]}

14.95%

^{[23],[25],[30]}

14.95%

^{[23],[25],[30]}

$ 26,356

^{[20],[26],[28]}

$ 26,422

^{[23],[27],[30]}

24,952

^[20],[28]

24,920

^[23],[30]

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

$ 27,163

^[20],[28]

$ 27,512

^[23],[30]

^[24]

2,000,000

^[24]

$ 1,399

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

^[24]

$ 0

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[16],[20]

5.00%

^[23],[24]

5.00%

^[23],[24]

5.00%

^[23],[24]

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.61%

^{[16],[19],[20]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

10.65%

^{[23],[24],[25]}

$ 45,125

^{[16],[20],[26]}

$ 45,243

^{[23],[24],[27]}

44,652

^[16],[20]

44,717

^[23],[24]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

$ 43,771

^[16],[20]

$ 43,886

^[23],[24]

559

^[16]

559

^[16]

559

^[16]

559

^[24]

559

^[24]

559

^[24]

^[24],[27]

$ 563

^[16]

563

^[24]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

$ 268

^[16]

$ 372

^[24]

9.50%

^[16],[20]

9.50%

^[16],[20]

9.50%

^[16],[20]

8.50%

^[23],[24]

8.50%

^[23],[24]

8.50%

^[23],[24]

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

13.99%

^{[23],[24],[25]}

13.99%

^{[23],[24],[25]}

13.99%

^{[23],[24],[25]}

9.95%

$ 3,012

^{[16],[20],[26]}

$ 5,403

^{[23],[24],[27]}

2,968

^[16],[20]

5,348

^[23],[24]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

$ 2,846

^[16],[20]

$ 5,160

^[23],[24]

9.50%

^[16],[20]

9.50%

^[16],[20]

9.50%

^[16],[20]

8.50%

^{[21],[23],[24]}

8.50%

^{[21],[23],[24]}

8.50%

^{[21],[23],[24]}

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

5.00%

^{[16],[19],[20]}

13.99%

^{[21],[23],[24],[25]}

13.99%

^{[21],[23],[24],[25]}

13.99%

^{[21],[23],[24],[25]}

9.95%

$ 5,536

^{[16],[20],[26]}

$ 2,939

^{[21],[23],[24],[27]}

5,486

^[16],[20]

2,884

^{[21],[23],[24]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

$ 5,232

^[16],[20]

$ 2,745

^{[21],[23],[24]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

6.00%

^{[21],[23],[24]}

^{[21],[23],[24],[25]}

11.42%

$ 0

^{[16],[17],[20],[26]}

$ 964

^{[21],[23],[24],[27]}

(26)

^{[16],[17],[20]}

936

^{[21],[23],[24]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

$ (27)

^{[16],[17],[20]}

$ 938

^{[21],[23],[24]}

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.53%

^{[16],[19],[20]}

11.53%

^{[16],[19],[20]}

11.53%

^{[16],[19],[20]}

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

$ 2,624

^{[16],[20],[26]}

$ 20,125

^{[23],[24],[27]}

2,581

^[16],[20]

19,912

^[23],[24]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

$ 2,585

^[16],[20]

$ 19,823

^[23],[24]

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^{[16],[17],[20]}

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.53%

^[19],[20]

11.53%

^[19],[20]

11.53%

^[19],[20]

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

11.52%

^{[23],[24],[25]}

$ 11,802

^{[16],[17],[20],[26]}

$ 2,631

^{[23],[24],[27]}

11,685

^{[16],[17],[20]}

2,587

^[23],[24]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

$ 11,625

^{[16],[17],[20]}

$ 2,591

^[23],[24]

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[16],[17],[20]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

7.50%

^{[21],[23],[24]}

12.86%

^{[16],[17],[19],[20]}

12.86%

^{[16],[17],[19],[20]}

12.86%

^{[16],[17],[19],[20]}

12.83%

^{[21],[23],[24],[25]}

12.83%

^{[21],[23],[24],[25]}

12.83%

^{[21],[23],[24],[25]}

$ 8,308

^{[16],[17],[20],[26]}

$ 1,466

^{[21],[23],[24],[27]}

8,070

^{[16],[17],[20]}

1,215

^{[21],[23],[24]}

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

$ 8,308

^{[16],[17],[20]}

$ 1,282

^{[21],[23],[24]}

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[16],[20]

7.50%

^[23],[24]

7.50%

^[23],[24]

7.50%

^[23],[24]

12.89%

^{[16],[19],[20]}

12.89%

^{[16],[19],[20]}

12.89%

^{[16],[19],[20]}

12.89%

^{[23],[24],[25]}

12.89%

^{[23],[24],[25]}

12.89%

^{[23],[24],[25]}

$ 40,538

^{[16],[20],[26]}

$ 40,538

^{[23],[24],[27]}

39,910

^[16],[20]

39,873

^[23],[24]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

$ 40,944

^[16],[20]

$ 39,833

^[23],[24]

5.50%

^{[16],[17],[20]}

5.50%

^{[16],[17],[20]}

5.50%

^{[16],[17],[20]}

5.50%

^{[21],[23],[24]}

5.50%

^{[21],[23],[24]}

5.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(55)

^{[16],[17],[20]}

(28)

^{[21],[23],[24]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

$ (27)

^{[16],[17],[20]}

$ (47)

^{[21],[23],[24]}

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[23],[24]

5.50%

^[23],[24]

5.50%

^[23],[24]

10.95%

^[19],[20]

10.95%

^[19],[20]

10.95%

^[19],[20]

10.99%

^{[23],[24],[25]}

10.99%

^{[23],[24],[25]}

10.99%

^{[23],[24],[25]}

$ 21,272

^{[16],[20],[26]}

$ 13,973

^{[23],[24],[27]}

20,949

^[16],[20]

13,936

^[23],[24]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

$ 21,060

^[16],[20]

$ 13,685

^[23],[24]

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[16],[20]

5.50%

^[23],[24]

5.50%

^[23],[24]

5.50%

^[23],[24]

10.95%

^{[16],[19],[20]}

10.95%

^{[16],[19],[20]}

10.95%

^{[16],[19],[20]}

10.99%

^{[23],[24],[25]}

10.99%

^{[23],[24],[25]}

10.99%

^{[23],[24],[25]}

$ 13,937

^{[16],[20],[26]}

$ 21,328

^{[23],[24],[27]}

13,897

^[16],[20]

21,021

^[23],[24]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

$ 13,797

^[16],[20]

$ 20,888

^[23],[24]

^{[16],[17],[20]}

5.50%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

^{[16],[17],[20]}

$ 0

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

$ 8,568

^{[16],[26],[28]}

$ 8,568

^{[24],[27],[30]}

8,502

^[16],[28]

8,495

^[24],[30]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

$ 8,139

^[16],[28]

$ 8,132

^[24],[30]

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

$ 8,568

^{[16],[26],[28]}

$ 4,284

^{[24],[27],[30]}

8,502

^[16],[28]

4,247

^[24],[30]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

$ 8,139

^[16],[28]

$ 4,066

^[24],[30]

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[16],[19],[20],[28]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

11.50%

^{[23],[24],[25],[30]}

$ 4,284

^{[16],[26],[28]}

$ 8,568

^{[24],[27],[30]}

4,251

^[16],[28]

8,495

^[24],[30]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

$ 4,070

^[16],[28]

$ 8,132

^[24],[30]

8.00%

^{[16],[19],[20],[28]}

8.00%

^{[16],[19],[20],[28]}

8.00%

^{[16],[19],[20],[28]}

8.00%

^{[23],[24],[25],[30]}

8.00%

^{[23],[24],[25],[30]}

8.00%

^{[23],[24],[25],[30]}

1.75%

^[16],[28]

1.75%

^[16],[28]

1.75%

^[16],[28]

1.75%

^[24],[30]

1.75%

^[24],[30]

1.75%

^[24],[30]

$ 9,129

^{[16],[26],[28]}

$ 9,106

^{[24],[27],[30]}

8,644

^[16],[28]

8,580

^[24],[30]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

$ 8,147

^[16],[28]

$ 8,013

^[24],[30]

66,817

^[16],[28]

66,817

^[16],[28]

66,817

^[16],[28]

259,877

^[24],[30]

259,877

^[24],[30]

259,877

^[24],[30]

^{[24],[27],[30]}

$ 23

^[16],[28]

545

^[24],[30]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

$ 27

^[16],[28]

$ 78

^[24],[30]

259,877

^[16],[28]

259,877

^[16],[28]

259,877

^[16],[28]

66,817

^[24],[30]

66,817

^[24],[30]

66,817

^[24],[30]

^{[24],[27],[30]}

$ 545

^[16],[28]

^[24],[30]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

$ 65

^[16],[28]

$ 33

^[24],[30]

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(35)

^{[16],[17],[20]}

(43)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

$ (67)

^{[16],[17],[20]}

$ (76)

^{[21],[23],[24]}

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.53%

^[19],[20]

12.53%

^[19],[20]

12.53%

^[19],[20]

12.52%

^{[23],[24],[25]}

12.52%

^{[23],[24],[25]}

12.52%

^{[23],[24],[25]}

$ 46,687

^{[16],[20],[26]}

$ 5,248

^{[23],[24],[27]}

46,322

^[16],[20]

5,220

^[23],[24]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

$ 46,033

^[16],[20]

$ 5,164

^[23],[24]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.53%

^{[16],[19],[20]}

12.53%

^{[16],[19],[20]}

12.53%

^{[16],[19],[20]}

12.52%

^{[23],[24],[25]}

12.52%

^{[23],[24],[25]}

12.52%

^{[23],[24],[25]}

$ 5,248

^{[16],[20],[26]}

$ 46,687

^{[23],[24],[27]}

5,225

^[16],[20]

46,239

^[23],[24]

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

$ 5,175

^[16],[20]

$ 45,940

^[23],[24]

6.75%

^[16],[20]

6.75%

^[16],[20]

6.75%

^[16],[20]

6.75%

^[23],[24]

6.75%

^[23],[24]

6.75%

^[23],[24]

13.60%

^{[16],[19],[20]}

13.60%

^{[16],[19],[20]}

13.60%

^{[16],[19],[20]}

12.51%

^{[23],[24],[25]}

12.51%

^{[23],[24],[25]}

12.51%

^{[23],[24],[25]}

$ 49,266

^{[16],[20],[26]}

$ 54,559

^{[23],[24],[27]}

49,001

^[16],[20]

54,236

^[23],[24]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

$ 48,034

^[16],[20]

$ 53,168

^[23],[24]

6.88%

^[19],[20]

6.88%

^[19],[20]

6.88%

^[19],[20]

6.88%

^[23],[25]

6.88%

^[23],[25]

6.88%

^[23],[25]

$ 10,191

^[26]

$ 10,191

^[27]

9,846

9,831

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

$ 10,368

$ 8,743

6.88%

^{[16],[20],[28]}

6.88%

^{[16],[20],[28]}

6.88%

^{[16],[20],[28]}

6.88%

^{[23],[24],[30]}

6.88%

^{[23],[24],[30]}

6.88%

^{[23],[24],[30]}

12.33%

^{[16],[19],[20],[28]}

12.33%

^{[16],[19],[20],[28]}

12.33%

^{[16],[19],[20],[28]}

12.29%

^{[23],[24],[25],[30]}

12.29%

^{[23],[24],[25],[30]}

12.29%

^{[23],[24],[25],[30]}

2.00%

^{[16],[20],[28]}

2.00%

^{[16],[20],[28]}

2.00%

^{[16],[20],[28]}

2.00%

^{[23],[24],[30]}

2.00%

^{[23],[24],[30]}

2.00%

^{[23],[24],[30]}

$ 73,547

^{[16],[20],[26],[28]}

$ 73,362

^{[23],[24],[27],[30]}

72,724

^{[16],[20],[28]}

72,459

^{[23],[24],[30]}

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

$ 70,201

^{[16],[20],[28]}

$ 69,694

^{[23],[24],[30]}

487,870

^[28]

487,870

^[28]

487,870

^[28]

487,870

^[30]

487,870

^[30]

487,870

^[30]

$ 0

^[28]

$ 0

^[30]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

$ 1,947

^[28]

$ 903

^[30]

487,870

^[28]

487,870

^[28]

487,870

^[28]

487,870

^[30]

487,870

^[30]

487,870

^[30]

$ 0

^[28]

$ 0

^[30]

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

$ 1,947

^[28]

$ 903

^[30]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[16],[20]

8.50%

^[23],[24]

8.50%

^[23],[24]

8.50%

^[23],[24]

13.93%

^{[16],[19],[20]}

13.93%

^{[16],[19],[20]}

13.93%

^{[16],[19],[20]}

13.99%

^{[23],[24],[25]}

13.99%

^{[23],[24],[25]}

13.99%

^{[23],[24],[25]}

$ 30,339

^{[16],[20],[26]}

$ 30,339

^{[23],[24],[27]}

30,040

^[16],[20]

30,021

^[23],[24]

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

$ 30,166

^[16],[20]

$ 29,007

^[23],[24]

9.50%

^[16],[20]

9.50%

^[16],[20]

9.50%

^[16],[20]

9.50%

^[23],[24]

9.50%

^[23],[24]

9.50%

^[23],[24]

14.83%

^{[16],[19],[20]}

14.83%

^{[16],[19],[20]}

14.83%

^{[16],[19],[20]}

14.89%

^{[23],[24],[25]}

14.89%

^{[23],[24],[25]}

14.89%

^{[23],[24],[25]}

$ 64,606

^{[16],[20],[26]}

$ 64,606

^{[23],[24],[27]}

64,689

^[16],[20]

64,720

^[23],[24]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

$ 63,185

^[16],[20]

$ 63,185

^[23],[24]

^{[16],[17],[20]}

6.00%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(28)

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

^{[16],[17],[20]}

$ (23)

^[16],[20]

6.00%

^{[16],[19],[20]}

11.37%

^{[16],[20],[26]}

$ 19,995

^[16],[20]

19,695

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

^[16],[20]

$ 19,751

^{[16],[17],[20]}

6.00%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(38)

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

^{[16],[17],[20]}

$ (38)

87.50%

^{[17],[28],[37],[38]}

87.50%

^{[17],[28],[37],[38]}

87.50%

^{[17],[28],[37],[38]}

87.50%

^{[21],[30],[39],[40]}

87.50%

^{[21],[30],[39],[40]}

87.50%

^{[21],[30],[39],[40]}

$ 0

$ 0

^{[17],[28],[37],[38]}

$ 0

^{[21],[30],[39],[40]}

$ 0

^{[17],[28],[37],[38]}

$ 0

^{[21],[30],[39],[40]}

$ 0

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

0.00%

4.50%

^{[16],[17],[20],[28],[37]}

4.50%

^{[16],[17],[20],[28],[37]}

4.50%

^{[16],[17],[20],[28],[37]}

4.50%

^{[21],[24],[30],[39]}

4.50%

^{[21],[24],[30],[39]}

4.50%

^{[21],[24],[30],[39]}

4.50%

9.94%

^{[16],[17],[19],[20],[28],[37]}

9.94%

^{[16],[17],[19],[20],[28],[37]}

9.94%

^{[16],[17],[19],[20],[28],[37]}

9.76%

^{[21],[23],[24],[25],[30],[39]}

9.76%

^{[21],[23],[24],[25],[30],[39]}

9.76%

^{[21],[23],[24],[25],[30],[39]}

7.67%

$ 58,349

^{[16],[17],[20],[26],[28],[37]}

$ 58,349

^{[21],[24],[27],[30],[39]}

$ 59,049

50,621

^{[16],[17],[20],[28],[37]}

50,330

^{[21],[24],[30],[39]}

$ 50,957

^{[16],[17],[20],[28],[37]}

$ 50,017

^{[21],[24],[30],[39]}

$ 49,536

50,283

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

3.40%

4.10%

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.46%

^{[16],[19],[20]}

12.46%

^{[16],[19],[20]}

12.46%

^{[16],[19],[20]}

12.49%

^{[23],[24],[25]}

12.49%

^{[23],[24],[25]}

12.49%

^{[23],[24],[25]}

$ 9,323

^{[16],[20],[26]}

$ 9,323

^{[23],[24],[27]}

9,216

^[16],[20]

9,210

^[23],[24]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

$ 9,183

^[16],[20]

$ 9,183

^[23],[24]

10.00%

^{[16],[20],[32]}

10.00%

^{[16],[20],[32]}

10.00%

^{[16],[20],[32]}

10.00%

^[23],[24]

10.00%

^[23],[24]

10.00%

^[23],[24]

^[23],[24]

15.67%

$ 1,303

^{[16],[20],[26],[32]}

$ 25,712

^{[23],[24],[27]}

1,202

^{[16],[20],[32]}

25,615

^[23],[24]

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

$ 1,074

^{[16],[20],[32]}

$ 25,069

^[23],[24]

10.00%

^{[16],[20],[32]}

10.00%

^{[16],[20],[32]}

10.00%

^{[16],[20],[32]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

$ 31,515

^{[16],[20],[26],[32]}

$ 0

^{[21],[23],[24],[27]}

26,979

^{[16],[20],[32]}

(11)

^{[21],[23],[24]}

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

$ 25,959

^{[16],[20],[32]}

$ (69)

^{[21],[23],[24]}

12.00%

^{[16],[17],[20],[32]}

12.00%

^{[16],[17],[20],[32]}

12.00%

^{[16],[17],[20],[32]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

^{[21],[23],[24]}

15.64%

$ 233

^{[16],[17],[20],[26],[32]}

$ 1,210

^{[21],[23],[24],[27]}

233

^{[16],[17],[20],[32]}

1,193

^{[21],[23],[24]}

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

$ 233

^{[16],[17],[20],[32]}

$ 1,169

^{[21],[23],[24]}

7.75%

^{[16],[17],[20]}

7.75%

^{[16],[17],[20]}

7.75%

^{[16],[17],[20]}

7.75%

^{[21],[23],[24]}

7.75%

^{[21],[23],[24]}

7.75%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(40)

^{[16],[17],[20]}

(42)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

$ (29)

^{[16],[17],[20]}

$ (36)

^{[21],[23],[24]}

7.75%

^[16],[20]

7.75%

^[16],[20]

7.75%

^[16],[20]

7.75%

^[23],[24]

7.75%

^[23],[24]

7.75%

^[23],[24]

13.13%

^{[16],[19],[20]}

13.13%

^{[16],[19],[20]}

13.13%

^{[16],[19],[20]}

13.12%

^{[23],[24],[25]}

13.12%

^{[23],[24],[25]}

13.12%

^{[23],[24],[25]}

$ 15,231

^{[16],[20],[26]}

$ 15,231

^{[23],[24],[27]}

14,908

^[16],[20]

14,892

^[23],[24]

Investment, Identifier [Axis]: Other cash accounts

15,003

^[16],[20]

14,945

^[23],[24]

122,975

62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

$ 122,975

$ 62,277

^[23],[25]

7.75%

^[27]

$ 4,519

4,550

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

$ 3,305

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[16],[17],[20]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

7.00%

^{[21],[23],[24]}

^{[16],[17],[19],[20]}

12.35%

$ 98

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

^{[16],[17],[20]}

(53)

^{[21],[23],[24]}

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

$ 44

^{[16],[17],[20]}

$ (54)

^{[21],[23],[24]}

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

12.36%

^{[16],[19],[20]}

12.36%

^{[16],[19],[20]}

12.36%

^{[16],[19],[20]}

12.32%

^{[23],[24],[25]}

12.32%

^{[23],[24],[25]}

12.32%

^{[23],[24],[25]}

$ 10,868

^{[16],[20],[26]}

$ 10,895

^{[23],[24],[27]}

10,497

^[16],[20]

10,505

^[23],[24]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

$ 10,469

^[16],[20]

$ 10,495

^[23],[24]

100,000

^[16]

100,000

^[16]

100,000

^[16]

100,000

^[24]

100,000

^[24]

100,000

^[24]

$ 109

^[16]

$ 109

^[24]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

$ 300

^[16]

$ 248

^[24]

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(30)

^{[16],[17],[20]}

(34)

^{[21],[23],[24]}

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

$ 0

^{[16],[17],[20]}

$ (3)

^{[21],[23],[24]}

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

12.04%

^{[16],[19],[20]}

12.04%

^{[16],[19],[20]}

12.04%

^{[16],[19],[20]}

12.01%

^{[23],[24],[25]}

12.01%

^{[23],[24],[25]}

12.01%

^{[23],[24],[25]}

$ 38,308

^{[16],[20],[26]}

$ 38,414

^{[23],[24],[27]}

37,902

^[16],[20]

37,960

^[23],[24]

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

$ 38,308

^[16],[20]

$ 38,380

^[23],[24]

5.00%

^[20]

5.00%

^[20]

5.00%

^[20]

5.00%

^[23]

5.00%

^[23]

5.00%

^[23]

10.46%

^[19],[20]

10.46%

^[19],[20]

10.46%

^[19],[20]

10.42%

^[23],[25]

10.42%

^[23],[25]

10.42%

^[23],[25]

$ 9,651

^[20],[26]

$ 9,676

^[23],[27]

9,500

^[20]

9,518

^[23]

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

$ 9,630

^[20]

$ 9,551

^[23]

5.75%

^[16],[20]

5.75%

^[16],[20]

5.75%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.32%

^{[16],[19],[20]}

11.32%

^{[16],[19],[20]}

11.32%

^{[16],[19],[20]}

11.57%

^{[23],[24],[25]}

11.57%

^{[23],[24],[25]}

11.57%

^{[23],[24],[25]}

$ 22,375

^{[16],[20],[26]}

$ 22,375

^{[23],[24],[27]}

22,201

^[16],[20]

22,189

^[23],[24]

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

$ 21,928

^[16],[20]

$ 21,896

^[23],[24]

^{[16],[17],[20]}

6.00%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(134)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

^{[16],[17],[20]}

$ (133)

^[16],[20]

6.00%

^{[16],[19],[20]}

11.36%

^{[16],[20],[26]}

$ 52,639

^[16],[20]

51,606

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

^[16],[20]

$ 51,618

^{[16],[17],[20]}

6.00%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(69)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

^{[16],[17],[20]}

$ (69)

^[16]

4,531,000

^[16]

$ 4,440

Investment, Identifier [Axis]: Picard Parent, Inc., Application Software, Fixed Rate Bond

^[16]

$ 4,444

^[19],[20]

6.50%

^[26]

$ 2,300

2,122

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

$ 2,192

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[23],[24]

7.25%

^[23],[24]

7.25%

^[23],[24]

12.70%

^{[16],[19],[20]}

12.70%

^{[16],[19],[20]}

12.70%

^{[16],[19],[20]}

12.74%

^{[23],[24],[25]}

12.74%

^{[23],[24],[25]}

12.74%

^{[23],[24],[25]}

$ 36,499

^{[16],[20],[26]}

$ 36,499

^{[23],[24],[27]}

35,490

^[16],[20]

35,458

^[23],[24]

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

$ 33,397

^[16],[20]

$ 33,214

^[23],[24]

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^{[16],[17],[20]}

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

8.00%

^{[21],[23],[24]}

13.56%

^{[16],[17],[19],[20]}

13.56%

^{[16],[17],[19],[20]}

13.56%

^{[16],[17],[19],[20]}

13.45%

^{[21],[23],[24],[25]}

13.45%

^{[21],[23],[24],[25]}

13.45%

^{[21],[23],[24],[25]}

$ 3,722

^{[16],[17],[20],[26]}

$ 3,003

^{[21],[23],[24],[27]}

3,649

^{[16],[17],[20]}

2,926

^{[21],[23],[24]}

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

$ 3,540

^{[16],[17],[20]}

$ 2,801

^{[21],[23],[24]}

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[23],[24]

8.00%

^[23],[24]

8.00%

^[23],[24]

13.56%

^{[16],[19],[20]}

13.56%

^{[16],[19],[20]}

13.56%

^{[16],[19],[20]}

13.45%

^{[23],[24],[25]}

13.45%

^{[23],[24],[25]}

13.45%

^{[23],[24],[25]}

$ 67,244

^{[16],[20],[26]}

$ 67,244

^{[23],[24],[27]}

66,418

^[16],[20]

66,353

^[23],[24]

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

$ 64,689

^[16],[20]

$ 64,406

^[23],[24]

^{[16],[20],[28]}

7.25%

^{[16],[19],[20],[28]}

12.60%

^{[16],[20],[26],[28]}

$ 28,818

^{[16],[20],[28]}

28,530

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

^{[16],[20],[28]}

$ 28,530

^[23],[24]

7.25%

^{[23],[24],[25]}

12.78%

^{[23],[24],[27]}

$ 24,503

^[23],[24]

24,255

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

^[23],[24]

$ 24,081

^[23],[24]

7.25%

^{[23],[24],[25]}

12.78%

^{[23],[24],[27]}

$ 2,819

^[23],[24]

2,797

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

^[23],[24]

$ 2,771

5.50%

^{[16],[20],[28]}

5.50%

^{[16],[20],[28]}

5.50%

^{[16],[20],[28]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

5.75%

^{[23],[24],[30]}

10.96%

^{[16],[19],[20],[28]}

10.96%

^{[16],[19],[20],[28]}

10.96%

^{[16],[19],[20],[28]}

11.21%

^{[23],[24],[25],[30]}

11.21%

^{[23],[24],[25],[30]}

11.21%

^{[23],[24],[25],[30]}

£ 6,136

^{[16],[20],[26],[28]}

£ 4,626

^{[23],[24],[27],[30]}

$ 7,677

^{[16],[20],[28]}

$ 5,897

^{[23],[24],[30]}

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

$ 7,353

^{[16],[20],[28]}

$ 5,166

^{[23],[24],[30]}

64,887,669

^[16]

64,887,669

^[16]

64,887,669

^[16]

64,887,669

^[24]

64,887,669

^[24]

64,887,669

^[24]

$ 375

^[16]

$ 375

^[24]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

$ 0

^[16]

$ 0

^[24]

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[16],[17],[20]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

6.50%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(40)

^{[16],[17],[20]}

(43)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

$ (35)

^{[16],[17],[20]}

$ (47)

^{[21],[23],[24]}

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[16],[20]

6.50%

^[23],[24]

6.50%

^[23],[24]

6.50%

^[23],[24]

11.96%

^{[16],[19],[20]}

11.96%

^{[16],[19],[20]}

11.96%

^{[16],[19],[20]}

11.92%

^{[23],[24],[25]}

11.92%

^{[23],[24],[25]}

11.92%

^{[23],[24],[25]}

$ 32,329

^{[16],[20],[26]}

$ 32,329

^{[23],[24],[27]}

32,089

^[16],[20]

32,070

^[23],[24]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

$ 31,915

^[16],[20]

$ 31,779

^[23],[24]

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

13.86%

^{[16],[19],[20],[28]}

13.86%

^{[16],[19],[20],[28]}

13.86%

^{[16],[19],[20],[28]}

13.90%

^{[23],[24],[25],[30]}

13.90%

^{[23],[24],[25],[30]}

13.90%

^{[23],[24],[25],[30]}

0.50%

^{[16],[20],[28]}

0.50%

^{[16],[20],[28]}

0.50%

^{[16],[20],[28]}

0.50%

^{[23],[24],[30]}

0.50%

^{[23],[24],[30]}

0.50%

^{[23],[24],[30]}

$ 9,697

^{[16],[20],[26],[28]}

$ 36,707

^{[23],[24],[27],[30]}

9,405

^{[16],[20],[28]}

35,548

^{[23],[24],[30]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

$ 9,115

^{[16],[20],[28]}

$ 34,505

^{[23],[24],[30]}

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

8.25%

^{[23],[24],[30]}

13.86%

^{[16],[19],[20],[28]}

13.86%

^{[16],[19],[20],[28]}

13.86%

^{[16],[19],[20],[28]}

13.90%

^{[23],[24],[25],[30]}

13.90%

^{[23],[24],[25],[30]}

13.90%

^{[23],[24],[25],[30]}

0.50%

^{[16],[20],[28]}

0.50%

^{[16],[20],[28]}

0.50%

^{[16],[20],[28]}

0.50%

^{[23],[24],[30]}

0.50%

^{[23],[24],[30]}

0.50%

^{[23],[24],[30]}

$ 32,133

^{[16],[20],[26],[28]}

$ 13,504

^{[23],[24],[27],[30]}

31,203

^{[16],[20],[28]}

13,058

^{[23],[24],[30]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

$ 30,205

^{[16],[20],[28]}

$ 12,694

^{[23],[24],[30]}

204,454

^[16],[28]

204,454

^[16],[28]

204,454

^[16],[28]

204,454

^[24],[30]

204,454

^[24],[30]

204,454

^[24],[30]

$ 1,202

^[16],[28]

$ 1,202

^[24],[30]

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Chemicals, Fixed Rate Bond

$ 1,073

^[16],[28]

$ 756

^[24],[30]

^[19],[20]

4.88%

^[26]

$ 1,680

1,539

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

$ 1,573

1,037

^[16]

1,037

^[16]

1,037

^[16]

1,037

^[24]

1,037

^[24]

1,037

^[24]

$ 1,037

^[16]

$ 1,037

^[24]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

$ 1,024

^[16]

$ 951

^[24]

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^[23],[24]

8.75%

^[23],[24]

8.75%

^[23],[24]

14.20%

^{[16],[17],[19],[20]}

14.20%

^{[16],[17],[19],[20]}

14.20%

^{[16],[17],[19],[20]}

14.18%

^{[23],[24],[25]}

14.18%

^{[23],[24],[25]}

14.18%

^{[23],[24],[25]}

$ 990

^{[16],[17],[20],[26]}

$ 8,010

^{[23],[24],[27]}

954

^{[16],[17],[20]}

7,799

^[23],[24]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

$ 921

^{[16],[17],[20]}

$ 7,778

^[23],[24]

8.75%

^[16],[20]

8.75%

^[16],[20]

8.75%

^[16],[20]

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

^{[16],[19],[20]}

14.21%

$ 8,010

^{[16],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

7,807

^[16],[20]

(35)

^{[21],[23],[24]}

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

$ 7,778

^[16],[20]

$ (68)

^{[21],[23],[24]}

1,184,630

^[16]

1,184,630

^[16]

1,184,630

^[16]

1,184,630

^[24]

1,184,630

^[24]

1,184,630

^[24]

$ 40,094

^[16]

$ 40,093

^[24]

$ 36,226

^[16]

$ 36,226

^[24]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

2.40%

12.00%

^[16]

12.00%

^[16]

12.00%

^[16]

12.00%

^[24]

12.00%

^[24]

12.00%

^[24]

$ 16,355

^[16],[26]

$ 15,874

^[24],[27]

14,634

^[16]

14,100

^[24]

$ 16,355

^[16]

$ 15,874

^[24]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

1.10%

12.00%

^[16],[17]

12.00%

^[16],[17]

12.00%

^[16],[17]

12.00%

^[21],[24]

12.00%

^[21],[24]

12.00%

^[21],[24]

$ 3,005

^{[16],[17],[26]}

$ 1,359

^{[21],[24],[27]}

2,951

^[16],[17]

1,337

^[21],[24]

$ 3,005

^[16],[17]

$ 1,359

^[21],[24]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

0.20%

66,686

^[16]

66,686

^[16]

66,686

^[16]

66,686

^[24]

66,686

^[24]

66,686

^[24]

$ 0

^[16]

$ 0

^[24]

$ 0

^[16]

$ 0

^[24]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

0.00%

4.75%

^[16],[20]

4.75%

^[16],[20]

4.75%

^[16],[20]

4.75%

^[23],[24]

4.75%

^[23],[24]

4.75%

^[23],[24]

10.39%

^{[16],[19],[20]}

10.39%

^{[16],[19],[20]}

10.39%

^{[16],[19],[20]}

10.38%

^{[23],[24],[25]}

10.38%

^{[23],[24],[25]}

10.38%

^{[23],[24],[25]}

$ 4,440

^{[16],[20],[26]}

$ 4,452

^{[23],[24],[27]}

3,833

^[16],[20]

3,806

^[23],[24]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

$ 4,307

^[16],[20]

$ 4,184

^[23],[24]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[23],[24]

8.00%

^[23],[24]

8.00%

^[23],[24]

13.64%

^{[16],[19],[20]}

13.64%

^{[16],[19],[20]}

13.64%

^{[16],[19],[20]}

13.63%

^{[23],[24],[25]}

13.63%

^{[23],[24],[25]}

13.63%

^{[23],[24],[25]}

$ 12,034

^{[16],[20],[26]}

$ 12,034

^{[23],[24],[27]}

11,280

^[16],[20]

11,250

^[23],[24]

Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, Fixed Rate Bond

$ 10,169

^[16],[20]

$ 9,928

^[23],[24]

^[19],[20]

8.75%

^[26]

$ 1,590

1,531

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

$ 1,592

6.75%

^{[16],[20],[32]}

6.75%

^{[16],[20],[32]}

6.75%

^{[16],[20],[32]}

6.75%

^[23],[24]

6.75%

^[23],[24]

6.75%

^[23],[24]

^{[23],[24],[25]}

12.40%

$ 25,462

^{[16],[20],[26],[32]}

$ 25,527

^{[23],[24],[27]}

23,085

^{[16],[20],[32]}

23,859

^[23],[24]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

$ 14,131

^{[16],[20],[32]}

$ 19,954

^[23],[24]

10.00%

^{[16],[17],[20]}

10.00%

^{[16],[17],[20]}

10.00%

^{[16],[17],[20]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

10.00%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

(87)

^{[16],[17],[20]}

(95)

^{[21],[23],[24]}

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

$ (85)

^{[16],[17],[20]}

$ (93)

^{[21],[23],[24]}

10.00%

^[16],[20]

10.00%

^[16],[20]

10.00%

^[16],[20]

10.00%

^[23],[24]

10.00%

^[23],[24]

10.00%

^[23],[24]

15.36%

^{[16],[19],[20]}

15.36%

^{[16],[19],[20]}

15.36%

^{[16],[19],[20]}

15.24%

^{[23],[24],[25]}

15.24%

^{[23],[24],[25]}

15.24%

^{[23],[24],[25]}

$ 25,418

^{[16],[20],[26]}

$ 25,558

^{[23],[24],[27]}

24,707

^[16],[20]

24,777

^[23],[24]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

$ 24,719

^[16],[20]

$ 24,791

^[23],[24]

991,019

^[16]

991,019

^[16]

991,019

^[16]

991,019

^[24]

991,019

^[24]

991,019

^[24]

$ 327

^[16]

$ 327

^[24]

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

$ 1,536

^[16]

$ 1,625

^[24]

9,307

^[28]

9,307

^[28]

9,307

^[28]

9,307

^[30]

9,307

^[30]

9,307

^[30]

$ 78

^[28]

$ 78

^[30]

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

$ 19

^[28]

$ 13

^[30]

87.50%

^{[17],[28],[36],[37],[38]}

87.50%

^{[17],[28],[36],[37],[38]}

87.50%

^{[17],[28],[36],[37],[38]}

87.50%

^{[21],[30],[39],[40],[41]}

87.50%

^{[21],[30],[39],[40],[41]}

87.50%

^{[21],[30],[39],[40],[41]}

$ 0

$ 54,791

^{[17],[28],[36],[37],[38]}

$ 54,791

^{[21],[30],[39],[40],[41]}

$ 29,587

^{[17],[28],[36],[37],[38]}

$ 28,878

^{[21],[30],[39],[40],[41]}

$ 24,108

20,715

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

2.00%

7.00%

^{[16],[17],[20],[28],[37]}

7.00%

^{[16],[17],[20],[28],[37]}

7.00%

^{[16],[17],[20],[28],[37]}

7.00%

^{[21],[24],[30],[39]}

7.00%

^{[21],[24],[30],[39]}

7.00%

^{[21],[24],[30],[39]}

7.00%

12.44%

^{[16],[17],[19],[20],[28],[37]}

12.44%

^{[16],[17],[19],[20],[28],[37]}

12.44%

^{[16],[17],[19],[20],[28],[37]}

12.26%

^{[21],[23],[24],[25],[30],[39]}

12.26%

^{[21],[23],[24],[25],[30],[39]}

12.26%

^{[21],[23],[24],[25],[30],[39]}

10.17%

$ 112,656

^{[16],[17],[20],[26],[28],[37]}

$ 112,656

^{[21],[24],[27],[30],[39]}

$ 112,656

112,656

^{[16],[17],[20],[28],[37]}

112,656

^{[21],[24],[30],[39]}

$ 112,656

^{[16],[17],[20],[28],[37]}

$ 112,656

^{[21],[24],[30],[39]}

$ 112,656

$ 96,250

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

7.50%

9.40%

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[23],[24],[30]}

7.88%

^{[23],[24],[30]}

7.88%

^{[23],[24],[30]}

^{[23],[24],[25],[30]}

12.88%

$ 0

^{[16],[17],[20],[26],[28]}

$ 7,191

^{[23],[24],[27],[30]}

^{[16],[17],[20],[28]}

6,934

^{[23],[24],[30]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

$ 0

^{[16],[17],[20],[28]}

$ 6,937

^{[23],[24],[30]}

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[16],[17],[20],[28]}

7.88%

^{[23],[24],[30]}

7.88%

^{[23],[24],[30]}

7.88%

^{[23],[24],[30]}

^{[23],[24],[25],[30]}

12.88%

$ 0

^{[16],[17],[20],[26],[28]}

$ 2,697

^{[23],[24],[27],[30]}

^{[16],[17],[20],[28]}

2,601

^{[23],[24],[30]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

$ 0

^{[16],[17],[20],[28]}

$ 2,602

^{[23],[24],[30]}

7.88%

^{[16],[20],[28]}

7.88%

^{[16],[20],[28]}

7.88%

^{[16],[20],[28]}

7.88%

^{[21],[23],[24],[30]}

7.88%

^{[21],[23],[24],[30]}

7.88%

^{[21],[23],[24],[30]}

^{[16],[19],[20],[28]}

12.88%

$ 7,191

^{[16],[20],[26],[28]}

$ 0

^{[21],[23],[24],[27],[30]}

6,946

^{[16],[20],[28]}

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

$ 6,880

^{[16],[20],[28]}

$ 0

^{[21],[23],[24],[30]}

7.88%

^{[16],[20],[28]}

7.88%

^{[16],[20],[28]}

7.88%

^{[16],[20],[28]}

7.88%

^{[21],[23],[24],[30]}

7.88%

^{[21],[23],[24],[30]}

7.88%

^{[21],[23],[24],[30]}

^{[16],[19],[20],[28]}

12.88%

$ 2,697

^{[16],[20],[26],[28]}

$ 0

^{[21],[23],[24],[27],[30]}

2,605

^{[16],[20],[28]}

^{[21],[23],[24],[30]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

$ 2,580

^{[16],[20],[28]}

$ 0

^{[21],[23],[24],[30]}

58,210

^[16],[28]

58,210

^[16],[28]

58,210

^[16],[28]

58,210

^[24],[30]

58,210

^[24],[30]

58,210

^[24],[30]

$ 182

^[16],[28]

$ 182

^[24],[30]

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

$ 44

^[16],[28]

$ 87

^[24],[30]

345,452

^[16]

345,452

^[16]

345,452

^[16]

345,452

^[24]

345,452

^[24]

345,452

^[24]

$ 367

^[16]

$ 367

^[24]

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

$ 0

^[16]

$ 0

^[24]

^[23],[24]

7.50%

^{[23],[24],[25]}

13.04%

^{[23],[24],[27]}

$ 821

^[23],[24]

813

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

^[23],[24]

$ 776

66,000

^[28]

66,000

^[28]

66,000

^[28]

66,000

^[30]

66,000

^[30]

66,000

^[30]

$ 139

^[28]

$ 139

^[30]

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

$ 8

^[28]

$ 6

^[30]

5.00%

^{[16],[17],[20]}

5.00%

^{[16],[17],[20]}

5.00%

^{[16],[17],[20]}

5.00%

^{[21],[23],[24]}

5.00%

^{[21],[23],[24]}

5.00%

^{[21],[23],[24]}

^{[21],[23],[24],[25]}

10.42%

$ 0

^{[16],[17],[20],[26]}

$ 618

^{[21],[23],[24],[27]}

(40)

^{[16],[17],[20]}

576

^{[21],[23],[24]}

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

$ (19)

^{[16],[17],[20]}

$ 577

^{[21],[23],[24]}

5.25%

^[16],[20]

5.25%

^[16],[20]

5.25%

^[16],[20]

5.25%

^[23],[24]

5.25%

^[23],[24]

5.25%

^[23],[24]

10.71%

^[19],[20]

10.71%

^[19],[20]

10.71%

^[19],[20]

10.67%

^{[23],[24],[25]}

10.67%

^{[23],[24],[25]}

10.67%

^{[23],[24],[25]}

$ 4,477

^{[16],[20],[26]}

$ 4,488

^{[23],[24],[27]}

4,415

^[16],[20]

4,423

^[23],[24]

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

$ 4,438

^[16],[20]

$ 4,425

^[23],[24]

^[19],[20]

7.50%

^[26]

$ 4,700

4,162

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

$ 4,377

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.25%

^{[16],[20],[28]}

8.50%

^{[23],[24],[30]}

8.50%

^{[23],[24],[30]}

8.50%

^{[23],[24],[30]}

12.21%

^{[16],[19],[20],[28]}

12.21%

^{[16],[19],[20],[28]}

12.21%

^{[16],[19],[20],[28]}

12.32%

^{[23],[24],[25],[30]}

12.32%

^{[23],[24],[25],[30]}

12.32%

^{[23],[24],[25],[30]}

€ 23,731

^{[16],[20],[26],[28]}

€ 23,731

^{[23],[24],[27],[30]}

$ 26,702

^{[16],[20],[28]}

$ 26,772

^{[23],[24],[30]}

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

$ 26,149

^{[16],[20],[28]}

$ 24,937

^{[23],[24],[30]}

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[23],[24]

8.00%

^[23],[24]

8.00%

^[23],[24]

13.36%

^{[16],[19],[20]}

13.36%

^{[16],[19],[20]}

13.36%

^{[16],[19],[20]}

13.32%

^{[23],[24],[25]}

13.32%

^{[23],[24],[25]}

13.32%

^{[23],[24],[25]}

$ 49,395

^{[16],[20],[26]}

$ 49,520

^{[23],[24],[27]}

48,462

^[16],[20]

48,536

^[23],[24]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

$ 48,901

^[16],[20]

$ 49,148

^[23],[24]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

12.66%

^{[16],[19],[20]}

12.66%

^{[16],[19],[20]}

12.66%

^{[16],[19],[20]}

12.44%

^{[23],[24],[25],[42]}

12.44%

^{[23],[24],[25],[42]}

12.44%

^{[23],[24],[25],[42]}

$ 1,552

^{[16],[20],[26]}

$ 1,552

^{[23],[24],[27],[42]}

1,541

^[16],[20]

1,540

^{[23],[24],[42]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

$ 1,476

^[16],[20]

$ 1,478

^{[23],[24],[42]}

^{[21],[23],[24],[42]}

7.00%

^{[21],[23],[24],[25],[42]}

12.51%

^{[21],[23],[24],[27],[42]}

$ 1,099

^{[21],[23],[24],[42]}

1,062

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

^{[21],[23],[24],[42]}

$ 943

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^[16],[20]

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

12.66%

^{[16],[19],[20]}

12.66%

^{[16],[19],[20]}

12.66%

^{[16],[19],[20]}

12.51%

^{[23],[24],[25],[42]}

12.51%

^{[23],[24],[25],[42]}

12.51%

^{[23],[24],[25],[42]}

$ 2,742

^{[16],[20],[26]}

$ 32,104

^{[23],[24],[27],[42]}

2,721

^[16],[20]

31,861

^{[23],[24],[42]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

$ 2,608

^[16],[20]

$ 30,579

^{[23],[24],[42]}

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

7.00%

^{[23],[24],[42]}

14.50%

^{[16],[19],[20]}

14.50%

^{[16],[19],[20]}

14.50%

^{[16],[19],[20]}

12.51%

^{[23],[24],[25],[42]}

12.51%

^{[23],[24],[25],[42]}

12.51%

^{[23],[24],[25],[42]}

$ 3,298

^{[16],[20],[26]}

$ 2,749

^{[23],[24],[27],[42]}

3,175

^[16],[20]

2,726

^{[23],[24],[42]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

$ 3,137

^[16],[20]

$ 2,618

^{[23],[24],[42]}

^[16],[20]

7.00%

^{[16],[19],[20]}

12.66%

^{[16],[20],[26]}

$ 32,022

^[16],[20]

31,799

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

^[16],[20]

$ 30,456

^{[22],[23],[24],[25],[30]}

11.50%

^{[22],[24],[27],[30]}

$ 4,984

^{[22],[24],[30]}

4,894

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

^{[22],[24],[30]}

$ 4,785

13.00%

^{[16],[19],[20],[28]}

13.00%

^{[16],[19],[20],[28]}

13.00%

^{[16],[19],[20],[28]}

13.00%

^{[23],[24],[25],[30]}

13.00%

^{[23],[24],[25],[30]}

13.00%

^{[23],[24],[25],[30]}

$ 50,419

^{[16],[26],[28]}

$ 50,419

^{[24],[27],[30]}

49,898

^[16],[28]

49,842

^[24],[30]

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

$ 49,869

^[16],[28]

$ 49,869

^[24],[30]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[16],[20]

8.00%

^[23]

8.00%

^[23]

8.00%

^[23]

13.47%

^{[16],[19],[20]}

13.47%

^{[16],[19],[20]}

13.47%

^{[16],[19],[20]}

13.43%

^[23],[25]

13.43%

^[23],[25]

13.43%

^[23],[25]

$ 12,843

^{[16],[20],[26]}

$ 12,843

^[23],[27]

12,617

^[16],[20]

12,603

^[23]

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

$ 12,847

^[16],[20]

$ 12,464

^[23]

^{[21],[23],[24],[30]}

6.00%

^{[21],[23],[24],[27],[30]}

$ 0

^{[21],[23],[24],[30]}

(29)

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

^{[21],[23],[24],[30]}

$ (22)

^{[23],[24],[30]}

6.00%

^{[23],[24],[25],[30]}

11.42%

^{[23],[24],[27],[30]}

$ 28,826

^{[23],[24],[30]}

28,595

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

^{[23],[24],[30]}

$ 28,537

9.75%

^{[16],[17],[20]}

9.75%

^{[16],[17],[20]}

9.75%

^{[16],[17],[20]}

9.75%

^{[21],[23],[24]}

9.75%

^{[21],[23],[24]}

9.75%

^{[21],[23],[24]}

15.21%

^{[16],[17],[19],[20]}

15.21%

^{[16],[17],[19],[20]}

15.21%

^{[16],[17],[19],[20]}

15.17%

^{[21],[23],[24],[25]}

15.17%

^{[21],[23],[24],[25]}

15.17%

^{[21],[23],[24],[25]}

$ 2,119

^{[16],[17],[20],[26]}

$ 1,861

^{[21],[23],[24],[27]}

2,105

^{[16],[17],[20]}

1,845

^{[21],[23],[24]}

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

$ 2,040

^{[16],[17],[20]}

$ 1,802

^{[21],[23],[24]}

9.75%

^[16],[20]

9.75%

^[16],[20]

9.75%

^[16],[20]

9.75%

^[23],[24]

9.75%

^[23],[24]

9.75%

^[23],[24]

15.28%

^{[16],[19],[20]}

15.28%

^{[16],[19],[20]}

15.28%

^{[16],[19],[20]}

15.26%

^{[23],[24],[25]}

15.26%

^{[23],[24],[25]}

15.26%

^{[23],[24],[25]}

$ 23,363

^{[16],[20],[26]}

$ 23,423

^{[23],[24],[27]}

23,174

^[16],[20]

23,207

^[23],[24]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

$ 22,545

^[16],[20]

$ 22,814

^[23],[24]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.36%

^{[16],[19],[20]}

11.36%

^{[16],[19],[20]}

11.36%

^{[16],[19],[20]}

11.32%

^{[23],[24],[25]}

11.32%

^{[23],[24],[25]}

11.32%

^{[23],[24],[25]}

$ 19,894

^{[16],[20],[26]}

$ 19,947

^{[23],[24],[27]}

19,014

^[16],[20]

19,013

^[23],[24]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

$ 19,211

^[16],[20]

$ 19,199

^[23],[24]

^{[23],[24],[33]}

7.30%

^{[23],[24],[27],[33]}

$ 19,163

^{[23],[24],[33]}

19,163

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

^{[23],[24],[33]}

18,340

^[16],[32]

10.00%

^{[16],[26],[32]}

$ 5,065

^[16],[32]

4,657

$ 4,290

^[16],[32]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

0.30%

^[16],[32]

10.00%

^{[16],[26],[32]}

$ 20,871

^[16],[32]

19,217

$ 18,723

^[16],[32]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

1.20%

^[16]

6.40%

$ 0

^[16]

$ 0

^[16]

$ 0

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

0.00%

^{[23],[24],[33]}

12.50%

^{[23],[24],[27],[33]}

$ 4,641

^{[23],[24],[33]}

4,641

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

^{[23],[24],[33]}

$ 4,170

9.00%

^{[16],[20],[32]}

9.00%

^{[16],[20],[32]}

9.00%

^{[16],[20],[32]}

7.00%

^[23],[24]

7.00%

^[23],[24]

7.00%

^[23],[24]

^[23],[24]

12.65%

$ 46,832

^{[16],[20],[26],[32]}

$ 46,832

^{[23],[24],[27]}

45,698

^{[16],[20],[32]}

45,698

^[23],[24]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

$ 28,099

^{[16],[20],[32]}

$ 37,231

^[23],[24]

358,299

^[16]

358,299

^[16]

358,299

^[16]

10,616

^[24]

10,616

^[24]

10,616

^[24]

$ 2,912

^[16]

$ 120

^[24]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

$ 0

^[16]

$ 0

^[24]

10,616

^[16]

10,616

^[16]

10,616

^[16]

358,299

^[24]

358,299

^[24]

358,299

^[24]

$ 120

^[16]

$ 2,912

^[24]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

$ 0

^[16]

$ 0

^[24]

60,862

^[16]

60,862

^[16]

60,862

^[16]

60,862

^[24]

60,862

^[24]

60,862

^[24]

$ 1,207

^[16]

$ 1,207

^[24]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

$ 0

^[16]

$ 108

^[24]

32,447

^[16]

32,447

^[16]

32,447

^[16]

32,447

^[24]

32,447

^[24]

32,447

^[24]

$ 33,353

^[16],[20]

$ 33,353

^[24]

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

$ 11,131

^[16],[20]

$ 31,701

^[24]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[16],[20]

6.00%

^[23],[24]

6.00%

^[23],[24]

6.00%

^[23],[24]

11.48%

^{[16],[19],[20]}

11.48%

^{[16],[19],[20]}

11.48%

^{[16],[19],[20]}

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

11.42%

^{[23],[24],[25]}

$ 11,642

^{[16],[20],[26]}

$ 11,671

^{[23],[24],[27]}

11,618

^[16],[20]

11,646

^[23],[24]

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

$ 11,321

^[16],[20]

$ 11,363

^[23],[24]

7.71%

^[20],[28]

7.71%

^[20],[28]

7.71%

^[20],[28]

7.71%

^[23],[30]

7.71%

^[23],[30]

7.71%

^[23],[30]

13.12%

^{[19],[20],[28]}

13.12%

^{[19],[20],[28]}

13.12%

^{[19],[20],[28]}

13.06%

^{[23],[25],[30]}

13.06%

^{[23],[25],[30]}

13.06%

^{[23],[25],[30]}

$ 1,000

^{[20],[26],[28]}

$ 1,000

^{[23],[27],[30]}

818

^[20],[28]

816

^[23],[30]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

$ 930

^[20],[28]

$ 917

^[23],[30]

4.75%

^{[19],[20],[28]}

4.75%

^{[19],[20],[28]}

4.75%

^{[19],[20],[28]}

6.50%

^{[23],[25],[30]}

6.50%

^{[23],[25],[30]}

6.50%

^{[23],[25],[30]}

$ 300

^[26],[28]

$ 4,500

^[27],[30]

266

^[28]

4,115

^[30]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

$ 259

^[28]

$ 2,953

^[30]

6.50%

^{[19],[20],[28]}

6.50%

^{[19],[20],[28]}

6.50%

^{[19],[20],[28]}

4.75%

^{[23],[25],[30]}

4.75%

^{[23],[25],[30]}

4.75%

^{[23],[25],[30]}

$ 4,500

^[26],[28]

$ 300

^[27],[30]

4,129

^[28]

264

^[30]

Investment, Identifier [Axis]: Venture Global LNG, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond

$ 3,252

^[28]

$ 245

^[30]

^[19],[20]

9.50%

^[20],[26]

$ 6,620

^[20]

6,620

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

^[20]

$ 7,009

^[23],[24]

7.25%

^{[23],[24],[25]}

12.68%

^{[23],[24],[27]}

$ 1,140

^[23],[24]

927

Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[23],[24]

$ 1,139

^[16],[20]

15.00%

^{[16],[19],[20]}

21.66%

^{[16],[20],[26]}

$ 1,290

^[16],[20]

1,278

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

^[16],[20]

$ 1,203

^{[16],[17],[20]}

6.75%

^{[16],[17],[20],[26]}

$ 0

^{[16],[17],[20]}

(81)

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

^{[16],[17],[20]}

$ (82)

6.75%

^[16],[20]

6.75%

^[16],[20]

6.75%

^[16],[20]

3.75%

^[23]

3.75%

^[23]

3.75%

^[23]

12.06%

^{[16],[19],[20]}

12.06%

^{[16],[19],[20]}

12.06%

^{[16],[19],[20]}

9.27%

^[23],[25]

9.27%

^[23],[25]

9.27%

^[23],[25]

$ 29,838

^{[16],[20],[26]}

$ 11,792

^[23],[27]

29,105

^[16],[20]

11,281

^[23]

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

$ 29,092

^[16],[20]

$ 11,127

^[23]

^[23],[24]

7.00%

^{[23],[24],[25]}

12.65%

^{[23],[24],[27]}

$ 5,000

^[23],[24]

4,925

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

^[23],[24]

$ 4,263

^[16],[20]

15.00%

^{[16],[19],[20]}

21.66%

^{[16],[20],[26]}

$ 1,543

^[16],[20]

1,530

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

^[16],[20]

$ 1,439

^[23],[24]

15.00%

^{[23],[24],[25]}

21.68%

^{[23],[24],[27]}

$ 1,565

^[23],[24]

1,551

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

^[23],[24]

$ 1,464

^[23],[24]

15.00%

^{[23],[24],[25]}

21.68%

^{[23],[24],[27]}

$ 1,323

^[23],[24]

1,311

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

^[23],[24]

$ 1,237

4,871

^[16]

4,871

^[16]

4,871

^[16]

4,871

^[24]

4,871

^[24]

4,871

^[24]

$ 46

^[16]

$ 46

^[24]

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

$ 42

^[16]

$ 107

^[24]

127,452

^[16]

127,452

^[16]

127,452

^[16]

127,452

^[24]

127,452

^[24]

127,452

^[24]

$ 2,057

^[16]

$ 2,057

^[24]

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

$ 1,485

^[16]

$ 1,319

^[24]

6.25%

^[20]

6.25%

^[20]

6.25%

^[20]

6.25%

^[23]

6.25%

^[23]

6.25%

^[23]

11.71%

^[19],[20]

11.71%

^[19],[20]

11.71%

^[19],[20]

11.67%

^[23],[25]

11.67%

^[23],[25]

11.67%

^[23],[25]

$ 4,664

^[20],[26]

$ 8,983

^[23],[27]

4,526

^[20]

8,698

^[23]

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

$ 4,425

^[20]

$ 8,678

^[23]

4.00%

^[16],[20]

4.00%

^[16],[20]

4.00%

^[16],[20]

4.00%

^[23],[24]

4.00%

^[23],[24]

4.00%

^[23],[24]

9.35%

^{[16],[19],[20]}

9.35%

^{[16],[19],[20]}

9.35%

^{[16],[19],[20]}

9.32%

^{[23],[24],[25]}

9.32%

^{[23],[24],[25]}

9.32%

^{[23],[24],[25]}

$ 19,578

^{[16],[20],[26]}

$ 19,578

^{[23],[24],[27]}

19,556

^[16],[20]

19,568

^[23],[24]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

$ 19,577

^[16],[20]

$ 19,489

^[23],[24]

^{[23],[24],[30]}

7.50%

^{[23],[24],[25],[30]}

12.72%

^{[23],[24],[27],[30]}

£ 20,000

^{[23],[24],[30]}

$ 25,841

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Fixed Rate Bond

^{[23],[24],[30]}

$ 22,914

^[19],[20]

6.50%

^[26]

$ 4,960

4,379

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

$ 4,506

21,523

^[16]

21,523

^[16]

21,523

^[16]

21,523

^[24]

21,523

^[24]

21,523

^[24]

$ 20,789

^[16]

$ 20,789

^[24]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

$ 20,542

^[16]

$ 20,074

^[24]

6.75%

^{[16],[17],[20]}

6.75%

^{[16],[17],[20]}

6.75%

^{[16],[17],[20]}

6.75%

^{[21],[23],[24]}

6.75%

^{[21],[23],[24]}

6.75%

^{[21],[23],[24]}

12.10%

^[19],[20]

12.10%

^[19],[20]

12.10%

^[19],[20]

12.14%

^{[21],[23],[24],[25]}

12.14%

^{[21],[23],[24],[25]}

12.14%

^{[21],[23],[24],[25]}

$ 377

^{[16],[17],[20],[26]}

$ 377

^{[21],[23],[24],[27]}

336

^{[16],[17],[20]}

334

^{[21],[23],[24]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

$ 276

^{[16],[17],[20]}

$ 296

^{[21],[23],[24]}

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[23],[24]

7.25%

^[23],[24]

7.25%

^[23],[24]

12.62%

^{[16],[19],[20]}

12.62%

^{[16],[19],[20]}

12.62%

^{[16],[19],[20]}

12.63%

^{[23],[24],[25]}

12.63%

^{[23],[24],[25]}

12.63%

^{[23],[24],[25]}

^[23],[24]

$ 24,427

^{[16],[20],[26]}

$ 24,427

^{[23],[24],[27]}

24,151

^[16],[20]

24,135

^[23],[24]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

$ 23,531

^[16],[20]

$ 23,548

^[23],[24]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[16],[20]

7.25%

^[23],[24]

7.25%

^[23],[24]

7.25%

^[23],[24]

12.62%

^{[16],[19],[20]}

12.62%

^{[16],[19],[20]}

12.62%

^{[16],[19],[20]}

12.63%

^{[23],[24],[25]}

12.63%

^{[23],[24],[25]}

12.63%

^{[23],[24],[25]}

$ 3,636

^{[16],[20],[26]}

$ 3,636

^{[23],[24],[27]}

3,604

^[16],[20]

3,602

^[23],[24]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

$ 3,537

^[16],[20]

$ 3,574

^[23],[24]

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[16],[17],[20]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

7.25%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

^{[16],[17],[20]}

^{[21],[23],[24]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

$ 0

^{[16],[17],[20]}

$ 0

^{[21],[23],[24]}

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^[23],[24]

8.75%

^[23],[24]

8.75%

^[23],[24]

^{[23],[24],[25]}

11.75%

$ 0

^{[16],[17],[20],[26]}

$ 5,212

^{[23],[24],[27]}

^{[16],[17],[20]}

4,987

^[23],[24]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

$ 0

^{[16],[17],[20]}

$ 4,990

^[23],[24]

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^{[16],[17],[20]}

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

$ 0

^{[16],[17],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

^{[16],[17],[20]}

^{[21],[23],[24]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

$ 0

^{[16],[17],[20]}

$ 0

^{[21],[23],[24]}

8.75%

^[16],[20]

8.75%

^[16],[20]

8.75%

^[16],[20]

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

8.75%

^{[21],[23],[24]}

^{[16],[19],[20]}

11.75%

$ 5,212

^{[16],[20],[26]}

$ 0

^{[21],[23],[24],[27]}

5,001

^[16],[20]

^{[21],[23],[24]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

$ 5,043

^[16],[20]

$ 0

^{[21],[23],[24]}

53,700

^[16]

53,700

^[16]

53,700

^[16]

53,700

^[24]

53,700

^[24]

53,700

^[24]

^[26]

$ 0

175

^[16]

$ 175

^[24]

Taxable/Distributable Income and Dividend Distributions

$ 212

^[16]

$ 258

^[24]

[1]	All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
[2]	Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
[3]	Equity ownership may be held in shares or units of companies related to the portfolio companies.
[4]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
[5]	All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
[6]	Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
[7]	Equity ownership may be held in shares or units of companies related to the portfolio companies.
[8]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
[9]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[10]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[11]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[12]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[13]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[14]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[15]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
[16]	As of December 31, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[17]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[18]	This investment represents a participation interest in the underlying securities shown.
[19]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[20]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of December 31, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.36%, the 90-day SOFR at 5.35%, the 180-day SOFR at 5.18%, the PRIME at 8.50%, the SONIA at 5.19%, the 90-day EURIBOR at 3.96% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[21]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[22]	This investment represents a participation interest in the underlying securities shown.
[23]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[24]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[25]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[26]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[27]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[28]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[29]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[30]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 74.3% of the Company's total assets and non-qualifying assets represented 25.7% of the Company's total assets.
[31]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[32]	This investment was on non-accrual status as of December 31, 2023.
[33]	This investment was on non-accrual status as of September 30, 2023.
[34]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[35]	This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[36]	Income producing through payment of dividends or distributions.
[37]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[38]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[39]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[40]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[41]	Income producing through payment of dividends or distributions.
[42]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 3,018,552	$ 2,892,420
Cash and cash equivalents	112,369	136,450
Restricted cash	19,328	9,089
Other assets	2,587	1,681
Total assets	3,266,195	3,217,839
Credit facilities payable	710,000	710,000
Secured borrowings	12,965	18,106
Due to affiliate	3,815	4,310
Total liabilities	1,754,544	1,702,075
Total liabilities and net assets	3,266,195	3,217,839
Investment owned, at cost	3,187,750	3,044,119
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	325,769	322,179
Cash and cash equivalents	35,218	31,950
Restricted cash	363	2,987
Other assets	11,408	18,988
Total assets	372,758	376,104
Credit facilities payable	149,000	149,000
Secured borrowings	30,760	38,845
Notes payable at fair value	128,750	128,750
Due to affiliate	30,648	26,630
Total liabilities	339,158	343,225
Members' equity	33,600	32,879
Total liabilities and net assets	372,758	376,104
Investment owned, at cost	334,451	331,808
Net proceeds	128,750	128,750
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	124,492	123,343
Cash and cash equivalents	8,953	12,119
Restricted cash	194	184
Other assets	5,537	5,521
Total assets	139,176	141,167
Credit facilities payable	53,000	53,000
Notes payable at fair value	58,259	57,201
Due to affiliate	14,952	12,860
Total liabilities	139,176	141,167
Members' equity	0	0
Total liabilities and net assets	139,176	141,167
Investment owned, at cost	128,333	127,788
Net proceeds	$ 66,685	$ 66,685

Subsequent Events	3 Months Ended
Subsequent Events	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2023, except as discussed below. Distribution Declaration On January 26, 2024, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on March 29, 2024 to stockholders of record on March 15, 2024.

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 145,539,000

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	25,025	22,982
Net realized (gains) losses	8,453	3,203
PIK interest income	(3,849)	(6,130)
Accretion of original issue discount on investments	(5,342)	(5,127)
Accretion of original issue discount on unsecured notes payable	326	170
Amortization of deferred financing costs	1,248	828
Deferred taxes	(5)	(35)
Purchases of investments	(359,866)	(261,404)
Proceeds from the sales and repayments of investments	217,624	108,831
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable	1,533	(1,842)
(Increase) decrease in due from portfolio companies	(1,595)	16,314
(Increase) decrease in receivables from unsettled transactions	31,510	(3,966)
(Increase) decrease in due from broker	27,740	5,770
(Increase) decrease in other assets	(905)	(2,546)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	323	(554)
Increase (decrease) in base management fee and incentive fee payable	(542)	931
Increase (decrease) in due to affiliate	(494)	80
Increase (decrease) in interest payable	2,973	5,432
Increase (decrease) in payables from unsettled transactions	46,273	(6,007)
Increase (decrease) in director fees payable	160	0
Net cash provided by (used in) operating activities	1,125	(109,898)
Financing activities:
Distributions paid in cash	(46,961)	(56,746)
Borrowings under credit facilities	20,000	202,000
Repayments of borrowings under credit facilities	(20,000)	(42,000)
Shares issued under the "at the market" offering	32,398	0
Deferred offering costs paid	(85)	0
Net cash provided by (used in) financing activities	(14,648)	103,254
Effect of exchange rate changes on foreign currency	(319)	(475)
Net increase (decrease) in cash and cash equivalents and restricted cash	(13,842)	(7,119)
Cash and cash equivalents and restricted cash, beginning of period	145,539
Cash and cash equivalents and restricted cash, end of period	131,697	19,245
Supplemental information:
Cash paid for interest	27,623	14,289
Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment plan	1,936	$ 1,933
Reconciliation to the Consolidated Statements of Assets and Liabilities
Cash and cash equivalents	112,369
Restricted cash	19,328
Total cash and cash equivalents and restricted cash	$ 131,697

Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,187,750	$ 3,044,119
Investments at fair value	3,018,552	2,892,420
Debt investments, fair value	$ 2,844,067	$ 2,719,775
% of Debt Portfolio	100.00%	100.00%
Investments in debt securities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,779,477	$ 2,654,484
Investments at fair value	2,680,454	2,557,102
Investments in equity securities
Schedule of Investments [Line Items]
Investment owned, at cost	190,205	171,858
Investments at fair value	144,898	143,767
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	163,277	162,986
Investments at fair value	163,613	162,673
Equity investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	54,791	54,791
Investments at fair value	29,587	28,878
Floating rate debt securities, including the debt investments in the JVs
Schedule of Investments [Line Items]
Debt investments, fair value	$ 2,397,664	$ 2,345,205
% of Debt Portfolio	84.30%	86.23%
Fixed rate debt securities
Schedule of Investments [Line Items]
Debt investments, fair value	$ 446,403	$ 374,570
% of Debt Portfolio	15.70%	13.77%

Fee Income (Details) - USD ($) $ in Thousands	3 Months Ended
Fee Income (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Fee income	$ 1,307	$ 2,021
Recurring fee income	$ 200	$ 200

Taxable/Distributable Income and Dividend Distributions

3 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.

As of September 30, 2023, the Company had net capital loss carryforwards of $558.3 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $70.3 million are available to offset future short-term capital gains and $488.0 million are available to offset future long-term capital gains. A portion of such net capital loss carryforwards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2023 and 2022.


	Three months ended December 31, 2023		Three months ended December 31, 2022
Net increase (decrease) in net assets resulting from operations	$	10,535	$	13,172
Net unrealized (appreciation) depreciation	25,025		22,982
Book/tax difference due to capital losses suspended (utilized)	6,540		8,013
Other book/tax differences	(7,178)		(12,910)
Taxable/Distributable Income (1)	$	34,922	$	31,257

__________

The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2023, $8.2 million of the $8.2 million deferred tax assets would not more likely than not be realized in future periods.

For the three months ended December 31, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.2 million, which was composed primarily of a current income tax expense. For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit.

As of September 30, 2023, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:


Undistributed ordinary income, net	$	33,525
Net realized capital losses	(509,832)
Unrealized losses, net	(175,031)
Accumulated overdistributed earnings	$	(651,338)

The aggregate cost of investments for U.S. federal income tax purposes was $3,070.0 million as of September 30, 2023. As of September 30, 2023, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $529.5 million. As of September 30, 2023, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $704.5 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $175.0 million.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

Earnings (loss) per common share — basic and diluted:

Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

3 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Net increase (decrease) in net assets resulting from operations

$ 10,535

$ 13,172

Weighted average common shares outstanding - basic (shares)

^[1]

77,840

61,142

Weighted average common shares outstanding - diluted (shares)

^[1]

77,840

61,142

Earnings (loss) per common share - basic (dollars per share)

^[1]

$ 0.14

$ 0.22

Earnings (loss) per common share - diluted (dollars per share)

^[1]

$ 0.14

$ 0.22

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-8

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-9

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-10

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483581/946-220-45-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-7

Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B

Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Securities Act File Number

N-2 - USD ($)
$ / shares in Units, $ in Millions

3 Months Ended

Dec. 31, 2023

Sep. 30, 2023

Dec. 31, 2022

Sep. 30, 2022

Cover [Abstract]

Entity Central Index Key

0001414932

Amendment Flag

false

1-33901

Document Type

10-Q

Entity Registrant Name

Oaktree Specialty Lending Corporation

Entity Address, Address Line One

333 South Grand Avenue

Entity Address, Address Line Two

28th Floor

Entity Address, City or Town

Los Angeles

Entity Address, State or Province

Entity Address, Postal Zip Code

90071

City Area Code

213

Local Phone Number

830-6300

Entity Emerging Growth Company

false

Financial Highlights [Abstract]

Senior Securities Amount

$ 1,662.9

$ 1,514.4

General Description of Registrant [Abstract]

Investment Objectives and Practices [Text Block]

Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.

In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital and (4) public credit, where we seek discounted, high quality public debt investments particularly in times of market dislocation.

NAV Per Share

$ 19.14

^[1]

$ 19.63

^[1]

$ 20.38

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt [Table Text Block]

Syndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of December 31, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of December 31, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of each of December 31, 2023 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.621% and 5.849% for the three months ended December 31, 2023 and 2022, respectively. For the three months ended December 31, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $9.6 million and $10.0 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated.

As of December 31, 2023 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% for the three months ended December 31, 2022. For the three months ended December 31, 2022, the Company recorded interest expense (inclusive of fees) of $2.7 million related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of each of December 31, 2023 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 8.204% for the three months ended December 31, 2023. For the three months ended December 31, 2023, the Company recorded interest expense (inclusive of fees) of $6.1 million related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the

2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2025 Notes in the open market.

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2027 Notes in the open market.

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus 1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

2029 Notes

On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes.

The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2029 Notes is paid semi-annually on February 15 and August 15, beginning February 15, 2024, at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2023, the Company did not repurchase any of the 2029 Notes in the open market.

The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture.

In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

2025 Notes [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

2025 Notes

Long Term Debt, Dividends and Covenants [Text Block]

2027 Notes [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

2027 Notes

Long Term Debt, Dividends and Covenants [Text Block]

2029 Notes [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Dividends and Covenants [Text Block]

Syndicated Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Syndicated Facility

Long Term Debt, Dividends and Covenants [Text Block]

Citibank Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Citibank Facility

OSI2 Citibank Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

OSI2 Citibank Facility

Long Term Debt, Dividends and Covenants [Text Block]

As of December 31, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations).

As of December 31, 2023, the OSI2 Citibank Facility had a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

Portfolio Investments - Narrative (Details)	3 Months Ended		12 Months Ended
Portfolio Investments - Narrative (Details)	Dec. 31, 2023 USD ($) borrower member	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) borrower	Aug. 15, 2023	Sep. 30, 2021 USD ($)	May 18, 2021	Mar. 19, 2021 member	Feb. 25, 2020
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	199.69%		190.82%
Investments at fair value	$ 3,018,552,000		$ 2,892,420,000
Number of borrowers \| borrower	146		143
Money market funds, percent of net assets	8.70%		9.60%
Cash, cash equivalents and restricted cash	$ 131,697,000	$ 19,245,000	$ 145,539,000		$ 26,364,000
Restricted cash	19,328,000		9,089,000
Net realized gains (losses)	(8,453,000)	(3,203,000)
Net unrealized appreciation (depreciation)	(25,025,000)	(22,982,000)
Credit facilities payable	710,000,000		710,000,000
Assets	3,266,195,000		3,217,839,000
Unfunded commitments	226,613,000		232,740,000
Investment owned, at cost	3,187,750,000		3,044,119,000
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	142,200,000		141,500,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 51,000,000		$ 50,000,000
Investment Owned, At Fair Value
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	199.69%		190.82%
Investments at fair value	$ 3,018,552,000		$ 2,892,420,000
Investment Owned, At Fair Value \| Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	100.00%		100.00%
Senior secured debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	172.36%		165.01%
Investments at fair value	$ 2,605,288,000		$ 2,501,385,000
Investment owned, at cost	$ 2,703,890,000		$ 2,594,640,000
Senior secured debt \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	86.31%		86.47%
Subordinated debt securities, including JV debt instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 238,779,000		$ 218,390,000
Subordinated debt securities, including JV debt instruments \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk	7.90%		7.50%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 142,200,000		$ 141,500,000
SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	112,700,000
Investment owned, at cost			112,700,000
Interest income	$ 3,600,000	2,600,000
Investment, basis spread, variable rate	7.00%
Investment, interest rate, floor	1.00%
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 29,600,000		28,900,000
Investment owned, at cost	54,800,000		54,800,000
Dividend income	1,400,000	1,100,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	51,000,000		50,000,000
Investment owned, at cost	50,600,000		50,300,000
Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	$ 1,800,000	1,600,000
Investment, basis spread, variable rate	4.50%
2025 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	3.50%							3.50%
2027 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	2.70%					2.70%
2029 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	7.10%			7.10%
The JVs
Investment Company, Nonconsolidated Subsidiary [Line Items]
Money market funds, percent of net assets	8.70%
Cash, cash equivalents and restricted cash	$ 131,700,000
Restricted cash	19,300,000
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 325,769,000		$ 322,179,000
Number of borrowers \| borrower	52		48
Restricted cash	$ 363,000		$ 2,987,000
Number of board of directors \| member	4
Number of board of directors selected by company \| member	2
Number of board of directors selected by counterparty \| member	2
Number of investment committee members selected by company \| member	1
Number of investment committee members selected by counterparty \| member	1
Investment owned, ownership percentage	87.50%		87.50%
Credit facilities payable	$ 149,000,000		$ 149,000,000
Assets	372,758,000		376,104,000
Financial support funded by company and counterparty	190,500,000		190,500,000
Financial support funded by company for investee	166,700,000		166,700,000
Unfunded commitments	13,100,000		13,100,000
Investment owned, at cost	334,451,000		331,808,000
Interest income	9,708,000	8,781,000
Investments sold		13,500,000
Proceeds from sale of investments		12,900,000
Gain (loss) on sale of investments		100,000
SLF JV I \| SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	9,800,000		9,800,000
SLF JV I \| SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	3,300,000		3,300,000
SLF JV I \| SLF JV I Facility \| Revolving Credit Facility \| Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	270,000,000
Credit facilities payable	$ 149,000,000		$ 149,000,000
SLF JV I \| SLF JV I Facility \| Revolving Credit Facility \| Line of Credit \| Until November 3, 2023 \| Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.00%
SLF JV I \| Kemper
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, ownership percentage	12.50%		12.50%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 124,492,000		$ 123,343,000
Number of borrowers \| borrower	42		38
Restricted cash	$ 194,000		$ 184,000
Number of board of directors \| member							4
Number of board of directors selected by company \| member							2
Number of board of directors selected by counterparty \| member							2
Number of investment committee members selected by company \| member							1
Number of investment committee members selected by counterparty \| member							1
Credit facilities payable	53,000,000		53,000,000
Assets	139,176,000		141,167,000
Financial support funded by company and counterparty	84,000,000		84,000,000
Financial support funded by company for investee	73,500,000		73,500,000
Investment owned, at cost	128,333,000		127,788,000
Interest income	3,798,000	$ 3,403,000
Financial commitment to investee by company and counterparty, aggregate amount	100,000,000		100,000,000
Financial commitment to investee, aggregate amount	87,500,000		87,500,000
Financial commitment to investee by counterparty, aggregate amount	12,500,000		$ 12,500,000
OCSI Glick JV LLC \| Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 51,000,000
Investment owned, ownership percentage	87.50%		12.50%
Unfunded commitments	$ 1,600,000		$ 1,600,000
Investment owned, at cost	51,000,000
Financial commitment to investee, aggregate amount	$ 8,700,000		8,700,000
OCSI Glick JV LLC \| Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value			$ 50,000,000
Investment owned, ownership percentage	87.50%		12.50%
Unfunded commitments	$ 12,400,000		$ 12,400,000
Investment owned, at cost			50,000,000
Financial commitment to investee, aggregate amount	78,800,000		78,800,000
OCSI Glick JV LLC \| Glick JV Facility \| Revolving Credit Facility \| Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	80,000,000
Credit facilities payable	$ 53,000,000		$ 53,000,000
OCSI Glick JV LLC \| Glick JV Facility \| Revolving Credit Facility \| Line of Credit \| Until November 3, 2023 \| Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate	2.00%

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net increase (decrease) in net assets resulting from operations	$ 10,535	$ 13,172
Net unrealized (appreciation) depreciation	25,025	22,982
Book/tax difference due to capital losses suspended (utilized)	6,540	8,013
Other book/tax differences	(7,178)	(12,910)
Taxable/Distributable Income	$ 34,922	$ 31,257

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (8,453)	$ (3,203)
Continental Intermodal Group LP
Schedule of Investments [Line Items]
Net realized gains (losses)	(6,800)
P&L Development LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,900)
Zephyr Bidco Limited
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,700)
Lift Brands Holdings, Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,400)
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net realized gains (losses)	4,100	4,400
Other, net
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (800)	(1,700)
Carvana Co.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,800)
ASP Unifrax Holdings Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,100)
Global Medical Response Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		$ (1,000)

Financial Highlights

3 Months Ended

Dec. 31, 2023

Financial Highlights


(Share amounts in thousands)	Three months ended December 31, 2023	Three months ended December 31, 2022 (6)
Net asset value per share at beginning of period	$19.63	$20.38
Net investment income (1)	0.57	0.63
Net unrealized appreciation (depreciation) (1)	(0.33)	(0.38)
Net realized gains (losses) (1)	(0.11)	(0.05)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	0.01
Distributions of net investment income to stockholders	(0.62)	(0.96)
Net asset value per share at end of period	$19.14	$19.63
Per share market value at beginning of period	$20.12	$18.00
Per share market value at end of period	$20.42	$20.61
Total return (2)	4.70%	19.90%
Common shares outstanding at beginning of period	77,225	61,125
Common shares outstanding at end of period	78,965	61,220
Net assets at beginning of period	$1,515,764	$1,245,563
Net assets at end of period	$1,511,651	$1,201,989
Average net assets (3)	$1,524,243	$1,241,806
Ratio of net investment income to average net assets (7)	11.50%	12.40%
Ratio of total expenses to average net assets (7)	14.39%	13.11%
Ratio of net expenses to average net assets (7)	14.00%	12.87%
Ratio of portfolio turnover to average investments at fair value	7.36%	4.24%
Weighted average outstanding debt (4)	$1,660,435	$1,441,326
Average debt per share (1)	$21.33	$23.57
Asset coverage ratio at end of period (5)	188.66%	176.31%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,662.9 million and $1,514.4 million as of December 31, 2023 and 2022, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			Interim periods are annualized.

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Policies	3 Months Ended
Significant Accounting Policies	Dec. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; •Preliminary valuations are then reviewed and discussed with management of Oaktree; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; •Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and •Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of December 31, 2023 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of December 31, 2023, there were seven investments on non-accrual status that in aggregate represented 5.9% and 4.2% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of December 31, 2023, included in restricted cash was $19.3 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $19.3 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility. As of September 30, 2023, included in restricted cash was $9.1 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Undistributed ordinary income, net		$ 33,525
Net realized capital losses		(509,832)
Unrealized losses, net		(175,031)
Accumulated overdistributed earnings	$ (689,700)	$ (651,338)

Amount of accumulated undistributed earnings (deficit).

Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Dec. 29, 2023	Dec. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)			$ 0.62	$ 0.96
Distributions to stockholders			$ 47,000	$ 56,800
Issuance of common stock under dividend reinvestment plan (shares)			98,605,000	94,879,000
Issuance of common stock under dividend reinvestment plan			$ 1,936	$ 1,933
Quarterly
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)	$ 0.55	$ 0.54
Distributions to stockholders	$ 41,700	$ 32,000
Issuance of common stock under dividend reinvestment plan (shares)	87,472,000	53,369,000
Issuance of common stock under dividend reinvestment plan	$ 1,700	$ 1,100
Special
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)	$ 0.07	$ 0.42
Distributions to stockholders	$ 5,300	$ 24,800
Issuance of common stock under dividend reinvestment plan (shares)	11,133,000	41,510,000
Issuance of common stock under dividend reinvestment plan	$ 200	$ 800

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Borrowings

3 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Borrowings

Syndicated Facility

Citibank Facility

OSI2 Citibank Facility

2025 Notes

2027 Notes

2029 Notes

The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of December 31, 2023 and September 30, 2023:


	As of December 31, 2023						As of September 30, 2023
($ in millions)	2025 Notes		2027 Notes		2029 Notes		2025 Notes		2027 Notes		2029 Notes
Principal	$	300.0	$	350.0	$	300.0	$	300.0	$	350.0	$	300.0
Unamortized financing costs	(0.9)		(2.3)		(3.4)		(1.1)		(2.5)		(3.5)
Unaccreted discount	(0.6)		(0.5)		(3.2)		(0.7)		(0.6)		(3.4)
Interest rate swap fair value adjustment	—		(30.4)		4.0		—		(40.5)		(7.0)
Net carrying value	$	298.5	$	316.8	$	297.4	$	298.2	$	306.4	$	286.1
Fair Value	$	291.2	$	315.1	$	310.4	$	286.4	$	301.8	$	290.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the three months ended December 31, 2023:


($ in millions)	2025 Notes				2027 Notes			2029 Notes
Coupon interest		$	2.6		$	2.4		$	5.3
Amortization of financing costs and discount		0.3			0.2			0.3
Effect of interest rate swap		—			4.2			1.2
Total interest expense		$	2.9		$	6.8		$	6.8
Coupon interest rate (net of effect of interest rate swaps)		3.500		%	7.455		%	8.679		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:


($ in millions)	2025 Notes				2027 Notes
Coupon interest		$	2.6		$	2.4
Amortization of financing costs and discount		0.3			0.2
Effect of interest rate swap		—			2.5
Total interest expense		$	2.9		$	5.1
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)		3.500		%	5.586		%

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I